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General Introduction  9
History 
Today, rotaviruses are recognized as the single most significant cause of severe 
gastroenteritis, malnutrition and diarrhea in young children in both developed and 
developing countries worldwide (28, 122, 203, 312). Although rotavirus can infect older 
children and adults, diarrheal disease is primarily observed in children under 2 years of age 
(122, 123, 203). Each year about 440.000 children <5 years of age die mainly in developing 
countries, because of an infection with rotavirus (313). Mortality rates in developed countries 
on the other hand are very low and illness is usually self limiting (429). 
In 1963 Adams and colleagues observed virus-like particles in intestinal tissue from mice 
infected with epizootic diarrhea of infant mice (EDIM) virus (1) (Figure 1). Ten years after 
Bishop and colleagues reported the discovery of human rotavirus and its association with 
severe endemic diarrhea in infants and young children (33). The identification of rotavirus in 
mucosa of infected children was achieved without the benefit of tissue culture technology 
and relied only on visualization by electron microscopy (EM). After this, rotavirus was also 
identified in feces by EM by several studies (32, 135, 207). Using EM, the viral particles 
observed above resembled a short-spiked wheel, which led to the name rotavirus (from the 
latin rota, meaning wheel)(136). After its discovery, it became obvious that rotavirus, was an 
important etiologic agent of diarrhea of infants and young children, causing about 35% to 
50% of the hospitalizations for severe diarrhea during the first 2 years of life (202). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Negative stain electron micrograph showing 
infectious triple-layered (double-shelled) rotavirus 
particles. Picture modified from (122). Bar, 100 nM. 
 
 
Structure, protein function and classification 
Rotaviruses comprise a genus within the family of the Reoviridae, which contains eight other 
genera (122). There are common morphologic and biochemical features that classify 
rotavirus in a separate genus; (i) the complete rotavirus particle, which is approximately 70 
nm in diameter, consists of a three-layered non-enveloped protein capsid; ii) from the outer 
layer, 60 spike-like projections extent from the surface; (iii) the virus genome consists of 11 
double-stranded RNA (dsRNA) segments and the virus can reassort these genome segments; 
(iv) within the inner shell, mature virus particles contain an RNA-dependent RNA 
polymerase and other enzymes to produce capped RNA transcripts; (v) virus replication 
occurs in the cytoplasm within distinct viral organelles called viroplasms (vi) rotavirus 
morphogenesis is unique in the way that immature double layered particles (formed in the 
cytoplasm) are translocated across the endoplasmic reticulum (ER) and transiently obtain an 
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envelope. Mature particles however are nonenveloped and are released from infected cells by 
a nonclassical vesicular transport pathway that bypasses the Golgi apparatus (198).  
 
Structure 
The complete rotavirus particle, which is approximately 70 nm in diameter, consists of a 
three-layered non-enveloped protein capsid that is composed of an outer layer, an 
intermediated layer and an inner core layer (Figure 2). The inner core contains the 11 dsRNA 
segments that code for six structural proteins (VP) that make up the virus particles and for 
six non-structural proteins (NSP) that are found in infected cells harbouring replicating 
viruses. The structural proteins are designated VP1 to 8 as originally proposed by Mason et 
al. (256). Two peptides VP5* and VP8* are formed by proteolytical cleavage of VP4 and are 
therefore not present as distinctive dsRNA segments (125). The presently accepted 
nomenclature for the non-structural proteins is NSP1 to NSP6 as proposed by Mattion et al. 
(262) (Figure 2).  
1
2
ds RNA Protein and size
3
4
5
6
7
8
9
125 →VP1
94 → VP2
88 → VP3
88 → VP4
53 → NSP1
41 → VP6
34 → NSP3
35 → NSP2
38 → VP7
28 → NSP4
26 → NSP5
12 → NSP6
Outer layer
Intermediate 
layer
Inner layer
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
10 
 
11 
 
Figure 2. Schematic presentation of the rotavirus triple layered particle and the gene coding assignment. The 11 
dsRNA segments are presented as typically obtained by polyacrylamide gel electrophoresis. Proteins encoded by the 
gene segments are shown together with their apparent molecular mass and position within the capsid structure. 
Modified from (122, 205). 
 
 
Structural proteins 
The inner core consists of the structural proteins VP1 and VP3 and is surrounded by a layer 
of VP2. These proteins have affinity for ssRNA, and play a role in the processes of RNA 
transcription and replication (Figure 3). VP1 is thought to be the viral RNA polymerase and 
functions as both the viral transcriptase and replicase (83, 315, 433). For replicase activity 
however, VP1 requires VP2 and the vital role of VP2 in replication is linked to its ability to 
bind the mRNA template for minus strand synthesis (316). In contrast to VP1, VP2 binds 
RNA nonspecifically (48, 328) and interacts with the dsRNA lining the VP2 shell (338).  
Very little is known about VP3. VP3 can bind to the N-terminus of VP2, involving a region 
of the innershell protein to which VP1 and ssRNA also bind and is required for RNA 
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replication (225, 478). VP3 also binds [α-32P] GTP, indicating that VP3 is the viral 
guanylyltransferase (237, 327) and VP3 was identified as a methyltransferase (73), indicating 
that VP3 is a multifunctional capping enzyme.  
VP6 is the major component of the mature virus particle. VP6 forms the middle shell or 
intermediate layer of the virus particle and is found in trimers, which it forms spontaneously 
in vitro (124). VP6 plays a key role in virion strucure, since it interacts with the outer capsid 
(VP4, VP7) and the inner layer (VP2) (122, 124). The fact that VP6 is extremely stable and 
contains epitopes that are conserved in many virus strains makes it the most important 
antigen used in diagnostic assays. VP6 is probably also involved in polymerase activity as 
removal of VP6 from double-layered particles results in a loss of viral polymerase activity 
(30, 372). It is however unclear whether VP6 plays a structural or functional role in this 
process. 
VP4 the product of gene segment 4, is a nonglycosilated outer capsid protein which forms 60 
homodimeric spikes that project from the surface of the virus (9, 256, 467). VP4 is also 
responsible for rotaviral hemagglutinin activity (200) and it is the protein responsible for cell 
attachment (93, 362). VP4 has been implicated as a virulence determinant in mice, calves, 
piglets, and humans (52, 277, 283, 300). VP4 is comprised of about 775 amino acids and it is 
proteolytically cleaved into two polypeptides VP5* (~60KD) and VP8* (~28KD) (125). 
Cleavage of VP4 results in an increase of viral infectivity (121, 125) and enhances 
penetration of virus into cells (81, 141, 201). Cell binding however is not dependent upon 
cleavage of VP4 (81, 121). 
For the SA11 strain, the cleavage sites have been located at two arginine residues (Arg 241 
and Arg 247), creating VP8* from the N-terminal portion, and VP5* from the C-terminal 
portion of the primary VP4 protein (241). In some cases, a third cleavage may occur at 
arginine 231 (10). 
The mechanism underlying cleavage-induced activation of infectivity is not apparent, but it 
is assumed that cleaved VP4 activates an early step of viral replication that may be triggered 
by one or both terminal regions generated by cleavage (122).  Recently it was shown that 
cleavage of VP4 confers correct conformation of the VP4 spikes, which is essential for the 
virus to enter the cell (94)  
Why the virus produces a single translate, which is subsequently cleaved is not known. It has 
been postulated that the full length VP4 is more stable upon entry into the host (291). 
However, it was shown that infectivity using cleaved virus was not significantly different 
from uncleaved virus (245). Therefore, it seems unlikely that greater stability in the external 
environment explains the need to translate VP5* and VP8* as the single peptide VP4. Ludert 
et al., showed that VP4 is already cleaved upon release from the intestinal cells and that virus 
shed into the lumen of the gastrointestinal tract of infected mice do not contain intact VP4 
(245). Therefore, a hypothesis in which an intact VP4 peptide is needed as the outer capsid is 
assembled or as the virus particles are transported intracellularly, seems more feasible. 
Another explanation may be that the individual VP5* and VP8* proteins are somehow toxic 
for the host cell. Prasad and coworkers localized the VP5* and VP8* proteins by three-
dimensional cryo-electron microscopy using neutralizing antibodies that recognize different 
epitopes of VP4 (337). It appeared that part of VP8* may interact with VP6, while VP5* 
seemed to be more externally exposed on the virus particle near the tips of the spikes (122, 
337). Hemagglutination activity has been mapped to VP8* (133). Monoclonal antibodies 
directed against VP8* more efficiently prevent binding of rhesus rotavirus to target cells than 
do antibodies against VP5* or VP7 (362). This indicates an important role for VP8* in cell 
12       Chapter 1 
binding. In contrast, monoclonal antibodies directed against VP5*, but not VP8*, prevent 
release of the fluorophore CF (6-carboxyfluorescein) from isolated pig intestinal membrane 
vesicles (364). Recent studies have shown that VP5* can permeabilize lipid membrane 
vesicles and that there are at least two domains within VP5* required for pore formation. An 
N-terminal basic domain permits VP5* to associate with membranes and an internal 
hydrophobic domain that is essential for altering membrane permeability (108, 146). These 
findings point to a prominent role for VP5* in cell penetration and membrane destabilization 
rather that cell binding.  
The glycoprotein VP7, the product of gene segment 9, is the major outer capsid protein and it 
forms trimers on the viral surface (122, 249). During morphogenesis, VP7 is directed to the 
ER by a cleavable signal peptide. As it is inserted in the membrane of the ER, VP7 is 
cotranslationally glycosylated (45, 119, 199). VP7 only contains N-linked high mannose 
oligosaccharides that are processed by trimming in the ER (9, 118, 199). VP7 does not 
contain the sequence KDEL found to confer retention for other ER proteins (122, 285). 
Instead, two hydrophobic domains that are only present in the pre-mature VP7 are thought to 
act as the signal sequence that directs VP7 to and across the ER membrane (122, 456). So 
far, two regions within VP7 (amino acids 51-61, and 61-111) are known to mediate retention 
in the ER (333, 336, 456). VP7 is processed exclusively in the ER, and rotaviruses are not 
transported to the Golgi apparatus during morphogenesis. Deletion of the two retention 
regions of VP7 however result in transport of VP7 through the Golgi and into the extra 
cellular medium (336). VP7 is resistant to proteolytic enzymes after insertion into 
membranes and remains membrane associated after high salt treatment or at alkaline pH 
(118, 199). This suggests that VP7 is not a membrane spanning protein but an integral 
membrane protein. VP7 also forms oligomer complexes with other proteins (VP4 and NSP4) 
in infected cells (249). These interactions together with the interaction of VP7 with calcium, 
appear to be important in the assembly of VP7 into the outer capsid  (115, 334, 335, 381). 
 
 
Nonstructural proteins 
The rotavirus genome codes for six nonstructural proteins (NSP1-6). The proteins are 
involved in replication (NSP1, 3, 5, 6) and morphogenesis (NSP4) and except for NSP4, 
interact with nucleic acid (Figure 3) (122). NSP1 is the least conserved of the rotavirus 
proteins. It seems to be nonessential for virus replication, although it was recognized as a 
virulence factor in mice (53), but not in piglets or rabbits (51, 80). NSP1 contains a relatively 
conserved zinc finger domain, but this domain is missing in some virus strains, showing it is 
not essential for virus replication and genome segment reassortment (304, 425). NSP2 is an 
oligomeric NTPase, is localized to viroplasms, possesses helix-destabilizing activity, and is 
possibly involved in RNA encapsidation and virulence (412). NSP3 is a sequence-specific 
RNA-binding protein that requires only four nucleotides at the 3’ end for RNA recognition 
(331). NSP3 functions similarly to the cellular poly (A)-binding protein (PABP). It binds to 
eIF4G and thereby inhibits cellular RNA translation and protein synthesis, while enhancing 
the translation of viral mRNA (325, 326, 330, 445). NSP5 is an O-glycosylated 
phosphoprotein. It self-assembles into dimers, has autokinase activity and exists in several 
phosphorylated isomers in infected cells (3, 36, 148). NSP5 interacts with NSP2 (147), and 
when co-expressed, NSP2 induces hyperphosphorylation of NSP5 (2, 332, 454). NSP6 is 
encoded in an alternative ORF on gene segment 11 of most rotaviruses and is known to 
interact with NSP5 and accumulate in viroplasms (264, 424). NSP2, NSP5, and NSP6 are 
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associated with viroplasms and co-expression of NSP2 and NSP5 is sufficient for the 
formation of viroplasms (127).  
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Figure 3. Major features of the replication cycle of rotaviruses. The different steps in the replication cycle of the 
virus are indicated by numbers. 1: attachment of the virion to the cell surface; 2: penetration and uncoating of the 
virus particle to yield double layered particle’s (DLP); 3: primary transcription of the genomic dsRNA; 4: synthesis 
of viral proteins; 5: assembly of core replication intermediates (Core-RI) and negative strand RNA synthesis; 6: 
assembly of double-layered core replication intermediates (DL-RI); 7: secondary transcription from double-layered 
RIs; 8: secondary, enhanced synthesis of viral proteins; 9: secondary, increased assembly of core RIs and negative 
strand RNA synthesis; 10: secondary, increased assembly of DL-RIs; 11: budding of DL-RIs through the membrane 
of the endoplasmic reticulum (ER), and acquisition of a transient membrane envelope; 12: loss of the membrane 
envelope and generation of mature triple-layered virions; 13 virions are released by a nonclassic vesicular transport 
mechanism that bypasses the Golgi apparatus (198). 
 
These proteins may therefore function to recruit other viral proteins into the viroplasms, or 
enhance RNA encapsidation or movement of nascent viral particles from the viroplasms to 
the ER membrane. In contrast, NSP1 and NSP3 show a diffuse cytoplasmic staining in cells 
(7, 180, 261). NSP4 is the only nonstructural protein that does not bind to RNA. The 
nonstructural protein NSP4 encoded by gene 10 is 175 amino acids in length and has been 
shown to play a key role in viral morphogenesis (11, 12, 122, 271). The primary product of 
gene 10 is a 20kD protein that is cotranslationally glycosylated to a 29kD species. 
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Oligosaccharide processing then eventually yields the mature 28kD protein (118, 199). NSP4 
is an ER glycoprotein that has been proposed as a receptor for double-layered particles 
(lacking the outer capsid proteins VP4 and VP7) and is crucial to translocate these immature 
viral particles across the endoplasmic reticulum membrane (11). During the process of 
budding, the subviral particles, assembled in the viroplasm adjacent to the ER, acquire a 
transient membrane envelope, which is lost when the two outer capsid proteins VP4 and VP7 
are assembled. The receptor role for NSP4 is further confirmed by the observation that 
double-layered particles bind to ER membranes containing only NSP4 (11, 122, 271). 
Glycosylation of NSP4 is required for removal of the transient envelope from the budding 
particles (118, 324). The topography of NSP4 in the ER membrane indicates that the 
hydrophilic carboxy terminus is projected into the cytoplasm and that the amino acid 
terminus, containing three hydrophobic domains, is responsible for maintenance in the ER 
membrane (67, 420). The carboxy terminus (amino acids 161-175) was found to be 
responsible for binding to VP6 present on nascent particles (12, 414, 415). NSP4 contains a 
VP4 binding domain between amino acids 112 and 146 (12) and forms heterooligomeric 
complexes with VP4 and VP7 (249, 334). This association however is transient and NSP4 is 
not incorporated in the mature virion (249). 
The amphipathic a-helix region is predicted to adopt an a-helical coiled-coil structure, and 
this region is thought to mediate oligomerization of the virus-binding domains into a 
homotetramer (416). Glycosylation of NSP4 is required for interaction with calnexin, but is 
not required for its binding activity to double-layered particles or for oligomerization (11, 
273, 415). 
Increasing lines of evidence show that the NSP4 protein is involved in pathogenicity of 
rotaviral infection and that it acts as a viral enterotoxin and can induce age-dependent 
diarrhea (see section mechanisms of rotavirus pathogenesis) (16, 173, 276, 374). 
Reassortment analyses showed that NSP4 might function as a virulence factor (174). 
Mutations in NSP4 have been associated with avirulence, and sequence changes correlated 
with an altered protein function (216, 479). Not all attenuated (avirulent) viruses however 
have been shown to contain mutations in NSP4 (5, 68). This is most probably caused by the 
fact that there are many mechanisms of virus attenuation, and other viral proteins (NSP1, 
NSP2, VP3, VP4, VP7) are also virulence factors (58).  
 
 
Classification 
Rotavirus can be classified serologically into seven distinct groups named A to G. This 
classification is according to antigenic groups detectable by a number of serologic tests, such 
as immunofluorescence, enzyme-linked immunosorbent assay (ELISA), and immunoelectron 
microscopy (122). The antigenic groups are mainly present on the major inner capsid protein 
VP6. Group A, B, and C rotaviruses are found in both humans and animals, whereas viruses 
in groups D, E, F, and G have been found only in animals to date (122). Group A has been 
established as the predominant group causing human rotavirus diarrheal disease and almost 
all information presented further in this thesis regards group A rotavirus. Group B seems to 
be limited to causing epidemic infection in Asia and the Indian subcontinent, whereas group 
C rotavirus causes endemic infections that frequently go unrecognized (204). Although 
coding assignments have been obtained for non-group A rotaviruses, information on these 
viruses have been hampered due to the inability to cultivate most of the non-group A viruses 
(122).  
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Within each group, rotaviruses can be further classified into serotypes defined by reactivity 
of viruses in plaque reduction neutralization assays using polyclonal or monoclonal antisera 
raised against the viral capsid proteins VP7 and VP4 (177, 263). In this way, serotype 
designation reflects the expression of neutralizing epitopes on VP4 (designated a P serotype 
because VP4 is protease sensitive) and VP7 (designated a G serotype because VP7 is a 
glycoprotein) as defined by reactivity of viruses in plaque reduction neutralizing assays 
(177). Lack of readily available typing serum or monoclonal antibodies to different VP4 
types has hindered classification of VP4 (P) serotypes. Therefore, serogroups can also be 
classified into genotypes by use of sequence analysis. Genotypes of VP4 and VP7 are 
determined by sequence or hybridization analysis, whereas serotypes are determined by 
reactivity with polyclonal or monoclonal antisera (122). For VP7, a correlation between 
genotype and serotype has been established. Such a correlation is less clear for VP4, 
although sequence variation between amino acids 84 and 180 has been suggested to be useful 
to define P-type–specific epitopes (227). An important feature of rotaviruses is that they can 
reassort (rearrange) their genes independently (176). Viruses within each group are capable 
of genetic reassortment, but reassortment does not occur among viruses in different groups 
(468). The great genetic diversity created in this way and the existence of numerous G- and P 
serotypes within group A rotaviruses, indicates that the development of a successful vaccine, 
which is usually based on neutralizing the outer capsid proteins VP4 and VP7, is therefore 
challenging. 
 
 
Binding and entry 
Rotavirus predominantly infects the mature enterocytes in the mid and upper part of the villi 
of the small intestine, which ultimately leads to diarrhea. Rotavirus binding and entry of host 
cells is thought to be a multifactorial process (240). Some animal rotavirus strains require 
sialic acid (SA, N-acetylneuraminic acid) residues on the surface of target cells for initial 
attachment (107, 356, 410). The infectivity of these rotavirus strains is greatly diminished by 
the treatment of cells with neuraminidase, and consequently, these strains are neuraminidase-
sensitive. In contrast, many animal strains and most strains isolated from humans are 
neuraminidase-resistant (79). This does not mean that these strains do not use sialic acid for 
cell attachment because sialic acid moieties that are internal in oligosaccharide structures are 
either less sensitive or not sensitive at all to neuraminidase(107). 
In their review, López and Arias proposed a model describing rotavirus-host cell interactions 
(240). For neuramidase sensitive rotavirus strains, initial binding to the cell surface is 
through a sialic acid (SA)-containing cell receptor, using the VP8 domain of VP4. This 
initial cell surface receptors containing sialic acid may be either glycolipids (gangliosides) or 
glycoproteins (107, 133, 356, 410, 472). The interaction with sialic acid probably induces a 
conformational change in VP4. This change allows the virus to subsequently interact with 
the integrin α2β1. This binding is mediated by the integrin ligand sequence DGE on VP5 
(150). Neuraminidase-resistant rotavirus strains have been hypothesized to use either a 
neuraminidase-resistant sialic acid-containing molecule (i.e. GM1) or a non-acidic sugar 
residue (i.e. galactose) for initial cell attachment or may be able to entirely bypass the 
binding to sialic acid and directly interact with integrin α2β1 (150, 167). 
After this second interaction, three more interactions are thought to take place; binding of 
VP5 and the ligand-binding domain of cell-surface heat shock cognate protein hsc70 (158, 
477), binding of VP7 (through its CNP region) and integrin αvβ3 (477), and binding of VP7 
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(via its integrin ligand sequence GRP) integrin αxβ2 (150). The order of these events 
however has not been established. The initial interactions of the virus with the cell surface 
might trigger conformational changes in VP4 to facilitate subsequent interactions of VP5 
with hsc70 and VP7 with integrins.  
Host cell binding ultimately leads to penetration and uncoating of the virus (removal of VP4 
and VP7 proteins from the virus to yield the transcriptionally active double-layered 
particles). There are several hypotheses on how rotavirus enters host cells. Virus 
internalization was previously thought to happen via direct entry or fusion (201) or through 
Ca2+-dependent endocytosis (70, 71, 363). In the latter process, the virus is internalized 
within clathrin-coated endocytic vesicles. Within these vesicles a decrease in the calcium 
concentration, solubilizes the surface proteins from the virus particle. The solubilized outer 
layer proteins then permeabilize the vesicle’s membrane to release the double-layered 
particle into the cytosol (71). A recent study however, showed that specific drugs that are 
known to impair clathrin- and caveolae-mediated endocytosis, did not affect rotavirus cell 
infection (371). Instead cholesterol and dynamin seemed to play a role in the entry of 
rotaviruses. 
The entry process was recently proposed to be mediated by lipid rafts (240). The pathway 
described as raft-dependent endocytosis is clathrin and caveolin independent (229, 240). 
Cellular lipid rafts are membrane lipid microdomains enriched in glycosphingolipids 
(gangliosides among others), cholesterol and a specific set of associated proteins. Rafts have 
been implicated in a variety of cellular functions such as apical cell-sorting of proteins, 
signal transduction, and endocytosis (240). In the rotavirus entry process, the rafts are also 
thought to serve as platforms to facilitate the efficient interaction of cell receptors with the 
virus particle (240). It however still remains ambiguous how virus particles penetrate the 
plasma membrane and how they loose the outer layer. 
 
 
Mechanisms of rotavirus pathogenesis 
Acute diarrhea caused by many viruses has been given significant attention in recent years. 
This section, in particular, describes the pathophysiological mechanisms proposed to 
underlie the intestinal fluid secretion and subsequent diarrhea caused by rotavirus. Several 
reviews have proposed the following hypotheses explaining age-dependent rotavirus diarrhea 
in young children and animals (126, 280). The watery diarrhea may be caused by i) reduction 
in total small intestinal surface area, leading to a decrease in net fluid absorption. This may 
especially have an impact at young age at the time when the absorptive capacity of the colon 
is not yet fully developed, ii) changes in the osmotic permeability of the mucosa secondary 
to destruction, and iii) changes in fluid and electrolyte secretion. All these phenomena may 
contribute to diarrhea at different times during infection. 
 
i) reduction in total small intestinal surface area, leading to a decrease in net fluid 
absorption. 
 
Histological changes during rotavirus infection 
Most knowledge of pathological changes that occur during rotavirus infections comes from 
animal studies. Most severe intestinal damage is observed in piglets, where intestinal villi 
can be completely eroded (389). Macroscopic changes in the pig intestine also include 
thinning of the intestinal wall, and microscopic changes include the conversion to a cuboidal 
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epithelium (85). In calves, infection also leads to a change in the villus epithelium from 
columnar to cuboidal, and villi become stunted and shortened (63). Histological changes in 
calves are not limited to a symptomatic response; in fact asymptomatically infected calves 
show also villus blunting (347). Compared with infections in piglets and calves, rotavirus 
infection in lambs results in less severe histopathological changes and mild clinical disease 
(151, 399). Rabbits and rats infected experimentally with rotavirus show normal intestinal 
histology, while vacuolation of enterocytes in the ileum was observed in rats (77, 171). 
Rotavirus infections have been studied most extensively in mice. The pathology of murine 
rotavirus is generally similar to that of lambs, pigs and calves, but differs in certain aspects. 
During infection, histologic changes are characterized by swollen and vacuolated enterocytes 
(306). Vacuolation of enterocytes is most prominent on the villus tip, but can occur in 
enterocytes throughout the villus. While vacuolation can also be observed in other species 
like rats, it is most extensive in mice (77, 302, 306). Vacuolation is absent in calves, lambs, 
and piglets (268, 389, 398). These differences have been attributed to the specific nature of 
the host response and not to the virus, since vacuolization is also a characteristic feature of 
heterologous infections in mice (24, 149, 251). Thus far, the origin and nature of the 
vacuoles remains ambiguous. Mice usually do not develop any symptoms when infection 
occurs beyond 2 weeks of age, and infection of adult mice occurs without disease or 
histopathological lesions (59, 130, 306, 341, 402, 453). Unlike other species, villus blunting 
is limited in mice (33, 59, 236, 389, 399, 402). 
In contrast to animal studies, there are few reports of the pathological changes in intestinal 
mucosa of infants infected with rotavirus. Studies of biopsies have revealed blunting and 
atrophy of villi, distended endoplasmic reticulum, mononuclear cell infiltration, 
mitochondrial swelling and denudation of microvilli (33, 97, 171). 
Histological changes would be expected to be associated with activation of significant 
immune responses, as is observed for bacterial toxins during for example dysentery and 
invasive diarrheal syndromes. This inflammatory component of diarrhea however, does not 
seems to occur in children and in many animal models. In mice, rotavirus infection is not 
associated with mucosal inflammation and only mild mononuclear infiltration of the lamina 
propria is seen (65, 126, 138). Moreover, diarrheal onset in animals regularly occurs during 
subclinical levels of infectious load, before alterations in cytopathology. Treatment of 
infected pigs with cytoprotective growth factors can inhibit histologic changes but fails to 
influence the occurrence of diarrhea (126). These observations suggest that there is no 
absolute correlation between histological lesions and clinical symptoms and led to the 
assumption that mucosal destruction is unlikely to play a primary role in the induction and/or 
propagation of diarrhea in animals (65, 126, 279). 
 
ii) changes in the osmotic permeability of the mucosa secondary to destruction 
 
Epithelial permeability 
Epithelial permeability is important for intestinal epithelial transport. Several studies report 
that transepithelial electrical resistance (TER) is decreased after rotavirus infection in 
enterocyte-like Caco-2 cells. Intestinal permeability to mannitol and dextran was also 
increased in these cells (112, 296). This increased paracellular permeability is possibly 
caused by a disorganization of tight junction associated proteins claudin, occludin and ZO-1 
(112, 296). The disorganization of the cytoskeleton and effects on TER are also activities 
that are attributed to NSP4, as will be discussed below (411, 465). In Ussing chamber 
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experiments, a transient increase in absorption of horseradish peroxidase (HRP) has also 
been observed ex vivo in piglets and mice after infection with rotavirus (168, 211). Intestinal 
permeability has also been investigated in young children with rotavirus diarrhea using 
polyethylene glycols (PEGs) (405). PEG absorption was significantly lower during the acute 
phase of virus infection than 3 to 5 weeks after infection. This observation was largely 
ascribed to the decreased surface area for absorption. However the relationship between the 
rates of absorption of large and small PEG molecules indeed suggested increased 
permeability especially for the small PEGs in acute disease (405). 
 
iii) changes in fluid and electrolyte secretion 
 
Effect of rotavirus infection on fluid/electrolyte transport and apical symporters 
Several reports show that rotavirus evokes in vivo a net secretion of fluid, caused by an 
attenuated uptake of sodium and secretion of chloride. When perfusing the rat intestinal 
lumen with an isotonic electrolyte solution devoid of glucose, net fluid secretion and a 
significantly decreased net sodium uptake was observed after rotavirus inoculation (370). In 
contrast, net fluid and sodium uptake was observed in control rats. At the peak of net fluid 
secretion, villus height was decreased to one third of control, whereas crypt depth was 
unaltered in infected rats. Mouse intestinal segments perfused with an isotonic electrolyte 
solution containing mannitol showed a significant secretion of fluid, sodium and chloride 
ions at 72 h post infection, when clinical signs of diarrhea in were most pronounced (306, 
401). In accordance with this finding, Lundgren et al. showed that rotavirus induced a net 
fluid secretion and increased electrolyte secretion at 48 to 60 h after infecting newborn mice 
(246).  
A mechanism that in part may explain the virus-induced attenuation of electrolyte and fluid 
absorption is an inhibition of the symporters for sodium and glucose/amino acids. Apical 
symporters in villus enterocytes transport sodium ions together with glucose or amino acids 
and numerous studies indicate that the co-transport of glucose and sodium is impaired in 
intestinal segments exposed to rotavirus. Using Ussing chambers, McClung et al. found a 
defect in glucose-stimulated sodium absorption in intestinal segments isolated from pigs with 
viral enteritis (265). In line with this, the glucose effect on intestinal net sodium and water 
flux, measured in infected piglets in vivo, was absent or considerably smaller than that seen 
in normal intestines (417). The influence of the virus infection on glucose transport has also 
been investigated in brush border membrane vesicles. Keljo et al. (212) were unable to 
demonstrate a high-affinity sodium-dependent glucose transporter in virus-infected 
intestines. In agreement with this, rotavirus infection was shown to impair intestinal brush-
border membrane Na (+)-solute co-transport activities of the Na-D-glucose symporter 
(SGLT1) in rabbits. This effect was found to be mediated by a direct inhibiting effect of 
NSP4 on SGLT1 (see also below) (162, 163). The apical membrane of enterocytes also 
harbors sodium/amino acids symporters. Na-L-alanine symport was reported to be inhibited 
in rotavirus-infected young rabbits (162), but not in infected pig intestines (348). 
A lowered activity of the brush border enzymes probably also contributes to a diminished 
absorptive capacity during rotavirus infection. The disaccharidases localized at the apical 
brush region of enterocytes are factors of importance for the absorption of glucose and other 
sugars. Several reports demonstrated that viral enteritis attenuates the activity of mucosal 
disaccharidases like sucrase, lactase, and maltase (84, 99, 172, 213, 389, 390). Decreased 
levels of disaccharidase activity have also been measured in biopsies from patients (97). 
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Decreased disaccharidase activity may be the consequence of decreased expression of these 
enzymes in infected mature enterocytes. A mechanism at work during rotavirus infection 
involves the nonstructural protein NSP3 and probably results in the reduction of mRNA 
translation through hijacking of the host cell machinery (Box1, Figure 4) (272, 326, 445). In 
Summary, the blunting of villi induced by rotavirus infection merely leads to a decrease in 
the surface area for fluid and solute uptake and probably also to the diminished absorptive 
capacity during infection. 
 
Sodium-potassium ATPase 
The sodiumpotassium pump (Na, K ATPase) situated on the basolateral membrane of 
enterocytes is essential for the electro-chemical gradient across the apical membrane. This 
gradient is largely important for the transport across the polar epithelium of the gut. Many 
studies report that the activity of Na, K ATPase is attenuated in rotavirus infected intestines 
(162, 172, 349, 389, 390). This observation may be caused by a decrease of ATPase pump 
activity but again this event, may also be explained by the blunting of the intestinal villi and 
the reduced numbers of enterocytes. The relative decrease in Na, K ATPase activity 
nevertheless is much smaller than observed, for sucrase or lactase (84, 212, 349, 390). 
 
Secretory diarrhea 
Secretory diarrhea is caused by electrogenic exit of Cl- across the apical plasma membrane of 
epithelial cells. The additional paracellular movement of Na+ and H2O leads to accumulation 
of fluid within the lumen of the gastrointestinal tract and, subsequently, diarrhea. Clinically, 
secretory diarrhea is diagnosed when fecal fluid Na+, K+, and accompanying anions are in 
isosmotic balance with plasma. In contrast in osmotic diarrhea an osmotic gap exists as 
nonabsorbed solutes within the lumen (in the colon) prevent fluid absorption. At least in 
mice, there exists no osmotic gap between luminal and plasma anion and cation 
concentrations and alternatively, electrolyte levels in the lumen exceed plasma levels, 
pointing to the presence of secretory diarrhea (401). At least two mechanisms seem to 
attribute to rotavirus induced secretory diarrhea; the viral nonsructural protein NSP4 and the 
enteric nervous system. 
 
NSP4 
As they expressed several individual rotavirus genes in cells, Ball and coworkers 
coincidentally discovered that intra-peritoneal or intra-ileal delivery of NSP4 as well as a 22 
amino acid synthetic peptide corresponding to residues (114-135), induced diarrhea in young 
mice (16). Since the diarrhea inducing effects of NSP4 were age dependent, it therefore 
mimicked the diarrhea provoked by virulent homologous rotavirus infections, although the 
time course was less prolonged. Moreover, the NSP4 114-135 peptide was shown to 
potentate chloride secretion of unstripped mouse mucosal sheets, by a calcium dependent 
signaling pathway. Interestingly, chloride secretion and induction of diarrhea were shown to 
be age and dose dependent and specific. Specificity was further demonstrated by the fact that 
substitution of lysine for tyrosine at amino acid position 131, resulted in complete 
abolishment of the diarrheal inducing effect of NSP4 114-135 (16). 
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Box 
Hijacking the host cell translation machinery. 
Viruses do not harbor functional ribosomes in their virions, successful amplification of the viral genomes thus
requires that viral mRNAs compete with cellular mRNAs for the host cell translation apparatus. Therefore,
many viruses (HIV, influenza, poliovirus, adenovirus, and herpes simplex) are known to interfere with the
host cell translational machinery, and shut off gene expression in a variety of ways (35, 223, 244, 258, 463).
In most eukaryotic mRNAs, translation initiation starts with the recruitment of the cap binding protein
complex eukaryotic initiation factor (eIF)4F, composed of factors eIF4E (cap binding protein), eIF4A, and
eIF4G (Figure 4), to the capped 5’end of the mRNA (166). The 40S ribosomal subunit, carrying eIF3 and the
ternary initiator tRNA-eIF2-GTP complex, are recruited to the 5’ end of the mRNA via interaction of eIF3
with eIF4G (166). When the 40S subunit finds a start codon in the mRNA, the large ribosomal 60S subunit
joins the complex and protein synthesis begins (166). Additionally, the polyadenosine binding protein (PABP)
interacts with eIF4G (Figure 4A) (366). In this way, circularization of the mRNA is accomplished, which may
lead to increased mRNA translation or mRNA stability (365). 
 
Figure 4 A. Model depicting the major participants that are involved in translational initiation in eukaryotic
mRNAs. Interactions of eukaryotic translation initiation factors eIF2 (2),eIF3 (3), and initiator tRNA with a
40S ribosomal subunit, eIF4E (4E), eIF4A (4A), and eIF4G (4G) with the m7G cap structure, and the
polyadenosine binding protein PABP with the polyadenosine tail in an mRNA are shown. B. Substitution of
PABP by NSP3. Eviction of PABP by viral NSP3 from the cap binding protein complex eIF4F in
rotavirusinfected cells. Interactions of eukaryotic initiation factors eIF4G (4G), eIF4A (4A), eIF4E (4E), and
eIF3 (3) are indicated. Modified from (61). 
 
The eleven double-stranded RNA segments of rotavirus are transcribed into mRNAs that possess a 5’terminal
cap structure but lack 3’terminal poly(A) tails (317). Instead, the 3’end sequences contain a tetranucleotide
motif which is conserved among different groups of rotaviruses. It was discovered that the rotavirus protein
NSP3 binds specifically to the conserved viral 3’end sequences (326). Using the two-hybrid system in yeast,
it was found that NSP3 interacts with a binding site in eIF4G that overlaps with the binding site for PABP
(Figure 4B) (326). Later it was found that eIF4G has a higher affinity for NSP3 than PABP. In this way, the
interaction between PABP and eIF4G is disrupted in rotavirus-infected cells (272, 445). The replacement of
PABP by NSP3 has two important consequences. First it achieves a circularization-mediated translational
enhancement of rotavirus mRNAs, while the NSP3-RNA complex confers stability to the viral mRNAs by
protecting them from 3’–5’exonucleases. (109). Second, eIF4F is known to modulate mRNA stability (343).
Removal of the eIF4F complex from cellular mRNA by NSP3 therefore may lead to decreased stability of the
mRNAs and a reduction in the efficiency of host mRNA translation. 
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Furthermore, pups born to dams immunized with the NSP4 peptide developed less severe 
diarrhea and with less frequency and duration, when challenged with a high dose of 
infectious rotavirus, reinforcing a major role of this peptide in the pathogenic process. The 
diarrhea inducing effects of NSP4 have subsequently also been confirmed by other groups 
(173, 276, 374). Diarrhea was observed using either group A or group C NSP4, indicating 
that the pathogenetic role of NSP4 is widespread between many rotavirus strains and groups. 
Recent studies indicate that a specific 7-kDa cleavage product of NSP4 (aa 112-175) is 
actively secreted from infected cells and that NSP4 is released from the apical side of 
infected epithelial cells via an atypical pathway that bypasses the Golgi apparatus and 
involves lipid microdomains called rafts (173, 373, 374). This suggests that NSP4 is 
extracellularly available for subsequent effects on the adjacent mucosa and provides a 
physiological basis for immunoprotection after NSP4 immunization (16, 279). 
After being secreted from infected cells, NSP4 is thought to bind to an unidentified apical 
receptor and mediate phospholipase C (PLC) dependent cell signaling by increasing 
intracellular calcium levels leading to chloride secretion in adjacent uninfected cells (16, 
114, 280, 421).  
Studies with cystic fibrosis knockout mice imply that the age-dependent diarrhea inducing 
properties of NSP4 are due to age-dependent changes in calcium mediated anion 
permeability (280). Rotavirus and NSP4 alone, induce age-dependent diarrhea and age-
dependent chloride permeability changes in these knockout mice (5, 280). 
Together these findings lead to the conclusion that NSP4 is a new type of secretory agonist, 
since other known secretagogues induce chloride secretion by activating cyclic adenosine 
monophosphate (cAMP), instead of mobilizing intracellular calcium as a second messenger. 
Moreover, NSP4 fails to cause diarrheal disease in CFTR knockout mice (280). Thus 
rotavirus-induced secretory diarrhea is not mediated by CFTR, and the molecular identity of 
the responsible channel remains to be determined. 
A secondary effect of NSP4 could also involve basolateral Ca2+-sensitive K+ conductances, 
which could facilitate transcellular Cl- secretion via cellular hyperpolarization and the 
upregulation of basolateral secondary active Cl- uptake (278). 
Besides the role of NSP4 as a viral enterotoxin, NSP4 is involved in other pathogenetic 
phenomena that occur during rotavirus replication. Intracellular Ca2+ mobilization is 
expected to affect the functioning of a variety of host cell Ca2+-sensitive processes, enzymes, 
and transporters (279). NSP4 was further found to have a direct inhibiting effect on the 
SGLT1, indicating that NSP4 inhibits water resorption (163). 
Extracellular and/or intracellular NSP4 may also contribute to diarrheal pathogenesis by 
altering the dynamics of intracellular actin distribution as NSP4 has been identified along 
microtubule-like structures, where it disrupts microtubule-mediated membrane trafficking 
from the ER to Golgi complex (465). Furthermore, administration of NSP4 was found to 
cause a reduction in the transepithelial electrical resistance (TER) and redistribution of 
Zonula occludens-1 in MDCK-1 cells (411), indicating that it can increase epithelial 
permeability as has been observed during rotavirus infection in piglets, mice and humans 
(168, 211, 405). 
An important recent finding is that crystal structure modelling predicts that the 95–137 
region of NSP4, which includes the enterotoxic domain (114–135), may form a 
homotetrameric pore (47). This region could possibly act as a Ca2+ channel in the ER, since it 
was previously found that endogenously expressed NSP4 could induce Ca2+ release from the 
ER via an non-PLC-dependent pathway in insect cells (421). The induced intracellular Ca2+ 
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mobilization provoked by intracellular NSP4 could extent the signal of extracellular NSP4 or 
itself initiate disease. 
 
The enteric nervous system 
Current evidence point to a role of the enteric nervous system (ENS) in rotavirus induced 
secretory diarrhea. The gastrointestinal ENS functions fairly independently from the central 
nervous system as suggested by both morphological and functional studies and it is estimated 
that the ENS contains about as many neurons as the spinal cord (142). The ENS is composed 
of two major nerve plexuses that are interconnected, the myenteric plexus (between the 
circular and longitudinal muscle layers) and the submucosal plexus. 
A recent study demonstrated that part of the fluid secretion induced by rotavirus in mice was 
also caused by an activation of ENS (246). Using Ussing chamber experiments Lundgren et 
al. demonstrated that tetrodotoxin (neuronal cation channel inhibitor), lidocaine (local 
anaesthetic) and mecamylamide (a nicotinic receptor blocker) could attenuate the increased 
potential difference across the epithelium observed in intestines exposed to rotavirus. 
Interestingly lidocaine was able to prevent the fecal fluid loss, when given intraperitoneally 
to mice inoculated with rotavirus (246). The authors furthermore calculated that at least two 
thirds of the fluid and electrolyte secretion caused by rotavirus could be attributed to the 
activation of the ENS. Similar levels of involvement of the ENS in fluid secretion were also 
found for many other luminal secretagogues (like bacterial enterotoxins) by these authors 
(247). 
A major question about how rotavirus can activate enteric nerves to induce fluid loss remains 
to be elucidated. For bacterial enterotoxin-evoked fluid secretion it has been proposed that 
enterotoxins via their effects on intracellular second messengers induce the release of 
amines/peptides from the endocrine cells of the intestinal epithelium. Experimental evidence 
indicates that cholera toxin causes the release of 5-hydroxytryptamine (5-HT) from 
enteroendocrine cells (247, 320). The released 5-HT activates mucosal 5-HT2 receptors or 5-
HT3 or 5-HT4 receptors present on nervous dendrites located just underneath the intestinal 
epithelium (320). This elicits neuronal VIP release, which results in both protein kinase C 
and phosphoinositol hydrolysis-dependent increases in fluid (Cl- or HCO3-) secretion as well 
as decreases in transmucosal absorption (279, 320). A similar mechanism seems also 
involved in rotavirus diarrhea, as it was recently demonstrated that 5-HT3 and VIP agonists 
were able to attenuate rotavirus-induced diarrhea. (218). This suggests that the 
neurotransmitter serotonin and VIP are involved in rotavirus disease.  NSP4 might function 
in this mechanism by affecting intracellular second messenger in endocrine cells as it 
increases the intracellular calcium concentration (247, 279). 
Other mechanisms may also explain how rotavirus activates the ENS. Normal epithelial cells 
can function as ’sensors’ for microorganisms. As part of an innate defence mechanism, cells 
release a wide range of biologically active compounds such as cytokines, prostaglandins and 
nitrous oxide when exposed to bacteria or viruses (128, 355). These compounds participate 
in the inflammatory response and result in impaired intestinal absorption and the initiation of 
a prosecretory state in the intestine (128). 
Rotavirus was shown to promote the synthesis and release of chemokines, such as interleukin 
(IL)-8 (65, 355), by intestinal epithelial cells. IL-8 is a known potent chemoattractant for 
polymorphonuclear leucocytes that enhance the inflammatory cascade and produce further 
mucosal and epithelial damage by release of reactive oxygen species. Interestingly, 
activation of the ENS by chemokines is one of the mechanisms that may explain the 
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rotavirus-induced age dependent diarrhea in mice (<15 days old), since chemokines were 
only shown to be released from epithelial cells during the first 2 weeks of life (355). 
Early studies have correlated rotavirus infection in mice with changes in vascular circulation 
and reversible cellular ischemia in the villus tips (306, 307, 402). It was proposed that 
diarrhea was likely to result from the release of a vasoactive substance from epithelial cells, 
causing villus ischemia and subsequent functional damage to enterocytes (307). It later was 
proposed that VIP and/or prostaglandins could exemplify the above suggested vasocative 
agent (279). Similar to rotavirus-induced damage, microbial organisms like cholera, also 
cause extensive structural changes in human small intestinal villi (257). A further similarity 
between cholera and rotavirus is that the duration of diarrheal illness is reduced after oral 
administration of aspirin (nonsteroidal anti-inflammatory), and elevated levels of 
prostaglandins (notably PGE2 and PGF2a) have been recorded in the plasma and stool of 
rotavirus-infected children (466) and cholera-infected adults (254). Moreover, rotavirus 
infection was shown to induce PGE2 production in infected enterocytes in vitro and was 
inhibitable by indomethacin, a COX1/2 inhibitor like aspirin (358). Therefore, there possibly 
exist similar prostaglandin-dependent cellular mechanisms that mediate the histological 
changes observed during both infections and contribute to the diarrhea.  
A clinical observation that supports the involvement of the ENS in rotavirus-induced 
diarrhea involves the enkephalinase inhibitor racedotril (acetorphan) (368). In hospitalized 
rotavirus-infected children this drug was shown to reduce the duration of diarrhea from an 
average of 48 to 24 h after admission (368). Racedotril, is used for the treatment of a variety 
of acute and chronic infectious and inflammatory diarrheas. It prevents the breakdown of 
endogenous enkephalins within the gastrointestinal mucosa, particularly those that interact 
with antisecretory (cAMP lowering) δ-receptors expressed on mucosal epithelial cells. This 
prevents elevations in cAMP levels and, therefore, cAMP dependent anion secretion.  
In some diarrheal infections intestinal motility is significantly increased. For various 
enterotoxins (like cholera toxin), experimental evidence shows that enterotoxins influence 
intestinal motility via the ENS since the motility pattern can be attenuated by lidocaine and 
by nicotinic receptor blockade ((247), and references therein). The molecular stimulator of 
motility however, is not known. 
Whether rotavirus infection affects intestinal transit time is not known. It was however 
recently reported that peristaltic activity in the distal small intestine was not altered during 
acute rotavirus infection children when compared to the convalescent period (19). 
 
 
Clinical features 
Infection with rotavirus typically occurs in infants between ages 6 months and 2 years, 
although severe infection in infants younger than 6 months and infection in neonatal 
intensive-care units are frequently observed (95, 384). Rotavirus infection results in 
responses that vary from subclinical infection to mild diarrhea to a severe and occasionally 
fatal dehydrating illness. In all age groups, the classic presentation of rotaviral infection is 
fever and vomiting for 2–3 days, followed by non-bloody diarrhoea (152).  
In an early study examining patients hospitalized with rotavirus diarrhea and patients 
hospitalized with a diarrheal illness that could not be associated with rotavirus, vomiting was 
significantly more frequently observed in rotavirus-infected patients. These patients also 
became dehydrated significantly more often than the rotavirus-negative group. (354). 
Especially when associated with vomiting, rotavirus diarrhea can lead to severe and even 
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life-threatening dehydration. Infants with repeated rotavirus infections are generally less-
severely affected than those with primary disease (444). 
Rotaviruses can produce a chronic symptomatic infection in immunodeficient children (190, 
303, 377, 461). For example, chronic diarrhea associated with prolonged shedding of 
rotavirus was described in children with primary immunodeficiency, T-cell 
immunodeficiency, or severe combined immunodeficiency (SCID). Rotaviruses also are a 
threat to patients who are immunosuppressed for bone marrow transplantation, and adult 
renal transplant recipients (319, 470). Rotaviruses do not appear to play an important role in 
diarrhea occurring in adults infected with human immunodeficiency virus (HIV) (153). 
Recent studies indicate that rotavirus infection is not confined to the intestine, but instead is 
able to leave the intestine and enters the circulatory system (40, 282, 342). Rotavirus has 
been detected in cerebral spinal fluid (188, 248, 294, 310, 474), liver and kidney (145), extra-
intestinal lymphoid tissue (54), and serum of infected children and animals (40, 431). Using 
in situ RT-PCR, rotavirus was also found in the heart (282). Further studies are needed to 
determine the significance of these findings. 
 
 
Epidemiology  
It was estimated that each year, rotavirus causes approximately 111 million episodes of 
gastroenteritis requiring only home care, 25 million clinic visits, 2 million hospitalizations, 
and 352,000–592,000 deaths (median, 440,000 deaths) in children below 5 years of age. By 
age 5, nearly every child worldwide will have had an episode of rotavirus gastroenteritis, 1 in 
5 will visit a clinic, 1 in 65 will be hospitalized, and approximately 1 in 293 will die as result 
of the infection. Children in underdeveloped countries account for 82% of rotavirus deaths 
((313), and references therein). 
The contribution of rotavirus as a cause of endemic gastrointestinal disease varies according 
to geographic distribution and characteristics of patients. In the United States, rotaviruses 
cause about 5% to 10% of all diarrheal episodes in infants and children under 5 years old, 
and account for 30% to 50% of severe diarrheal episodes (87). Several long-term (6-8 years) 
and short-term (1 year) studies in the USA, Japan, Australia, the UK and Finland 
demonstrated that rotaviruses was associated with disease in about 35-52% cases of 
hospitalized infants with diarrhea,(49, 98, 217, 231, 448). A recent study in The Netherlands 
investigated a broad range of pathogens recovered from an unselected population of patients 
who had consulted general practitioners because of gastroenteritis (101). From this study it 
was found that in children <5 years of age with gastroenteritis, rotavirus was the most 
common pathogen (21% of patients), followed by Norwalk-like virus (NLV; 15% of 
patients). In older patients (>5 years), Campylobacter species and Giardia lamblia were the 
most common pathogens (101). Rotaviruses have also been documented consistently as the 
most important etiologic agents of diarrheal illnesses in developing countries (27). In a study 
performed over a 1-year period in Bangladesh, rotaviruses were the most frequently detected 
pathogen in children under 2 years of age, as 46% of the studied group was rotavirus positive 
(34). The next most important agent was enterotoxigenic E. coli, detected in 28%. In the 
over-2-year age group, bacterial agents were recovered more frequently than rotavirus. 
Similar results were obtained in an analysis in a hospital in Cairo, Egypt, were rotavirus was 
most frequently detected, accounting for 34% of the cases. Enterotoxigenic E. coli ranked 
second (27%) (393). 
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Rotavirus infection in children is seasonal, with peak incidence in winter months in 
temperate climates. In the United Kingdom and in the USA, increasing numbers of infections 
begin in December or January, with peaks in March or April and incidence falling to almost 
zero by July (189, 206). Several studies suggest that rotavirus disease in adults do not mirror 
the winter seasonality of infection in children (92, 288). 
Among adults, endemic outbreaks of rotavirus infections seem to occur most frequently in 
communities that are more or less sheltered from routine exposure to rotavirus-infected 
children. These communities may be college communities, military bases, long-term health-
care facilities (especially those with compromised host immunity), and geriatric facilities 
((4), and references therein). Rotavirus has been implicated as an important cause of 
travellers’ diarrhea among adults, especially among those visiting Central America and the 
Caribbean (for a review see (4), and references therein). Interestingly these rotavirus-infected 
adults shed 10–100 times less rotavirus than do infected children (41, 449). 
 
 
Immunity 
The mechanisms responsible for immunity to rotavirus infections are not completely 
understood. However, animal models have been particularly useful in elucidating the role of 
antibodies and in exploring the relative importance of systemic and local immunity (299, 
367). The immunological response of the host to infection with rotavirus results in rotavirus 
antigens being transported to Peyer’s patches, undergo processing by B cells, macrophages, 
or dendritic cells and are presented to helper T cells. This cascade culminates in stimulation 
of rotavirus-specific B cell and cytotoxic T-lymphocyte-precursor expansion (298). 
Polyclonal B cell activation was induced by the rotavirus outercapsid protein VP7 (39). 
Although many physicians presume that rotavirus infection will confer lifelong immunity, 
several investigations show that (multiple) re-infection(s) can occur. (31, 444, 473). 
A symptomatic infection with rotavirus stimulates a strong humoral IgG, but protection from 
rotavirus disease is however primarily thought to be mediated by local IgA antibodies. 
Several studies demonstrated that local IgA is important or at least a good predictor of 
protection (29, 451). A recent study in which IgA knockout mice were challenged with 
murine rotavirus showed that in the absence of IgA, other compensatory antibody isotypes, 
IgG in particular, were able to mediate protection against homologous rotavirus challenge 
(305). 
VP4 and VP7 were shown to be very important in inducing neutralizing antibodies and they 
can do so independently from each other (122, 175, 204). Children infected with a particular 
serotype of rotavirus are more likely to be protected against challenge with the same serotype 
than against re-infection with a different serotype. However, heterotypic protection is 
operating, as has been demonstrated in several studies. It appears that predominantly 
homotypic immunity is induced following the first naturally occurring or vaccine-induced 
rotavirus infection (204) and this immunity is mediated by antibodies against VP7 and VP4 
(175). In both infants and animals, subsequent rotavirus infections increase antibodies that 
cross-react with multiple serotypes. (192, 204). Several other rotavirus proteins could also 
play a role in mounting a protective immune response and mediate heterotypic protection. 
VP6 is a hydrophobic protein that is highly antigenic and immunogenic and may play a role 
in inducing protective immunity and modulate protection (122). NSP4 could also be involved 
in this process as immunization with NSP4 can induce immunity that protects neonatal mice 
from disease induced by virus (16, 122). The role of cell-mediated immunity in the immune 
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response to rotavirus infection is under investigation in humans and in animal models (204). 
Following studies using adult mice infected with a selected murine rotavirus strain and SCID 
mice, it was shown that cytotoxic T-lymphocytes play a major role in resolution of primary 
rotavirus infection ((204), and references therein). It was shown that VP7 is the dominant 
target for cytotoxic T-lymphocyte (CTL) activity in mice (139, 301). 
 
 
Diagnosis, treatment, and prevention 
Initially, diagnosis of rotavirus infection was performed using electron microscopy, by the 
visualization and observation of the rotavirus wheel-like appearance (457, 469).  Nowadays, 
ELISA or EIA have become more commonly used. The commercial assays are reliable, and 
inexpensive, but require at least 104–107 virions to generate a positive result (457, 469). A 
more sensitive and newer method is PCR, which is up to 1000 times more sensitive than 
immunoassays (457). A further major limitation of most commercial assays is that they only 
detect group A rotavirus. (178, 344). 
Treatment of rotavirus infections is mainly aimed at symptom relief and restoration of 
normal physiological function. Oral rehydration is by far, the most commonly used treatment 
and oral rehydration salt solutions are extensively used in children in developing countries. If 
rotavirus infected patients become dehydrated, administration of intravenous fluids and 
hospital admission might be necessary. An additional intervention that has been used is 
administration of Lactobacillus spp bacteria that shorten the duration of diarrhea (155, 392). 
Codeine, diphenoxylate and loperamide, were reported to result in symptom relief and 
decrease in diarrheal fluid loss (111), although the latter appeared to have no significant 
effect on the course of acute gastro-enteritis in an earlier study (308). Bismuth salicylate, was 
successful in treating the symptoms of rotavirus diarrhea (400).  
As mentioned above, the enkephalinase inhibitor racedotril has successfully been used for 
the treatment of a variety of infectious and inflammatory diarrheas and was found to reduce 
the duration of diarrhea in rotavirus-infected children (368). Several studies report the oral 
administration of human serum immunoglobulins that show anti-rotavirus activity by binding 
free rotavirus antigen. This approach was able to shorten the duration of diarrhea and clear 
rotavirus antigen (154, 242). 
Although not used on a regular basis, the following agents could be useful in effective 
treatment of rotavirus-induced diarrhea. Diarrheal illness was reduced after oral aspirin, a 
non-specific COX inhibitor as elevated levels of PGE2 and PGF2 were observed in the 
plasma and stool of rotavirus-infected children (466). Furthermore, indomethacin and a 
NFκβ inhibitor have been shown to inhibit rotavirus infection in vitro (358).  
Various carbohydrates including mucins were shown to inhibit rotavirus infection in vivo 
and vitro (72, 289, 323, 440, 459, 471, 472). Mucins serve protective functions in the gut 
(438). The secretory mucin Muc2, which is the most important structural component of the 
intestinal mucus layer (426, 427, 438, 440), is secreted into the lumen and forms a protective 
mucus gel layer that acts as a selective barrier to protect the epithelium from mechanical 
stress, noxious agents, viruses, and other pathogens (116, 137, 407, 426, 438, 440). Muc2 
and other mucins contain many O-linked sialic acid moieties and are important inhibitors of 
rotavirus infection (72, 289, 323, 440, 459, 471, 472). It was suggested that intestinal mucins 
represent a barrier to rotaviruses via binding of rotavirus to sialic acid moieties thereby 
hindering virus-to-cell attachment (72, 472).  
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Prevention of rotavirus infection can be facilitated by avoiding exposures and faecal-oral 
spread. It was shown that 43% of rotavirus virions placed on human fingers survive for 1h 
(6), and rotavirus survives best in low humidity on non-porous surfaces at room temperature 
or cooler (376). Phenolic disinfectants fail to inactivate rotavirus, instead hypochlorite or 
sodium dichloroisocyanurate are effective (344). Ethanol (70%) is also effective in 
inactivation of rotavirus and can help to prevent environmental spread (318). 
Since there is a significant disease-related morbidity and mortality associated with rotavirus, 
the development of an effective vaccine is a priority. Several rotavirus vaccines candidates 
have been developed and tested (312). However, there has been variable efficacy with the 
use of some live-attenuated rotaviruses developed for oral administration and at present no 
effective rotavirus vaccine is available (18, 186). 
Up till now, a live attenuated tetravalent rhesus-human reassortant rotavirus vaccine 
(Rotashield) seemed to produce the best results and prevented about half of rotavirus 
infections, while it was in particular effective in preventing severe disease (194, 321). This 
vaccine was the first licensed rotavirus vaccine in the United States and recommended for 
routine immunization of U.S. infants in 1998. Shortly after the vaccine was approved, the use 
of Rotashield was suspended because reports suggested a possible association with 
intussusception (287). After the association was established, the recommendation for use of 
Rotashield was withdrawn and the manufacturer stopped vaccine production. Efforts are 
ongoing to develop other rotavirus vaccines, and several candidates are undergoing clinical 
testing (50). 
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Aims and outline of this thesis 
 
Our overall aim was to attain a more profound understanding of rotavirus pathogenesis. 
Chapter 2 focuses on the effect of rotavirus infection on epithelial homeostasis and 
dysfunction during rotavirus infection in neonatal mice. To get insight in the pathogenesis of 
infection, the induction of diarrheal illness, timing and extent of rotavirus replication in the 
mice small intestine are related to viral replication and alterations in mucosal structure, 
epithelial homeostasis, kinetics, and differentiation. 
The study outlined in Chapter 3 was performed to evaluate whether goblet cells and mucins 
play a role in the active defense against rotavirus infection. The chapter describes the 
changes in goblet cell homeostasis during rotavirus infection in neonatal mice. Different 
experiments are performed to examine structural changes of mucins during rotavirus 
infection. Moreover, by isolating mucins from infected and control mice, it is determined 
whether age-dependent differences in mucin composition and/or structure alter the anti-viral 
capabilities of small intestinal mucins. Next in Chapter 4, our goal was to evaluate the role 
of prostaglandins in mucin expression during rotavirus infection. Chapter 5 focuses on the 
effects of rotavirus exposure on immune maturation in young mice. As a model for 
vaccination, we examined the immune responses in infant mice following oral inoculation 
with standardized amounts of different fractions of purified simian rotavirus SA11 that 
differed in antigen composition. Finally, in Chapter 6 we aim to identify cellular proteins 
that interact with the rotavirus enterotoxin NSP4. Identifying these proteins is important 
since it might lead to new therapeutic approaches and viral intervention in order to reduce 
and prevent rotavirus disease. 
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Abstract 
 
Rotavirus is the most important cause of infantile gastroenteritis. Since in vivo mucosal 
responses to a rotavirus infection thus far are not extensively studied, we related viral 
replication in the murine small intestine to alterations in mucosal structure, epithelial cell 
homeostasis, cellular kinetics, and differentiation. Seven-day-old suckling BALB/c mice 
were inoculated with 2 x 104 ffu of murine rotavirus and were compared to mock-infected 
controls. Diarrheal illness and viral shedding were recorded and small intestinal tissue was 
evaluated for rotavirus- (NSP4 and structural proteins) and enterocyte specific (Lactase, 
SGLT1, LFABP) mRNA and protein expression. Morphology, apoptosis, proliferation and 
migration were evaluated (immuno-) histochemically. Diarrhea was observed from day 1 to 5 
post infection, and viral shedding from day 1 to 10. Two peaks of rotavirus replication were 
observed at 1 and 4 days post infection. Histological changes were characterized by the 
accumulation of vacuolated enterocytes. Strikingly, the number of vacuolated cells exceeded 
the number of cells in which viral replication was detectable. Apoptosis and proliferation 
were increased from day 1 to 7, resulting in villus atrophy. Epithelial cell turnover was 
significantly higher (<4 days) than in controls (7 days). Since epithelial renewal occurred 
within 4 days, the second peak of viral replication was most likely caused by infection of 
newly synthesized cells. Expression of enterocyte specific genes was downregulated in 
infected cells at mRNA- and protein-levels starting as early as 6 h after infection. 
In conclusion, we show for the first time that rotavirus infection induces apoptosis in vivo, an 
increase in epithelial cell turnover and a shut-off of gene expression in enterocytes showing 
viral replication. The shut-off of enterocyte specific gene expression, together with the loss 
of mature enterocytes through apoptosis and the replacement of these cells by less 
differentiated dividing cells, likely lead to a defective absorptive function of the intestinal 
epithelium, which contributes to rotavirus pathogenesis. 
 
 
Introduction 
 
Rotaviruses are one of the most significant causes of gastroenteritis, malnutrition and 
diarrhea in young children and animals (123, 203). Mortality rates are low in developed 
countries where illness is usually self limiting (429). However, each year more than 600.000 
young children die in developing countries throughout the world (269). Rotavirus infection 
in children is mainly restricted to the small intestinal villus epithelium, resulting in the 
occurrence of total villus atrophy (33). Although rotavirus can infect older children and 
adults, diarrheal disease is primarily observed in children under 2 years of age (122, 123, 
203). 
Rotavirus induced diarrhea is thought to be caused by a combination of factors (369), which 
include a reduction in epithelial surface area, replacement of mature enterocytes by immature 
(crypt-like) cells  (306), an osmotic effect resulting from incomplete absorption of 
carbohydrates from the intestinal lumen in combination with bacterial fermentation of these 
non-absorbed compounds, secretion of intestinal fluid and electrolytes through activation of 
the enteric nervous system (ENS)(246), and the effect of the rotavirus non-structural protein 
4 (NSP4), which is thought to act as a viral enterotoxin (16). 
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Since the epithelium is the primary target of rotavirus infection, epithelial dysfunction plays 
an important role in rotavirus pathogenesis. However thus far, in vivo data concerning 
specific epithelial responses are rather limited (84, 162, 209, 306, 355, 389). Studies on the 
effect of infection on epithelial homeostasis in vivo are mainly restricted to studies in piglets, 
young rabbits and mice (84, 162, 209, 389). In piglets, sucrase-isomaltase activity was found 
decreased, whereas thymidine kinase activity was increased during rotavirus infection (389). 
In rabbits, rotavirus infection was shown to impair epithelial homeostasis and intestinal 
brush-border membrane Na (+)-solute co-transport activities were affected (162, 163). In 
young mice, homologous rotavirus infection affects the small intestinal epithelium by 
reducing leucine uptake, lactase and alkaline phosphatase activities, whereas the maturation 
of sucrase-isomaltase activity was found to be precocious (84, 209). 
Vacuolization of enterocytes during rotavirus infection is observed in mice and rats (77, 302, 
306), but is not a feature of rotavirus infection in calves, lambs, and piglets (268, 389, 398). 
These differences have been attributed to the specific nature of the host response and not to 
the virus, since vacuolization is also a characteristic feature of heterologous infections in 
mice (24, 149, 251). Mice usually do not develop any symptoms beyond 2 weeks of age, and 
infection of adult mice occurs without disease or histopathological lesions (59, 130, 306, 
341, 402, 453). 
The present study was designed to get more insight into the pathogenesis of rotavirus 
infection by studying epithelial homeostasis and dysfunction during rotavirus infection in 
mice. We examined the induction of diarrheal illness, timing and extent of rotavirus 
replication in the murine small intestine, and related viral replication to alterations in 
mucosal structure, epithelial homeostasis, kinetics, and differentiation. 
 
 
Materials and Methods 
 
Animals 
Pregnant dams were obtained from Harlan (Zoetermeer, The Netherlands). Dams, either with 
their control or inoculated litters, were housed in micro-isolator cages under negative 
pressure in a specified pathogen-free environment. Rodent chicken-protein free chow 
(9605/9608; Harlan Teklad TRM (A)) and deionized water were autoclaved and provided ad 
libitum until the end of the experiment. All dams were rotavirus antibody negative as 
measured by enzyme-linked immunosorbent assay (ELISA, as described below). All the 
experiments were performed with the approval of the Animal Studies Ethics Committee of 
the National Institute of Public Health and the Environment. 
 
Virus 
The EDIM (Epizootic Diarrhea of Infant Mice) mouse rotavirus strain was obtained from Dr. 
R. Ward, Children’s Hospital Research Foundation, Cincinnati, USA (266). The strain used 
is an unpassaged virus isolated directly from the stools of ill mice. 
 
Virus inoculations and subsequent animal-handling procedures 
Seven-day-old BALB/c mice were inoculated intra-gastrically with 2 x 104 focus forming 
units (ffu) of the EDIM rotavirus strain.  Control mice were mock infected through 
inoculation with PBS. To analyze epithelial proliferative kinetics, 30 mg/kg body weight 5-
bromo-2'-deoxyuridine (BrdU; Sigma, St Louis, USA) was injected intraperitoneally just 
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before inoculation. After inoculation and injection of BrdU, the mice were returned to their 
mothers and allowed to suckle. After 6 h and at days 1, 2, 4, 7, 10, and 14 5 infected and 3 
control mice were sacrificed per time point. Segments of jejunum (anatomic middle of the 
small intestine) and ileum (distal 2 cm of the small intestine) were rinsed in PBS and fixed 
for 4 h in 4% (wt/vol) paraformaldehyde (Merck, Darmstadt, Germany) dissolved in PBS. 
The segments were then dehydrated through a graded series of ethanol and xylene (Merck), 
and embedded in Paraplast Plus (Sherwood Medical, Den Bosch, The Netherlands) as 
previously described (446). In addition, adjacent segments of the jejunum and ileum were 
dissected and snap frozen in liquid nitrogen and stored at -80°C for RNA and protein 
isolation. 
 
Detection of rotavirus in stools 
To determine the rotavirus shedding, fecal samples were collected from each individual 
sacrificed mouse at 0-14 days post infection (dpi) and stored at –20°C. Samples were then 
homogenized in PBS in a 10% (wt/vol) solution/suspension and centrifuged (1000 g for 5 
min) to remove debris before being analyzed. The presence of rotavirus antigen in fecal 
samples was determined by enzyme-linked immunosorbent assay (ELISA) using the Premier 
rotaclone kit (Meridian Diagnostics, Cincinnati, Ohio). The test was considered positive if 
the optical density (OD, at 450 nm) of the well containing stool minus the OD of control 
wells was ≥ 0.1. 
 
Diarrhea score 
The severity of diarrheal illness was assessed by examination of fecal material. Stools were 
scored from 1 to 4 based on color, texture and amount of stool. Normal feces was defined as 
a score of 1, exceptionally loose feces was scored as 2, loose yellow-green feces was scored 
3, and watery feces was defined as a score of 4. Stools with a score of ≥ 2 were considered as 
diarrhea. The percentage diarrhea was calculated by dividing the number of diarrheic 
samples by the total number of mice scored for diarrhea each day.  Mice from which no stool 
could be obtained were considered as mice with no diarrhea. The diarrhea severity was 
determined by dividing the sum of all scores by the number of total stool samples collected 
each day. 
 
Antibody production 
Polyclonal rabbit hyperimmune sera were raised against cesium chloride purified simian 
rotavirus (SA11) or a synthetic peptide corresponding to amino acids 114-135 of NSP4 from 
the SA11 strain (KLTTREIEQVELLKRIYDKLTV). The NSP4 peptide was coupled to 
keyhole limpet hemocyanin using the EDC-kit from Pierce (Pierce, Rockford, IL), following 
the manufacturer’s protocol. Purified rotavirus or the NSP4 peptide were emulsified with 
Freund’s adjuvant and injected subcutaneously into rabbits following the method we have 
described previously (426). The polyclonal serum raised against purified rotavirus was used 
for quantifying rotavirus protein in intestinal homogenates. The polyclonal serum raised 
against the NSP4 peptide was used for immunohistochemistry. 
 
Histology and morphometry 
For standard histochemical staining or immunohistochemistry, paraffin-embedded tissues 
were sectioned (5 µm), deparaffinized with xylene (Merck) and rehydrated in graded ethanol 
solutions as previously described.(346) Epithelial morphology was analyzed after Gill’s 
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hematoxylin (Vector Laboratories, Burlingame, England) and eosin (Merck) staining (HE). 
Crypt depth and villus height were measured manually in well-orientated sections (10 
measurements per region per mouse) using a micrometer (Nikon, Bunnik, The Netherlands) 
mounted in an Eclipse E600 Microscope (Nikon). By dividing the crypt-villus axis into 5 
equal regions, the position of vacuolated cells and cells containing replicating virus along the 
crypt-villus axis were assessed. The positions were scored from 1 to 5 representing the tips 
of the villi to the crypts, respectively. The presence of vacuoles was judged by standard HE 
staining.  The vacuoles were examined for the presence of acid and neutral carbohydrates 
using a combined alcian blue-periodic acid-Schiff (PAS) staining. The presence of 
replicating virus was determined by immunohistochemistry using the antibody against the 
non-structural protein NSP4 (see below). Ten crypt-villus units per segment of the small 
intestine per animal were analyzed. All scores were averaged per intestinal segment per 
animal, and subsequently averaged between animals to calculate the mean score per segment 
per time-point (± SEM). 
 
Immunohistochemistry 
Deparaffinized and rehydrated sections were incubated overnight at 4°C using the primary 
mouse monoclonal antibodies anti-human proliferating cell nuclear antigen (PCNA, 1:1500; 
Boehringer), anti-BrdU (1:250; Boehringer), anti-rat lactase (1:1000;(339)) or the rabbit 
polyclonal antibodies, anti-(cleaved) caspase-3 (1:500; Cell Signaling Technology, Beverly, 
USA), anti-NSP4 (1:1000), anti-rat liver fatty acid binding protein (L-FABP, 1:2000;(359)), 
or anti-rabbit sodium glucose co-transporter 1 (SGLT1, 1:1000;(169)). 
Immunohistochemistry was carried out as described previously (346). 
 
Epithelial proliferation and apoptosis 
The effects of rotavirus infection on intestinal epithelial cell migration kinetics were 
analyzed through detection of BrdU, a nucleotide analog that is incorporated into the DNA of 
proliferating cells. At different time-points after injection of BrdU the position of the 
foremost and least advanced-BrdU labeled cells in ten crypt-villus units per animal were 
expressed as the number of cell-positions from the crypt-villus axis. Proliferating (PCNA-
positive) and apoptotic (caspase-3-positive) cells were counted in villi and crypts of the 
jejunum until 14 dpi, of respectively 10 and 30 well-oriented crypt-villus units per animal per 
time-point. 
 
In situ hybridization and probe preparation 
Non-radioactive in situ hybridization was performed using the method as previously 
described (233, 346). Digoxigenin (DIG)-11-UTP labeled RNA probes were prepared 
according to the manufacturer’s protocol (Boehringer Mannheim GmbH, Mannheim, 
Germany) using T3, T7 or SP6 RNA polymerase. The following probes were used: A 1 kb 
Nco1 fragment based on a 2.4 kb rat SGLT1 cDNA ligated in pBluescript (88), a 350 bp 
fragment of rat L-FABP cDNA ligated in pBluescript,(394) a 250 bp EcoRI/HindIII mouse 
beta-actin fragment ligated in pSP65 (221), and a 750 bp NcoI/SmaI NSP4 (SA11 strain) 
fragment ligated in pBluescript (see below). Transcripts longer than 450 bp were hydrolyzed 
in 80 mM NaHCO3 and 120 mM Na2CO3, pH 10.2 to obtain probes of various lengths ≤ 450 
bp (91). 
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Quantitation of mRNA 
Total RNA was isolated from frozen small intestinal segments, using Trizol reagent (Gibco-
BRL, Gaithersburg MD) following the manufacturer’s protocol. Integrity of the RNA was 
assessed by visual analysis of the 28S and 18S ribosomal RNAs after electrophoresis and 
staining with ethidium bromide. Subsequently, 1 µg of total RNA was dot-blotted on 
Hybond-N+ (Amersham, Bucks, England) using a vacuum-operated manifold (BioDot, 
BioRad, Hercules, CA). All blots were hybridized using specific 32P-labeled cDNA probes as 
described previously (446). To correct for the amount of RNA that was spotted, hybridized 
signals were corrected for glyceraldehyde-3- phosphate dehydrogenase (GAPDH) mRNA 
expression using a 1.4 kb human GAPDH probe (446). Hybridization signals were measured 
through autoradiography using a PhosphorImager and ImageQuant software (Molecular 
Imaging, Sunnyvale CA, USA). The following probes were used: a 394 bp NcoI fragment of 
rat SGLT1 (obtained from Charles Burant), a 400 bp XhoI/EcoRI fragment of rat 
LFABP,(394) a 1.8 kb EcoRI fragment of rat lactase (57). For the construction of the NSP4 
probe, RT-PCR was performed on RNA from simian rotavirus (SA11 strain) infected 
MA104 monkey kidney cells. NSP4 was cloned using the primers 
GGAACCATGGAAAAGCTTACCGACCTC (nt 46-62) and TCCCCCGGGTCACATTAA-
GACCGTTCCT (nt 730-750), based on the NSP4 SA11 coding sequence (46). PCR 
fragments were cloned into the EcoRI sites of PCR 2.1 (Invitrogen). 
 
Quantitation of rotavirus protein 
Proteins were isolated from frozen segments by homogenization of the tissue in 500 µl (Tris-
) homogenization buffer containing Triton X-100 (BDH, Poole, England), 1% SDS and 
various protease inhibitors as previously described (252). Protein concentration was 
measured using a bicinchoninic acid (BCA) protein assay reagent kit (Pierce). Bovine serum 
albumin was used as a standard. To quantify rotavirus structural protein contents, protein 
homogenates were dot-blotted on nitrocellulose (Nitran; Schleier & Schuell, Dassell, 
Germany). The blots were blocked for 1 h with blocking buffer (50 mM Tris-HCl, pH 7.8, 
5% (wt/vol.) nonfat dry milk powder (Lyempf, Kampen, The Netherlands), 2 mM CaCl2, 
0.05% (vol./vol.) Nonidet P40 (BDH), and 0.01% (vol./vol.) antifoam (Sigma)), and 
incubated for 18 h with rabbit hyperimmune serum raised against SA11 rotavirus particles 
(1:1000). After being washed in blocking buffer, the blots were incubated with 125I-labeled 
protein A (specific activity 33.8 mCi/mg; Amersham) for 2 h. Bound 125I-labeled protein A 
was then detected and the elicited signals were quantified using a PhosphorImager and 
ImageQuant software (Molecular Imaging). 
 
Statistical analysis 
Statistical analysis of all data from control and infected groups was performed using 
Student’s t-test for unpaired data (two-tailed). To compare three ore more groups, data were 
analyzed by ANOVA followed by an unpaired t-test. Data were expressed as the mean ± 
SEM and P values of ≤ 0.05 were considered statistically significant. 
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Results 
 
Rotavirus infection of 7-day-old mice caused diarrhea and virus shedding starting at 1 
day post-infection 
To be able to study rotavirus infection in vivo, 7-day-old suckling mice were inoculated 
orally with 2 x 104 ffu of EDIM rotavirus. As a control, mice of the same age were PBS 
inoculated. Control mice did not develop diarrhea at any time-point, and did not shed 
rotavirus antigen over a period of 14 days after PBS inoculation as measured by ELISA (data 
not shown). Mice inoculated with rotavirus, developed diarrhea over a period of 5 days 
(Figure 1A).  
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Figure 1. Percentage diarrhea (•) and mean diarrheal score (o) (A), and viral antigen-shedding (B) in neonatal mice 
inoculated with rotavirus. Percentage of diarrhea per day was calculated by dividing the number of diarrheic 
samples by the number of total samples collected each day. A score of ≥2 was considered diarrhea, whereas a score 
of <2 was considered normal. The mean diarrheal score was determined by dividing the sum of all diarrhea or not-
diarrhea scores (1 to 4) by the number of total samples scored each day (numbers are listed at the bottom of the 
figure). Fecal samples (n=5 per day) from 0 to 14 dpi were assayed for rotavirus antigen shedding by ELISA (B). 
Data are expressed as net and mean OD readings at 450 nm and represent individual values obtained for fecal 
samples. Readings of  ≥ 0.1 are considered positive. 
 
The onset of diarrhea occurred as early as 1 day post infection (dpi). The highest percentage 
of diarrhea occurred at 3 dpi, reaching 93%  (Figure 1A). At this time-point also the severity 
of diarrheal illness was maximal. The duration of viral antigen shedding was maximally 10 
days (Figure 1B).  
At 1 dpi three of the five animals examined shed virus and at 4 dpi viral shedding was 
maximal. At 10 dpi only two of five examined animals still shed virus. None of the infected 
mice died spontaneously. Thus, the onset of diarrhea occurred approximately at the same 
time as viral antigen shedding began. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Histopathological lesions in mouse small intestine (jejunum) during rotavirus infection at 1 dpi. Sections 
were stained with hematoxylin and eosin. In control animals (A), enterocytes were clearly polarized and the nuclei 
were localized at the base of the enterocytes. In infected mice at 1 dpi (B), histopathological changes were 
characterized by vacuolization of the enterocytes, swelling of the villus tips (arrow), constriction of the bases, and 
nuclei that were irregularly positioned within the cells (arrowhead). In many villi, lesions seemed to be present at the 
tips (open arrowhead). Original magnification, X 250. 
 
Histopathological lesions in mouse small intestine during rotavirus infection 
At necropsy, accumulation of fluid in the small intestine was observed in infected mice. This 
was first observed at 1 dpi, persisted through 4 dpi, and was accompanied by distention of 
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the ileum and large intestine. At these time points the diameter of the duodenum of infected 
mice however, appeared smaller when compared to controls (data not shown). In control 
animals, jejunal enterocytes were clearly polarized and the nuclei were localized at the base 
of the enterocytes (Figure 2A). Histopathological changes in the small intestine of rotavirus 
infected mice, were characterized by swollen villus tips and constricted villus bases. In many 
villi, lesions seemed to be present at the tips (Figure 2B, open arrowhead). In infected mice 
at 1 dpi, nuclei were enlarged and irregularly positioned within the cells. At the constricted 
bases of the jejunal villi, the cells were flattened and rounded (Figure 2B, arrowhead). 
During infection, large vacuoles occurred in the enterocytes lining most of the surface of the 
villi in the small intestine (Figure 2B, arrow). Particularly in the ileum, accumulation of 
supra-nuclear vacuoles was observed, while in the duodenum histological changes were 
mainly restricted to rounding of enterocytes (data not shown). Vacuolization was observed 
from 1 to 7 dpi and was most pronounced in the ileum at 2 dpi. Almost complete resolution 
of the histopathological changes was observed by 7 dpi. At the start of the weaning period at 
10 dpi, when the pups were 17 days old, minimal vacuolization was noticeable at the tips of 
the villi in (formerly) infected and control animals. These vacuoles however were only 
detected in the ileum, morphologically different from-, and always far less in number than 
the vacuoles observed in the inoculated mouse pups before 7 dpi (data not shown). The 
vacuoles observed during infection and during the start of the weaning period did not stain 
for acid or neutral carbohydrates using a combined alcian blue-periodic acid-Schiff (PAS) 
staining (data not shown). 
 
Kinetics of rotavirus replication in the mouse small intestine 
To determine the kinetics of rotavirus replication in young mice, the presence of replicating 
virus in small intestinal tissue was determined by detection of rotavirus structural proteins 
and NSP4. NSP4 is not found in mature infectious virus particles and is only synthesized 
within host cells during virus replication. The presence of NSP4 is therefore an 
incontrovertible indication for viral replication. At 6 hours post infection (hpi), NSP4 was 
detected at RNA and protein level in an occasional epithelial cell in the duodenum and 
jejunum of infected mice, as observed by in situ hybridization and immunohistochemistry, 
respectively (data not shown). 
At 1 dpi rotavirus NSP4 protein and mRNA was detected in almost all the epithelial cells 
located in the upper part of the small intestinal villi of rotavirus infected mice (Figure 3A and 
B, jejunum). At 2 dpi, when vacuolated cells were still abundantly present, NSP4 expression 
was only detected in a few cells in the villus epithelium. At 4 dpi, a second peak of rotavirus 
replication was observed (Figure 3A and B). No rotavirus antigen was detected beyond 7 dpi 
in any part of the small intestinal epithelium. Analysis of adjacent sections revealed that the 
localization of NSP4 RNA and protein within the small intestinal epithelium correlated well 
and matched with that of the structural proteins (data not shown). Viral replication was not 
observed in the crypt compartment at any time during infection and replication was confined 
solely to the villus epithelium. No rotavirus structural proteins (data not shown), or NSP4 
mRNA or protein could be detected in the vacuoles at any time-point. Quantitatively, very 
low expression of NSP4 mRNA was first observed in gut homogenates of the jejunum at 6 
hpi (Figure 3C). In agreement with the histological data, two peaks of viral replication were 
observed in both the jejunum and ileum. At 1 dpi there was a first peak of NSP4 mRNA 
expression. Expression was low at 2 dpi, and a second peak of replication was observed at 4 
dpi. At 1 dpi, expression of NSP4 mRNA was statistically significantly higher in the ileum 
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than the jejunum. Quantitative data of rotavirus structural protein expression in gut 
homogenates correlated well with the expression of NSP4 mRNA (Figure 3D). Some 
animals did not shed rotavirus at 1 dpi (Figure 1). However, NSP4 mRNA and rotavirus 
structural protein expression was observed in the duodenum and jejunum, but not ileum, of 
these animals (data not shown). Rotavirus antigen was not detected in any section of the 
small intestine of control mice. 
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Figure 3. Kinetics of rotavirus replication in the mouse small intestine. NSP4 mRNA (panel A) and protein (panel 
B) expression in jejunum at several days post infection were detected by in situ hybridization and 
immunohistochemistry respectively. No rotavirus antigen was detected beyond 7 dpi in any part of the small 
intestinal epithelium. Quantitative expression of NSP4 mRNA and structural rotavirus proteins were analyzed by 
RNA- and protein dot-blotting respectively (panels C and D). At 1 dpi, the levels of NSP4 mRNA and structural 
protein expression were significantly higher in the ileum compared to the jejunum, *P<0.05, using Student’s t-test. 
Original magnification, X 150. a.u., arbitrary units. 
 
The pattern of epithelial vacuolization is more extensive than the pattern of replicating 
virus 
To determine whether replicating virus and vacuolated cells were found in the same region 
along the villi, crypt-villus units in the jejunum were divided into 5 regions of equal length. 
The positions were scored from 1 to 5 representing the tips of the villi to the crypts, 
respectively (Figure 4). As stated earlier, the first infected cells where observed at 6 hpi and 
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vacuolated cells were first observed at 1 dpi. At 1 and 2 dpi, infected cells were exclusively 
found in the upper halves of the villi. However, vacuolated cells where observed along the 
entire villi, even at the base of the villi where no rotavirus was detected. At 4 dpi, infected 
and vacuolated cells were found in the same region. At 7 dpi, no virus antigen was detected, 
but occasionally there was still some vacuolization of the enterocytes in the upper villus 
regions. A very similar pattern of vacuolization and replicating virus was observed in the 
ileum (data not shown). Note that these scores do not present data on the severity of 
histological pathology but rather present information on where the pathology was observed. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. The pattern of epithelial vacuolization is more extensive than the pattern of replicating virus. Crypt-villus 
units in the jejunum were divided into 5 regions of equal length (see left part of the figure). The position of the 
vacuolated cells (open bars) and virus-containing cells (solid bars) on the crypt-villus axis was scored from 1 to 5 
representing the regions from the tips of the villi to the crypts. At 1 and 2 dpi, infected cells were exclusively found 
in the upper part of the villi, whereas vacuolated cells were observed along the entire villi and even at the base of the 
villi. Values are means ± SEM. *P<0.01, **P<0.001 using Student’s t-test. At the left, a crypt/villus unit is shown 
and the different regions are indicated. 
 
Villus and crypt length during rotavirus infection 
We wanted to examine whether villus atrophy occurred in our homologous rotavirus model. 
In control mice, villus length in the jejunum remained constant during development in the 
second week after birth (i.e. 6 hpi to 7 dpi, Figure 5A). Then, when the control mice were 17 
and 21 days old (i.e. 10- and 14 dpi), villi became significantly shorter (74-78%) when 
compared to control length at 6 hpi-7 dpi. In control mice, the crypts of the jejunum 
increased in depth by about 100% during development in the period between 1 and 3 weeks 
(i.e. 6 hpi to 14 dpi) after birth. During infection, villus atrophy was observed as villi in the 
jejunum were shortened to 69-75% (i.e. at 6 hpi to 4 dpi) of control length. Villus length of 
infected and control mice were comparable at 7 to 14 dpi. Crypt depth increased from 6 hpi 
to 14 dpi in control as well as infected mice. During infection there was a trend towards an 
increased crypt depth at 1 (142%) and 2 dpi (134%) compared to control mice, however this 
did not reach statistical significance. From day 4 to 14 crypt depth of infected mice was 
comparable to controls. 
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Figure 5. Villus length (A) and crypt depth (B) in the jejunum of control mice (open bars) and during rotavirus 
infection (solid bars). Data from 3-5 animals at each time point are expressed as mean villus height and mean crypt 
depth (µm) ± SEM. *P<0.05, **P<0.01 using Student’s t-test. Controls at 6 hpi to 7 dpi were compared to controls 
at 10 and 14 dpi, and analyzed by ANOVA followed by an unpaired t-test, ‡P<0.05. 
 
Apoptosis and proliferation of intestinal epithelial cells are increased during rotavirus 
infection 
To analyze jejunal epithelial proliferation and apoptosis during the course of rotavirus 
infection, proliferating cells were identified by expression of PCNA and apoptotic cells were 
identified by expression of cleaved caspase-3. In control animals, proliferating cells were 
almost exclusively observed in the crypt compartment (Figure 6A, arrow). However in 
infected animals at 1 and 2 dpi, proliferating cells were abundantly covering the crypt 
epithelium and reached up to two-third of the length of the villi (Figure 6B, arrows). The 
number of proliferating cells were strongly increased at 1 (153%) and 2 (206%) dpi, but were 
returned to control numbers from 4 to 14 dpi (Figure 6E). Note that the number of 
proliferating cells in control animals is gradually declining during development in the second 
week after birth. Apoptotic cells were rarely observed in control animals (Figure 6C). During 
infection, apoptotic cells were particularly observed in the upper parts of the villi (Figure 6D, 
arrow). Quantitative analysis of the number of cleaved caspase-3 positive cells showed that 
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apoptosis follows the course of infection (Figure 6F). At 1 and 4 dpi, there was a strong 
increase in the number of apoptotic cells. At 2 dpi, the number of apoptotic cells was not 
increased. Apoptosis was still slightly but significantly increased at 7 dpi, but thereafter at 10 
and 14 dpi normalized. 
 
Rotavirus infection alters epithelial cell migration kinetics in mouse small intestine  
As rotavirus infection caused increased epithelial proliferation as well as apoptosis, we 
wanted to investigate the effects of infection on intestinal epithelial cell migration kinetics. 
Cell kinetics were analyzed through detection of incorporated BrdU that was injected at t=0 
just before inoculation. The position of the foremost- as well as least progressed BrdU-
labeled cells in a crypt-villus unit in the ileum was expressed as the number of cell-positions 
from the crypt-villus boundary. There was no significant difference in the number of cells 
that had incorporated BrdU during the first 6 h after inoculation (data not shown). At 6 hpi, 
BrdU-positive cells in control- and infected animals were restricted to the crypt compartment 
(Figure 7). At 1 dpi, there was no difference between the position of BrdU-labeled cells in 
infected and control animals. From 2 to 7 dpi, BrdU-positive cells in infected animals 
migrated significantly faster up the villi than in respective controls. During infection, also the 
number of cell positions between the foremost cells and least advanced cells was increased at 
2 dpi. In control animals, BrdU-labeled cells where observed until 7 dpi. However in infected 
animals, most of the BrdU-labeled cells where lost from the tips of the villi already at 4 dpi. 
 
Analysis of enterocyte gene expression in mouse small intestine during infection 
In order to examine enterocyte gene expression during rotavirus infection, we analyzed serial 
small intestinal sections (jejunum) by in situ hybridization. As markers for enterocyte gene 
expression we used lactase (the brush border protein that hydrolyzes the milk-sugar lactose), 
SGLT1 (the brush border protein involved in the uptake of sodium, glucose and water), and 
L-FABP (a cytoplasmic protein involved in fatty acid metabolism). L-FABP- (Figure 8C), 
SGLT1- (Figure 8G), and beta-actin mRNA (data not shown) expression was detected in all 
enterocytes along the entire small intestinal villi of control animals. At 1 dpi, there was 
massive expression of NSP4 mRNA in the upper halves of the intestinal villi (Figure 8A). In 
cells and areas on the villi that were NSP4 positive, there was an apparent downregulation of 
enterocyte (L-FABP and SGLT1) and housekeeping (beta-actin) mRNA expression (Figure 
8B, F, and E). At subsequent days after inoculation this phenomenon was also observed, 
although not as prominent as during the first replication peak at 1 dpi.  During infection, 
lactase mRNA expression followed the same pattern as SGLT1 and L-FABP mRNA 
expression (data not shown). 
To examine whether enterocyte-specific gene expression in the jejunum was also 
quantitatively affected during infection, expression of lactase-, L-FABP-, and SGLT1 mRNA 
was assessed by RNA spot blotting. Since the expression of the housekeeping gene beta-
actin was also affected by rotavirus infection, the amount of RNA spotted was corrected for 
GAPDH mRNA- and 28S rRNA expression. Only data from spot blots normalized to 
GAPDH mRNA are shown, since spot blots normalized to 28S rRNA gave very similar 
results. Already at 6 hpi all three markers were downregulated (Figure 9). During massive 
viral replication at 1 dpi, mRNA levels were decreased to 15-22% of control levels. The 
mRNA levels were significantly decreased until 7 dpi (L-FABP and SGLT1) and 10 dpi 
(lactase). Notice that at 4 dpi, when there was a second peak of viral replication, no second 
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decline of marker mRNA levels was observed. This suggests that mRNA levels in the 
remaining cells on the villi were increased at this time-point. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Proliferation and apoptosis in jejunum during rotavirus infection as analyzed by staining of PCNA and 
cleaved caspase-3 respectively. In control animals, proliferating cells were exclusively found in the crypt 
compartment (A, arrow). In infected animals at 1 dpi, proliferating cells were observed up to two-third of the length 
of the villi (B, arrows). The number of proliferating cells in infected animals were strongly increased at 1 and 2 dpi 
(solid bars), and were comparable to control numbers (open bars) between 4 to 14 dpi (E). Apoptotic cells were 
rarely observed in control animals (C and F open bars). During infection at 1 dpi however, apoptotic cells were 
abundantly observed at the villus tips (D, arrow) and the number of apoptotic cells were significantly increased at 1, 
4, and 7 dpi (F solid bars). *P<0.05, **P<0.01 using Student’s t-test. Original magnification, X 250. 
 
In addition to the mRNA expression, SGLT1 protein expression was examined by 
immunohistochemistry. In the jejunum of control animals, SGLT1 membrane protein was 
expressed in the enterocyte brush border (Figure 8D). During rotavirus infection at 1 dpi, 
SGLT1 expression was almost completely lost from the brush border of enterocytes along 
the villi (Figure 8H). Expression of SGLT1 protein was largely recovered by 4 dpi and was 
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40completely recovered by 7 dpi (data not shown). Lactase and LFABP protein expression was 
also affected by rotavirus infection, and expression largely followed the pattern seen for 
SGLT1 (data not shown). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. Cell migration kinetics in the mouse small intestine (ileum) during rotavirus infection. Just before 
inoculation, mice were injected with BrdU. The position of the foremost - as well as least progressed BrdU-labeled 
cells in each crypt-villus unit are expressed as the number of cell-positions from the crypt-villus boundary (shown as 
a dotted line at 0 in the graph). At 6 hpi, BrdU-positive cells in control- (open bars) and infected animals (closed 
bars) were restricted to the crypt compartment. From 2 to 7 dpi, BrdU-positive cells in infected animals migrated 
significantly higher up the villi than in respective controls (*P<0.05, **P<0.01) The number of cell positions 
between the foremost- and least-advanced cells was also increased at 2 dpi (‡P<0.05). However, in infected animals, 
BrdU-labeled cells where predominantly lost from the villi at 4 dpi. 
 
 
Discussion 
 
In this study, we infected suckling mice with a homologous rotavirus strain. All phenomena 
that are presented in this paper were at least observed in 2 independent experiments. 
Mice developed diarrhea over a period of 5 days, starting at 1 day after inoculation. The 
onset of diarrhea coincided with the onset of viral shedding, however rotavirus antigen was 
shed for a total period of maximally 10 days. This means that after 5 dpi to 10 dpi, virus 
antigen was shed, while no diarrheal illness occurred. Viral antigen in small intestinal tissue 
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however, was only observed until 4 dpi, indicating that diarrhea correlated with the presence 
of replicating virus in the intestinal tissue.  
C
G
D
H
Two peaks of viral replication in small intestinal tissue were observed at 1 and 4 dpi. The 
occurrence of two antigen peaks during homologous (murine) rotavirus infection is in 
agreement with electron microscopic studies in infant mice (306, 402). The second peak of 
viral replication at 4 dpi is most likely caused by infection of newly formed cells, since we 
show that most BrdU-labeled cells, present during inoculation, were lost within 4 days. 
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Figure 8. Histological analysis of enterocyte gene expression during rotavirus infection. NSP4 (A), L-FABP (B), 
beta-actin (E), and SGLT1 (F) mRNA expression in serial small intestinal (jejunum) sections during rotavirus 
infection as examined by in situ hybridization (at 1 dpi). During massive expression of NSP4 in enterocytes in the 
upper halves of the villi at 1 dpi (A), enterocyte specific L-FABP, beta-actin and SGLT1 mRNA expression was 
downregulated in these cells (B, E, and F). In control animals, L-FABP mRNA (C), SGLT1 mRNA (G), and beta-
actin mRNA (data not shown) were expressed in all enterocytes along the entire villi. SGLT1 protein was observed 
in the brush border of control animals (D). At 1 dpi, expression of SGLT1 protein was almost completely lost in 
infected animals (H). Original magnification: A, B, C, E, F, and G, X 150; D and H, X 175. 
 
During both peaks of infection, levels of NSP4 mRNA and structural rotavirus proteins were 
higher in the ileum than in the jejunum. Although some animals did not shed rotavirus at 1 
dpi, replicating virus was observed in the duodenum and jejunum, but not ileum, of these 
animals (data not shown). These findings suggest that infection begins in the proximal small 
intestine, but eventually is more severe in the distal small intestine at later stages during 
infection. 
With respect to the exact timing of the induction of damage and viral replication, it is 
important to note that it appears that the initial load of viral inoculum is of particular 
importance. From previous experiments, we observed that when mice were inoculated with 
less ffu (2 X 103 or 5 x 102), the development of histological damage and the first peak of 
viral replication were delayed by one day compared to mice inoculated with the high dose of 
2 X 104 ffu. Interestingly, the mice inoculated with the lower virus load eventually developed 
peaks of infection that were comparable with that of the higher load (unpublished data). 
During infection at 1-7 dpi, large vacuoles were observed in enterocytes lining most of the 
surface of the villi in the small intestine. The vacuoles seemed largely devoid of rotavirus 
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antigen as determined by immunohistochemistry. This observation is in agreement with other 
studies in mice and rats (157, 306, 341), although rotavirus particles were observed by 
electron microscopy to be associated with intracytoplasmic vacuoles in canine rotavirus 
infected gnotobiotic dogs (195). At 1 and 2 dpi, many vacuolated cells were found lower on 
the villi than infected cells. Moreover, vacuolization was observed in many cells in which no 
NSP4 or structural proteins were detected, and cells that were strongly positive for rotavirus 
antigen seemed histologically undamaged. In agreement with other studies, these findings 
suggest that there is no direct correlation between the occurrence and severity of 
vacuolization of the enterocytes and the presence of virus (77, 82, 306). The vacuoles do not 
stain for acid or neutral carbohydrates with alcian blue or periodic acid-Schiff (PAS), 
respectively. Others found that the vacuoles in infected neonatal rats also did not contain 
neutral lipids (77). Therefore, the origin and nature of these vacuoles remains obscure. 
It has been suggested that vacuolization is a late state of infection preceding extrusion (82). 
However, the fact that the vacuolated cells were found lower on the villi than virus-infected 
cells at various time-points during infection, suggests that vacuolization is not directly 
caused by infection of these cells. Therefore, vacuolization might be caused by a systemic 
mechanism or by a secreted (viral) factor. One such viral factor could be the non-structural 
protein NSP4. After being secreted from infected cells, NSP4 is thought to mediate cell 
signaling by increasing intracellular calcium levels leading to chloride secretion in 
uninfected cells (16).  
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Figure 9. Quantitative analyses of enterocyte mRNA expression during rotavirus infection. Control 
values per day were arbitrarily set at a relative expression of 1 and are represented as a dotted line. At 6 
hpi enterocyte mRNA levels in the jejunum of infected animals were decreased compared to controls 
(dotted line). mRNA levels remained significantly decreased until 7 dpi (L-FABP and SGLT1) and 10 
dpi (lactase). The amount of RNA spotted was corrected for GAPDH mRNA expression. * P<0.05, ** 
P<0.01, ***P<0.001 vs. control using Student’s t-test. a.u., arbitrary units. 
 
In addition to the morphological damage, we analyzed the changes in epithelial homeostasis 
during rotavirus infection by studying epithelial proliferation, migration and apoptosis. In our 
study, the rate of proliferation during infection was strongly increased at 1 and 2 dpi as 
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indicated by increased numbers of PCNA-positive cells. Indications for increased 
proliferation rates in mice during rotavirus infection, also come from studies showing that 
the activity of thymidine kinase is increased (84, 99, 306). Epithelial migration was also 
drastically increased as indicated by the BrdU-labeling study. Overall, this led to an increase 
in epithelial cell turnover from 7 days in control mice to 4 days in infected mice. 
To our knowledge, this is the first study to describe increased apoptosis during rotavirus 
infection in vivo. Apoptotic cells were mainly observed in the upper parts of the villi where 
most infected cells where observed. The number of apoptotic cells followed the course of 
infection. These findings indicate that rotavirus is directly causing the increased apoptosis of 
villus enterocytes. In HT-29 human adenocarcinoma cells, SA11 rotavirus infection was also 
found to trigger apoptosis, and the authors stated that the specific histological features of 
rotavirus infected enterocytes may be a consequence of virus-induced apoptosis (409). 
However, in our study most damaged and vacuolated cells were not caspase-3-positive and 
also were found lower on the villi than infected cells. Moreover, many apoptotic cells were 
not morphologically damaged upon histological examination. This suggests that 
vacuolization is not a direct consequence of apoptosis, but rather precedes it.  
Rotavirus infection in children can result in the occurrence of a flat mucosa with total villus 
atrophy (33), and the most severe form of villus atrophy is observed in piglets, where small 
intestinal villi can be completely eroded (389). Villus atrophy in mice is mild when 
compared to observations in other mammalian species (33, 59, 236, 389, 399, 402). Villus 
atrophy in our model occurred as early as 6 hpi, before the onset of massive viral replication. 
At this stage of infection, no obvious histological damage or increased apoptosis was 
observed.  The shortening of the villi is therefore possibly caused by an effect of infection on 
the smooth muscle cells or the subepithelial network of myofibroblasts within the villi. 
Speculatively this rapid villus contraction involves the enteric nervous system (ENS).  
On the subsequent days, villus atrophy is likely attributed to the strong increase in apoptosis. 
One of the most plausible explanations for the relatively minor villus atrophy in mice is our 
observation of a very strong increase in the number of proliferating cells and cellular 
migration that potently counteracts the increased number of shed and apoptotic cells. The 
pathogenesis of this enhanced proliferation is unknown, but a negative feedback from mature 
villus epithelium has been postulated (210, 351, 378). The shedding of differentiated 
enterocytes may result in a deficient negative feedback of mature enterocytes, resulting in 
enhanced proliferation. In our model, the small intestinal epithelium likely responds to the 
increased loss of epithelial cells by enhancing the replacement of these cells through 
induction of proliferation in the crypts, as well as at the base of the villi. As has been 
proposed by others, we think that the basal region of the villi might constructively contribute 
to the process of enhanced renewal of villus cells (306, 353). 
We studied the expression of enterocyte-specific Lactase, LFABP and SGLT1 mRNAs as 
markers for the absorptive and metabolic functions of the enterocytes. Lactase is essential for 
the hydrolysis of lactose (434), the most important sugar in milk. LFABP is a protein that is 
involved in the uptake and intra-cellular transport of fatty acids (179) and SGLT1 is a 
glucose co-transporter involved in the uptake of glucose, salts and water (104). Already after 
6 hours, we observed reduced levels of these enterocyte specific mRNAs. The 
downregulation of these genes in vivo persisted till 10 dpi. The most prominent effect of viral 
infection was observed at 1 dpi. At this time-point there was a very distinct downregulation 
of enterocyte gene expression in cells that harbored replicating virus. Enterocyte-specific 
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protein levels were also reduced at days 1 and 2 dpi, following the reduced levels of the 
cognate mRNAs. This is in agreement with an earlier study where mice were infected with a 
homologous (murine) rotavirus, lactase and alkaline phosphatase activities were reduced, 
whereas sucrase-isomaltase activity showed a precocious maturation (84). Katyal and co-
workers found that there was a reduced amino acid (leucine) uptake in the jejunum and ileum 
of mice infected with a homologous rotavirus (209). In rabbits, rotavirus infection was 
shown to impair intestinal brush-border membrane Na (+)-solute co-transport activities of 
SGLT1. This effect was found to be mediated by a direct inhibiting effect of NSP4 on 
SGLT1 and not by means of reduced levels of SGLT1 in brush border vesicles (162, 163). 
Our data however, show that these observed reduction of Na (+)-solute co-transport 
activities, at least in mice, are probably not only caused by a direct inhibitory effect of 
rotavirus proteins (NSP4) on SGLT1 activity, but also by reduced levels of SGLT1 
transcripts and SGLT1 protein in the brush border of enterocytes.   So from our study, it 
seems that a reduced amount the transporter (SGLT1) in the brush border membrane of 
enterocytes might be one of the mechanisms underlying the reduced Na+ solute transport 
activity observed during rotavirus infection in rabbits (162).  
Together these findings suggest that the enterocyte absorptive- and metabolic capacity are 
affected, which might contribute to pathogenesis of rotavirus infection.  
Many viruses (HIV, influenza, poliovirus, adenovirus, and herpes simplex) are known to 
interfere with the host cell translational machinery, and shut off gene expression in a variety 
of ways (35, 223, 244, 258, 463). The rotavirus non-structural protein NSP3 is capable of 
inducing the shut off of host cell translation during in vitro rotavirus infection, by interacting 
with the eukaryotic initiation factor eIF4GI, which is part of the eIF4F holoenzyme complex 
(326). Since eIF4F modulates mRNA stability (343), the shut off of enterocyte gene 
expression during rotavirus infection we observed here in vivo, might also be mediated by 
NSP3. Furthermore, we hypothesize that NSP3 could mediate this shut off by removing 
eIF4F from cellular mRNA resulting in decreased stability of these mRNAs and 
subsequently a decreased translation. However this shut off might not be absolute, since 
several in vitro studies indicate an upregulation of specific genes in infected cells (96, 464). 
Based on the presented data we suggest that the hypothesis of Hamilton and colleagues (164, 
212, 350) to explain one of the mechanisms for rotavirus induced diarrhea, that is decreased 
solute absorption and water reabsorption in the intestine through substitution of mature 
enterocytes by non-transporting crypt cells needs further refinement. In relation to the 
inhibitory effect of rotavirus on the absorptive function of the small intestinal epithelium, we 
propose that in addition to the direct inhibition of Na (+)-solute co-transport activities 
through NSP4, at least 3 sequential processes are implicated in this mechanism of rotavirus 
induced diarrhea. (i) Early on during infection, enterocyte specific gene expression is directly 
downregulated in infected cells at the mRNA level. This results in reduction of mature 
enterocyte specific protein levels and thus in a functional less differentiated status relatively 
early during infection while there is still little histological damage. (ii) Mature enterocytes 
are lost from the villi through apoptosis and shedding. (iii) These mature enterocytes are 
replaced by immature and actively dividing cells. 
In summary, we report that during a homologous rotavirus infection in mice, villus atrophy 
and an increase in crypt depth are accompanied by highly induced epithelial apoptotic- and 
proliferation rates. Epithelial cell turnover was increased from 7 days in controls to 4 days in 
infected mice, indicating that the second peak of viral replication was most likely caused by 
infection of newly synthesized epithelial cells. Rotavirus infection caused a downregulation 
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of enterocyte specific gene expression in vivo in infected cells. This suggests that rotavirus 
infection causes a shut-off of endogenous gene expression in favor of viral gene expression. 
The shut-off of enterocyte specific gene expression, together with the loss of mature 
enterocytes through apoptosis and the replacement of these cells by less differentiated 
dividing cells, likely lead to a defective absorptive function of the intestinal epithelium, 
which contributes to rotavirus pathogenesis. 
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Abstract 
 
Rotaviruses are the leading cause of severe viral gastroenteritis in young children. To gain 
insight in goblet cell homeostasis and intestinal mucin expression during rotavirus infection, 
6-day-old mice were inoculated with murine rotavirus. To determine epithelial cell 
migration, mice were injected with BrdU just before inoculation. Small intestines were 
isolated at different days post infection (dpi) and evaluated for rotavirus and goblet cell 
specific gene-expression. Small intestinal mucins of control and infected animals at 1, 2, and 
4 dpi were isolated and tested for their capability to neutralize rotavirus infection in vitro. 
After inoculation, two peaks of viral replication were observed at 1 and 4 dpi. During 
infection, the number of goblet cells in infected mice was decreased in duodenum and 
jejunum, but was unaffected in the ileum. Goblet cells in infected animals accumulated at the 
tips of the villi. Muc2 mRNA levels were increased during the peak of viral replication at 1 
dpi, whereas at other time-points Muc2 and Tff3 mRNA levels were maintained at control 
levels. Muc2 protein levels in the tissue were also maintained, however Tff3 protein levels 
were strongly decreased. The number of goblet cells containing sulfated mucins was reduced 
during the two peaks of infection. Mucins isolated at 1 and 2 dpi from control and infected 
mice efficiently neutralized rotavirus infection in vitro. Moreover, mucins isolated from 
infected mice at 4 dpi were more potent in inhibiting rotavirus infection than mucins from 
control mice at 4 dpi. In conclusion these data show that during rotavirus infection goblet 
cells, in contrast to enterocytes, are relatively spared from apoptosis especially in the ileum. 
Goblet cell-specific Muc2 expression is increased and mucin structure is modified in the 
course of infection. This suggests that goblet cells and mucins play a role in the active 
defense against rotavirus infection, and that age-dependent differences in mucin quantities, 
composition and/or structure alter the anti-viral capabilities of small intestinal mucins. 
 
 
Introduction 
 
Rotavirus is the major infectious agent in the development of gastroenteritis, malnutrition 
and diarrhea in young children and animals (122, 204). In developed countries mortality rates 
are low and illness is usually self-limiting (429). In developing countries however, each year 
about 440.000 children of under 5 years of age die due to infection with rotavirus (313). 
Mortality is essentially related to dehydrating diarrhea. So far, no vaccine is available. 
Therefore it is important to develop alternative therapies, based on a better knowledge of 
rotavirus pathogenesis. 
Rotavirus binding and entry of host cells is thought to be a multifactorial process (240). 
Sialic acid-dependent rotavirus strains use sialic acid (SA) residues on the surface of target 
cells for initial attachment (107, 356, 410). The initial cell surface receptors containing sialic 
acid may be either glycolipids or glycoproteins (107, 133, 356, 410, 472). For SA-dependent 
strains, these receptors are though to play a key role in cellular entry, since SA-independent 
strains can infect cells through either the apical or basolateral membrane, while SA-
dependent strains infect cells only through the apical membrane (78). Most animal and 
human rotaviruses nevertheless, are SA-independent (79). It is however important to realize 
that apparently most rotavirus strains, SA-dependent as well as SA-independent, indeed bind 
to SA, but rather have different requirements regarding sialic acids on the host cell (23, 196). 
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For glycolipids it was found that the position of SA residues influenced the binding capacity 
of the different rotavirus strains. SA-dependent rotavirus strains bind to terminal SA residues 
in glycolipids, while SA-independent rotavirus strains bind glycolipids with internal sialic 
acids (which are resistant to neuraminidase treatment) (107). The fact that many 
glycoproteins can inhibit rotavirus infection in vivo and in vitro is possibly based on the 
ability of rotavirus to bind to SA residues, since treatment with neuraminidase abolishes the 
inhibitory effect of these agents (72, 289, 323, 459, 472). Some studies however indicate that 
removal of sialic acid from glycoproteins does not significantly alter the inhibitory properties 
of these compounts (471). 
Previous studies have shown that rotavirus infection has a profound effect on small intestinal 
epithelial homeostasis. It was found that rotavirus induced apoptosis, mild villus atrophy, 
increased epithelial cell turnover and hampered enterocyte gene expression (43, 84, 209, 306, 
389, 402). Rather than concentrating on enterocyte cell function, we wanted to focus our 
attention on the function of goblet cells during rotavirus infection and the expression of 
specific gene products that are secreted by these cells. Goblet cells are characteristic for the 
intestinal epithelium and are known to secrete molecules such as mucins and trefoil factor 
family peptides that serve protective and healing functions in the gut, respectively (419, 
438). The secretory mucin Muc2, which is the most important structural component of the 
intestinal mucus layer, is exclusively and abundantly expressed by goblet cells in the small 
intestine (426, 427, 438, 440). After synthesis, Muc2 is secreted into the lumen and forms a 
protective mucus gel layer that acts as a selective barrier to protect the epithelium from 
mechanical stress, noxious agents, viruses, and other pathogens (116, 137, 407, 426, 438, 
440). Muc2 and other mucins contain many O-linked SA moieties and are important 
inhibitors of rotavirus infection (72, 289, 323, 440, 459, 471, 472). It was suggested that 
intestinal mucins may represent a barrier to certain rotaviruses by neutralizing rotavirus 
infection through direct interaction with the virus, whilst hindering virus-to-cell attachment 
(72, 472). Interestingly, it was found that mucins isolated from suckling mice neutralize 
rotavirus more effectively than adult mucins (72). Besides Muc2, the trefoil factor family 
peptide 3 (Tff3) is another secretory protein synthesized by goblet cells. Tff3 is a small 
bioactive peptide that is involved in epithelial repair (255, 419). Because Tff3 acts as a 
motogen, i.e., promotes cell migration without promoting cell division, it stimulates 
epithelial restitution and thus epithelial repair (460). Therefore, Tff3 could also be involved 
in both protection against rotavirus infection as well as epithelial restitution after rotavirus-
induced injury.  
In this paper we examined the timing and extent of rotavirus replication in the murine small 
intestine, and related this to the number of goblet cells and the production of the goblet cell-
specific markers Muc2 and Tff3. Moreover, we performed qualitative analyses of the 
structural changes of mucins through histochemical staining, and we assessed the ability of 
isolated intestinal mucins to inhibit rotavirus infection in vitro. 
 
 
Materials and Methods 
 
Animals 
Pregnant dams were obtained from Harlan (Zoetermeer, The Netherlands). Dams, either with 
their control or inoculated litters, were housed in micro-isolator cages under negative 
pressure in a specified pathogen-free environment. Rodent, chicken protein-free, chow 
Homeostasis and function of goblet cells  55 
 
(9605/9608; Harlan Teklad TRM (A)) and deionized water were autoclaved and provided ad 
libitum until the end of the experiment. All dams were rotavirus antibody negative as 
measured by enzyme-linked immunosorbent assay (ELISA, as described below). All the 
experiments were performed with the approval of the Animal Studies Ethics Committee of 
the National Institute of Public Health and the Environment. 
 
Virus inoculations and subsequent animal-handling procedures 
The EDIM (Epizootic Diarrhea of Infant Mice) mouse rotavirus strain was obtained from Dr. 
R. Ward, Children’s Hospital Research Foundation, Cincinnati, USA (266). This strain is an 
unpassaged virus isolated directly from the stools of ill mice. Six days-old BALB/c mice 
were inoculated intra-gastrically with 2 x 104 focus forming units (ffu) of the EDIM rotavirus 
strain, as described previously (43). To analyze epithelial proliferative kinetics, 30 mg/kg 
bodyweight 5-bromo-2'-deoxyuridine (BrdU; Sigma, St Louis, USA) was injected 
intraperitoneally 5 minutes before inoculation. Control mice were mock infected through 
inoculation with PBS. After 6 h and at days 1, 2, 4, 7, and 14, three infected and three control 
mice were sacrificed per time point. The infection of mice and all subsequently experiments 
and data analysis, except the experiment measuring the mucin inhibitory capacities, were 
performed twice independently. The results of the independent experiments were comparable 
in all aspects. Segments of duodenum (i.e. proximal 2 cm of the small intestine), jejunum 
(i.e. 2 cm intestine taken from the anatomic middle of the small intestine) and ileum (i.e. 
distal 2 cm of the small intestine) were rinsed in PBS and fixed for 4 h in 4% (wt/vol.) 
paraformaldehyde (Merck, Darmstadt, Germany) dissolved in PBS. The segments were 
subsequently dehydrated through a graded series of ethanol and xylene (Merck), and 
embedded in Paraplast Plus (Sherwood Medical, Den Bosch, The Netherlands) as previously 
described (43, 446). In addition, adjacent segments of the jejunum and ileum were dissected 
and snap frozen in liquid nitrogen and stored at -80°C for RNA and protein isolation. 
 
Histology 
Paraffin-embedded tissues were sectioned (5 µm), deparaffinized with xylene (Merck) and 
rehydrated in graded ethanol solutions as previously described (43, 346). Histochemical 
staining was performed by using: Alcian blue (AB) at pH 2.5 followed by periodic acid–
Schiffs reagent (PAS), or high iron diamine (HID) followed by AB at pH 2.5 as previously 
described (252). The numbers of goblet cells per villus were counted after AB-PAS staining 
in 20 well-oriented crypt-villus units of the duodenum, jejunum, and ileum, respectively, per 
animal per time point until day 7 dpi. The numbers of HID positive goblet cells were counted 
in 10-well-oriented crypt-villus units per animal in the ileum per animal per time point until 
day 7 dpi. 
 
Immunohistochemistry 
Deparaffinized and rehydrated sections were incubated overnight at 4°C using the primary 
mouse antibody anti-BrdU (1:250; Boehringer, Mannheim GmbH, Mannheim, Germany), 
caspase-3 (1:500; Cell Signaling Technology, Beverly, USA), or a rabbit hyperimmune 
serum raised against SA11 rotavirus particles (1:1500; (43)). Immunohistochemistry was 
carried out as described previously (43, 346). Sections that had been incubated with the anti-
BrdU antibody were washed with PBS and subsequently treated with AB at pH 2.5. 
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In situ hybridization and probe preparation 
Non-radioactive in situ hybridization was performed using the method as previously 
described (233, 346). Digoxigenin (DIG)-11-UTP labeled RNA probes were prepared 
according to the manufacturer’s protocol (Boehringer) using T3, T7 or SP6 RNA 
polymerase. The following probes were used: a 244-bp murine Muc2 probe (440) and a 901 
bp VP4 fragment (EDIM strain) ligated in pBluescript (see below). Transcripts longer than 
450 bp were hydrolyzed in 80 mM NaHCO3 and 120 mM Na2CO3, pH 10.2 to obtain probes 
of various lengths ≤ 450 bp (91). 
 
Quantitation of mRNA 
Total RNA was isolated from frozen small intestinal segments, using Trizol reagent (Gibco-
BRL, Gaithersburg MD, USA) following the manufacturer’s protocol. Integrity of the RNA 
was assessed by visual analysis of the 28S and 18S ribosomal RNAs after electrophoresis 
and staining with ethidium bromide. Subsequently, 1 micro-g of total RNA was dot-blotted 
on Hybond-N+ (Amersham, Bucks, England) using a vacuum-operated manifold (BioDot, 
BioRad, Hercules, CA). All blots were hybridized using specific 32P-labeled cDNA probes as 
described previously (446). To correct for the amount of RNA that was spotted, hybridized 
signals were standardized by glyceraldehyde-3- phosphate dehydrogenase (GAPDH) mRNA 
levels using a 1.4 kb human GAPDH probe (43, 446). Hybridization signals were measured 
through autoradiography using a PhosphorImager and ImageQuant software (Molecular 
Imaging, Sunnyvale CA, USA). The following probes were used: The pBluescript cDNA 
probes that were used were the 244-bp murine Muc2 probe (440), a 438-bp rat Tff3 probe 
(408), or a 900 bp VP4 probe. For construction of the VP4 probe, RT-PCR was performed on 
RNA isolated from EDIM infected neonatal mice. VP4 was cloned using the primers 
TATACCATGGCTTCACTCATTTATAGAC and TTGGTAGTTCGCTGGTTTGAA, 
based on the EDIM VP4 coding sequence accession number AF039219 (GenBank). PCR 
fragments were TA-cloned into the PCR 2.1 vector (Invitrogen, Breda, The Netherlands) and 
sequenced. 
 
Quantitation of rotavirus protein 
Proteins were isolated from frozen segments by homogenization of the tissue in 500 µl (Tris-
) homogenization buffer containing Triton X-100 (BDH, Poole, England), 1% SDS and 
various protease inhibitors as previously described. (43, 345). Protein concentration was 
measured using a bicinchoninic acid (BCA) protein assay reagent kit (Pierce, Rockford, IL, 
USA). Bovine serum albumin was used as a standard. To quantify rotavirus structural protein 
contents, protein homogenates were dot-blotted on nitrocellulose (Nitran; Schleier & 
Schuell, Dassell, Germany). The blots were blocked for 1 h with blocking buffer (50 mM 
Tris-HCl, pH 7.8, 5% (wt/vol.) nonfat dry milk powder (Lyempf, Kampen, The 
Netherlands), 2 mM CaCl2, 0.05% (vol./vol.) Nonidet P40 (BDH), and 0.01% (vol./vol.) 
antifoam (Sigma, St Louis, USA), and incubated for 18 h with anti-mouse Muc2 serum 
(1:500) (440), or anti-rat Tff3 serum (1:1500), a generous gift from Daniel K. Podolsky 
(408). After being washed in blocking buffer, the blots were incubated with 125I-labeled 
protein A (specific activity 33.8 mCi/mg; Amersham) for 2 h. Bound 125I-labeled protein A 
was then detected and the elicited signals were quantified using a PhosphorImager and 
ImageQuant software (Molecular Imaging). 
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Isolation of mucins 
Mouse colonic mucin was isolated and prepared from mucosal scrapings, as described 
previously (440). Mucins from the small intestine (distal jejunum) of rotavirus-infected or 
control mouse neonatal pups were isolated with the following procedure. Whole tissue 
segments were homogenized at 4°C in 6M guanidium hydrichloride (Sigma). The mucins 
were reduced by addition of 100 mM dithiotreitol (Sigma) to enhance solubility. Sulfhydride 
groups were carboxymethylated through addition of 250 mM iodoacetamide (Sigma) and 
stirring for 24 h at 4 °C. Mucins were then fractionated by gelfiltration on a sepharose 
column (Bio-Gel A-50m; Bio-Rad, Veenendaal, The Netherlands). Fractions were analyzed 
for purity and mucin content by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
followed by periodic acid–Schiff (PAS) staining. Mucin containing fractions were pooled 
and dialyzed extensively against distilled water at 4ºC. Mucin preparations were quantified 
as described previously by a hexose assay using orcinol (Sigma) and galactose:fucose (3:2) 
as standard (426).                                                                                                                                        
 
Cell culture, rotavirus infection and immunofluorescence assay to measure the 
protective capacities of mucins 
Human colonic adenocarcinoma Caco-2 cells (ATCC, Manassas, VA, USA) were grown and 
maintained in 75 cm2 tissue culture flasks in DMEM (Dulbecco’s Modified Eagle’s Medium; 
Gibco BRL) with glutamax-1, pyridoxine, sodium pyruvate, and 4.5 g/l glucose, 
supplemented with 10% fetal calf serum (Integro, Zaandam, The Netherlands), 100 U/ml 
penicillin (Sigma), 100 micro-g/ml streptomycin (Sigma) and non-essential amino acids (Bio 
Whittaker Europe, Verviers, Belgium) at 37°C, 5% CO2 in a humidified atmosphere. One 
day prior to infection, Caco-2 cells were seeded on 10 well heavy Teflon-coated microscopic 
slides (7mm, Nutacon, Leimuiden, The Netherlands) at 104 cells/well as described previously 
(358). One hour prior to infection, the Caco-2 cells were rinsed 3 times in serum free DMEM 
and incubated together with diluted purified mucins. Meanwhile, the human rotavirus strain 
Wa was activated using 10 mg/ml trypsin (Sigma) at 37°C for 1 hour. Rotavirus was diluted 
to 2 x 102 ffu/ml (corresponding to about 100 ffu per well) in serum free DMEM containing 
the diluted mucins. Cells were infected with rotavirus at 37°C, 5% CO2 in a humidified 
atmosphere. After 15 hours of incubation, infection was terminated using ice-cold methanol 
and cells were stored for 10 minutes at -20°C. The microscopic slides with the methanol-
fixed infected Caco-2 cells (358) were rinsed 3 times in PBS and then incubated for 90 
minutes at RT with rabbit hyperimmune serum raised against SA11 rotavirus particles 
(1:1600) (43, 358). Slides were then rinsed again 3 times and incubated with a secondary 
anti-rabbit Texas Red conjugated antibody (1:200; Jackson Immuno Research laboratories 
inc., West Grove, PA, USA). Slides were mounted with a solution containing Mowiol 
(Sigma), 2.5% DABCO (1,4-Diazabicyclo[2.2.2]octane, Sigma) and 0.5 micro-g/ml DAPI 
(4’,6’-Diamidino-2-phenylindole Dihydrochloride:Hydrate, Sigma) (165). Fluorescence was 
observed using a Nikon Eclipse 800 microscope and the number of foci was determined at 
200X magnification. 
 
Statistical analysis 
Statistical analysis of all data from control and infected groups was performed using 
Student’s t-test for unpaired data (two-tailed). To compare three or more groups, data were 
analyzed by ANOVA followed by an unpaired t-test. Data were expressed as the mean ± 
SEM and P values of ≤ 0.05 were considered statistically significant. 
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Results 
 
Kinetics of rotavirus replication in the mouse small intestine 
In the present study we used 6-day-old suckling mice and inoculated them orally with 2 x 104 
ffu of EDIM rotavirus. As a control, mice of the same age were PBS inoculated. As in a 
previous study (43), rotavirus-inoculated mice, developed diarrhea over a period of 5 days 
starting at 1 day post infection (dpi). Control mice did not develop diarrhea at any time-point 
(data not shown). As observed by immunohistochemical staining of rotavirus particles or 
detection of VP4 RNA by in situ hybridization, rotavirus replication was confined solely to 
the upper-villus epithelium (Figure 1A and B). To determine the kinetics of rotavirus 
replication in the present experiment, replicating virus in small intestinal tissue was 
determined by detection of VP4 RNA. In agreement with previous studies (43, 306, 402), 
two peaks of viral replication were observed in both the jejunum and ileum. At 6 hours post 
infection (hpi), very low levels of VP4 RNA were detected in each segment (Figure 1C). At 
1 dpi there was a first peak in the amount of VP4 RNA. The VP4 mRNA level was low at 2 
dpi, and a second peak of replication was observed at 4 dpi. Thereafter replication decreased 
to very low (7 dpi) and finally undetectable levels (14 dpi). As in our previous studies, the 
extend of virus replication in the ileum was more extensive than in the jejunum. 
 
Number of goblet cells during rotavirus infection 
We performed AB-PAS staining on intestinal tissue sections and counted the number of 
goblet cells per villus in duodenum, jejunum, and ileum. In control mice, the number of 
goblet cells per villus in the duodenum, jejunum and ileum remained constant during 
development in the second week after birth (i.e. 6 hpi to 7 dpi, Figure 2). We however 
observed a difference in goblet cell numbers during infection, when the duodenum and 
jejunum were compared to the ileum. During infection, the number of goblet cells in the 
duodenum and jejunum were significantly decreased at 1 and 2 dpi and 1, 2, and 4 dpi 
respectively. In contrast, in the ileum numbers of goblet cells in infected animals remained 
comparable to controls during infection. Thus, in the proximal parts of the small intestine 
there seems to be an early loss of goblet cells. In order to detect apoptotic goblet cells in the 
different regions of the small intestine in control and infected mice, we performed a double 
staining of alcian blue and the apoptotic marker (cleaved) Caspase-3. With this double 
staining however we never observed apoptotic goblet cells (i.e. Caspase-3 positive AB 
staining cells, data not shown) after screening numerous intestinal sections. 
 
Rotavirus infection alters goblet cell survival and migration kinetics 
In order to investigate the effects of rotavirus infection on goblet cell survival and migration 
in the small intestine, mice were injected with BrdU just before inoculation with rotavirus. 
Goblet cell kinetics were analyzed by combined AB staining of the goblet cells and detection 
of incorporated BrdU in epithelial cells. Brdu-labeled goblet cells are recognized by blue-
stained granula and brown-stained nuclei. In control animals, BrdU-labeled enterocytes 
migrated in cohorts along the villus epithelium (Figure 3 A-D, see Appendix), and at 7 dpi 
the enterocytes had reached the villus tips. Goblet cells had a different migration pattern and 
remained evenly distributed in the villus epithelium as can be seen at 7 dpi (Figure 3D, 
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Appendix). BrdU-labeled cells in infected mice in general migrated faster up the villus than 
in control animals. BrdU-labeled enterocytes were already lost from the villi in infected 
animals at 4 dpi. 
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Figure 1. Rotavirus replication in the mouse small intestine. Rotavirus protein (panel A) and VP4 RNA (panel B) 
expression in ileum at 1 dpi were detected by immunohistochemistry and in situ hybridization, respectively. Virus 
replication was solely confined to the upper villus epithelium. Quantitative expression of VP4 RNA at several days 
post infection was analyzed by RNA dot-blotting (panel C). VP4 showed two peaks of expression at 1 and 4 dpi in 
both jejunum and ileum. At 1 dpi, the level of VP4 RNA was significantly higher in the ileum compared to the 
jejunum, *P<0.05 (using Student’s t-test). No VP4 RNA was detected beyond 7 dpi in any part of the small 
intestinal epithelium. Error bars in panel C represent ± SEM. 
 
In infected mice, goblet cells where not evenly distributed along the villi during infection (1, 
2, and 4 dpi). Instead the goblet cells tended to accumulate at the tips of the villi (Figure 3 E-
H, Appendix). This was most prominent in the ileum, but was also observed in the duodenum 
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and jejunum. At 4 dpi almost all BrdU-labeled cells, that were still present in the villus 
epithelium, were goblet cells, located at the tips of the villi. BrdU-labeled goblet cells were 
even found at the tops of the villi in infected animals at 7 dpi, when all BrdU-labeled 
enterocytes were lost form the epithelium (Figure 3H, Appendix). 
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Figure 2. The numbers of goblet cells per villus in the duodenum, jejunum, and ileum of control mice (hatched bars) 
and during rotavirus infection (solid bars). During infection, goblet cell numbers in the duodenum and jejunum were 
significantly decreased at 1 and 2 dpi and 1, 2, and 4 dpi, respectively. In the ileum, goblet cell numbers in infected 
animals were only significantly decreased at 4 dpi. Data from 3 animals at each time-point are expressed as mean 
number of goblet cells per villus as analyzed after AB-PAS staining ± SEM. Statistical significance in the infected 
tissue relative to the control tissue is indicated per time-point per tissue, *P<0.05, **P<0.01 using Student’s t-test. 
 
Muc2 and Tff3 mRNA and protein levels in jejunum and ileum during rotavirus 
infection 
Our previous findings showed that enterocyte gene expression rapidly deteriorated during 
rotavirus infection (43). In contrast, infection did not seem to have large effects on goblet 
cell gene expression. Muc2 mRNA remained detectable in goblet cells during the course of 
infection even at time-points of extensive damage and vacuolization of enterocytes (Figure 
4). To examine whether goblet cell-specific expression was quantitatively affected during 
infection, Muc2 and Tff3 mRNA and protein levels in jejunum and ileum were assessed by 
RNA and protein spot blotting, respectively. Subsequently the expression levels were 
corrected for the numbers of goblet cells in the tissue, as shown in Figure 2, to obtain values 
for Muc2 en Tff3 expression per goblet cell. In general, there were only minor differences in 
the levels of Muc2 and Tff3 mRNAs in the jejunum versus the ileum. Muc2 mRNA levels 
were decreased in the jejunum of infected animals when compared to controls (Figure 5A). 
In ileum the Muc2 mRNA levels were comparable with controls, with exception of the Muc2 
mRNA levels 1 dpi that were significantly increased. When these Muc2 mRNA values were 
corrected for the number of goblet cells in the respective tissues, it appeared that the level of 
Muc2 mRNA per goblet cell was similar in jejunum and ileum (Figure 5C). In both jejunum 
and Ileum there was a peak increase in Muc2 mRNA level per goblet cell at 1 dpi. Tff3 
mRNA levels in the jejunum as well as in the ileum remained largely unaltered during 
infection, i.e. the levels of Tff3 mRNA did not differ form the control values (Figure 5B). 
We normalized the Tff3 mRNA levels for the number of goblet cells, and found that the Tff3 
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mRNA levels per goblet cell were not statistically different form control levels (Figure 5D). 
The Muc2 protein levels appeared different in jejunum and ileum. In the jejunum the Muc2 
protein levels were decreased in infected tissue at 1 to 4 dpi, and after correction for the 
number of goblet cells the Muc2 protein levels appeared to be significantly increased at 1 
and 2 dpi (Figures 6A and 6C). In the ileum the Muc2 protein levels remained largely 
unaltered during infection both before and after normalization for the number of goblet cells 
(Figures 6A and 6C). Tff3 protein levels were decreased compared to controls at 6 hpi to 4 
dpi (Figures 6B and 6D). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Muc2 mRNA levels in jejunal sections in control mice (A) and during rotavirus infection (B) as examined 
by in situ hybridization at 1 dpi. At the time-point of massive expression viral replication and extensive damage and 
vacuolization of enterocytes, goblet cell-specific Muc2 mRNAs remained detectable and comparable with controls. 
Original magnification: X 200. 
 
Sulfated mucins and sialylated mucins during rotavirus infection 
To analyze mucins qualitatively, mucins in control and infected tissues were detected with a 
combined AB-PAS staining (Figure 7, see Appendix). With this staining neutral mucins stain 
magenta, whereas acid mucins stain purple/blue. In the control animals at 4 dpi, goblet cells 
stained pink, indicating that they primarily contain neutral mucins (Figure 7A, Appendix). In 
infected animals at 4 dpi however, goblet cells stained blue in the crypt region or dark purple 
on the villi indicating that these goblet cells contained abundantly acidic mucins (Figure 7B, 
Appendix). The increase in AB-stained cells, further suggests that the fraction of acidic 
mucins increased during rotavirus infection. This phenomenon was observed from 1 to 4 dpi 
in all analyzed sections from infected animals (Figure 7B, Appendix and data not shown). To 
further examine mucins qualitatively, the mucins in control and infected ileum were detected 
with a combined High Iron Diamine-alcian blue (HID-AB) staining. With the HID-AB 
staining, sulfated mucins stain black or brown, whereas sialomucins stain blue (Figure 7C-E, 
Appendix). In control mice at 7 dpi, goblet cells predominantly stained black/brown 
indicating that they contained sulfated mucins (Figure 7C, Appendix). In infected mice at 7 
dpi however, many goblet cells stained blue indicating that they predominantly contained 
sialomucin (Figure 7D, Appendix). We then counted the number of HID positive goblet cells 
and represented them as percentage of all goblet cells that were detected by AB-PAS at the 
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villi of control- and infected animals (Figure 7E, Appendix). During infection, the fraction of 
HID-stained goblet cells was decreased at 1 and 7 dpi. At 2 dpi there was a trend towards a 
decreased number of HID-stained goblet cells compared to controls, but this did not reach 
statistical significance. These results indicate that at specific time-points during rotavirus 
infection, mucins become less sulfated. 
 
Protective capacities of mucins during rotavirus infection 
As an initial experiment, we serially diluted mucin isolated from adult mouse large intestine 
(440) and assayed viral (Wa strain) infectivity in Caco-2 cells in the presence of mucin (data 
not shown). The mucin preparation was able to neutralize rotavirus infection in a 
concentration dependent manner. The concentration at which viral infectivity was reduced by 
50% of this mucin preparation was 10 micro-g/ml. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Quantitative analyses of goblet cell-specific mRNA levels during rotavirus infection. Muc2 (A) and TFff3 
(B) mRNA levels in jejunum and ileum during rotavirus infection as measured by RNA-dot blot analysis and after 
normalization by the number of goblet cells in the respective tissue (C and D, respectively). Control values per day 
were arbitrarily set at a relative expression of 1 and are represented as a dotted line. The amount of RNA spotted 
was corrected for GAPDH mRNA expression. * P<0.05, ** P<0.01, ***P<0.001 vs. control using Student’s t-test. 
a.u., arbitrary units. Error bars in represent ± SEM. 
 
We determined if the changes in mucin structure during rotavirus infection in neonatal mice 
had functional implications, in particular on the mucin’s capability to inhibit rotavirus 
infection. We isolated mucins from the small intestines (distal jejunum) of three control and 
three infected animals per time-point at 1, 2, and 4 dpi. These mucin preparations were tested 
for neutralization of the rotavirus Wa strain (SA-independent) at a concentration of 10 micro-
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g/ml. Note that we could not use the mouse EDIM strain for our in vitro experiments, since 
this strain is not cell culture-adapted and does not infect or replicate within the Caco-2 cell 
line. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Quantitative analyses of goblet cell-specific protein levels during rotavirus infection. Muc2 (A) protein 
levels in jejunum and ileum, and Tff3 (B) protein levels in jejunum during rotavirus infection as determined by 
protein dot-blot analysis and after normalization by the number of goblet cells in the respective tissue (C and D, 
respectively). Control values per day were arbitrarily set at a relative expression of 1 and are represented as a dotted 
line. .* P<0.05, ** P<0.01, ***P<0.001 vs. control using Student’s t-test. a.u., arbitrary units. Error bars represent ± 
SEM. 
 
Mucins isolated from control and infected mice were able to significantly neutralize Wa 
rotavirus infection in Caco-2 cells when compared to a similar amount of cells incubated 
with virus in the absence of mucins. Inhibiting effects of the individual mucin isolates ranged 
from 78.3% to 27.3% (Table 1). Mucins isolated at 4 dpi from control and infected mice 
were less efficient in inhibiting rotavirus infection than the respective mucins isolated from 
control and infected mice at 1 and 2 dpi (P<0.05). At 4 dpi, mucins isolated from infected 
mice were capable of inhibiting rotavirus infection more efficiently (57.1%) than mucins 
isolated from control mice (27.3%). We also performed an inhibition study using the 
rotavirus SA11 (SA dependent) strain and obtained similar results as for the Wa strain (data 
not shown). 
All abovementioned experiments, i.e. the infection of mice and the whole data analysis, 
except the isolation and subsequent measurement of the mucin inhibitory capacities, were 
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performed twice independently. The results of both experiments were comparable in all 
aspects. 
 
 
Discussion 
 
Previous studies demonstrated that rotavirus infection has a profound effect on small 
intestinal epithelial homeostasis. It was found that rotavirus infection induces apoptosis at the 
tips of the villi, increases epithelial cell turnover and hampers enterocyte gene expression 
(43, 84, 209, 306, 389, 402). Rather than concentrating on enterocyte cell function, we 
focused on goblet cell homeostasis during rotavirus infection and on the expression of 
specific gene products that are secreted by these cells. In the present study, we investigated 
changes in the number of goblet cells, goblet cell migration kinetics, Muc2 and Tff3 mRNA 
and protein levels, and analyzed the qualitative changes in intestinal mucin glycosylation and 
sulfation during rotavirus infection in neonatal mice. 
Neonatal mice infected with EDIM rotavirus developed diarrhea over a period of 5 days 
starting at 1 -day post infection (dpi). As in other studies, viral infection occurred in two 
peaks of replication at 1 and 4 dpi (43, 306, 402). Our previous findings demonstrated a 
severe loss of enterocytes during infection, through increased apoptosis (43). In these 
infected mice the expression of specific enterocyte markers was reduced to only 10-20% of 
control levels. We found in the duodenum and jejunum that also the number of goblet cells 
decreased significantly between 1 and 4 dpi. In the ileum however infection had little effect 
on the number of goblet cells. Epithelial cells in infected mice migrated faster up the villus 
than in control animals, a process during which the goblet cells accumulated at the tips of the 
villi. This phenomenon was most prominent in the ileum, but occurred in all of the small 
intestine. At 4 and 7 dpi all BrdU-labeled cells that were still present at the villus tips of 
infected mice were goblet cells. These findings suggest that, at least in the ileum (where we 
found the highest levels of viral replication) goblet cells, in contrast to enterocytes, are 
comparatively spared from the apoptosis during severe rotavirus infection. The sparing of 
goblet cells could be a mechanism within the epithelium to uphold their protective function 
in epithelial defense. This event was also observed in rats during severe intestinal damage 
induced by the cytostatic drug methotrexate (446). The potential protective role of goblet 
cells and their products was further corroborated by our observation that Muc2 and Tff3 
levels produced by these cells were maintained or even enhanced during infection. Muc2 
mRNA levels per goblet cell in the small intestine were increased during most severe 
damage and viral replication. Moreover, Tff3 mRNA levels were maintained during 
rotavirus-induced damage at levels not different from control levels. Interestingly in the 
jejunum, total Muc2 protein levels were decreased during viral replication at 1 and 2 dpi, 
probably due to the observed decrease in the number of goblet cells. However, when the 
jenunal Muc2 protein levels were considered in relation to their numbers, it appeared that the 
Muc2 protein production per cell was even increased. This was in contrast to the Tff3 protein 
levels that were decreased during rotavirus infection. Given the fact that the expression 
patterns of Muc2 and Tff3 differ in space and time, our results suggest that the Muc2 and 
Tff3 genes are not coordinately regulated in goblet cells during rotavirus infection. This was 
also observed in a methotrexate-induced damage and regeneration model in rats (447). 
 
 
Homeostasis and function of goblet cells  65 
nhibition of rotavirus infection by mucins isolated from neonatal mice
% inhibition ±SEM
1 dpi 2 dpi 4 dpi
ontrol mice 68.2 ± 2.9 78.3 ± 2.0 27.3 ± 6.1a
nfected mice 78.1 ± 2.1 69.1 ± 2.9 57.1 ± 4.1a
I 
 
 
 
 
c 
 
i 
 
 
Table 1. Inhibition of rotavirus infection by mucins. Mucins were isolated from the small intestines (distal jejunum) 
of three control and three infected animals per time-point at 1, 2, and 4 dpi. Mucin preparations (10 micro-g/ml) 
were tested to neutralize infection of rotavirus Wa strain in the Caco-2 cell line. Mean ± SEM percentages inhibition 
of infection in Caco-2 cells incubated with and without mucins are indicated. Mucins isolated from control and 
infected mice at 4 dpi were less efficient of inhibiting infection than mucins isolated from control and infected mice 
at 1 and 2 dpi (a, P<0.05). The experiments were performed in at least ten-fold. a P<.005, using Student’s t-test. 
 
The increased Muc2 mRNA levels observed during infection could be mediated through 
several mechanisms. Mucus overproduction has long been recognized as an important 
symptom of respiratory viral infections, but only recently it was shown that mucin is induced 
as a direct effect of viral double stranded RNA (dsRNA) on airway epithelial cells (238). The 
signaling pathways mediating MUC2 transcription by dsRNA were shown to resemble those 
shown previously to mediate cytokine induction and include the activation of mitogen-
activated protein kinases (MAPK) and nuclear factor kappa-B (NF- kappaB)(238). Rotavirus 
is also able to rapidly activate NF-B during infection (355). Instead of via dsRNA, 
however this activation was shown to be provoked primarily via binding of its outer capsid 
protein VP4 to the TNFR-associated factor 2 (TRAF2) and activation of TRAF signaling 
(226). The above-mentioned pathways are also known to induce the expression of 
cyclooxygenase 2 (COX2) a key enzyme for the production of prostaglandins (PGs). Our 
group recently demonstrated that COX2 mRNA and PGE2 levels are increased during 
rotavirus infection in Caco-2 cells and that PGE2 and COX activity is crucial for rotavirus 
replication (358). Interestingly, MUC2 protein expression is mediated through PGE1 and 
PGE2 (458) and moreover, PGE2 was shown to enhance mucin release via a cAMP-
dependent mechanism (25). 
Bacteria were also shown to induce MUC2 transcription mainly via production of NF-
kappaB and various cytokines (110, 113, 232, 250). Among the many (pro-inflamatory) 
cytokines that stimulate mucin gene expression are IL-1, IL-4, IL-6, IL-9 and tumor necrosis 
factor alpha (TNF-alpha), (110, 443) and references therein. It still has to be defined which 
of these multiple pathways and to what extent are mediating the increased levels of Muc2 
mRNA at 1 dpi in this study. 
Mucins can roughly be classified into neutral and acidic subtypes. Acidic mucins can further 
be distinguished by sulfated (sulfomucins) or non-sulfated (sialomucins) groups. In most 
mammalian species, neutral mucins appear to be the predominant subtype expressed in 
gastric mucosa, whereas acidic mucins dominate in the small and large intestine (386). 
During rotavirus infection, we found a reduction in the number of goblet cells producing 
sulfated mucins. Studies of SA11 rotavirus infection in rats also showed a reduction in the 
number of sulfated mucin-containing cells (156). SA11-infected rats fed with milk fermented 
by Lactobacillus casei, had less diarrhea and the number of sulfated mucin-containing cells 
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was comparable to controls (156). We observed that the small intestinal mucins particularly 
were less sulfated during or after the two replication peaks. At these time-points, sulfated 
mucins could have been preferentially secreted or the mucin molecules could be 
undersulfated as has been observed in patients with ulcerative colitis or in a rat model for 
colitis (191, 345, 442). Sulfate content of mucins is thought to present resistance to 
(bacterial) enzymatic degradation of the mucus layer (293, 352) and therefore the decrease in 
sulfated mucins could influence the consistency of the mucus layer. Changes in mucin 
sulfation particularly will be of relevance in the colon where sulfate-reducing bacteria reside. 
It will therefore be of special interest to determine whether sulfation is also reduced in the 
colon during rotavirus infection. 
AB-PAS staining suggested that the fraction of acidic mucins was strongly increased during 
rotavirus infection in mice. Since we found that the number of goblet cells producing 
sulfated mucins was decreased, these acidic mucins most probably embody heavily sialylated 
mucins. Several studies have reported that glycosylation and sialylation of mucins changes 
during bacterial or parasite infections (100, 170). Davril et al. reported that in patients who 
were severely infected with Pseudomonas aeruginosa, mucins isolated from bronchial 
mucosa had a higher sialic acid content than mucins from non-infected patients (100). The 
authors also concluded that bacterial infection influences the expression of sialyltransferases 
and fucosyltransferases in the human bronchial mucosa. In vitro, cytokines have been 
implicated in the sialylation of mucins (106). In particular, TNF-alpha was shown to 
upregulate mRNA levels of sialyl- and of fucosyl-transferases and increase the sialylation of 
mucins in a human respiratory gland cell line. Interestingly TNF-alpha levels were found 
increased in rotavirus-infected children and increased levels correlated with the severity of 
the symptoms (193). 
Mucins of various origins have been implicated in the inhibition of rotavirus infection (72, 
289, 323, 459, 471, 472). Mucins are thought to present a barrier for infection through direct 
interaction with the virus, thereby preventing virus-cell attachment (72, 472). The changes in 
mucin sulfation and especially sialylation during rotavirus infection in mice suggested that 
these mucins would have an altered competence to inhibit rotavirus infection. Mucins 
isolated at 4 dpi from control and infected mice were less efficient in inhibiting rotavirus 
infection than mucins isolated from control and infected mice at 1 and 2 dpi. Our data 
therefore suggest that, as was previously found (72), age-dependent differences in mucin 
composition alter the inhibitory capabilities of small intestinal mucins. Mucins isolated from 
infected mice at 4 dpi were more efficient in neutralizing rotavirus infection than mucins 
isolated from control mice at 4 dpi. This implies that the increase in sialylated mucins in 
infected animals at 4 dpi, results in the increased protective capacity compared to controls at 
this time-point. This observation could represent part of an innate defense mechanism to 
remove pathogens. The specific relationship between mucin oligosaccharide composition 
alterations and susceptibility to infection however is still the subject of ongoing 
investigations. Additionally, more experiments have to be performed in order to substantiate 
the possible role of the rotavirus-increased occurrence of acid mucins and their role in the 
defence against rotavirus infection. 
In conclusion our data show that during rotavirus infection goblet cells, in contrast to 
enterocytes, are spared from apoptosis in the ileum, Muc2 levels are up-regulated and mucin 
structure is changed. This suggests that mucins and in particular Muc2, play an important 
role in the active defense against rotavirus infection. The data further imply that age-
dependent differences in mucin composition and increased occurrence of acidic (most likely 
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sialylated) mucins alter the inhibitory capabilities of mucins isolated from the small intestine. 
This suggests that posttranslational modification in glycosylation of mucins during infection, 
may affect specific epithelial barrier function against intestinal pathogens. 
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Abstract 
 
Rotaviruses are recognized as the leading cause of severe viral gastroenteritis in young 
children. Previously we have shown that cyclooxygenase (COX) 2 mRNA and secreted 
prostaglandin (PG) E2 levels are increased after rotavirus infection in Caco-2 cells. PGs have 
been implicated in production and secretion of mucins. Mucins are the key components of 
the intestinal mucus layer and represent a barrier to rotavirus infections. The purpose of this 
study was to determine whether PGs and COX could be involved in rotavirus-induced mucin 
expression. Using quantitative RNA dot blotting and semi-quantitative RT-PCR, we 
determined Cox2 and mucin mRNA expression during rotavirus infection in neonatal mice 
and in Caco-2 cells. The results showed that Cox2 mRNA expression is strongly enhanced 
during rotavirus infection in mice, implying increased PG production. Infected mice also 
showed increased levels of Muc2, Muc3 and Muc5AC mRNAs. As an enterocyte model, 
Caco-2 cells “mirrored” the observations in mice and showed increased enterocyte-specific 
MUC3 mRNA expression during rotavirus infection. In the goblet cell line LS174T, PGE1 
and PGE2 were able to induce MUC2, -3, and -5AC mRNA expression in a time and 
concentration dependent manner. These findings suggest that mucin upregulation during 
rotavirus infection is mediated through upregulation of rotavirus-induced Cox2 and PG 
levels. 
 
 
Introduction 
 
Rotavirus is the major infectious agent in the development of gastroenteritis, malnutrition 
and diarrhea in young children and animals (122, 204). By the age of 5, nearly every child 
worldwide will have had at least one episode of rotavirus gastroenteritis, whereas 
approximately 1 in 300 of these children will die as result of the infection. Children in 
developing countries account for 82% of the 440.000 children younger than 5 years of age 
that annually die worldwide because of an infection with rotavirus (313). Rotavirus infection 
in children and animals is mainly restricted to the small intestinal villus epithelium. 
Replication generally occurs in mature enterocytes and leads to the induction of a variety of 
pro-inflammatory cytokines, reduction of enterocyte gene expression, and vacuolization and 
apoptosis of enterocytes. As a result of enhanced cell death villus atrophy occurs (33, 43, 65, 
355). Recently however, it was reported that rotavirus infection is not confined to the 
intestine, but in addition is able to leave the intestine and enters the circulatory system 
resulting in antigenaemia and possible viraemia (40, 282, 342). 
Prostaglandin E2 levels rise early after rotavirus infection in pigs (481). Furthermore, 
elevated levels of the prostaglandins PGE2 and PGF2 have been reported in the plasma and 
stool of rotavirus-infected children (466), indicating that cyclooxygenases (COXs) and 
prostaglandins (PGs) might be involved in rotavirus pathogenesis. PGs are lipid mediators 
that are produced through cyclooxygenases (COXs). The COX1 gene is constitutively 
expressed, whereas in most cell types, COX2 is induced by pro-inflammatory or mitogenic 
activators including cytokines, endotoxin, and inflammatory molecules (74). Especially 
PGE2 was shown to be involved in regulation of viral replication. Aside from a few 
exceptions, increased production of PGE2 or exogenously added PGE2 leads to increased 
replication of most viruses, e.g., Herpesvirus (CMV), Retrovirus (HIV), and Rhabdovirus 
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(403). We recently demonstrated that COX2 mRNA and PGE2 levels are increased during 
rotavirus infection in the enterocyte-like cell line Caco-2. PGE2 and COXs activity were 
shown to be crucial for rotavirus replication via a post-binding mechanism (358). 
The intestinal epithelium is covered by mucus that primarily consists of mucus glycoproteins 
(mucins) (137, 438). Mucins play a crucial role in epithelial protection against luminal 
bacterial compounds (116), and references therein), and it was suggested that mucins 
represent a barrier to rotavirus infections by neutralizing rotavirus infection through direct 
interaction with the virus, by hindering virus-cell attachment (72, 472). Mucins are encoded 
by the MUC-gene family and are classified into either membrane-bound or secretory 
glycoproteins (105). The secretory mucin MUC2, the most important structural component 
of the intestinal mucus layer, is exclusively and abundantly expressed by goblet cells in the 
large and small intestine (426, 427, 438, 440). In the human small intestine, the membrane 
bound mucin MUC3 is mainly confined to the more mature enterocytes at the tips of the villi, 
although occasional expression in goblet cells has been observed (69). The secretory mucin 
MUC5AC is normally confined to gastric epithelium (437), but is aberrantly expressed in 
Barrett’s oesophagus, gastric metaplasia in the duodenum, the colon in inflammatory bowel 
disease (IBD) and colorectal adenomas (55, 239, 382, 435, 436). Mucin gene expression 
patterns in mouse are very similar to those described in humans (13, 116, 120, 197, 387, 440, 
443). 
PGs were previously shown to play a role in the production and secretion of mucins, as PGE2 
enhanced mucin release via a cAMP-dependent mechanism in LS174T cells and in the rat 
colon (25), and MUC2 protein expression is enhanced by short chain fatty acids through 
PGE1 and PGE2 produced by myofibroblasts (458). 
In this study we wanted to evaluate the role of PGs in mucin expression during rotavirus 
infection. We examined whether COX and mucin mRNA expression were enhanced during 
rotavirus infection in neonatal mice and during rotavirus infection of Caco-2 cells, as PG 
levels are elevated in both rotavirus-infected children and the enterocyte-like cell line Caco-2 
(358, 466). We furthermore wanted to determine if the prostaglandins PGE1 and PGE2 could 
differentially regulate mucin mRNA expression in the goblet cell-like cell line LS174T. Our 
findings suggest that the increased intestinal mucin mRNA expression during rotavirus 
infection in vivo is mediated by rotavirus-induced increase in PG levels. 
 
 
Materials and Methods 
 
Animals and virus inoculations 
Seven-day-old BALB/c mice were inoculated intra-gastrically with 2 x 104 focus forming 
units (ffu) of the EDIM rotavirus strain as previously described (43). Control mice were 
mock infected through inoculation with PBS. At different time points after infection, mice 
were sacrificed and segments of the ileum were dissected and snap frozen in liquid nitrogen 
and stored at -80°C for RNA isolation. 
 
Cell culture and rotavirus infection 
The human colonic adenocarcinoma cell lines Caco-2 and LS174T (American Type Culture 
Collection, Manassas, VA, USA) were grown and maintained in 75 cm2 tissue culture flasks 
in DMEM (Dulbecco’s Modified Eagle’s Medium; Gibco BRL, Paisly, Scotland) containing 
10% (v/v) fetal bovine serum (FBS, Integro, Dieren, The Netherlands), 100 U/ml Penicillin, 
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100 µg/ml Streptomycin and 1% (v/v) Non-Essential Amino Acids (BioWhittacker, 
Verviers, Belgium) at 37oC and 5% CO2. One day prior to infection, Caco-2 cells were 
seeded on 10 wells heavy teflon coated microscopic slides (7mm, Cel-line/Erie Scientific, 
Portsmouth, NH) at 104 cells/well. One hour prior to infection, the Caco-2 cells were rinsed 3 
times in serum free DMEM. Simultaneously, the human rotavirus strain Wa, obtained from 
Dr. M. Koopmans (National Institute for Public Health and the Environment, Bilthoven, The 
Netherlands), was activated at 37°C for 1 h using 10 µg/ml trypsin (Sigma) diluted in 
DMEM-FCS. Viral infectivity in culture media and cells were determined as previously 
described (358). Rotavirus was diluted to 2 x 103 ffu/ml (corresponding to 100 ffu per well) 
in serum-free DMEM and cells were subsequently infected with rotavirus at 37°C, 5% CO2 
in a humidified atmosphere. After 15 hours of incubation, infection was terminated using ice-
cold methanol and cells were stored for 10 minutes at -20°C. Five to seven days after 
seeding, LS174T cells were incubated with 0, 1.4, 2.8 or 28 µM PGE1 or PGE2 (Sigma-
Aldrich; St. Louis, MO) for 8, 16 or 24 h. Cells were then rinsed 3 times with PBS and RNA 
was isolated using RNeasy (QIAGEN, Venlo, The Netherlands) following the 
manufacturer’s instructions.  
 
RNA isolation, RNA dot blotting, and RT-PCR 
Total RNA from frozen small intestinal segments, was isolated using Trizol reagent (Gibco-
BRL, Gaithersburg MD) following the manufacturer’s protocol. Total RNA from LS174T or 
Caco-2 cells was isolated with the RNeasy RNA isolation kit according to the manufacturer’s 
protocol (Qiagen, Hilden, Germany). Integrity of the RNA was assessed by visual analysis of 
the 28S and 18S ribosomal RNAs after electrophoresis and staining with ethidium bromide. 
Random and oligo(dT)15 primers (ratio of 2:1) were used to synthesize cDNA by the M-
MLV Reverse Transcriptase according to the manufacturer’s protocol (Promega, Madison, 
WI). Mouse Muc3 was amplified using the oligo’s 5’-GAGACATGCAAGAAGGAGGC-3’ 
and 5’CCAAGTCCATACACCAGGCT-3’ (nucleotide positions 786-805 and 1011-1030, 
accession number AF027131 (387), resulting in a 245 bp product. Mouse Muc5ac was 
amplified using the oligo’s 5’-CCAATTGGCTAGATGGCAGT-3’ and 5’-
CAGATCAAACCCTCCTCTCG-3’ (nucleotide positions 373-393 and 553-575, accession 
number L42292; (388)) resulting in a 175 bp product. The temperature cycling protocol for 
these PCR reactions consisted of 10 min pre-heating at 96oC followed by 30 cycles of 1 min 
denaturation at 96oC, 1 min primer annealing at 60oC and 1 min primer extension at 72oC. 
The mouse Cox1 orthologue prostaglandin-endoperoxide synthase 1 (Ptgs1) was amplified 
using the oligo’s 5’-TGTTCAGCTTCTGGCCCAAC-3’) and 5’-ATCAACACGGACGCC-
TGTTC-3’ (nucleotide positions 561-580 and 841-860, respectively, accession number 
NM008969; (286) resulting in a 300 bp product. The mouse Cox2 orthologue prostaglandin-
endoperoxide synthase 2 (Ptgs2) was amplified using the oligo’s 5’-
TTCAAAAGAAGTGCTGGAAAAG-3’ and 5’-AGATCATCTCTACCTGA-GTGTCTT-3’ 
(nucleotide positions 577-598 and 858-881, accession number NM011198; (222)) resulting 
in a 305bp product. The temperature cycling protocol for the Cox1 and 2 PCR reactions 
consisted of 4 min pre-heating at 94oC followed by 35 (Cox1) or 40 (Cox2) cycles of 1 
minute denaturation at 94oC, 45 seconds primer annealing at 51 (Cox1) or 56 oC (Cox2) and 
1 min primer extension at 72oC. The efficiency of the PCR reactions on mouse cDNA was 
determined by amplifying β-actin using the oligo’s 5’-CAAGGCCAACCGCGAGAA G-3’ 
and 5’-CAGGGTACATGGTGGTGCC-3’, resulting in a 587 bp PCR product, as described 
previously (439). The temperature cycling protocol for this PCR reaction consisted of 4 min 
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pre-heating at 94oC followed by 35 cycles of 45 seconds denaturation at 94oC, 1 min primer 
annealing at 60oC  and 1 min primer extension at 72oC. 
Human MUC2 and MUC3 were amplified using the oligo’s 5’-
CTGCACCAAGACCGTCCTCATG-3’ and 5’-GCAAGGACTGAACAAAGACTCAGAC-
3’ (nucleotide positions 15291-15312 and nt 15667-15691, accession number L21998 (160)) 
resulting in a 401 bp product, or 5’-AGTCCACGTTGACCACCACTGC-3’ and 5’-
TGTTCACATCCTGGCTGGCG-3’ (159) resulting in a 522 bp product, respectively. 
Human MUC5AC was amplified using the oligo’s 5’-TGATCATCCAGCAGCAGGGCT-3’ 
and 5’-CCGAGCTCAGAGGACATATGGG-3’ (nucleotide positions 2897–2917 and 3284–
3305, respectively, accession number AJ001402; (56)), resulting in a 409 bp product. The 
efficiency of the PCR reactions performed on human cell line cDNA was determined by 
amplifying human 18S rRNA using the oligo’s 5’-TCCTGCCAGTAGCATATGCTTG-3’ 
and 5’-AGAGGAAGCGAGCGAC-3’ and resulting in a 120 bp product (358). The 
temperature cycling protocol for the PCR reactions for MUC2, MUC3 and 18S consisted of 
2 min pre-heating at 94oC followed by 30 (MUC2 and 18S) or 35 (MUC3) cycles of 45 
seconds denaturation at 94oC, 1 min primer annealing at 60oC and 1 min primer extension at 
72oC. The temperature cycling protocol for the MUC5AC PCR reaction consisted of 2 min 
pre-heating at 94oC followed by 35 cycles of 45 seconds denaturation at 94oC, 1 min primer 
annealing at 62oC and 1 min primer extension at 72oC. All PCR products were visualized and 
quantified using the Gel Doc 2000 system and Multi-Analyst software version 1.1 (Bio-Rad 
Laboratories, Inc., Hercules, CA). 
For RNA blotting, 1 µg of total RNA was dot-blotted on Hybond-N+ (Amersham, Bucks, 
England) using a vacuum-operated manifold (BioDot, BioRad). All blots were hybridized 
using specific 32P-labeled cDNA probes as described previously (43). To correct for the 
amount of RNA that was spotted, hybridized signals were corrected for glyceraldehyde-3- 
phosphate dehydrogenase (GAPDH) mRNA expression using a 1.4 kb human GAPDH probe 
(43). Hybridization signals were measured through autoradiography using a PhosphorImager 
and ImageQuant software (Molecular Imaging, Sunnyvale CA, USA). The following probes 
were used: The pBluescript cDNA probes that were used were the 244-bp murine Muc2 
probe (440), and a 900 bp VP4 probe. For construction of the VP4 probe, RT-PCR was 
performed on RNA isolated from EDIM infected neonatal mice. VP4 was cloned using the 
primers 5’-TATACCATGGCTTCACTCATTTATAGAC-3’ and 5’-TTGGTAGTTCGCTG-
GTTTGAA-3’, based on the EDIM VP4 coding sequence (nucleotide positions 7-28 and 
883-900, accession number AF039219 (309)). PCR fragments were TA-cloned into the PCR 
2.1 vector (Invitrogen) and sequenced. 
 
Statistical analysis 
Statistical analysis of all data was performed using Student’s t-test for unpaired data (two-
tailed). Data were expressed as the mean ± SEM and P values of ≤ 0.05 were considered 
statistically significant. 
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Results 
 
Mucin gene expression increased during rotavirus infection in neonatal mice 
Rotavirus infected 6-day-old suckling mice showed two peaks of viral replication in the 
ileum at 1 and 4 days post infection (dpi) as determined by rotavirus VP4 RNA expression 
(Figure 1A). Muc2 is the most prominent mucin in the small and large intestine in humans 
and mice (120, 426, 427, 438, 440). Using dot blotting, Muc2 mRNA levels in the ileum 
were found to be significantly increased 2.5 fold at 1 dpi (Figure 1B).  
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Figure 1. Analyses of rotavirus VP4 RNA and Muc2, Muc3 and Muc5ac mRNA expression in the ileum of 
rotavirus-infected neonatal mice. VP4 and Muc2 expression were quantitatively analyzed by RNA dot blotting. 
Muc3 and Muc5ac levels were semi-quantitatively determined by densitometric analysis of RT-PCR products. 
Control values per day were arbitrarily set at a relative expression of 1 and are represented as a dotted line. 
Rotavirus infected 7-day-old suckling mice showed two peaks of viral replication in the ileum at 1 and 4 dpi, as 
determined by VP4 RNA expression (A). Muc2 mRNA levels were found to be significantly increased 2.5 fold at 1 
dpi (B). Muc3 mRNA levels were increased 1.5-fold at 6 hpi and nearly 2.5-fold at 1 dpi (C). Muc5ac expression 
was strongly increased in rotavirus infected neonatal mice (D). The amount of VP4 and Muc2 RNA spotted was 
corrected for GAPDH mRNA expression. The efficiency of the Muc3 and Muc5ac PCR reactions was verified by 
amplifying β-actin. * P<0.05 vs. control using Student’s t-test. a.u., arbitrary units.* P<0.05, ** P<0.01, vs. control 
using Student’s t-test. a.u., arbitrary units. 
 
The membrane-bound non-secretory mucin Muc3 was analyzed by semi-quantitative RT-
PCR. Muc3 mRNA levels were increased 1.5-fold at 6 hpi and nearly 2.5-fold at 1 dpi 
(Figure 1C). The secretory mucin MUC5AC is normally confined to gastric epithelium (197, 
388, 437), but its expression is altered in Barrett’s oesophagus, gastric metaplasia in the 
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small intestine, in IBD and colorectal cancer (55, 239, 435, 436). Using RT-PCR, only 
minute expression of Muc5ac mRNA was observed in the ileum of control mice. Muc5ac 
expression was considerably and significantly increased in the ileum of rotavirus infected 
neonatal mice. At 1 and 4 dpi, during the two peaks of viral replication, expression was 
increased 12- and 6-fold respectively (Figure 1D). 
 
Expression of cyclooxygenase 2 mRNA increased during rotavirus infection in neonatal 
mice 
We previously showed that expression of COX2 mRNA is increased in the intestinal colon 
carcinoma cell line Caco-2 during rotavirus infection and that COX activity is crucial for 
rotavirus replication (358). In this study, we wanted to investigate whether cyclooxygenase 
expression is also increased during rotavirus infection in mice. Using semi-quantitative RT-
PCR analysis, we determined that Cox1 mRNA levels were comparable to controls at 6 hpi 
and 1, 4, and 7 dpi (Figure 2). Only at 2 dpi, levels were decreased compared to controls. 
This is probably due to the extensive loss of epithelial cells due to increased apoptosis at this 
time point (43). Cox2 mRNA expression was significantly increased during rotavirus 
infection and peaked at 6 hpi and 4 dpi reaching a maximum of 8.5-fold increase (Figure 2). 
At 7 dpi, as there was resolution of rotavirus infection, Cox2 mRNA expression returned to 
control levels. These results show that Cox2 mRNA expression, but not Cox1 mRNA, is 
strongly enhanced during rotavirus infection in mice, implying increased PG production. 
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Figure 2. Analyses of Cox1 and Cox2 mRNA expression in the ileum during rotavirus infection in neonatal mice. 
Cox1 and Cox2 mRNA levels were semi-quantitatively determined by densitometric analysis of RT-PCR products. 
Control values per day were arbitrarily set at a relative expression of 1 and are represented as a dotted line. Cox1 
mRNA levels were comparable to controls except for 2 dpi. Cox2 mRNA expression was significantly increased 
during infection and peaked at 6 hpi and 4 dpi reaching a maximum of 8.5-fold increase. The efficiency of the PCR 
reactions was verified by amplifying β-actin.* P<0.05, ** P<0.01, vs. control using Student’s t-test. a.u., arbitrary 
units. 
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Mucin expression during rotavirus infection in colon carcinoma cell line Caco-2 
To verify the effect on mucin expression in an in vitro model for enterocytes, enterocyte-like 
Caco-2 cells were infected with human rotavirus Wa. In this cell system, viral RNA and 
protein synthesis was first detected from 4 hpi by RT-PCR and Western blotting, 
respectively (358). Caco-2 cells are known to express MUC3 and low levels of MUC2 
mRNA (295, 441). In rotavirus-infected Caco-2 cells, MUC3 mRNA expression was 
increased to 1.5- to 2-fold at 2 and 4 hpi, although this did not reach statistical significance 
(Figure 3). We did however not observe increased or induced expression of the secretory 
mucins MUC2 and MUC5AC in these cells, respectively. MUC2 mRNA expression 
remained unaltered (Figure 3), whereas MUC5AC mRNA could not be detected in mock 
infected or rotavirus infected Caco-2 cells (data not shown). 
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Figure 3. Analyses of mucin mRNA expression in rotavirus-infected Caco-2 cells. MUC2 and MUC3 mRNA levels 
were semi-quantitatively determined by densitometric analysis of RT-PCR products. Control values per day were 
arbitrarily set at a relative expression of 1 and are represented as a dotted line. MUC2 levels remained unaltered 
during infection. MUC3 expression was increased at 2 and 4 hpi. MUC5AC could not be detected in mock infected 
or rotavirus infected Caco-2 cells (not shown). The efficiency of the PCR reactions was verified by amplifying 18S 
ribosomal RNA. 
 
Mucin expression by LS174T cells after incubation with prostaglandin 
MUC2 and MUC5AC are not expressed by enterocytes in vivo. MUC2 is normally expressed 
by goblet cells (426), whereas MUC5AC is normally confined to gastric epithelium (437), 
but can atypically be expressed by goblet cells in Barrett’s oesophagus, gastric metaplasia in 
the small intestine, in IBD and colorectal adenomas (55, 239, 382, 435, 436). The altered 
expression of Muc2 and Muc5ac found in infected mice can therefore not be explained by 
altered expression of these mucins in infected enterocytes, but are most likely brought about 
by goblet cells. Goblet cells are not a target for rotavirus infection. However, secreted PGE2 
and COX2 mRNA levels are increased between 2 and 8 hpi in rotavirus infection in Caco-2 
cells (358) and we observed a strong increase in Cox2 mRNA expression in rotavirus 
infected mice, suggesting a role for PGs in the induction of mucin expression observed 
during rotavirus infection. To determine whether prostaglandins could induce mucin mRNA 
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transcripts, we used the goblet cell-like cell line LS174T. LS174T cells express MUC2 
mRNA at a high level whereas MUC3 and MUC5AC mRNAs are present at low levels 
(441). Besides PGE2, we also wanted to examine the role of PGE1, since this PG was shown 
to induce MUC2 protein expression in the human adenocarcinoma cell line T84 (458). We 
therefore, incubated LS174T cells with different concentrations of the prostaglandins PGE1 
and PGE2 and examined if they could differentially regulate MUC2, MUC3 and MUC5AC 
mRNA expression. 
As an initial experiment, we incubated LS174T cells with PGE2 for respectively 8, 16 and 24 
hours (Figure 4). After 8 h induction with PGE2 semi-quantitative analysis of MUC2 mRNA 
expression showed increased transcripts at a concentration of 2.8 and 28 µM PGE2. After 16 
h no induction by PGE2 was observed, whereas after 24 h incubation with PGE2 resulted in a 
decrease of Muc2 mRNA expression compared to mock incubation. After 8 h of incubation 
PGE1 was able to induce MUC2 (2-fold compared to controls) and MUC3 (2.5-fold 
compared to control) levels at all tested concentrations, while this was significant for both 
mucins at a concentration of 1.4 µM (Figure 5A). PGE1 was able to increase MUC5AC 
mRNA expression only at a concentration of 1.4 µM (2-fold increase). However, this did not 
reach statistical significance. At all three concentrations, addition of PGE2 gave induction of 
MUC2 and MUC3 expression to maximal levels of 2.6- and 2.8-times the control values 
respectively (Figure 5B). For both mucins, this increase was statistically significant at a 
concentration of 1.4 µM. MUC5AC expression in LS174T was unaffected by addition of 
PGE2. 
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Figure 4. MUC2 expression in LS174T at different time-points after incubation with PGE2. LS174T cells were 
incubated with 2.8 and 28 µM of PGE2 for respectively 8, 16 and 24 hours. MUC2 mRNA levels were semi-
quantitatively determined by densitometric analysis of RT-PCR products. After 8 h induction with PGE2, MUC2 
mRNA levels were increased, whereas after 16 h or 24 h no induction with PGE2 was observed. The efficiency of 
the PCR reactions performed on human cell line cDNA was determined by amplifying human 18S rRNA. 
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Discussion 
 
We previously showed that COX2 mRNA and PGE2 levels were increased after rotavirus 
infection in vitro (358), whereas elevated levels of PGE2 and PGF2 were observed in the 
plasma and stool of rotavirus-infected children (466). Moreover, PGE2 and COX activity 
were shown crucial for rotavirus replication in Caco-2 cells and rotavirus illness in young 
children is reduced after oral aspirin, a non-specific COX inhibitor (358, 466). These 
findings strongly indicate that COX and PGs are involved in rotavirus replication and 
pathogenesis. 
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Figure 5. MUC2, MUC3, and MUC5AC expression in LS174T cells after 8 h of incubation with 0, 1.4, 2.8, or 28 
µM of PGE1 or PGE2. Mucin mRNA levels were semi-quantitatively determined by densitometric analysis of 
specific RT-PCR products. PGE1 was able to induce MUC2 and MUC3 mRNA significantly (A). PGE1 induced 
MUC5AC expression only at a concentration of 1.4 µΜ. Addition of PGE2 significantly increased MUC2 and 
MUC3 mRNA levels. MUC5AC expression in LS174T was unaffected by addition of PGE2. The efficiency of the 
PCR reactions performed on human cell line cDNA was determined by amplifying human 18S. * P<0.05, ** 
P<0.01, vs. control using Student’s t-test. a.u., arbitrary units. 
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In the present study, we found that Cox2 mRNA levels were also strongly increased in the 
ileum of rotavirus infected neonatal mice. Increased levels were found between 6 hours and 4 
days after infection, with peaks at 6 hpi and 4 dpi, largely corresponding to the peaks of viral 
replication at 1 and 4 dpi. These results imply that following Cox2 mRNA induction, PG 
levels could also have been increased in the small intestine in infected mice as was observed 
in infected children and Caco-2 cells (358, 466). Cox1 expression was not induced during 
infection and instead was even found to be slightly decreased at 2 dpi, which is possibly 
caused by the loss of epithelial cells at the tips of the villi, as has been previously described 
(43). 
Mucin mRNA levels were also found to be increased during rotavirus infection in mice. 
Goblet cell-specific Muc2 mRNA levels were found to be significantly increased at 1 dpi, 
whereas enterocyte-specific Muc3 mRNA levels were increased at 6 hpi and 1 dpi. The 
secretory mucin Muc5ac is normally confined to gastric epithelium (388) and expression in 
the small intestine of control mice was found to be extremely low as determined by RT-PCR. 
Expression of this mucin was however upregulated considerably in rotavirus infected 
neonatal mice. For all three mucins it was found that induction was observed at 1 dpi. 
Muc5ac levels followed the course of infection as expression of mRNA was provoked at 
both peaks of viral infection. 
Previous studies demonstrated that rotavirus infection has a profound effect on intestinal 
epithelial homeostasis. It was found that rotavirus infection hampers the expression of 
enterocyte absorptive genes (43, 84, 209, 306, 389, 402). In contrast, we found in this study 
that goblet cell and enterocyte-specific mucin expression were upregulated during massive 
viral replication. As mucins are recognized to serve protective functions in the gut (438), the 
upregulation might indicate that this is part of an innate protective response against 
infections of the gut. 
Mucin expression was also increased in the enterocyte-like Caco-2 cell line after infection 
with the rotavirus strain Wa. In accordance with the in vivo data, enterocyte-specific MUC3 
mRNA levels were moderately increased at 2 and 4 hpi. However, MUC2 mRNA levels 
remained unaltered and MUC5AC mRNA could not be detected in mock infected nor 
rotavirus infected Caco-2 cells. MUC2 and MUC5AC are not expressed by enterocytes in 
vivo, which might explain the non-responsiveness of these genes in infected Caco-2 cells. 
During rotavirus infection in Caco-2 cells, Cox2 mRNA and PGE2 levels are increased from 
2 to 8 hpi (358). Moreover, in this study we observed a strong increase in Cox2 mRNA 
expression in rotavirus-infected mice, suggesting a role for PGs in the induction of mucin 
expression observed in vivo during rotavirus infection. Whether PGE1 levels are increased in 
infected mice and-or Caco-2 cells still has to be determined. 
The induced expression of Muc2 and possibly also Muc5ac in rotavirus-infected mice was 
counted for by goblet cells. However, goblet cells are not a target for rotavirus infection, and 
therefore we aimed to determine whether PGs, that are apparently produced by infected 
entercytes and secreted in the lumen during rotavirus infection, could induce mucin 
transcription in the goblet cell culture model LS174T. After incubation, PGE1 and PGE2 
could directly induce MUC2 mRNA expression in LS174T cells in a dose-dependent 
manner. PGE1 and PGE2 were also able to induce MUC3 mRNA expression to a maximum 
increase of about three-fold. PGE1 induced MUC5AC expression about 2-fold, and this was 
only observed at a concentration of 1.4 µM. In contrast to studies in NCI-H293 airway 
epithelial cell (215), PGE2 was unable to induce MUC5AC expression in LS174T cells. 
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Since the increase of MUC5AC by PGE1 in LS174T cells was only moderate, other 
mediators are additionally involved in the induction of Muc5ac in infected mice. An 
interesting candidate that could be involved in the latter is TNF-α. TNF-α is found increased 
in rotavirus infected children (15) and is able to upregulate MUC5AC in airways via an 
epidermal growth factor receptor mediated route. Moreover TNF-α increases MUC5AC 
mRNA half-life (42) and induces MUC5AC secretion in HT29-MTX cells (397). The above 
findings suggest that the induction of mucin expression during rotavirus infection in vivo is 
to a large extent mediated by PGs.  
The increased PG levels during rotavirus infection could be produced by either infected- or 
noninfected epithelial cells, and/or the underlying submucosa. In agreement with this and 
other studies (14, 396, 458), our previous data (358) indicated that PGs indeed can be 
derived from (infected) epithelial cells. Submucosal cells like myofibroblasts can also induce 
PGs and were shown to alter the PGE1/PGE2 ratio in response to short chain fatty acids in 
favor of PGE1 (458). 
COX2 expression is mediated through the activation of mitogen-activated protein kinases 
(MAPK) (like extracellular signal-regulated kinase ERK and p38) and nuclear factor κB 
(NF-κB) (215, 238). The increased COX2 transcription in rotavirus-infected mice and 
infected Caco-2 cells (358), could directly have been stimulated by double stranded viral 
RNA (dsRNA) as has been observed in macrophages (404). However, a recent study 
indicates that the activation of COX2 transcription during rotavirus infection is most 
probably not primarily provoked by dsRNA, but via binding of the rotavirus outer capsid 
protein VP4 to the TNFR-associated factor 2 (TRAF2) leading to activation of TRAF 
signaling (226). This is in agreement with our previous findings, since we found that COX2 
levels were increased in Caco-2 cells after binding of rotavirus to the cells (358). 
Interestingly COX2 and PGE2 were induced by mucins in macrophages (184), suggesting the 
existence of a forward-loop mechanism. In rotavirus-infected mice however, induced Cox-2 
expression (6 hpi) preceded the increased mucin transcripts suggesting that a Cox-mediated 
pathway induced the mucin increase and not visa versa. 
In summary, our data show that Cox mRNA expression correlates with Muc2, Muc3 and 
Muc5ac mRNA levels during rotavirus infection in mice, indicating that PGs are mediating 
the mucin induction. In vitro data showed that rotavirus infection of enterocytes led to 
MUC3 mRNA induction and that PGE1 and PGE2 are both important inducers of mucin 
expression in goblet cells. PGE1 was able to induce MUC2, MUC3 and MUC5AC mRNA 
levels, whereas PGE2 was able to induce MUC2 and MUC3 mRNA levels. The in vitro 
induction of MUC2 and MUC3 mRNA by PGE1 and PGE2 mirrored the in vivo induction. 
However, the increase of MUC5AC by PGE1 in LS174T cells was only moderate, indicating 
that other pathways or other PGs (e.g. PGF) are likely to be involved in the induction of 
Muc5ac in infected mice. Moreover, it should be noted that although PGE1 could be involved 
in the increase in mucin expression during rotavirus infection, it has to be determined 
whether PGE1 levels are increased in infected mice and Caco-2 cells. 
Additional experiments will be required to define the precise role of PGs in mucin induction, 
and which (other) pathways or effectors are involved in the observed induction of Muc5ac. 
The present study suggests that mucin upregulation during rotavirus infection is mediated 
through rotavirus-induced Cox2 and PG upregulation. The rotavirus-induced prostaglandin 
production and subsequent mucin induction could have beneficial effects on the gut by 
supporting mucosal barrier integrity. 
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Abstract 
 
Rotavirus is an important cause of morbidity and mortality worldwide, and vaccines are 
currently under development. An unexpected side effect of the first licensed rotavirus 
vaccine, however, drew attention to possible effects of childhood infection or vaccination on 
the maturation of the immune system early in life. We examined the immune responses in 
infant BALB/c mice following oral inoculation with a standardized amount (2x106 CCID50) 
of heterologous simian rotavirus SA11 as a model for vaccination. The SA11 infectious virus 
was presented in in different backgrounds, which differed in antigen composition. Virus was 
purified from cell lysate by cesium chloride density gradient centrifugation. Fraction I was 
enriched for single shelled rotavirus particles, fraction II for double-shelled particles and 
fraction III consists mainly of infected-cell components. Inoculation with murine rotavirus 
EDIM (2x104 focus forming units) served as natural control infection. 
Diarrhea was observed after inoculation with EDIM and all three SA11 fractions. Viral 
shedding was observed in the EDIM inoculated group but not in any of the SA11 inoculated 
mice. We could not detect virus replication in the small intestine either by 
immunohistochemistry or in situ hybridization in SA11-infected mice, in contrast to 
observations in the EDIM inoculated mice indicating extra-intestinal replication. 
EDIM and SA11 fractions induced similar IgG responses but marginal IgA responses were 
found in the SA11 infected mice compared to the EDIM could be explained by the non-
mucosal replication of SA11. The rotavirus specific IgG1/2a ratio were similar in the EDIM 
and SA11 fraction 2 but a higher ratio was found for SA11 fraction 3 and a lower ratio was 
observed for SA11 fraction 1. This data shows that the composition of the fractions 
influences the outcome of the immune responses following infection with the same amount 
of infectious virus. The effect of different preparations of orally administered (vaccine) virus 
has become increasingly relevant following the finding of an as yet unexplained adverse 
effect (i.e. intussusception) of oral rotavirus vaccine. 
 
 
Introduction 
 
Immune-mediated gastrointestinal disorders including classic IgE-mediated food allergy 
(275), eosinophilic gastroenteritis (423), allergic colitis (391) and eosinophilic esophagitis 
(360) are primarily polygenic allergic disorders that involve Th2-type immune responses and 
are occurring with increased frequency in the developed countries. In infants, the immune 
system is skewed towards Th2 and thereby set favourably for IgE-mediated responses. 
Immunologic maturation is stimulated by different types of microbial exposure in early life 
that induce Th1 responses (134, 224). 
In the so called “hygiene hypothesis” (406) it has been postulated that reduced exposure of 
young children to common infections of childhood may lead to delayed maturation of the 
immune system, reflected by skewing of the Th1/Th2 balance in favor of Th2, and an 
increased likelihood of developing IgE mediated allergies in atopic individuals. Matricardi et 
al., suggested a role of enteric pathogens, following the observation of a 60% reduction of 
allergic diseases in 20 yr old military recruits that had a history of exposure to food and 
orofecal pathogens (259, 260). Rotavirus is a common enteric infection in early childhood, 
and even in developed countries the great majority of children under 5 years of age 
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experience at least one rotavirus infection (102). Therefore, the effect of a rotavirus infection 
in early life on the infant immune system may be important in relation to the hygiene 
hypothesis.  Worldwide approximately 440,000 children die each year from rotavirus 
diarrhea, mostly in the developing countries (313). For that reason, rotaviruses have received 
a high priority as a target for vaccine development. Most current rotavirus vaccine strategies 
are based on the use of heterologous (animal) rotaviruses to immunize humans to prevent 
subsequent infections with homologous (human) rotavirus (reviewed by (452). 
Studies of natural rotavirus infection have relied for a major part on the mouse model. 
Infections with murine rotavirus result in diarrhea through epithelial dysfunction and the 
effects of the virus-encoded enterotoxin NSP4 when given before 15 days of age, after which 
mice no longer experience clinical signs but shed the rotavirus in stools for 7 days after oral 
inoculation (59, 357, 453). Non-murine (heterologous) rotaviruses can be used in the same 
experimental design as a model for rotavirus vaccine, thus allowing us to compare wild-type 
(homologous) infection with vaccination (129, 140). For these infections, however, studies 
on the virulence and replication in the gastrointestinal epithelium in vivo are limited (24, 149, 
251). The dose of heterologous simian strains required to induce diarrhea in suckling mice is 
about 105 to 106 times higher than that required for a homologous murine virus strain. For 
that reason most of the studies on the oral heterologous rotavirus infections are done with 
unpurified tissue culture concentrates of rotaviruses. These crude virus preparations contain a 
mixture of complete and incomplete viral particles, as well as cellular proteins, and therefore 
are very different in antigenic composition from the (low dose) inocula used in the natural 
rotavirus infection. This lack of standardization makes a direct comparison of the data on 
rotavirus pathogenesis and immune responses for the different viruses very difficult. As part 
of ongoing studies on the hygiene hypothesis in which we measure the effects of rotavirus 
exposure on immune maturation and allergic challenge in young mice, we analyzed 
differences in the immune responses stimulated by different purified simian rotavirus SA11 
fractions. Furthermore we examined the pathogenesis of a heterologous rotavirus infection 
by examining the induction of diarrhea, and timing and extent of rotavirus replication in the 
gastrointestinal epithelium in mice. 
 
 
Materials and methods 
 
Virus and antigen preparation 
Two viruses were used in this study: The simian rotavirus SA11 was obtained from the 
American Type Culture Collection (ATCC, Rockville, MD) and the murine EDIM 
(Epizootic Diarrhea of Infant Mice) strain was provided by Dr. R. Ward, Children’s Hospital 
Research Foundation, Cincinnati, USA. The EDIM strain was titrated by fluorescent focus 
assay in monkey kidney MA104 cells (453). SA11 rotavirus was serially plaque purified 
three times by limiting dilution in MA104 cells. SA11 virus (trypsin-activated by adding 
10µg/ml at 37°C for 1hr) was subsequently grown at a multiplicity of infection (m.o.i.) of 0.1 
on MA104-cells attached to cytodex-3 microcarriers in a 3-liter spin culture flask (Wheaton 
Science products, Millville, USA) in Eagle MEM supplemented with, 2 mM glutamine, 
penicillin, streptomycin, 0.125% NaHCO3 and 0.5 µg/ml trypsin (Sigma Chemical Company 
St. Louis, MO.). Cells and medium were harvested when 100% cytopathological effect 
(CPE) was observed, and subjected to one cycle of freezing and thawing. The lysate was 
extracted with 10% arklone (tri-chloro-tri-floroethane, ICI), centrifuged 30 min 3000 rpm 
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and the aqueous phase was concentrated by ultrafiltration through a 10,000 MW membrane 
(Millipore Corporation, Bedford, MA). Finally cesium chloride (CsCl) was added to the 
suspension to reach a final density of 1.37 g/ml. Rotavirus particles and cellular components 
were separated by density gradient centrifugation (35,000 rpm, 18 hr, 4°C in a SW 40Ti rotor 
(Beckman)). Three fractions enriched for double-shelled (1.34 g/cm3) and single-shelled 
(1.36 g/cm3) rotavirus particles, and cellular/virus components (1.26 g/cm3) were collected 
and dialyzed extensively against PBS. For each preparation, the infectivity and 
(predominant) type of particles were determined by virus titration assays on MA104 cells 
and electron microscopy (EM). Purified SA11 rotavirus ELISA antigen was obtained by 
centrifugation of the concentrated virus suspension (ultrafiltrated as described above) 
through a 40% sucrose cushion. The pellet was resuspended in PBS by vigorous pipetting, 
and stored frozen in -20°C in aliquots. 
 
Preparation of monoclonal antibody AC3H7 
This antibody was used for many years in the lab and produced as follows. BALB/c mice (6-
10 week old) were immunized subcutaneously with 30µg CsCl purified double-shelled (ds) 
SA11 rotavirus emulsified in complete Freunds adjuvant, a second immunization 2 weeks 
later with 60 µg, and a final intravenous injection 1 week later with 100 µg purified ds SA11 
rotavirus. Fusion of single cell suspension of splenocytes with myeloma P3-X63-Ag8653 
cells was performed 3 days after the last vaccination using 40% polyethylene glycol and 
selection in HAT medium (455). Supernatants of wells with cell growth were screened for 
rotavirus specific IgG antibodies in an EIA as described below. Antibody-secreting 
hybridomas were cloned twice by limiting dilution. Five million viable cells were injected 
intraperitoneally into BALB/c mice previously primed with pristane (Sigma-Aldrich, Saint 
Louis, MO, USA). Ascitic fluid was harvested 1-2 weeks after cell inoculation, and stored at 
-70°C. 
 
Animals 
Pregnant BALB/c dams were obtained from Harlan CPB (Zeist, the Netherlands) at least 1 
week before partus and housed in microisolator cages containing sterile bedding, water and 
ovalbumin depleted food. All pups used in the experiments were between 6-8 days of age. 
Experiments were reviewed and approved by the ethics committee of the National Institute 
of Public Health and the Environment. 
 
Virus inoculation 
Litters of 6-8 days old BALB/c mice were orally infected with 100 µl EDIM (2*104 focus 
forming units (FFU) or one of the three different CsCl purified fractions of SA11 rotavirus. 
The infectious virus titers of the fractions administered were standardized to 2x106 CCID50  
(cell-culture infectious dose 50%) per mouse. Control animals were inoculated with mock-
infected cell lysate. Infected pups were examined daily for diarrhea by gentle palpation of the 
abdomen. Stools were scored from 0 to 4 based on color, texture and amount of stool. 
Normal feces were scored as 1, loose feces as 2, yellow feces as 3 and watery feces as 4. 
Stools with a score of ≥ 2 were considered as diarrhea (16). The daily proportion diarrheal 
samples was calculated by dividing their total by the total number of samples collected each 
day. Mice were anaesthetized with barbiturate/chloral hydrate i.p. and sacrificed. Segments 
of jejunum and ileum were collected immediately after euthanasia at different time points (1, 
2, 4, 7, 10 and 14 days post infection) for 5 infected and 3 control mice per time point. Gut 
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sections were flushed in cold PBS and fixed in 4% (wt/vol) paraformaldehyde (Merck, 
Darmstadt, Germany) for 4 hours and embedded in paraffin wax using routine procedures 
(446). Twenty-one days after oral infection, blood samples were taken by retro-orbital 
puncture. Sera were stored at -20°C before testing. 
 
Immunohistochemistry and in situ hybridization 
To determine the presence of replicating virus, immunohistochemistry and in situ 
hybridization were used. Paraffin-embedded tissues were sectioned (5 µm), deparaffinized 
with xylene (Merck) and rehydrated in graded ethanol solutions. Sections were incubated 
overnight at 4°C using the rabbit polyclonal antibodies K3PPIV (1/1000) directed against 
rotavirus SA11 and the rabbit polyclonal antibodies directed against the rotavirus non-
structural protein NSP4 (1/1000) as previously described (43, 346). In situ hybridization was 
performed as previously described using non-radioactive digoxigenin (DIG)-11-UTP labeled 
750 bp NSP4 (SA11 strain) hydrolyzed in 80 mM NaHCO3 and 120 mM Na2CO3, pH10.2 to 
obtain probes of various lengths (43, 91). 
 
Detection of rotavirus specific serum antibodies 
Rotavirus specific IgG, IgG1, IgG2a and IgA were determined by enzyme-linked 
immunosorbent assay (ELISA). After each incubation step the microtiter plates were washed 
four times with wash buffer (PBS supplemented with 0.05% Tween-20). Optimal dilutions of 
antigen, serum and conjugate were determined by checkerboard titration. Rotavirus specific 
IgG levels were measured by coating 96-wells maxisorp microtiter plates (Nalgene Nunc 
International, Roskilde, Denmark) with 1/100 dilution of polyclonal rabbit anti SA11 serum 
(K3PPIV) in coating buffer (0.05 M sodium carbonaat buffer [pH 9.6]. After an overnight 
incubation at 4°C, 100 µl of sucrose purified SA11 virus, 1/100 diluted in dilution buffer 
(PBS plus 0.5% Tween-20 plus 1% BSA) was added and incubated for 1 hour at 37°C. 
Subsequently, plates were loaded with 1/50 diluted mouse serum samples in dilution buffer 
and a pool of known positive and negative sera from rotavirus infected and sham infected 
mice respectively as controls. Plates were incubated for 1 hour at 37°C. The detector, 
phosphatase-conjugated goat anti-mouse Immunoglobulin G (Sigma Chemical Company St. 
Louis, Mo.) was added for 1 hour at 37°C. Incubation of the substrate p-
nitrophenylphosphate in a concentration of 1 mg/ml in 0.1 M glycine buffer (pH 10.4) was at 
room temperature for 10 min. The absorption values were measured at a wavelength of 405 
nm in an ELISA reader (Organon Teknika, Boxtel, Netherlands). A sample was considered 
positive when the OD was above the cutoff levels (mean + 3 SD of the samples of non-
immunized mice). 
For the detection of rotaspecific IgA titers in serum a capture ELISA was performed. Briefly, 
96-well microtiter plates (Nalgene Nunc International, Roskilde, Denmark) were coated 
overnight at 4°C with goat anti-mouse IgA (Sigma Chemical Company St. Louis, Mo.) in 
coating buffer. Serum samples were diluted 1/100 in dilution buffer and added to the plates. 
After an incubation of 1 hour at 37°C the plates were incubated with sucrose purified SA11 
virus, 1/100 diluted in dilution buffer for another hour at 37°C. Monoclonal antibody anti-
rotavirus SA11 [AC3H7] conjugated with horseradish peroxidase was added for 1 hour 37°C 
as a detector. After incubation with the substrate 3,3’,5,5’-tetramethyl-benzidine (Sigma 
Chemical Company St. Louis, Mo.) for 5 min at room temperature the absorption values 
were measured at a wavelength of 450 nm in an ELISA reader (Organon Teknika, Boxtel, 
Netherlands). The test was valid when the OD of the known positive control serum was 
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above 1.000 and a sample was considered positive when the OD was above the cutoff levels 
(mean + 3 SD of negative sera from sham infected mice). 
 
Detection of viral shedding 
Intestinal contents were collected from each sacrificed mouse at different time points (0-14 
days) post infection and stored at –20ºC. Fecal suspensions (10%) were prepared in PBS, 
clarified by centrifugation (1000g for 5 min) and analyzed by ELISA using the Premier 
rotaclone kit (Meridian Diagnostics, River Hills, USA) according to the manufacturer’s 
instructions or cultured on MA104 cells. 
 
Statistical analysis 
Statistical analysis of all data was performed using Student’s t-test for unpaired data (two-
tailed). Data were expressed, as the mean ± SEM and P values of ≤0.05 were considered 
statistically significant. 
 
 
Results 
 
Virus preparation 
CsCl fractionation of SA11-infected cell supernatant yielded three distinct visible bands in 
the gradient containing single shelled particles, double shelled particles and cell components 
respectively as determined by electron microscopy (EM) (Fig.1). Virus titers were 10 9.1, 10 
10.0 and 10 7.6 per ml, respectively. The final rotavirus antigen concentrations of the 
inoculated fractions as measured by ELISA were higher in fractions 1 (ss) (OD value 900) 
and 3 (mix) (OD >1400) compared to fraction 2 (ds) (OD 200) as shown in Fig. 1. 
 
Diarrhea in newborn mice inoculated with different fractions of simian SA11 and 
murine EDIM rotavirus strains 
The development and duration of diarrhea after inoculation with the different fractions of the 
heterologous SA11 rotavirus (2x106 CCID50) and homologous EDIM (2x104 FFU) over a 
period of seven days varied among the different CsCl fractions compared with wild type 
virus strain (Fig. 2). All virus preparations induced diarrhea in the newborn animals. In mice 
inoculated with the EDIM strain and SA11 fraction 3 (enriched with cell components) 
diarrhea was observed from day 1 after inoculation in respectively 45 and 30% of the 
animals, whereas diarrhea was observed from day 2 onwards in the groups inoculated with 
the other gradient purified fractions of SA11. Viral shedding in the EDIM inoculated group 
was observed from day 2 up to day 10 as we reported earlier (43) and no viral shedding was 
found in the SA11 infected animals (data not shown). 
 
Rotavirus-specific serum antibody responses in mice inoculated with different 
preparations of SA11 and the EDIM rotavirus strain 
Systemic rotavirus specific antibody responses (IgA, IgG, IgG1 and IgG2a) were measured 
in serum of individual mice at day 21 after inoculation. High rotavirus specific IgG responses 
were obtained in the EDIM-infected group, and in mice inoculated with SA11 fractions 1,2 
and 3 (Fig.3A). The mean IgG responses were significantly higher in the SA11 fraction 3 
infected animals compared to EDIM or the other fractions (p<0.05). The IgA responses on 
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the other hand were much lower in all SA11 infected animals compared to the EDIM 
infected animals (Fig. 3B). 
To examine the role of replication in the induction of IgA and IgG responses we orally 
inoculated mice with UV inactivated SA11 triple layered virus particles (fraction 2) 
corresponding to an original titer of 2x106 CCID50. We found a marginal IgG (one positive 
out of 25 mice) and no IgA responses in these mice (Fig.3), similar as in the mock-infected 
animals. 
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Figure 1. Virus preparations of SA11 infected cell supernatant. Virustitration, electron microscopy and rotavirus 
antigen ELISA determined the infectivity and type of particles and rotavirus antigen concentrations for each CsCl 
purified fractions of SA11. 
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Figure 2. Proportion of neonatal mice with diarrhea following oral inoculation with rotavirus murine EDIM strain 
or different CsCl purified fractions of simian SA11 strain or mock control. All fractions contained 1x106 TCID50 as 
determined by virus titration.  
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We then tested sera for specific IgG subtype responses, plotted as the IgG1/IgG2a ratio of 
SA11 compared to the EDIM group (Fig. 4). The IgG1/IgG2a ratio of specific antibodies in 
sera from mice inoculated with EDIM and fraction 1 (ss) of SA11 were similar but a 
significantly higher ratio was observed in the mice infected with fraction 3 of SA11. 
Furthermore the fraction 2 (ds) serum IgG1/IgG2a ratio of SA11 infected mice was 
significantly lower than that of EDIM infected mice and fraction 3 (Fig.4). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Systemic rotavirus-specific antibody responses in neonatal mice orally inoculated with rotavirus murine 
EDIM strain or different CsCl purified fractions of simian SA11 strain or mock control. Serum antirotavirus IgG (A) 
and IgA (B) levels were determined using ELISA from blood samples collected 21 days after inoculation. The data 
represent individual sera and the median. * (p<0.05) fraction 3 compared to fr1, fr2 and EDIM. ** (p<0.01) EDIM 
compared to fr1, fr2 and fr3. 
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Figure 4. Ratio of anti rotavirus IgG1/IgG2a subclass responses in serum of neonatal mice orally inoculated with 
rotavirus murine EDIM strain or different CsCl purified fractions of simian SA11 strain. Serum anti-rotavirus IgG1 
and IgG2a levels were determined using ELISA from a 1/50 dilution of blood samples collected 21 days after 
inoculation. The data represent the mean value ± SEM. * (p<0.01) fraction 1 compared with fraction 3; (p<0.05) # 
EDIM compared to fraction 1. 
 
Histological changes in the small intestine during rotavirus infection 
Histopathological changes in the small intestine were observed at 1 day past infection (dpi), 
and persisted through 7 dpi. In the EDIM as in the SA11 rotavirus fraction 2 infected animals 
throughout the whole intestine (duodenum, jejenum en ileum), these changes were 
characterized by swollen villus tips with enterocytes containing large vacuoles shown for 1 
dpi post infection in the jejunum (Fig.4). After 7 dpi almost complete resolution of the 
histopathological changes was observed (data not shown). In control animals no vacuoles 
were seen at any time-point. To determine the presence of replicating rotavius in the small 
intestine, NSP4 and rotavirus structural proteins were detected by immunohistochemistry and 
NSP4 mRNA was detected by in situ hybridization. At 1 dpi rotavirus structural -protein, 
NSP4 protein and mRNA were detected in almost all epithelial cells of the upper part of the 
small intestinal villi of EDIM-infected mice. No rotavirus proteins or mRNA could be 
detected in any section of the small intestine of SA11-infected or control mice at any time-
point (Fig.5). 
 
 
Discussion 
 
 
In most studies of immune response against heterologous rotavirus infections, crude 
concentrates of cell-culture grown virus are used (129, 140, 187, 209, 267, 270). That means 
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that in addition to the virus, these preparations contain unknown and non-standardized 
amounts of cellular proteins. We postulated that the type of purification of the viruses used in 
such infection experiments might influence the ensuing immune responses, thus leading to 
potentially ambiguous conclusions. The present study was designed to gain more insight into 
the influence of different preparations of the simian SA11 rotavirus on the immune response 
following oral delivery to suckling BALB/c mice. We found that each of the purified 
fractions of SA11, corresponding with the two forms of virus particles (double-shelled and 
single-shelled) and infected-cell components, are able to induce diarrhea in seven days old 
suckling BALB/c mice but with different kinetics. These fractions are enriched, but do not 
exclusively contain the specified components; infectious virus was present in all fractions 
administered but in different amounts. The preparations were standardized to 2x106 CCID50 
per mouse and effects were compared with those following infection with the murine EDIM 
strain (2x 104 FFU per animal). This standardization resulted in great differences in antigen 
content of the preparations. Nevertheless, similar serum IgG antibody responses were found 
in the different groups with a slightly higher response in the mice infected with the fraction 
with the highest concentration of cell components, which had the highest antigen content (fr. 
3). The IgG subtype responses were not equally distributed and we found a significantly 
higher IgG1/2a ratio in the animals inoculated with fraction 3 compared to the other fractions 
and the EDIM infected animals. This indicates an more Th2-like immune response following 
infection with rotavirus in the presence of abundant cell associated protein compared with 
infection with a more purified preparation or with EDIM (134). This shows that the 
composition of the fractions influences the outcome of the immune responses following 
infection with the same amount of infectious virus. This ‘adjuvant’ effect may be the result 
of the increased amount of antigen to which these mice are exposed, or result from adjuvant 
effect of an unknown component of infected cells. The effect of different preparations of 
orally administered (vaccine) virus has become increasingly relevant following the finding of 
an as yet unexplained adverse effect (i.e. intussusception) of oral rotavirus vaccine (287). 
This raised questions about the exact effect of heterologous rotavirus infection on the 
(neonatal) gut. There are additional reasons for this increased interest: 
Immune-mediated gastrointestinal disorders including classic IgE-mediated food allergy 
(275), eosinophilic gastroenteritis (423), allergic colitis (391) and eosinophilic esophagitis 
(360) are primarily polygenic allergic disorders that involve Th2-type immune responses and 
are occurring with increased frequency in the developed countries. Concomitantly, an 
increased prevalence of Th1-driven diseases like inflammatory bowel disease (IBD) (413, 
450) is seen. Therefore a better understanding of the factors that influence the development 
of a balanced mucosal immune response is essential. Mucosal vaccinations are part of the 
challenges of the immunological balance. 
The IgA titers were lower for the three fractions of SA11 compared to the EDIM strain 
despite comparable IgG titers. This observation has been found previously (385) and may be 
related to reduced replication in the intestine of the heterologous SA11 strain compared to 
the murine EDIM strain since replication is an important determinant of IgA responses to 
rotavirus. Indeed we did not find measurable virus shedding in the SA11-infected animals 
whereas virus antigen was readily detected in feces of the EDIM-infected animals. 
Contradictory to this observation is the fact that we did find diarrhea in infected animals up 
to 1 week after oral delivery of the SA11 virus. This suggests that replication took place 
since NSP4, thought to be important for the induction of diarrhea in young siblings, is not 
found in mature infectious virus particles and is only synthesized within the host cells during 
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virus replication (16). We cannot exclude the possibility of contamination with a small 
amount of NSP4 protein in the double-shelled and single-shelled particle fractions produced 
during virus growth in cell culture. Ball et al. (16) reported that diarrhea was observed within 
1 to 4 hours after inoculation of purified NSP4, which continued for up to 8 hours but 
occasionally persisted for 24 hours. Therefore, the diarrhea on day 1 in mice inoculated with 
fraction 3 may be explained by the presence of free NSP4. It seems unlikely that this was the 
case for mice inoculated with fraction 2 in our study as UV treatment resulted in abolishment 
of diarrhea and immune response. 
 
 
 
 
  
  
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Histological analysis of rotavirus replication in the small intestine in neonatal mice 2 days post oral 
inoculation with rotavirus murine EDIM strain or CsCl purified fraction 2 of simian SA11 strain or mock control. 
Sections were stained using polyclonal anti-rotavirus antigen (A) and NSP4 protein expression in jejunum was 
detected by immunohistochemistry (B) and NSP4 mRNA was detected by in situ hybridization (C). 
 
To further study the effects of heterologous infection, we examined intestinal sections from 
the mice infected with SA11 fraction 2 and EDIM. We observed large vacuoles in the small 
intestinal enterocytes of the villus following rotavirus exposure with the SA11, similar to 
those observed after EDIM infection (43). As indicated by the lack of viral shedding, we 
could not detect virus replication in the small intestine either by immunohistochemistry or in 
situ hybridization in SA11-infected mice, in contrast to observations in the EDIM inoculated 
mice. This suggests that replication may have occurred extraintestinally, as shown by Uhnoo 
et al. who found that infection with a heterologous rhesus rotavirus resulted in hepatitis in 
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84% of SCID and 21% of BALB/c mice (430). Furthermore, Blutt and coworkers showed 
viraemia and antigenaemia in infected patients and in animal models, suggesting that 
extraintestinal spread might be a common event (40). We cannot rule out intestinal 
replication as only a small segment of the different regions were analyzed by immuno-
histochemistry and in situ hybridization. However, replication of the heterologous SA11 
virus at a non-mucosal site could explain the low induction of (mucosal) IgA with a high 
systemic IgG response. In case of extraintestinal replication of the virus, the histological 
damage and diarrhea might be induced by a secreted viral factor and not by direct viral cpe 
(77, 306). A candidate factor could be NSP4, which is thought to mediate cell signaling by 
increasing intracellular calcium levels leading to chloride secretion in uninfected cells and 
diarrhea in young mice (16). 
Recently, we have shown that after EDIM infection of mice, NSP4 is produced in and 
secreted basolaterally from infected entrocytes (44). It is tempting to speculate that the 
basolaterally secreted NSP4 can subsequently be transported via the blood stream to the 
small intestine and initiate the pathological damage and diarrhea in inoculated mice. In 
summary, we show that the polarization of the immune response (Th1/Th2) against 
heterologous rotavirus is depending on the exact composition and the purification of the 
inoculum used, and that the level and possibly site of replication differs from wild-type 
rotavirus infection. Furthermore, it is demonstrated that the mucosal immune response is 
lacking after a heterologous infection by SA11. These factors should be evaluated with new 
rotavirus vaccines in upcoming trails, as they may have a significant impact on the neonatal 
immune system. 
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Abstract 
 
Rotavirus is the most important cause of viral gastroenteritis and dehydrating diarrhea in 
young children. The rotavirus non-structural protein 4 (NSP4) is an enterotoxin that was 
identified as an important agent in symptomatic rotavirus infection. To identify cellular 
proteins that interact with NSP4, a two-hybrid technique with Saccharomyces cerevisiae was 
used. NSP4 cDNA, derived from the human rotavirus strain Wa, was cloned into the yeast 
shuttle vector pGBKT7. An intestinal cDNA library derived from Caco-2 cells cloned into 
the yeast shuttle vector pGAD10 was screened for proteins that interact with NSP4. Protein 
interactions were confirmed in vivo by coimmunoprecipitation and immunohistochemical 
colocalization. After two-hybrid library screening, we repeatedly isolated cDNAs encoding 
the extracellular matrix (ECM) protein laminin-β3 (aa 274–878) and a cDNA encoding the 
ECM protein fibronectin (aa 1755-1884). Using deletion mutants of NSP4, the region of 
interaction with the ECM proteins was mapped between aa 87-145. Deletion analysis of 
laminin-β3 indicated that aa region 726-875 of laminin-β3 interacts with NSP4. Interaction 
of NSP4 with either laminin-β3 or fibronectin was confirmed by coimmunoprecipitation. 
NSP4 was present in infected enterocytes and in the basement membrane (BM) of infected 
neonatal mice and colocalized with laminin-β3, indicating a physiological interaction. In 
conclusion, the two-hybrid screening with NSP4 yielded two potential target proteins, 
laminin-β3 and fibronectin, interacting with the enterotoxin NSP4. The release of NSP4 from 
the basal side of infected epithelial cells and the subsequent binding to ECM proteins 
localized at the BM may signify a new mechanism by which rotavirus disease is established. 
 
 
Introduction 
 
Rotavirus is the most important cause of a severe, life-threatening viral gastroenteritis and 
dehydrating diarrhea in young children (123, 203). Mortality rates are low in developed 
countries, but about 440,000 children <5 years of age die each year in developing countries 
because of an infection with rotavirus (313). The high incidence of rotavirus disease, 
especially in developing countries, calls for the development of effective vaccines. However, 
efforts to develop safe and useful rotavirus vaccines are continuing, since the first vaccine 
routinely used in the U.S. was suspended in 1999 because of a possible association with 
intussusception (287). 
The nonstructural protein NSP4 encoded by rotavirus gene 10 has been shown to play a key 
role in viral morphogenesis (11, 12, 122, 271). In the ER membrane, NSP4 functions as a 
receptor for newly formed virus particles that are translocated across the ER membrane (11). 
Increasing lines of evidence show that NSP4 is involved in pathogenicity of rotavirus 
infection and that it acts as a viral enterotoxin (16, 173, 276, 374). When administered to 
young mice, NSP4 from different rotavirus groups, or a synthetic peptide corresponding to aa 
114-135 was able to induce age-dependent diarrhea (16, 173, 276, 374). After being secreted 
from infected cells, NSP4 is thought to mediate phospholipase C (PLC) dependent cell 
signaling by increasing intracellular calcium levels leading to chloride secretion in adjacent 
uninfected cells (16, 114, 280, 421). Studies with cystic fibrosis knockout mice imply that 
the age-dependent diarrhea-inducing properties of NSP4 are due to age-dependent changes in 
calcium-mediated anion permeability (280). Recent studies indicate that a specific cleavage 
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product of NSP4 (aa 112-175) is actively secreted from infected cells and that NSP4 is 
released from the apical side of infected epithelial cells via an atypical pathway that bypasses 
the Golgi apparatus and involves lipid microdomains called rafts (373, 480). Consistent with 
its proposed apical secretion, only apical but not basolateral administration of NSP4 was 
found to cause a reduction in the transepithelial electrical resistance (TER) and redistribution 
of Zonula occludens-1 in MDCK-1 cells (411). On the other hand, NSP4 is able to cause 
chloride secretion when added to either the apical (luminal) or basal (submucosal) surface of 
mouse mucosal sheets (16), indicating that NSP4 is possibly also active at the basal side of 
the intestinal epithelium. 
Laminin and fibronectin are multifunctional proteins with diverse biological activities. They 
can influence cell adhesion, growth, morphology, differentiation, migration, and 
agglutination as well as the assembly of the extracellular matrix (ECM) (86, 329). Members 
of the laminin family of glycoproteins are major constituents of basement membranes (BMs), 
ECMs found in close contact with individual cells and cell layers. Each laminin is a 
heterotrimer assembled from α, β, and γ chain subunits, secreted and incorporated into cell-
associated ECMs. Laminins can be found in association with other BM components 
(collagens, proteoglycans, and nidogens) and with a variety of other macromolecules 
including fibronectin and growth factors (422, 475). Through these interactions, laminins 
contribute to cell differentiation, cell shape and movement, maintenance of tissue 
phenotypes, and promotion of tissue survival. Laminin-5, a heterotrimer of α2, β3, and γ2 
chain subunits, can bind to α3β1, α6β4, and α6β1 integrins (64, 253, 292) and is distributed 
in BMs in several epithelial tissues including the intestine (75, 243). Fibronectin is a large 
multidomain protein that can exist in multiple forms that arise from alternative splicing of a 
single pre-mRNA (131, 220). Fibronectin mediates a wide variety of cellular interactions 
with the ECM and plays important roles in cell adhesion, migration, growth and 
differentiation (311). Each monomer consists of three types of repeating units (termed FN 
repeats): type I, type II and type III. These repeats account for approximately 90% of the 
fibronectin sequence and are also found in other molecules (311, 314). Fibronectin can be a 
ligand for many members of the integrin receptor family, including α5β1, α4β1, α4β7, α9β1 
(329), and it has several heparin binding sites (17, 60, 185). 
In this study, we used a two-hybrid system with Saccharomyces cerevisiae to identify 
proteins that interact with NSP4. After screening, we repeatedly isolated cDNAs encoding 
the ECM proteins laminin-β3 and fibronectin. The region of NSP4 responsible for interaction 
with both proteins was mapped between aa 87-145. Binding of NSP4 to laminin-β3 and 
fibronectin was further confirmed by coimmunoprecipitation in rotavirus-infected Caco-2 
cells and colocalization in the BMs of neonatal mice infected with rotavirus. These findings 
might reveal a novel pathway via which NSP4 is involved in rotavirus-induced diarrhea. 
 
 
Materials and Methods 
 
Two-hybrid screening 
The Matchmaker system 3 two-hybrid assay in the yeast S. cerevisiae (Clontech) (76, 132) 
was used to detect interactions between NSP4 and cellular proteins. An intestinal cDNA 
library derived from Caco-2 cells cloned into the yeast shuttle vector pGAD10 was obtained 
from C. Mitchelmore and O. Norén, Copenhagen, Denmark. The construct used as bait 
corresponded to the NSP4 protein of human rotavirus (Wa strain).  The NSP4 bait lacked the 
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hydrophobic N-terminus (aa 1-86) and was designated NSP4∆N (nt 300-750 and 
corresponding to aa 87-175). To obtain the pGBKT7-NSP4∆N bait a RT-PCR was 
performed with RNA from rotavirus Wa infected MA104 monkey kidney cells. NSP4∆N 
was cloned using a NSP4 forward primer (5’-
GGTACCATGGAGCAGGTTACTACAAAAGACG-3’) based on the NSP4 Wa coding 
sequence (nt 300-321; accession number AF093200 (68) and a reverse primer (5’-
TCCCCCGGGTCACATTAAGACCGTTCCT-3’) based on the SA11 coding sequence (nt 
730-750) (46). With these primers a NcoI restriction site was introduced at the 5’ 
(underlined) end and a SmaI restiction site was introduced at the 3’ end to allow in-frame 
insertion into the plasmid pGBKT7 (Clontech) containing the GAL4 DNA binding domain. 
The S. cerevisiae AH109 strain (Clontech) containing the four reporter genes ADE2, HIS3, 
MEL1 and lacZ was cotransfected with the pGBKT7-NSP4∆N bait plasmid and the pGAD10 
Caco-2 cDNA library by the lithium acetate method (144, 379). AH109 cells were grown on 
plates containing medium lacking tryptophan and leucine (Trp- Leu-) to select for the 
presence of both the bait and the library plasmids. 2 X 106 of these double transformants 
were then grown on dropout medium deprived of tryptophan, leucine, histidine and adenine 
(Trp- Leu- His- Ade-) to select for protein-protein interactions. Transformants that grew were 
assayed for α-galactosidase activity on X- α-Gal plates according to the manufacturer’s 
instructions (Clontech). Plasmids were extracted from blue yeast clones and were then 
transfected into Escherichia coli DH5α. Bacteria were grown on medium with ampicillin to 
select for bacteria containing library plasmids.  The plasmid DNA was then isolated and 
sequenced with an ABI 310 sequencer using a primer identical to nt 788-820 of the pGAD10 
cloning vector and a primer reverse complementary to nt 862-893 of the pGAD10 vector as a 
forward and reverse primer, respectively. Homology searches were performed using the 
National Center for Biotechnology Information database with Mega BLAST. All positive 
constructs were rescreened for their ability to grow on complete dropout medium when 
transfected together with the NSP4 bait or with the empty pGBKT7 plasmid to verify 
potential interactions and to eliminate false positives. 
 
Serum and monoclonal antibodies 
For immunostaining and immunoprecipitation experiments, we used the following 
antibodies: a NSP4 polyclonal rabbit hyper immune serum directed against aa 114-135 of the 
NSP4 SA11 strain (43), a rabbit polyclonal serum against aa 120-147 of SA11 NSP4 (480), a 
rabbit hyperimmune serum raised against SA11 rotavirus particles (43), the rabbit polyclonal 
anti-laminin-β3 (H300, Santa Cruz), the rabbit polyclonal anti-fibronectin (Sigma), and the 
goat polyclonal anti-laminin-β3 (C-19, Santa Cruz). Peroxidase-conjugated secondary 
antibodies were purchased from DAKO. 
 
Immunohistochemistry 
Tissue was obtained from 7-day-old BALB/c mice that were inoculated intra-gastrically with 
2 x 104 focus forming units (ffu) of the EDIM rotavirus strain as previously described (43). 
At different time points after infection, mice were sacrificed and tissue from the small 
intestine was fixed for immunohistochemistry as previously described (43). Deparaffinized 
and rehydrated sections of neonatal control mice and mice infected with the murine EDIM 
strain (43) were incubated overnight at 4°C using the following rabbit polyclonal antibodies, 
anti-NSP4 (114-135; 1:1000), anti-NSP4 (120-147; 1:1000), anti-SA11 (1:1500), or anti-
laminin-β3 (1:500). Immunohistochemistry was carried out as described previously (43, 
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346), however antigen unmasking for laminin-β3 was carried out by heating the sections for 
10 min in 0.01 M sodium citrate (pH 6.0) at 100°C and additional treatment with protease 
XXIV (Sigma) for 10 min at 37°C. The slides were analyzed by microscopy using a Nikon 
eclipse 800 microscope and Leica IM-500 software. 
 
Infection of Caco-2 cells, co-immunoprecipitation, and Western blotting 
Human colonic adenocarcinoma Caco-2 cells (Numico Research, Wageningen, The 
Netherlands) were grown and maintained in 75 cm2 tissue culture flasks in DMEM 
(Dulbecco’s Modified Eagle’s Medium; Gibco BRL) with glutamax-1, pyridoxine, 0.11g/L 
sodium pyruvate, 4.5 g/l glucose, 10% fetal calf serum (Integro), 100 U/ml penicillin 
(Sigma), 100 µg/ml streptomycin (Sigma) and non essential amino acids (Bio Whittaker 
Europe, Verviers, Belgium) at 37°C and 5% CO2 in a humidified atmosphere. One day prior 
to infection, Caco-2 cells were seeded in 175 cm2 tissue culture flasks at 2.6 X 105 cells per 
cm2.  
The human rotavirus strain Wa was obtained from Dr. M.Koopmans (National Institute for 
Public Health and the Environment, Bilthoven, The Netherlands), was activated using 10 
mg/ml trypsin (Sigma) at 37°C for 1 h. Rotavirus was diluted to 2 x 102 ffu/ml 
(corresponding to a multiplicity of infection of 0.5) in serum free DMEM. Cells were 
infected with rotavirus at 37°C, and 5% CO2 in a humidified atmosphere. After 15 h of 
incubation, cells were washed in phosphate-buffered saline (PBS) and harvested into Tris 
lysis buffer (20mM Tris pH7.5, 100mM NaCl, 0.5% NP-40, 0.5 mM EDTA, 0.5 mM PMSF, 
10 µg/ml Leupeptin, 10 µg/ml aprotinin and 10 µg/ml SBTI). Cells were swelled on ice for 
10 minutes and then lysed by 10 passages through a 23-gauge needle. The cellular 
homogenate was centrifuged at 10,000 X g for 10 min. Lysates (corresponding to 2.35 X 106 
cells) were immunoprecipitated with anti-NSP4 antibody for 2 h at 4°C, and then 25 µl of 
protein A-Sepharose CL-4B beads (Pharmacia) was added to the mixture and incubated for 
another 2 h at 4°C. Beads coupled to immune complexes were washed three times with Tris 
lysis buffer. The immune complexes were then suspended in 3X SDS-PAGE sample buffer 
and analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE; 
7.5% or 10% polyacrylamide) and Western blotting. Proteins were transferred to 
nitrocellulose membranes (Nitran; Schleier & Schuell, Dassell, Germany) and were 
consecutively incubated with the rabbit polyclonal antibodies anti-NSP4 (114-135; 1:1000) 
and anti-fibronectin (1:500) or the goat polyclonal antibody anti-laminin-β3 (1:500) and 
peroxidaseconjugated anti-rabbit or anti-goat secondary antibodies (1:2000). Bands were 
revealed by enhanced chemiluminescence (ECL), according to the instructions by the 
manufacturer (Amersham). 
 
Deletion analysis of NSP4 and laminin-β3 
Five NSP4 deletion fragments and five laminin-β3 deletion clones were obtained by PCR. 
For all forward primers used to create deletion mutants of NSP4 an NcoI site (underlined) 
was added at the beginning of the forward primer to direct in-frame subcloning in the 
pGBKT7 plasmid. 
The NSP4 clones NSP4-(87-114), NSP4-(87-145), NSP4-(113-145), NSP4-(145-175), and 
NSP4-(113-175) were obtained using the following primers; 5’-GGTACCATGGAGCAG-
GTTACTACAAAAGACG-3’ and 5’-ATCAATCATCTCCAGCTGACGTCTC-3’ (nt 301-
321 and nt 359-383); GGTACCATGGAGCAGGTTACTACAAAAGACG-3’ and 5’-
CCTTCGACATATCTATAACG-3’(nt 301-321 and nt 461-480); 5’-ACGCCATGGT-
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GATTGATAAACTAACTACTCG-3’ and 5’-CCTTCGACATATCTATAACG-3’(nt 376-
397 and nt 461-480); 5’-ATAGCCATGGCGAAGGAATTCAATCAGAA-3’ and 5’-
TCAACC TCTCACATGGATGC-3’(nt 475-493 and nt 558-577); 5’-ACGCCATGGTG-
ATTGATAAACTAACTACTCG-3’ and 5’-TCAACCTCTCACATGGATGC-3’ (nt 376-
397 and nt 558-577), based on accession number AF093200 (68). Primers for human 
laminin-β3 were based on the sequence with accession number NM_000228 (143). The 
laminin-β3 fragments corresponding to aa regions 274-377 (nt 903 to 1212), 368-497 (nt 
1185-1572), 488-618 (nt 1545-1935), 605-739 (nt 1896-2298), and 726-875 (nt 2259-2706) 
were obtained by PCR using the following oligonucleotides; 5’-
GAATTCGTCCACGATGTCTGTGTCTGC-3’ and 5’-GGTCTCCTGAATGGAAGCTCC-
3’; 5’-GAATTCGGAGCTTCCATTCAGGAGACC-3’ and 5’-CTGGTTGCACTGTGGG-
CTGAG-3’; 5’-GAATTCCCTCAGCCCACAGTGCAACCA-3’ and 5’-CTCCAGCC-
CAGGCCCTGACCA-3’; 5’-GAATTCACCGCCAGCCTGTGGTCAGGG-3’ and 5’-
GCGCGAGCTGTCGGAGACCTG-3’; 5’-GAATTCCAGGCTGCTCAGCAGGTCTCC-3’ 
and 5’CCTGGGTCTCCAAGCGCTGGG-3’, respectively. An EcoRI site (underlined) was 
added ad the beginning of the forward primers to direct in-frame insertion in the pGADT7 
plasmid containing the GAL4 activation domain. All constructs were controlled by DNA 
sequencing and expression of the corresponding fusion proteins in yeast cells. 
We investigated the interaction of the fragmented NSP4 proteins with a pGAD10 laminin-β3 
library clone (D19), the fragmented laminin-β3 clones in the PGADT7 vector, and the 
pGAD10 fibronectin library clone in yeast cells. Qualitative and quantitative results were 
obtained by assessing the ability of yeast to grow in the absence of histidine and adenine 
(Trp- Leu- His- Ade-), by the appearance of blue colonies in the presence of X-α-Gal (5-
bromo-4-chloro-3-indolylphosphate), and by assaying the α-galactosidase activity of yeast 
grown in liquid medium with the chromogenic substrate PNP-α-Gal (p-nitrophenyl-α-D-
galactopyranoside; Sigma-Aldrich) according to the manufacturer’s instructions (Clontech). 
 
Statistical analysis 
Statistical analysis of all data was performed using Student’s t-test for unpaired data (two 
tailed). Data were expressed as the mean ± SEM and P values of ≤ 0.05 were considered 
statistically significant. 
 
 
Results 
 
Identification of proteins binding to NSP4 
To identify host cell proteins that interact with the NSP4 enterotoxin of rotavirus, we used 
the yeast two-hybrid approach. NSP4 cDNA, derived from the human rotavirus strain Wa, 
was cloned into the yeast shuttle vector pGBKT7. We used amino acid region 87-175 of 
NSP4 (NSP4∆N) to screen an intestinal Caco-2 cell cDNA library, since the first 86 amino 
acids of NSP4 contain three hydrophobic domains. These domains could possibly interfere 
with the two-hybrid system, since the fusion proteins have to travel into the nucleus of the 
yeast cell where transactivation of the reporter genes occurs. Additionally, many functionally 
properties of NSP4 are located between amino acid 112 and 175 (12, 16, 163, 480). The 
intestinal cDNA library derived from Caco-2 cells was screened for proteins that might 
interact with NSP4∆N. The Caco-2 cell line has enterocyte-like characteristics and can be 
infected by the human rotavirus Wa strain. In total 238 transformants were able to activate 
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transcription of all reporter genes (MEL1, HIS3, ADE2). These transformants grew in the 
absence of histidine and adenine and showed blue colonies in the presence of X-α-Gal 
substrate. After re-screening, restriction analysis, and sequencing, twenty-three clones fused 
to the activating domain of GAL4 were identified.  
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Figure 1. Coimmunoprecipitation of NSP4 and laminin-β3, and NSP4 and fibronectin protein in infected Caco-2 
cells. NSP4 (fully glycosylated form 28 kD, nonglycosylated form 20 kD, lane 1), laminin-β3 (Lamβ-3, 140 kD, 
lane 2) and fibronectin (FN, 250 kD. lane 9) were detected by Western blotting in lysates from respectively infected 
(NSP4) and mock-infected Caco-2 cells (laminin-β3 and fibronectin) using specific antibodies. Lysates from 
infected or mock-infected Caco-2 cells were subjected to immunoprecipitation with protein A-Sepharose beads 
loaded with anti-NSP4 antibody (lanes 3 to 8). Immunoprecipitates were analyzed by SDS-PAGE and anti-NSP4 
(lanes 3 and 4), anti-laminin-β3 (lanes 5 and 6), or anti-fibronectin (lanes 7 and 8) Western blotting. The bands 
around 50 kD (asterisk; lanes 3-8) correspond to the immunoglobulin heavy chain. The immune complexes were 
analyzed on a 7.5% (lanes 7-9) or 10% (lanes 1-6) polyacrylamide gel. 
 
Twenty-two of these clones encoded a 1172 aa protein identified as laminin-β3 (accession 
number NM_000228). These clones were derived from three independent clones. The 
common overlapping sequence of these clones corresponded to aa 274 to 878 (nt 903-2716) 
of laminin-β3. One clone encoded aa 1755 to 1884 of a protein identified as fibronectin (nt 
5532-5919;accession number NM_002026). 
 
NSP4 interacts with laminin-β3 and fibronectin during rotavirus infection in Caco-2 
cells 
 
To establish that NSP4 associates in vivo with laminin-β3 and fibronectin, we performed co-
immunoprecipitation studies. Cell lysates from mock-infected or rotavirus Wa infected Caco-
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2 cells were prepared in a mild Tris lysis buffer. NSP4 (fully glycosylated and 
nonglycosylated forms 28 kD and 20 kD, respectively), laminin-β3 (140 kD) and fibronectin 
(250 kD) can be detected by Western blotting in lysates from respectively infected (NSP4) 
and mock-infected Caco-2 cells (laminin-β3 and fibronectin) using specific antibodies (Fig. 
1, lanes 1, 2 and 9). NSP4 was immunoprecipitated with hyper immune anti-NSP4 serum in 
lysates from infected Caco-2 cells, but not from mock infected Caco-2 cells (Fig 1, lanes 3 
and 4). After immunoprecipitation with anti-NSP4 serum, both fibronectin and laminin-β3 
could be detected in coimmunoprecipitated material from infected cells by Western blotting 
with specific goat and rabbit polyclonal antisera (Fig.1, lanes 6 and 8, respectively). No 
coimmunoprecipitation of NSP4 and fibronectin or NSP4 and laminin-β3 was observed in 
lysates from mock-infected Caco-2 cells (Fig.1B, lanes 5 and 7). Therefore, we demonstrated 
that NSP4 interacts with both fibronectin and laminin-β3 during rotavirus infection in Caco-
2 cells.  
 
NSP4 co-localizes with the enterocyte basement membrane during rotavirus infection 
in suckling mice 
As NSP4 interacts with laminin-β3 and fibronectin, proteins that are localized in the 
extracellular matrix (ECM), we wanted to investigate whether NSP4 could be detected in the 
ECM in vivo. We used embedded tissue from 11-day-old BALB/c mice that had been 
inoculated with 2 x 104 focus forming units (ffu) of the EDIM rotavirus strain or tissue from 
control mice that were mock infected with PBS. In this mouse model that we previously 
described, virus replication occurs in two peaks at 1 and 4 days post infection (dpi) and mice 
develop diarrhea over a period of 5 days (43).  The onset of diarrhea is at 1 dpi, with the 
highest percentage of diarrhea and maximal severity of diarrheal illnes at 3 days post 
infection (dpi). In infected mice at 1 (data not shown) and 4 dpi, anti-NSP4 (114-135) rabbit 
polyclonal serum stained infected epithelial cells of the small intestine (jejunum) (Fig. 2A 
and C, see Appendix). The antiserum however also stained the BM of infected cells on the 
villi as well as the BM of non-infected cells further down the villus (Fig. 2C, Appendix). 
When infected cells were observed low on the villus, we could detect NSP4 in the BM of 
lower villus- and crypt cells (Fig 2F, Appendix). Pre-immune serum (obtained before antigen 
boosting with NSP4; Fig.2B, Appendix) did not stain an adjacent section of infected tissue, 
indicating that the NSP4 staining was specific. With control mice 4 days after mock infection 
with PBS, no staining was observed with the NSP4 antiserum (Fig. 2D, Appendix). Similar to 
the anti-NSP4 (114-135) rabbit serum, a rabbit polyclonal serum against SA11 NSP4 aa 120-
147 (480), also stained the BM of uninfected as well as infected epithelial cells in infected 
mice (data not shown). A rabbit polyclonal antiserum against SA11 rotavirus only stained 
infected cells and not the BM (Fig 2E, Appendix), indicating that rotavirus structural proteins 
are not present in the BM and that BM staining was specific for the NSP4 antibodies. Using 
adjacent immunohistochemical sections NSP4 could be colocalized with laminin-β3 in the 
BM of small intestinal epithelial cells (Fig 3). During rotavirus infection in neonatal mice, 
laminin-β3 was detected in the BM of small intestinal epithelium at 4 days post infection 
(Fig 3A). In the adjacent section (Fig 3B), rotavirus-infected cells were detected with the 
anti-NSP4 antibody, whereas the BM of infected- and non-infected cells was also stained. 
During development, laminin-5 (or its single subunits) is initially present in the BM 
associated with both the villus- and crypt epithelium. Expression in the adult human small 
intestine is eventually mainly restricted to the villus region, with only weak expression in the 
BM of the upper crypt region (219, 230, 243). In agreement with these data, laminin-β3 was 
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detected in the BM associated with villus- as well as crypt epithelium in eleven-day-old mice 
(Fig 3C). In twenty eight-day-old mice that are not susceptible to rotavirus-induced diarrhea 
(341), laminin-β3 expression appeared decreased and was only weak in the BM of the villus 
and upper crypt region (Fig 3D). These observations suggest that NSP4 is released on the 
basal side from infected epithelial cells in neonatal mice and binds to laminin-β3 in the 
extracellular matrix. We also tested several anti-fibronectin antibodies in order to stain the 
BM. Using paraffin embedded tissue all the antibodies failed to stain the BM.  In contrast, 
using frozen tissue sections, numerous studies previously described expression of fibronectin 
in the BM of small intestinal tissue in different species (20, 22, 26, 219, 228, 340, 395). 
These studies point out that fibronectin is found predominantly in the crypt region while 
expression gradually decreases towards the tips of the villi. Therefore, it is apparent that 
NSP4, similar to laminin-β3, also co-localizes with fibronectin in the extracellular matrix, 
although we could not detect fibronectin with our methods. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Colocalization of NSP4 with laminin-β3 in the BM of small intestinal epithelial cells during rotavirus 
infection in neonatal mice. Laminin-β3 was detected in the BM of small intestinal epithelium at 4 days post 
infection (A, arrow). In the adjacent section (B), rotavirus-infected cells were detected with the anti-NSP4 antibody 
(arrowhead), whereas the BM of infected- and non-infected cells were also stained (arrow). Laminin-β3 was 
detected in the BM associated with the villus and crypt epithelium (open arrowhead) in eleven-day-old mice (C).  In 
twenty eight-day-old old mice, laminin-β3 expression was decreased in the BM of the villus region, weak in the 
upper crypt region, and not observed in the lower crypt region (D, open arrowhead). Panels A and B are cross-
sectional slides, original magnification, X 600. Panels C and D are longitudinal slides, original magnification, X 
200. 
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Characterization of the interacting domains of NSP4, laminin-β3, and fibronectin 
The laminin-β3 aa 274-878 insert region contains four laminin-type epidermal growth factor 
like (EGF) domains  (aa 277-304, aa 378-428, aa 431-478, and aa 533-570), an intermediate 
filament protein domain (aa 627-686), and a small region of the coiled-coil forming domain 
(myosin tail; aa 868-878) (Fig. 4; NM_000228; (143) and using the NCBI, conserved domain 
database). To evaluate which regions or domains of laminin-β3 interact with NSP4 we 
constructed five different deletion fragments of the laminin-β3 clones and tested them 
against NSP4∆N in the yeast-two-hybrid screening (Fig 4). The readout of the interaction 
between the various laminin-β3 deletion mutants with NSP4∆N was the growth of yeasts 
harboring the two plasmids in His- Ade- medium and the development of a blue color in the 
presence of X-α-Gal substrate (Fig. 4). As a negative control, the laminin-β3 clones were 
also screened against the pGBKT7 plasmid without NSP4 as bait. Only laminin-β3 aa 274–
878 or the laminin-β3 clone aa 726-875 interacted with NSP4. None of the other constructs 
encoding a fragment of laminin-β3 was able to interact with NSP4 (Fig. 4). This indicates 
that NSP4 interacts with the region between aa 726 and 875 of laminin-β3. 
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Figure 4. Binding domain analysis of laminin-β3 with NSP4∆N. Laminin-β3 insert of clone D19 (aa 274-875) was 
fragmented into 5 subclones using PCR. Bars represent truncated laminin-β3 inserts fused to the GAL4 activation 
domain. Amino acid positions are indicated. AH109 yeast was cotransformed with the laminin-β3 clones and 
pGBKT7-NSP4∆N. The interaction was assessed by checking for blue colonies in the presence of X-α-Gal. 
Functional and structural domains of laminin-β3 are presented in boxes. 
 
The NSP4∆N bait (aa 87-175) presents several previously described functional domains 
including: an amphipatic alpha helical region (aa 95-137) involved in the formation of a 
coiled coil domain, oligomerization and membrane destabilizing activities of NSP4 (290, 
416, 420); an enterotoxic peptide sequence (aa 114-135) domain that was shown to induce 
diarrhea in young mice and potentate chloride secretion (16), and seems to be involved in the 
direct inhibitory effect of NSP4 on the Na-D-glucose symporter (SGLT1) (163); a VP4 
binding site (aa 112-146) (12); and a region that functions as a receptor for inner capsid 
particles (aa 156-175) (297). Using polymerase chain reaction (PCR), we constructed five 
mutants of NSP4. In order to map the sites of NSP4 involved in binding, these mutants were 
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sub-cloned in the pGBKT7 plasmid, to obtain deletion mutants of NSP4 fused to the DNA 
binding domain of the yeast transcription factor GAL4, and screened against the GAL4-
activating domain fusion proteins laminin-β3 aa 274-878, laminin-β3 aa 726-875, and 
fibronectin in a yeast-two-hybrid screening (Fig 5A). The interaction of the five NSP4 
deletion clones with laminin-β3 aa 274-878, laminin-β3 aa 726-875, or fibronectin was 
assayed on His- Ade- selection medium in the presence of X-α-Gal substrate through 
selection by growth and the development of blue colonies (Fig. 5A). Interactions were 
confirmed in a quantitative α-galactosidase assay based on the induction of the Mel1 gene 
(Fig. 5B). NSP4∆N was used as a positive control. Deletion of aa 87-114 of NSP4 in the 
NSP4 aa 113-175 subclone abolished or suppressed the interaction of NSP4 with laminin-β3 
274-878 and laminin-β3 aa 726-875 respectively (Fig 5A and B). The laminin-β3 aa 726-875 
fragment was able to interact with the NSP4 truncated clones aa 87-114 and aa 113-145. 
These interactions however were significantly suppressed compared to the interactions with 
NSP4∆N and NSP4 aa 87-145. Interaction of laminin-β3 aa 726-875 with NSP4 was much 
stronger than with the full length laminin-β3 clone. This could be due to the fact that the 
laminin-β3 subclones were constructed in the pGADT7 high copy number vector instead of 
the pGAD10 low copy number vector used for the construction of the Caco-2 cDNA library. 
However, on the other hand, shorter fragments frequently give stronger interactions than 
longer fragments when using the two-hybrid system, which can be caused by differences in 
folding of the fusion proteins (183, 326). 
The fibronectin insert (aa 1755-1884) contains the last 57 aa of the fibronectin type III FN 
repeat FN12, and the first 72 aa of FN13 (383). This region of fibronectin lies within a region 
known as the heparin-binding site II (HepII) (17, 60, 185), and shown to be involved in the 
binding of fibronectin to syndecan-4 (462), tenascin-C (181), and the integrins α4β1 and 
αIIbβ3, (274, 284). Interaction of NSP4 with fibronectin was only abolished when the C-
terminal clone NSP4 aa 145-175 was used in the two-hybrid screening (Fig 5A and B). 
These data indicate that for the interaction of NSP4 with laminin-β3 and fibronectin, aa 87-
145 are sufficient and that for binding to laminin-β3 aa 87-114 are most important. 
 
 
Discussion 
 
To date, several cellular partners of NSP4 have been identified. NSP4 has been shown to 
interact with the ER-associated lectin-like chaperone calnexin during infection in MA104 
cells (273). For this interaction glycosylation of NSP4 was important and glucose trimming 
was necessary, indicating that the N-terminal domain of NSP4 is involved, and that binding 
to calnexin is of a carbohydrate nature. NSP4 has a direct inhibiting effect on the Na-D-
glucose symporter (SGLT1), indicating that NSP4 inhibits water resorption and thus is 
crucial for rotavirus pathogenesis (163). However, whether or not the inhibition involves 
direct binding of NSP4 to SGLT1 has to be confirmed. Finally, NSP4 has been identified 
along microtubule-like structures, where it disrupts microtubule-mediated membrane 
trafficking from the ER to Golgi complex (465). Although several NSP4-interacting proteins 
have thus far been identified, none revealed more insight into the mechanism of NSP4-
induced chloride secretion. 
In the present work we, searched for cellular proteins that interact with the rotavirus protein 
NSP4, in order to gain more insight into rotavirus pathogenesis. For this purpose we used the 
two-hybrid technique in yeast and screened a human Caco-2 cell cDNA library fused to the 
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GAL4 activation domain with aa 87-175 of NSP4 fused to the DNA-binding domain of 
GAL4. As NSP4-interacting cDNA clones, laminin-β3 and fibronectin were isolated. The 
interaction of NSP4 with the ECM proteins, laminin-β3 and fibronectin, was confirmed by 
coimmunoprecipitation of infected Caco-2 cell lysates. The interaction with laminin-β3 was 
further established by colocalization of NSP4 with laminin-β3 in the basement membranes of 
infected neonatal mice. Deletion analysis showed that aa 87-145 of NSP4 were sufficient for 
interaction with laminin-β3 and fibronectin. For binding to laminin-β3 aa 87-114 of NSP4 
were the most important. Interaction of NSP4 with laminin-β3 and fibronectin was only 
abolished when the C-terminal clone NSP4 aa 145-175 was used in the two-hybrid 
screening, indicating that this C-terminal region is not involved in NSP4 binding. The insert 
of the laminin-β3 clones encoded several conserved domains. NSP4 was only found to 
interact with a truncated laminin-β3 fragment (aa 726-875) containing the N-terminal part of 
a domain involved in the formation of the triple-stranded α-helical coil-coiled structure that 
represents the rod of the long arm of laminins (182, 432). 
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Figure 5. Binding domain analysis of NSP4 with laminin-β3 (aa 274-878), laminin-β3 (aa 726-875), and fibronectin 
(aa 1755-1885). NSP4∆N was fragmented into 5 subclones using PCR (A). Bars represent truncated NSP4 clones 
fused to the GAL4 binding domain. Amino acid positions are indicated. AH109 yeast was cotransformed with the 
laminin-β3 clones and pGBKT7-NSP4∆N. The interactions were assessed by checking for blue colonies in the 
presence of X-α-Gal. Functional and structural domains of NSP4 are presented in boxes. Quantitative analysis of the 
interactions were obtained from independent yeast cotransformants assayed with p-nitrophenyl-α-D-galactosidase as 
substrate (B). α-Galactosidase activity was expressed in units and calculated by the following formula: (OD410 X 
Vf X 1,000)/[OD600 X T X (ε x b) X Vi], where OD410 is the absorbance of the reaction mixture, OD600 is the cell 
density of the culture, T is the reaction time (in minutes), Vf is the total volume (in milliliters) of the assay, Vi is the 
volume of culture medium supernatant added, ε is the molar absorbtivity for p-nitrophenol, and b is the light path (in 
centimeters). Solid, open, and striped bars correspond to interactions of laminin-β3 (D19 clone), laminin-β3 aa 726-
875, and fibronectin (clone D22) with the indicated NSP4 constructs, respectively.  Standard error of the mean are 
shown (n =3). * P<0.05, ***P<0.001 using Student’s t-test. 
 
The fibronectin insert (aa 1755-1884) contains the last 57 aa of the fibronectin type III FN 
repeat FN12, and the first 72 aa of FN13 (383). This region of fibronectin called the HepII 
region, is known to be involved in cell binding and cell spreading (38, 462), and binds to 
heparan sulfate proteoglycans like syndecan-4 (17, 60, 185, 462), tenascin-C (181), and 
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integrins α4β1 and αIIbβ3, (274, 284), (17, 60, 185). The fibronectin insert found with the 
two-hybrid system, contains all six basic residues previously shown to be crucial for heparin 
binding (60) and thus represents the principal heparin-binding site of fibronectin. By binding 
to the HepII region in fibronectin, syndecan-4 has been shown to function as a co-receptor in 
integrin signaling (462). It might be possible that NSP4, through binding to fibronectin, 
could interfere with this interaction and influence integrin signaling. Such a mechanism was 
observed for tenascin-C as binding of tenascin-C interfered with fibronectin-syndecan-4 
interaction and replaced syndecan-4, thereby influencing cell signaling and proliferation 
(181). The fibronectin type III domain is a very common constituent of animal proteins, and 
its main functions are to mediate protein-protein interactions and to act as a linker (62). 
Fibronectin type III domains have been found in intracellular, extracellular, and membrane-
spanning proteins and are additionally found in many bacterial extracellular glycohydrolases 
(62, 235). 
Rotavirus-induced disease is thought to be caused by a combination of factors (369), 
including a reduction in epithelial surface area, replacement of mature enterocytes by 
immature (crypt-like) cells  (43, 306), an osmotic effect resulting from incomplete absorption 
of carbohydrates from the intestinal lumen in combination with bacterial fermentation of 
these non-absorbed compounds, secretion of intestinal fluid and electrolytes through 
activation of the enteric nervous system (ENS)(246), and the secretory effect of NSP4, which 
is thought to act as a viral enterotoxin (16). During rotavirus infection, there is an enhanced 
turnover of epithelial cells that is thought to result in the presence of immature cells on the 
villi (43, 306). Since laminin-5 and fibronectin are proteins involved in cell differentiation 
and cellular migration (20, 22, 311, 340, 395), it is possible that NSP4 could modulate 
migration and/or differentiation of epithelial cells via binding to fibronectin and laminin. The 
mechanism contributing to diarrheal disease and involving NSP4 is thought to occur through 
release of NSP4, or its cleavage product (NSP4 (112-175), from infected cells and binding to 
a yet-unidentified apical membrane receptor. Binding would directly or indirectly trigger a 
signal transduction pathway to enhance chloride secretion, eventually resulting in diarrhea 
(16, 126, 279, 480). This secretory mechanism however is thought to act in the intestinal 
crypts (247). It is still not clear if and how NSP4 reaches the intestinal crypts. However, it 
seems unlikely that this occurs via the luminal route since continuous abundant secretion 
from the crypts results in a hydrodynamic flow against which NSP4 has to diffuse (247). We 
observed a BM localization of NSP4 and colocalization with laminin-β3 in the ECM during 
rotavirus infection in neonatal mice. BM localization was found underneath infected as well 
as non-infected cells. Our data therefore suggest that NSP4 is also released from the basal 
side of infected enterocytes. We currently can only speculate about whether NSP4, or a 
cleavage product, is being released from the basal side of infected cells. However, since we 
detected NSP4 in vivo at the BM with antibodies against aa 114-135 and aa 120-147, it can 
be concluded that the released peptide sequence at least contains the enterotoxic domain. 
After basal release, NSP4 would bind to the extracellular matrix proteins laminin-β3 and 
fibronectin. Since, we could detect NSP4 in the BM of lower villus cells and occasionally 
underneath epithelial cells in the crypts, it is temping to speculate that, via a route involving 
the ECM, NSP4 could travel towards the crypt region where it can induce fluid secretion. In 
concurrence with the hypothesis stated above and with our results, Ball and coworkers found 
that NSP4 is able to cause chloride secretion when added to the submucosal (basal) surface 
of mouse mucosal sheets (16). 
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Recent studies indicate that rotavirus infection is not confined to the intestine, but instead is 
able to leave the intestine and enters the circulatory system (40, 282). Rotavirus has been 
detected in cerebral spinal fluid ((188, 248, 294, 310, 474)), liver and kidney (145), extra-
intestinal lymphoid tissue (54), and serum of infected children and animals (40, 431). Using 
in situ RT-PCR, rotavirus was also found in the heart, where it was mainly localized to 
endothelial cells (282). It was suggested that rotavirus, analogous to what has been found for 
reovirus, gets into the circulatory system through M cells that are present in the epithelium 
that overlies the Peyer’s patches (40, 282). Our data also imply that NSP4 could be able to 
get into the circulatory system, as it is apparently at least partly secreted into the tissue 
underlying the enterocytes. If NSP4 is also able to get into the circulatory system, it is likely 
that it does so through release from the basal side of infected epithelial cells.  
In summary, our results show that NSP4 binds to the ECM molecules laminin-β3 and 
fibronectin in vitro and in vivo. Binding to the ECM and localization at the BM imply that 
NSP4 is released from the basal side of infected epithelial cells. From our data the 
significance of the deposition of NSP4 in the BM is still unclear, but it could possibly point 
to a new mechanism by which rotavirus disease is established. The involved mechanisms 
however, remain to be defined. 
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Summary 
 
Rotaviruses comprise a genus within the family of the Reoviridae and are recognized as the 
single most significant cause of severe gastroenteritis, malnutrition and diarrhea in young 
children. Each year rotavirus causes the death of about 440.000 children <5 years of age 
(313). The research described in this thesis focuses on the multifactorial process of rotavirus 
pathogenesis. This chapter summarizes and discusses the results of the preceding chapters 
and will focus on some aspects in more detail. 
Chapter 1 provides a general overview on rotaviruses, describes the current “state of the art” 
on rotavirus pathogenesis and outlines the aims of this thesis. Chapter 2 of this thesis 
describes the effect of rotavirus infection on epithelial homeostasis and dysfunction during 
rotavirus infection in neonatal mice. After inoculating seven-days-old suckling mice with a 
homologous rotavirus, virus replication occurred in two peaks, and histological changes were 
characterized by the accumulation of vacuolated enterocytes. During infection, apoptosis as 
well as proliferation were increased and epithelial cell turnover was significantly higher than 
in control mice. The overall outcome of these changes was an increase in crypt depth and the 
occurrence of villus atrophy. Rotavirus infection also caused a down regulation of enterocyte 
specific gene expression (mRNA and protein) in infected cells. This shut-off of enterocyte 
specific gene expression, together with the loss of mature enterocytes through apoptosis and 
the replacement of these cells by less differentiated dividing cells, are expected to lead to a 
defective absorptive function of the intestinal epithelium that contributes to rotavirus 
pathogenesis. In chapter 3, we evaluated the role of goblet cells and mucins in the active 
defense against rotavirus infection. We found that during rotavirus infection goblet cells, in 
contrast to enterocytes, are spared from apoptosis, intestinal mucin Muc2 expression is up-
regulated and mucin structure is changed. This suggests that mucins and in particular Muc2, 
play an important role in the active defense against rotavirus infection. In this chapter, we 
further show that age-dependent differences in mucin composition and increased occurrence 
of sialylated mucins after infection alter the inhibitory capabilities of mucins isolated from 
the mouse small intestine. This suggests that posttranslational modification in glycosylation 
of mucins during infection alters their anti-viral capabilities and ultimately can affect their 
specific epithelial barrier function against intestinal pathogens. In chapter 4, the role of 
prostaglandins in mucin expression during rotavirus infection was examined. We found that 
Cox2 mRNA expression is strongly enhanced during rotavirus infection in neonatal mice, 
implying increased PG production. Infected mice also showed increased levels of Muc2, 
Muc3 and Muc5AC mRNAs. In vitro experiments were performed to evaluate the role of 
PGs in mucin transcription. As an enterocyte model, Caco-2 cells “mirrored” the 
observations in mice and showed increased enterocyte-specific MUC3 mRNA expression 
during rotavirus infection. In the goblet cell line LS174T, PGE1 and PGE2 were able to 
induce MUC2 and MUC3 mRNA. However, PGE2 failed to induce MUC5AC mRNA, 
whereas the PGE1 was only able to moderately increase MUC5AC mRNA levels, indicating 
that other pathways and/or other PGs are likely to be involved in the induction of this mucin. 
In particular, these findings suggest that mucin up regulation during rotavirus infection is 
mediated at least in part through up regulation of rotavirus-induced Cox2 and PG levels. 
Moreover, the rotavirus-induced prostaglandin production and subsequent mucin induction 
could have beneficial effects on the gut by supporting mucosal barrier integrity. Chapter 5 
describes the immune responses in infant mice following oral inoculation with murine 
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rotavirus as a model for natural infection and heterologous simian rotavirus (SA11) as a 
model for vaccination. For the heterologous infections, three different fractions (with 
dissimilar composition) obtained after purification by cesium chloride density gradient 
centrifugation were used for inoculation. Diarrhea was observed after inoculation with EDIM 
and all three SA11 fractions. Viral shedding was observed in the group inoculated with the 
murine virus, but not in any of the mice inoculated with the heterologous virus. Moreover, in 
contrast to the homologous infection, heterologous virus replication could not be detected in 
the mouse small intestine using various techniques. The homologous virus and the 
heterologous virus fractions induced similar IgG responses but only minor IgA responses 
were found in the mice infected with the heterologous virus compared to the murine virus. 
The rotavirus specific IgG1/2a ratios differed between the three heterologous virus fractions. 
The results suggest that the polarization of the immune response (Th1/Th2) against 
heterologous rotavirus is depending on the composition of the inoculum used. Furthermore, 
the level and possible site of replication of heterologous rotavirus differs from wild-type 
rotavirus infection, whereas the mucosal immune response is lacking after a heterologous 
infection. These factors should be evaluated with respect to the development of novel 
rotavirus vaccines as they may have a significant impact on the neonatal immune system. In 
chapter 6 we aimed to identify cellular proteins that interact with the rotavirus enterotoxin 
NSP4. Using the two-hybrid technique as an approach, we isolated cDNAs encoding the 
extracellular matrix (ECM) proteins laminin-β3 and fibronectin. By means of deletion 
analyses, we mapped the regions of NSP4 and Laminin-β3 responsible for interaction. 
Interaction of NSP4 with either laminin-β3 or fibronectin was further confirmed by 
coimmunoprecipitation. Additionally, NSP4 was present in the basement membrane (BM) of 
infected mice and colocalized with laminin-β3, indicating a physiological interaction. 
Binding to the ECM and localization at the BM suggests that NSP4 is released from the basal 
side of infected epithelial cells. These findings may denote a new mechanism by which 
rotavirus disease is established. 
 
 
Discussion 
 
Rotavirus induced diarrhea is thought to be a multifactorial process that is caused by a 
combination of factors (369), which include a reduction in epithelial surface area, 
replacement of mature enterocytes by immature (crypt-like) cells (84), down regulation of 
genes involved in digestion and absorption of nutrients, salt and water, an osmotic effect 
resulting from incomplete absorption of carbohydrates from the intestinal lumen in 
combination with bacterial fermentation of these non-absorbed compounds, secretion of 
intestinal fluid and electrolytes through activation of the enteric nervous system (ENS)(246), 
and the effect of the rotavirus non-structural protein 4 (NSP4), which is thought to act as a 
viral enterotoxin (16). An overview showing established (see also chapter 1) or speculative 
events that are or might be involved in the multifactorial process of rotavirus pathogenesis is 
presented in figure 1. The speculative events are also pointed out in the next sections.  
 
The epithelium is the primary target of rotavirus infection, and it is not surprising that 
epithelial dysfunction plays an important role in rotavirus pathogenesis (84, 162, 209, 306, 
355, 389). Although there have been various reports regarding the effect of rotavirus 
infection on epithelial homeostasis in vivo (84, 162, 209, 389), none of these studies did 
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present a more complete and overall picture of rotavirus infection but rather they presented 
fragmentary data. In chapter 2, we performed an elaborate study in order to obtain a more 
comprehensive and complete understanding of rotavirus infection in vivo. We found that 
during homologous rotavirus (EDIM) infection in mice, villus atrophy and an increase in 
crypt depth are accompanied by highly induced epithelial apoptotic- and proliferation rates. 
Along with this, epithelial cell turnover also increased. In addition to these processes, we 
found that rotavirus caused a strong down regulation of enterocyte specific gene expression 
at the mRNA and protein level (SGLT1, Lactase, LFABP) in infected cells. The shut off of 
gene expression has been demonstrated for various viruses (HIV, influenza, poliovirus, 
adenovirus, and herpes simplex (35, 223, 244, 258, 463)), but was not shown previously for 
rotavirus in vivo. The rotavirus non-structural protein NSP3 is known to induce the shut off 
of host cell translation during in vitro rotavirus infection, by interacting with the eukaryotic 
initiation factor eIF4GI, which is part of the eIF4F holoenzyme complex (326). Since eIF4F 
modulates mRNA stability (343), the shut off of enterocyte gene expression during rotavirus 
infection we observed in chapter 2, might also be mediated by NSP3. Furthermore, we 
hypothesize that NSP3 could mediate this shut off by removing eIF4F from cellular mRNA 
resulting in decreased stability of these mRNAs and subsequently a decreased translation 
(see also Box in chapter 1). The shut off of enterocyte gene expression is further in 
accordance with earlier studies in mice and rabbits were the enzymatic activity 
(dissacharidase activity, amino acid uptake, solute co-transport) in the brush border was 
markedly decreased (84, 162, 209). Our data further showed that there are reduced levels of 
the sodium glucose co-transporter SGLT1 transcripts and protein in the brush border of 
enterocytes. This might be an important mechanism underlying the reduced Na+ solute 
transport activity observed during rotavirus infection in rabbits (162). Based on the findings 
stated above, and with respect to one of the established mechanisms leading to rotavirus 
diarrhea that is decreased solute absorption and water reabsorption in the intestine through 
substitution of mature enterocytes by non-transporting crypt cells (164, 212, 350), we 
propose that in addition to the direct inhibition of Na (+)-solute co-transport activities 
through NSP4 (163), at least 3 sequential processes are implicated in this mechanism of 
rotavirus-induced diarrhea. 1) Early on during infection, enterocyte specific gene expression 
is directly down regulated in infected cells at the mRNA level. This results in reduction of 
mature enterocyte specific protein levels and thus in a functional less differentiated status 
relatively early during infection while there is still little histological damage. 2) Mature 
enterocytes are lost from the villi through apoptosis and shedding. 3) These mature 
enterocytes are replaced by immature and actively dividing cells.  
 
Adult Mice 
Mice usually do not develop any symptoms when infected beyond 2 weeks of age, and 
infection of adult mice occurs without diarrheal disease or histopathological lesions (59, 130, 
306, 341, 402, 453). As part of the in vivo studies we performed in young mice, we did a 
comparative study of rotavirus infection in adult (> 6 weeks) mice (the same standardized 
amount of EDIM virus inoculum was used; unpublished data). As for the suckling mice, we 
examined the pathogenesis of rotavirus infection in the adult mice by examining the 
induction of diarrhea, and timing and extent of rotavirus replication in the gastrointestinal 
epithelium. During the course of our experiment (14 days), the adult mice, in contrast to the 
suckling mice, did not experience diarrhea. We used in situ hybridization and 
immunohistochemistry to detect viral replication in the small intestinal epithelium and found, 
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in contrast to the massive replication in young mice, that only a few enterocytes were 
infected at day 2 and 4 post infection. 
Age-dependent diarrhea has been explained by various hypotheses (126, 280). For example, 
the decrease in net fluid absorption may especially have an impact at young age at the time 
when the absorptive capacity of the colon is not yet fully developed, and changes in the 
osmotic permeability of the mucosa secondary to destruction, and changes in fluid and 
electrolyte secretion may be different in adults and young. Since the mice in our experiments 
were naïve and did not encounter rotavirus before, the (maturation of) immune system may 
be of little importance, at least in mice. The absence of diarrhea in the adult mice seems to be 
directly related to the amount of infected cells and virus replication. This may be explained 
by age-dependent differences in expression or appearance of molecules involved in the 
different stages of infection and replication (various stages of binding, entry, replication, 
mechanisms of secondary infection). Gangliosides, sialic acid-containing glycosphingolipids, 
are found in the outer layer of the plasma membrane of all vertebrate tissue cells and 
gangliosides like GM1 and GM3 have been suggested to play a role as possible receptors for 
rotavirus (161, 356). Interestingly, GM1 and GM3 ganglioside contents increase in mouse 
small intestine during the suckling period, and decreased after weaning (375). Like GM1 and 
GM3, integrins which are also involved in rotavirus binding, appear to be differentially 
expressed throughout development as well, (21, 89, 418), indicating that all these molecules 
could be implicated in age-dependent differences in susceptibility towards rotavirus 
infections. 
In agreement with what we found in mice, rotavirus-infected human adults were shown to 
shed 10–100 times less rotavirus than do infected children (41, 449). We have to bear in 
mind however, that the mechanisms of age-dependent diarrhea in humans is most likely very 
different from naïve mice, since in humans the acquired immune system plays a pivotal role 
in protection (31, 444, 473). 
 
 
Role of Mucins and Prostaglandins during rotavirus infection 
 
In chapter 2, we demonstrated that rotavirus infection has a profound effect on small 
intestinal epithelial homeostasis and induces apoptosis at the tips of the villi, increases 
epithelial cell turnover and hampers enterocyte gene expression. In chapter 3 and chapter 4, 
we evaluated the role of goblet cells and mucins in the active defense against homologous 
rotavirus (EDIM) infection in mice. We focused our attention on goblet cell homeostasis 
during infection in conjunction with the expression of specific gene products that are 
secreted by these cells. Goblet cells are characteristic for the intestinal epithelium and are 
known to secrete molecules such as mucins and trefoil factor family peptides that serve 
protective and healing functions in the gut, respectively (419, 438). 
We found that in the ileum, the intestinal region with highest levels of viral replication, 
goblet cells in contrast to enterocytes, are spared from apoptosis during severe rotavirus 
infection. The sparing of goblet cells could uphold their protective function in epithelial 
defense and this event has also been observed in rats after intestinal damage has been 
induced by the cytostatic drug methotrexate (446). Muc2, Muc3 and Muc5AC mRNA levels 
were increased in the ileum during infection, whereas Muc2 protein expression was 
maintained during infection. In contrast, protein expression of goblet cell specific protein 
TFF3 was strongly affected.  
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Many rotavirus strains use sialic acid (SA) residues on the surface of target cells for initial 
attachment (107, 356, 410). Mucins of various origins have previously been implicated in the 
inhibition of rotavirus infection in vivo and in vitro via binding of rotavirus to sialic acid 
moieties (72, 289, 323, 440, 459, 471, 472).  
In chapter 3, we found that the number of goblet cells containing sulfated mucins was 
reduced whereas the fraction of heavily sialylated mucins was strongly increased. A 
reduction in the number of sulfated mucin-containing cells was also found during infection 
of simian SA11 rotavirus in rats (156). One of the possible explanations for this observation 
is that sulfated mucins could have been preferentially secreted into the intestinal lumen, or 
that the mucin molecules are undersulfated as has been observed in patients with ulcerative 
colitis or in a rat model for colitis (191, 345, 442). As sulfate content of mucins is thought to 
present resistance to (bacterial) enzymatic degradation of the mucus layer (293, 352), a 
decrease in sulfated mucins during rotavirus infection could therefore influence the 
consistency of the mucus layer. Changes in mucin sulfation particularly will be of relevance 
in the colon where sulfate-reducing bacteria reside. It will therefore be of special interest to 
determine whether sulfation is also reduced in the colon during rotavirus infection. 
Changes in the glycosylation and sialylation of mucins are observed during bacterial or 
parasite infections (100, 170). In vitro, cytokines have been implicated in the sialylation of 
mucins (106). In particular, TNF-α was shown to upregulate mRNA levels of sialyl- and of 
fucosyl-transferases and increases the sialylation of mucins in a human respiratory gland cell 
line. Prostaglandins (PGs) were also shown to alter the terminal glycosylation and sialylation 
of mucins (117). Interestingly both prostaglandins (see also below) and TNF-α levels were 
found increased in rotavirus-infected children (193, 466). 
The changes in mucin sulfation and especially sialylation during rotavirus infection in mice 
suggested that these mucins would have an altered competence to inhibit rotavirus infection. 
As described in chapter 3, we isolated mucins from the small intestines of control and 
infected mice at several time-points and tested these mucins for neutralization of rotavirus in 
an in vitro infection system. We show that age-dependent differences in mucin composition 
and increased occurrence of sialylated mucins alter the inhibitory capabilities of mucins 
isolated from the mouse small intestine. This suggests that posttranslational modification in 
glycosylation and sialylation of mucins during infection alters their anti-viral capabilities and 
ultimately can affect their specific epithelial barrier function against intestinal pathogens. 
PGs are lipid mediators that are produced through cyclooxygenases (COXs). A number of 
studies have shown that COX and PGs are involved in rotavirus replication and 
pathogenesis. Prostaglandin E2 (PGE2) levels rise early after rotavirus infection in pigs (481) 
and elevated levels of prostaglandin PGE2 and PGF2 have been observed in the plasma and 
stool of rotavirus-infected children (466). Moreover, Rossen et al. showed that COX2 mRNA 
and PGE2 levels are increased after rotavirus infection in vitro (358). PGE2 and COX activity 
were shown to be crucial for rotavirus replication in Caco-2 cells and rotavirus illness in 
young children is reduced after oral aspirin, a non-specific COX inhibitor (358, 466). PGs 
were previously shown to play a role in the production and secretion of mucins, as PGE2 
enhanced mucin release via a cAMP-dependent mechanism in LS174T cells and in the rat 
colon (25), and MUC2 protein expression is enhanced by short chain fatty acids through 
PGE1 and PGE2 produced by myofibroblasts (458). 
In chapter 4, we examined whether PGs could be involved in the induced mucin expression 
during rotavirus infection. We found that Cox2 mRNA expression is strongly enhanced 
during rotavirus infection in mice, implying increased PG production. The enhancement of 
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Cox2 mRNA expression largely followed the course of infection as expression of mRNA 
was provoked at both peaks of viral replication. The increased levels of Cox2 were 
accompanied by elevated levels of Muc2, Muc3 and Muc5AC mRNAs. We performed in 
vitro experiments to evaluate the role of PGs in mucin transcription. By using Caco-2 cells as 
an enterocyte model, enterocyte-specific MUC3 mRNA expression was also increased 
during rotavirus infection in vitro. PGE1 and PGE2 were shown to be inducers of mucin 
expression in the goblet cells. PGE1 was able to induce MUC2, MUC3 and MUC5AC 
mRNA levels, whereas PGE2 was able to induce MUC2 and MUC3 mRNA levels. The in 
vitro induction of MUC2 and MUC3 mRNA by PGE1 and PGE2 mirrored the in vivo 
induction in mice. Although MUC5AC expression could be induced by PGE1 in LS174T 
cells, the increase was only moderate, indicating that other pathways or other PGs (e.g. PGF) 
are likely to be important in the induction of Muc5ac in infected mice. These data suggest 
that rotavirus-induced Cox2 and PG levels are involved in mucin upregulation. 
The increased mucin expression observed during infection (chapter 3 and 4) could be 
mediated through several other mechanisms apart from PGs. Induction of mucins can be 
directly affected by viral double stranded RNA (dsRNA) (238). This signaling pathway 
includes the activation of mitogen-activated protein kinases (MAPK) and nuclear factor κB 
(NF- κB)(238). Rotavirus was indeed shown to activate NF-κB (355). However, instead of 
via dsRNA, activation is most likely provoked primarily via binding of its outer capsid 
protein VP4 to the TNFR-associated factor 2 (TRAF2) and activation of TRAF signaling 
(226). NF-κB and various cytokines also are involved in the induction of mucin transcription 
by bacteria (110, 113, 232, 250). Among the many (pro-inflamatory) cytokines that stimulate 
mucin gene expression are IL-1, IL-4, IL-6, IL-9 and tumor necrosis factor α (TNF-α), (110, 
443). TNF-α is particularly interesting, since this cytokine is involved in the induction of 
Muc5ac in infected mice. TNF-α is found increased in rotavirus infected children (15) and is 
able to upregulate MUC5AC in airways via an epidermal growth factor receptor mediated 
route. Moreover TNF-α increases MUC5AC mRNA half-life (42) and induces MUC5AC 
secretion in HT29-MTX cells (397).  
 
Other than the induction of mucins, rotavirus-induced PGs are doubtlessly implicated in 
various other processes during rotavirus infection (See figure 1). PGs could participate in the 
inflammatory response and result in impaired intestinal absorption and the initiation of a 
prosecretory state in the intestine (128). Rotavirus infection in mice has been correlated with 
changes in vascular circulation and ischemia (306, 307, 402). The authors proposed that 
diarrhea was likely to result from the release of a vasoactive substance causing villus 
ischemia and functional damage to enterocytes (307). It later was proposed that VIP and/or 
prostaglandins could embody this vasoactive agent (279). Thus, there possibly exist 
prostaglandin-dependent mechanisms that mediate the histological changes observed during 
rotavirus infections and contribute to diarrhea. 
 
 
Implications of a basal release of NSP4 and binding to the ECM 
 
Cell signaling 
The rotavirus non-structural protein 4 (NSP4) is an enterotoxin that was identified as an 
important agent in symptomatic rotavirus infection (16). In chapter 6, we showed that NSP4 
interacts with the ECM proteins laminin-β3 and fibronectin and colocalizes with laminin-β3 
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in the BM of infected mice suggesting that NSP4 is released from the basal side of infected 
epithelial cells. Laminin and fibronectin are multifunctional proteins that can be found in 
association with each other (422, 475). They can influence cell adhesion, growth, 
morphology, differentiation, migration, and agglutination as well as the assembly of the 
ECM (86, 311, 329). Laminin-5, a heterotrimer of α2, β3, and γ2 chain subunits, can bind to 
α3β1, α6β4, and α6β1 integrins (64, 253, 292), whereas fibronectin can be a ligand for other 
members of the integrin receptor family, including α5β1, α4β1, α4β7, α9β1 (329). The 
fibronectin insert that we found using the two-hybrid system contains a domain called the 
HepII region that is involved in cell binding and spreading (38, 462). The HepII region also 
binds to heparan sulfate proteoglycans like syndecan-4 (17, 60, 185, 462), tenascin-C (181), 
and integrins α4β1 and αIIbβ3, (274, 284), (17, 60, 185). By binding to the HepII region in 
fibronectin, syndecan-4 has been shown to function as a co-receptor in integrin signaling 
(462). It might be possible that NSP4, through binding to fibronectin, could interfere with 
this sort of interactions and influence integrin mediated signaling pathways. This has been 
observed for tenascin-C as binding of tenascin-C interfered with fibronectin-syndecan-4 
interaction and influenced cell signaling and proliferation (181).  
Thus from this knowledge, it is possible that NSP4 could intervene and mediate several 
physiological processes through binding to the ECM underneath the intestinal epithelium, 
thereby influencing epithelial differentiation, migration, and cell survival/apoptosis, 
processes that are apparently disturbed during rotavirus infection in mice, as we have 
stablished in chapter 2. e
 
Possible effect on virus entry and binding 
Recently, it was reported that integrins are involved in rotavirus binding and that the 
rotavirus capsid proteins VP4 and VP7 contain integrin ligand sequences (89, 150, 476). VP4 
(VP5 part) contains the DGE tripeptide sequence motif and interacts with integrin α2β1 
(150), while VP7 binds to αxβ2 and αvβ3 via its integrin ligand site GPR and CNP region 
(150, 476), and contains a α4β1 binding motif LDV (89). Most rotavirus strains use integrins 
for cell-binding and infection, although all porcine viruses seem to be integrin independent 
(150). 
The role of integrins as one of the receptors for rotavirus remains however conflicting with 
their almost exclusive basal localization at intestinal cells (20, 322). For example α2β1 
integrin was found at the basal domain of human intestinal cells according to strict 
complementary staining patterns (20, 322). 
Integrins can adopt inactive and active configurations, which differ by change in relative 
orientation of the α- and β- subunits. The active orientation has enhanced affinity for both 
external and cytoplasmic (talin and α-actinin) ligands. Binding of ligand on either side 
promotes the change to active form, so cytoplasmic ligands can promote binding to ECM, 
and ECM binding can enhance interaction with cytoplasmic ligands or binding partners. 
(380). 
Administration of NSP4 was found to cause a reduction in the transepithelial electrical 
resistance (TER) in MDCK-1 cells (411) indicating that it can increase epithelial 
permeability as has been observed during rotavirus infection in piglets, mice and humans 
(168, 211, 405). Together with our finding of binding of NSP4 to the ECM, we hypothesize 
that NSP4 could simultaneously increase epithelial permeability during rotavirus infection 
and interfere with integrin ECM interactions. This interference would yield additional 
unbound integrins. Consequently, via the cooperative effects on conformation, this 
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interference would results in a lower affinity of the integrins for cytoplasmic ligands. In this 
way, integrins could become more readily accessible for rotavirus particles at the more apical 
surfaces of the intestinal cells. Since NSP4 is not present in the infectious rotavirus particles 
during primary infection, this mechanism would play a role to expedite secondary infections. 
 
Chloride secretion and diarrhea 
The mechanism contributing to diarrheal disease involving NSP4 is thought to occur through 
release of NSP4, or its cleavage product NSP4 (112-175), from infected cells and binding to 
a yet-unidentified apical membrane receptor. Binding would directly or indirectly trigger a 
signal transduction pathway to enhance chloride secretion, eventually resulting in diarrhea 
(16, 126, 279, 480). This secretory mechanism however is thought to act in the intestinal 
crypts (247). It is still not clear if and how NSP4 reaches the intestinal crypts. However, it 
seems unlikely that this occurs via the luminal route since continuous abundant secretion 
from the crypts results in a hydrodynamic flow against which NSP4 has to diffuse (247). The 
data presented in chapter 6 suggest that NSP4 or a cleavage product (containing the 
enterotoxic domain aa 114-135) is released from the basal side of infected enterocytes and 
colocalizes with the ECM. From these data, we hypothesize that via a route involving the 
ECM, NSP4 could travel towards the crypt region where it can induce fluid secretion. In 
concurrence with this hypothesis and with our results, Ball and coworkers found that NSP4 is 
able to cause chloride secretion when added to the submucosal (basal) surface of mouse 
mucosal sheets and in vivo when injected intraperitoneally into mice (16). 
 
The extraintestinal rotavirus 
Numerous studies indicate that rotavirus infection is not confined to the intestine and is able 
to enter the circulatory system (40, 282). Rotavirus has been detected in cerebral spinal fluid 
((188, 248, 294, 310, 474)), liver and kidney (145), extra-intestinal lymphoid tissue (54), and 
serum of infected children and animals (40, 431). The data presented in Chapter 6 imply 
that NSP4 could be able to get into the circulatory system, as it is apparently secreted into the 
tissue underlying the enterocytes. If NSP4 is also able to get into the circulatory system, it is 
likely that it does so through release from the basal side of infected epithelial cells. 
Additional evidence for this possible scenario comes from our unpublished data. Using the 2-
hybrid system, we found that NSP4 also interacts with the ECM and acute phase protein 
fibrinogen. In this system NSP4 interacts with both the fibrinogen α subunit (5 clones of 
which 2 independent) and the fibrinogen β subunits (3 clones of which 2 independent). Like 
the other ECM molecules we found with the 2-hybrid system laminin-β3 and fibronectin, 
fibrinogen is known to bind to integrins (e.g. α(IIb)β3, αMβ2 and α5β1 (234, 428)), and the 
fibrinogen α subunit insert contains two integrin ligand sequences (RGD). 
Fibrinogen plays a key role in platelet aggregation, the final step of the coagulation cascade 
(37, 281). It is questionable whether NSP4 could have any effect on for example blood 
clotting, or that NSP4 merely uses fibrinogen as a vehicle to get into the circulatory system 
to exert some secondary effects. 
Fibrinogen is also known to play a role in immune and inflammatory responses (234, 428). 
Directed migration of phagocytic leukocytes through the extracellular matrix for example, 
requires the engagement of integrin leukocyte adhesion receptors to fibrinogen (234). The 
integrin α4β7 is expressed by B and T cells responsible for immunity to intestinal antigens 
and α4β7 expressing lymphocytes have been shown to play a part in the defense against 
rotavirus (37, 281). α4β7 mediates lymphocyte attachment within the ECM by adhering to 
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one of the other ECM proteins found to interact with NSP4, fibronectin (66, 361). Since both 
fibronectin and fibrinogen play a role in the inflammatory response through mediating the 
attachment and recruitment of lymphocytes to the ECM, it is temping to speculate that NSP4 
could modulate these processes. 
Further studies are therefore needed to determine the significance of the above findings while 
it still has to be determined whether NSP4 binds to fibrinogen in vitro and in vivo using, 
among others, the co-immunoprecipitation technique. 
 
 
Immune response after rotavirus infection in neonatal mice 
 
There has been variable efficacy with the use of live-attenuated rotaviruses developed for 
oral administration (18, 186). A live attenuated tetravalent rhesus-human reassortant 
rotavirus vaccine (Rotashield) seemed to produce the best results and prevented about half of 
rotavirus infections, while it was particularly effective in preventing severe disease (194, 
321). In 1998 this vaccine, the first licensed rotavirus vaccine, was recommended for routine 
immunization of U.S. infants. Shortly after the vaccine was approved however, the use of 
Rotashield was suspended because of the possible association with intussusception (287). 
This side effect draws attention to possible effects of childhood infection or vaccination on 
the maturation of the immune system early in life.  
Immune responses against heterologous rotavirus infections are usually studied using crude 
concentrates of cell-culture grown virus (129, 140, 187, 209, 267, 270). Obviously, this 
approach implies that in addition to the virus, animals are inoculated with viral preparations 
containing unknown and non-standardized amounts of cellular proteins. From this 
standpoint, we proposed that the type of purification of the viruses used in such infection 
experiments might influence subsequent immune responses. 
The study presented in chapter 5 was designed to assess the influence of different 
preparations of simian rotavirus (SA11) on the immune response following oral delivery to 
suckling mice as a model for vaccination. Using cesium chloride density gradient 
centrifugation, we purified three different fractions of simian rotavirus, corresponding with 
the two forms of virus particles (triple layered and double layered) and infected-cell 
components. These fractions are enriched, but did not exclusively contain the specified 
components; while infectious virus was present in all fractions administered but in different 
amounts. We found that all three fractions of SA11, as well as the homologous mouse 
rotavirus strain EDIM, were able to induce diarrhea in suckling mice but with different 
kinetics. Standardization of the SA11 preparations resulted in notable differences in antigen 
content. In mice, the different preparations however produced very similar serum IgG 
antibody responses that were comparable to responses after infection with EDIM. 
Interestingly, the IgG subtype responses of the different fractions were not similar. We found 
a significantly higher IgG1/2a ratio in the animals inoculated with the infected-cell 
component fraction compared to the other fractions and the EDIM infected animals. This 
means that the presence of cell associated proteins results in a skewed Th2-type immune 
response (134) and indicates that the composition of the inoculum determines the sort of the 
immune response following infection with the same amount of infectious virus. The presence 
of high amounts of antigen in the virus preparation could result in an adjuvant effect. 
Another possibility is that unknown components of infected cells, like cytokines that are 
produced during infection in vitro, could influence the immune response in mice. 
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As was found in a previous study (385), we observed that the SA11 fractions produced only 
minor IgA titers when compared to the homologous EDIM strain. Since replication is an 
important determinant of IgA responses to rotavirus (385), the low levels of IgA are most 
likely caused by the inferior intestinal replication of the heterologous SA11 strain, with 
respect to the EDIM strain. In fact, we did not find measurable virus shedding in the SA11-
infected animals and in contrast to EDIM inoculated mice, could not detect virus replication 
in the small intestine either by immunohistochemistry or in situ hybridization. Paradoxically, 
we did observe diarrhea in animals up to 1 week after oral delivery of the SA11 virus. 
Moreover, mice inoculated with UV-treated triple layered fraction did not experience 
diarrhea or show an immune response. The results therefore suggest that there was indeed 
replication of SA11, but that replication occurred extraintestinally. 
As stated above, extraintestinal spread of rotavirus might be a common event (40, 282). In 
case of extraintestinal replication of the virus, the histological damage and diarrhea might be 
induced by a secreted viral factor and not by direct viral cytopathological effect (CPE) (77, 
306). Again, a plausible candidate for this effect would be NSP4. We can also not exclude 
the possibility that the fractions used for inoculation were contaminated with a small amount 
of NSP4 protein produced during virus growth in cell culture. This mechanism however, 
could only account for diarrhea observed on day 1 after inoculation, since it was reported 
that mice inoculated with purified NSP4, do not experience diarrhea beyond 24 hours after 
inoculation (16).  
The following question still remains; where did SA11 replication occur in the inoculated 
mice and how did the virus escape the intestine? Rotavirus has been detected in cerebral 
spinal fluid (188, 248, 294, 310, 474), liver and kidney (145), macrophages in (extra-) 
intestinal lymphoid tissue (54), serum (40, 431) and heart (282). Moreover, Coulson et al. 
found that pancreatic islet cells are susceptible to rotavirus infection suggesting that rotavirus 
can also infect the pancreas (90). It still has to be determined where the SA11 virus replicates 
in mice, and whether extraintestinal replication is perhaps a common event for heterologous 
rotaviruses. 
It was suggested that rotavirus, gets into the circulatory system through M cells that are 
present in the epithelium that overlies the Peyer’s patches (40, 282). Intestinal replication of 
rotavirus has been correlated with production of IgA (385), and we found very low levels of 
IgA after infection with the SA11 strain. From this, we therefore propose that the uptake of 
SA11 probably occurs via the epithelium of the Peyer’s patches and that the virus is 
subsequently transported to the underlying lymphoid follicles. Replication of SA11 would 
only occur beyond the intestinal epithelium and Peyer’s patches, accounting for the lack of 
intestinal specific IgA induction, despite the high levels of serum IgG.  
The described data might also have important implications with respect to the as yet 
unexplained adverse effects (i.e. intussusception) of oral rotavirus vaccines (287) and should 
be evaluated with respect to the development of novel rotavirus vaccines as they have a 
significant impact on the neonatal immune system. Currently no effective rotavirus vaccine 
is available. Together with the adverse effects of live attenuated (reassortant) rotavirus 
vaccines, there is need for alternative strategies for prevention of rotavirus infection and 
disease. In this light, several studies indicate that a more feasible target for vaccination might 
prove to be NSP4 (16, 214). Additionally cyclooxygenase inhibitors may also be useful as an 
antiviral drug, since PGE2 and COX activity were shown to be crucial for rotavirus 
replication in vitro and rotavirus illness in young children is reduced after oral aspirin, (358, 
466). 
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Figure 1. Speculative hypotheses of rotavirus-induced pathogenesis. 
The anatomy of the villus is shown in panel A. Intestinal mucosal epithelial cells are formed by 
division from undifferentiated cells in the villus crypt region. Crypt cells function primarily to secrete 
fluid into the intestinal lumen. As they mature the cells migrate up the lateral surface of the villus 
toward the tip. During this process the cells develop microvilli and specialized enzyme systems and 
carrier proteins for the digestion and absorption of certain nutrients. Rotavirus predominantly infects 
the more mature enterocytes in the mid and upper part of the villi of the small intestine. In panel B the 
pleiotropic cellular effects of rotavirus infection and NSP4 are depicted. Different simultaneous effects 
of rotavirus on cellular homeostasis may achieve the decreased capacity of the intestinal epithelium to 
absorb solutes and reabsorb water [1]. 1) Early on during infection, enterocyte specific gene expression 
is directly down regulated in infected cells at the mRNA level. This results in reduction of mature 
enterocyte specific protein levels and thus in a functional less differentiated status relatively early 
during infection while there is still little histological damage. 2) Mature enterocytes are lost from the 
villi through apoptosis and shedding. 3) The mature enterocytes are replaced by immature and actively 
dividing cells. 4) NSP4 directly inhibits SGLT1 thereby impairing Na (+)-solute co-transport activities 
(162, 163). NSP4 can affect cells through its effect on intracellular Ca2+. It can increase calcium levels 
in both infected cells (by acting as a Ca2+ channel in the ER (421)) [2], and in neighboring uninfected 
cells (secreted NSP4 (aa 112-175) binds to an unidentified apical receptor and mediates PLC dependent 
Ca2+ increase  (16, 114, 480) [3]. NSP4 may also disperse into the crypts to directly influence the 
secretory epithelium (Cl- secretion) through its effect on intracellular calcium [4]. By binding to 
Laminin-β3 and fibronectin (and fibrinogen?), NSP4 could reach the crypt region via a route involving 
the ECM. NSP4 or rotavirus may also be involved in enteric nervous system (ENS)-mediated disease. 
For example similar to cholera toxin, NSP4 induced increases the intracellular calcium concentration 
may cause the release of 5-hydroxytryptamine (5-HT) from enteroendocrine cells (247, 320) [5]. 5-HT 
activates nervous dendrites to release vasoactive intestinal polypeptide (VIP), this results in both PKC 
and phosphoinositol hydrolysis-dependent increases in Cl- (or HCO3-) and fluid secretion in crypts as 
well as decreases in transmucosal absorption (279, 320). NSP4 may influence integrin mediated 
signaling through binding to the ECM (Laminin-β3, fibronectin, and fibrinogen?), thereby affecting 
epithelial proliferation, differentiation, migration, and cell survival/apoptosis [6]. NSP4 causes a 
reduction in the transepithelial electrical resistance (TER) (411) indicating that it can increase epithelial 
permeability. NSP4 could simultaneously increase epithelial permeability during rotavirus infection 
and interfere with integrin ECM interactions. This would yield additional unbound integrins that are 
more readily accessible for rotavirus particles at the more apical surfaces of the intestinal cells [7]. By 
its effect on intracellular Ca2+ or possibly integrin mediated signaling, NSP4 could cause the extensive 
vacuolization observed during rotavirus infection in mice [8]. Rotavirus is able to enter the circulatory 
system (40, 282). Like rotavirus, NSP4 could possibly be able to get into the circulatory system (blood 
and lymphatic system) via release from the basal side of infected epithelial cells [9]. Inflammatory 
mediators like cytokines, prostaglandins and nitrous oxide, may participate in the inflammatory 
response and result in impaired intestinal absorption and the initiation of a prosecretory state in the 
intestine. Rotavirus promotes the synthesis and release of chemokines, such as interleukin (IL)-8 (65, 
355). This can enhance the inflammatory cascade producing mucosal and epithelial damage by release 
of reactive oxygen species. Moreover, activation of the ENS might be accomplished by these 
chemokines (355) [10]. COX2 and PGE2 levels are increased after rotavirus infection in vitro (358) and 
elevated levels of prostaglandins have been observed in the plasma and stool of rotavirus-infected 
children (466). As high levels of PGs (PGE2) can enhance VIP (accomplished by NSP4?), 
acetylcholine and substance P-induced chloride secretion in intestinal crypts (208), elevated levels of 
PGs during rotavirus infection might augment ENS mediated fluid secretion [11]. 
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Rotavirus infection increases mucin transcription and alters mucin glycosylation (and sialylation). 
These events are mediated by the rotavirus-induced prostaglandins and most probably also by 
rotavirus-induced cytokines [12]. The alteration in mucin expression and glycosylation probably affect 
the epithelial barrier function against intestinal pathogens. 
 
 
Concluding remarks and future directions 
 
There are many unanswered questions regarding the multifactorial rotavirus-induced 
diarrheal disease and yet more questions have arisen from the work presented in this thesis. 
In the recent years, many promising and advanced new methods were developed that could 
shed more light on these questions. One of the most promising methods is RNA interference 
(RNAi). This technique was already successfully used to to study rotavirus proteins and 
silence VP4 gene expression in virus-infected cells (103). RNAi is a double-stranded RNA-
triggered mechanism for suppressing gene expression, which is conserved in evolution and 
has emerged as a powerful tool to study gene function. Especially for rotavirus, RNAi is an 
excellent technique to study the role of individual rotavirus proteins like NSP4, as reverse 
genetic techniques for rotavirus are not available. By silencing cellular proteins, rotavirus-
cell interactions can also be studied. Most importantly however, RNAi may additionally 
prove important for therapeutic approaches for rotavirus and many other viruses (8, 103). 
In figure 1, an overview is presented showing established (see also chapter 1) and 
speculative events that are or might be involved in the multifactorial process of rotavirus 
pathogenesis. In view of the processes presented in figure 1 the following questions remain: 
 
► It was shown that NSP4 mobilizes intracellular calcium ([Ca2+]i) in human intestinal 
cells through receptor-mediated phospholipase C activation (114). Does this 
mechanism involve a specific receptor and is this receptor specifically localized at 
the apical or basal side of epithelial cell?  
 
► What is the role of the basal release of NSP4 in the induction of diarrhea? Is the 
entire NSP4 protein or a cleavage product secreted from the basal side of infected 
enterocytes? 
 
► Does NSP4 induce a signalling cascade through binding to ECM molecules at the 
BM (eg. can NSP4 elicit for example integrin mediated cell signalling by disturbing 
ECM/integrin interactions.) and what cell types are affected (enterocytes, 
enteroendocrine cells, goblet cells)? 
 
► Have intracellular NSP4 and extracellular NSP4 (112-175) different roles in 
rotavirus induced pathogenesis?  
 
► In order to induce fluid secretion, can NSP4 travel towards the crypt region via a 
route involving the ECM? With respect to this, NSP4 fails to cause diarrheal disease 
in CFTR knockout mice (280). Rotavirus-induced secretory diarrhea is therefore 
probably not mediated by CFTR. What is the molecular identity of the channel(s) 
responsible for chloride transport? 
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► Does a specific cell type (enteroendocrine?) transfer NSP4 mucosal signalling 
effects into the ENS through release of a mucosal cell neuroactive substance? 
 
► Is NSP4 able to get into the circulatory system? 
 
► Our data suggest that posttranslational modification in glycosylation and sialylation 
of mucins during infection, affect the specific epithelial barrier function against 
intestinal pathogens. Which specific modifications in mucin structure take place and 
are PGs involved in these alterations (glycosylation and sialylation)? 
 
► There are four prostaglandin E type receptors (EP1-4), which of these receptors is 
involved in the PG-mediated increase in mucin expression during infection? 
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Rotavirussen maken deel uit van de familie van de Reoviridae en danken hun naam aan de 
vorm van de virus deeltjes zoals die met een elektronenmicroscoop kunnen worden 
waargenomen. De deeltjes lijken op een wiel met spaken, vandaar de naam rota wat in het 
Latijn wiel betekent. 
Rotavirussen zijn de belangrijkste veroorzakers van ernstige en soms levensbedreigende 
virale gastro-enteritis en diarree bij de mens. Symptomen zoals koorts, overgeven, diarree en 
uitdroging worden voornamelijk waargenomen bij jonge kinderen onder de 5 jaar. Rotavirus 
wordt verspreid via de ontlasting en komt via de mond het lichaam weer binnen. Jaarlijks 
sterven wereldwijd naar schatting gemiddeld 440.000 kinderen onder de 5 jaar ten gevolge 
van een rotavirus infectie. Dit houdt in dat wereldwijd 1 op de 293 kinderen die geïnfecteerd 
worden met rotavirus hieraan sterven. Hierbij moet dan worden opgemerkt dat veruit de 
meeste slachtoffers vallen in ontwikkelingslanden. De sterke ziektegerelateerde morbiditeit 
en mortaliteit maakt het noodzakelijk een beter inzicht te krijgen in het ontstaan van 
symptomen en het ziekteverloop tijdens een rotavirus infectie. Bovendien is de ontwikkeling 
van een effectief vaccin van groot belang. Er zijn tot nu toe verscheidene vaccins ontwikkeld 
op basis van eiwitten die de buitenste laag van het virus vormen (VP4 en VP7), maar helaas 
is er op dit moment geen effectief vaccin tegen rotavirus beschikbaar. In 1999 werd in de 
Verenigde Staten licentie verleend aan een tetravalent rotavirus vaccin (Rotashield). Dit 
vaccin werd echter al na enige maanden uit de handel genomen vanwege een verhoogde 
incidentie van intussusceptie (invaginatie of instulping van de darm) die gecorreleerd bleek 
te zijn aan de vaccinatie. 
Ondanks de hoge prevalentie van rotavirus infecties en de vele uitgebreide studies in 
verschillende diermodellen, is het inzicht in de mechanismen die leiden tot ziekte beperkt. 
Het onderzoek dat in dit proefschrift wordt beschreven richt zich in het bijzonder op 
verschillende factoren die leiden tot rotavirus geïnduceerde ziekte en symptomen.  
Hoofdstuk 1 geeft een overzicht van de literatuur betreffende de mechanismen die betrokken 
zijn bij rotavirus pathogenese. Het dunne darm epitheel bestaat uit verschillende celtypen 
waaronder enterocyten en slijmbekercellen (goblet cellen). Enterocyten zijn betrokken bij de 
vertering, opname en transport van voedingstoffen (zoals suikers en vetten) en deze cellen 
worden door het rotavirus geïnfecteerd. Slijmbekercellen produceren en scheiden eiwitten 
zoals mucines uit die belangrijk zijn voor de bescherming van het epitheel. Het mucine Muc2 
bijvoorbeeld is de belangrijkste component van de beschermende slijmlaag in de darm.  
Het darmepitheel wordt constant vernieuwd en de darmcellen ontstaan uit stamcellen die 
gelegen zijn in darm instulpingen (crypten). Deze cellen migreren dieper de instulping in of 
in de richting van de darmholte waar de darm vlokken (villi; deze uitstulpingen zorgen voor 
een vergroting van de oppervlakte van het darmepitheel) zich bevinden (voor een overzicht 
van een crypt en villus zie figuur 1 in hoofdstuk 7). Tijdens deze migratie differentiëren de 
cellen tot de verschillende gespecialiseerde celtypen van het darmepitheel. De 
gespecialiseerde en gedifferentieerde cellen in de crypt en op de darmvlokken gaan na 
verloop van tijd dood of worden in de darmholte uitgestoten en vervangen door jongere 
cellen. Op deze manier is er een constante aanmaak en aanstroom van nieuwe cellen. Het is 
de homeostase van de epitheelcellen waar het rotavirus op ingrijpt. 
In hoofdstuk 2 van dit proefschrift gebruiken we een muizenmodel om het effect van 
rotavirus infectie op darm homeostase en disfunctie te bestuderen. In dit onderzoek werden 
7-dagen oude zogende muisjes geïnfecteerd met een muizen rotavirus. De replicatie van het 
virus vond plaats in twee pieken, namelijk op dag 1 en dag 4 na infectie. De histologische en 
morfologische veranderingen werden gekarakteriseerd door het ontstaan van vacuoles in de 
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enterocyten. We vonden dat door de infectie het aantal apoptotische cellen (celdood) en 
delende cellen was toegenomen. Bovendien was in geïnfecteerde muizen de snelheid 
verhoogd waarmee het darmepitheel werd vernieuwd. Het gevolg van deze veranderingen 
was dat de diepte van de crypten toenam en de darm villi (vlokken) korter werden en 
daardoor de totale oppervlakte van het darmepitheel kleiner werd. In rotavirus geïnfecteerde 
enterocyten werd een sterke afname gevonden van de expressie (op zowel eiwit- en RNA 
niveau) van specifieke eiwitten die betrokken zijn bij de opname en het transport van suikers, 
zouten, vetten en water. Verschillende factoren, zoals de uitschakeling van genexpressie in 
enterocyten samen met het verlies van gedifferentieerde enterocyten door apoptose en de 
vervanging van deze cellen door minder gedifferentieerde cellen, zijn waarschijnlijk 
verantwoordelijk voor een gebrekkige opname functie van het darmepitheel. Deze 
gebrekkige opname functie levert vervolgens een belangrijke bijdrage aan het ontstaan van 
diarree tijdens een rotavirus infectie. 
 
Veel rotavirus stammen gebruiken siaalzuur residuen, die aanwezig zijn op verschillende 
moleculen in de celmembraan als een soort opstapplaats voor binding aan de gastheercel. 
Ook veel mucines waaronder Muc2 bevatten veel siaalzuur residuen en er wordt 
aangenomen dat deze siaalzuren erg belangrijk zijn voor de rotavirus remmende 
eigenschappen die mucines bezitten. In hoofdstuk 3 hebben we de rol die slijmbekercellen 
en mucines spelen bij de bescherming van het darmepitheel tegen een rotavirus infectie 
geëvalueerd. We laten zien dat tijdens een rotavirus infectie in jonge muizen de 
slijmbekercellen, in tegenstelling tot enterocyten, niet massaal in apoptose gaan. Bovendien 
vonden we dat de expressie van intestinale mucine Muc2 was verhoogd tijdens infectie met 
rotavirus en dat de structuur van deze mucines was veranderd, wat er op duidt dat mucines en 
in het bijzonder Muc2 een belangrijke rol spelen bij de bescherming tegen infectie. We laten 
tevens zien dat leeftijdsafhankelijke verschillen in de samenstelling van mucines en een 
verhoogde aanwezigheid van sterk gesialyleerde mucines tijdens infectie een rol spelen bij 
hun beschermende capaciteit. De resultaten suggereren dat posttranslationele veranderingen 
in de glycosylering en sialylering van mucines tijdens rotavirus infectie hun beschermende 
capaciteit kunnen veranderen. Dit kan uiteindelijk een invloed hebben op de barrière functie 
van de slijmlaag tegen darm pathogenen. 
Hoofdstuk 4 beschrijft een onderzoek naar de rol van prostaglandines (PGs) in de toename 
van mucine expressie tijdens rotavirus infectie. We vonden dat de expressie van 
cyclooxygenase 2 (Cox2) mRNA, een eiwit dat essentieel is voor de synthese van PGs, sterk 
verhoogd is tijdens infectie in muizen. Dit impliceert tevens dat er tijdens infectie zeer 
waarschijnlijk ook een verhoogde productie van PGs moet zijn geweest.  
In geïnfecteerde muizen werden verhoogde niveaus van Muc2, Muc3 en Muc5AC mRNA 
gemeten. Om de rol van PGs in de transcriptie van mucines te bestuderen werd gebruik 
gemaakt van 2 celkweek modellen. Als een model voor enterocyten werd de humane colon 
adenocarcinoma cellijn Caco-2 gebruikt. Net als in geïnfecteerde muizen kwam het mucine 
MUC3 mRNA verhoogd tot expressie tijdens een rotavirus infectie. De PGs PGE1 en PGE2 
waren in staat om MUC2 and MUC3 specifieke mRNA niveaus te verhogen in LS174T 
cellen. Deze cellen werden gebruikt als model voor slijmbekercellen. De expressie van 
MUC5AC werd in mindere mate verhoogd door PGE1 en helemaal niet door PGE2. Dit 
suggereert dat de inductie van dit mucine tijdens rotavirus infectie in muizen niet uitsluitend 
wordt bewerkstelligd door PGs, maar ook door andere mediatoren en mechanismen. De 
bevindingen in hoofdstuk 4 impliceren dat de inductie van mucine expressie tijdens een 
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rotavirus infectie in ieder geval deels het gevolg zijn van de door rotavirus verhoogde 
niveaus van Cox2 en PGs. 
 
De meeste rotavirus vaccins worden ontwikkeld op basis van zogenaamde heterologe 
virussen voor de mens. Dit houdt in dat de mens normaal gesproken geen gastheer is voor 
deze virussen. Kennis over heterologe infecties in diermodellen zoals de muis is meestal 
beperkt tot de inductie van diarree en het meten van de aanwezigheid van het virus in de 
ontlasting. Replicatie van heterologe virussen wordt zelden bestudeerd en bevestigd in het 
darmweefsel. Daarentegen wordt een toegenomen hoeveelheid (infectieus) virus in de 
ontlasting gebruikt als maat voor replicatie in de darm. 
In hoofdstuk 5 is onderzocht of er verschillen bestaan in de afweerreactie na infectie met een 
muizen rotavirus (EDIM stam) als model voor een natuurlijke infectie en een heteroloog 
apen rotavirus (SA11 stam) als model voor vaccinatie. Voor de heterologe infectie werden 
drie verschillende fracties van het SA11 virus (met verschillende samenstelling) gebruikt die 
waren verkregen met behulp van cesium chloride gradiënt zuivering. EDIM en alle drie 
geteste fracties van SA11 bleken in staat om diarree te veroorzaken in jonge muizen, terwijl 
fecale uitscheiding van het virus alleen werd waargenomen bij het EDIM virus. In 
tegenstelling tot EDIM, werd er met behulp van verschillende technieken geen replicatie van 
SA11 gedetecteerd in het dunne darmweefsel van geïnfecteerde muizen. Er bestaan dus grote 
verschillen in de mate van virus replicatie en het (mogelijke) weefsel tropisme van het 
homologe EDIM virus en het heterologe SA11 virus. Dit gegeven is waarschijnlijk 
verantwoordelijk voor het feit dat er werd aangetoond dat de specifieke mucosale 
afweerreactie (ontwikkeling van IgA antilichamen) niet tot stand komt na de heterologe 
infectie, dit in tegenstelling tot de homologe infectie. Het EDIM virus en de drie 
verschillende SA11 fracties induceerden dezelfde hoeveelheid IgG. De rotavirus specifieke 
IgG1/IgG2a ratio verschilde echter tussen de verschillende SA11 fracties. Dit betekent dat 
het type immuun respons (Th1/Th2) dat wordt opgewekt tegen een heteroloog virus 
afhankelijk is van de exacte samenstelling van het inoculum dat gebruikt is voor de infectie 
van de muizen. Het is derhalve van groot belang om met deze factoren rekening te houden 
met betrekking tot de ontwikkeling van nieuwe rotavirus vaccines. 
 
Het rotavirus genoom codeert voor zowel eiwitten die een onderdeel uitmaken van het virus 
deeltje (structurele eiwitten), als eiwitten die geen deel uitmaken van het virus maar alleen 
tot expressie komen als het virus zich vermenigvuldigt in de gastheercel (niet structurele 
eiwitten). De niet structurele eiwitten spelen een belangrijke rol bij de morfogenese en 
vermenigvuldiging van het virus. Eén van de niet structurele eiwitten, NSP4, is recentelijk 
geïdentificeerd als het eerste virale enterotoxine. NSP4 is in staat om diarree te veroorzaken 
als het in de buikholte of in de darm van jonge dieren wordt ingespoten. De inductie van 
diarree door NSP4 is leeftijdsafhankelijk en lijkt in die zin op de leeftijdsafhankelijke diarree 
veroorzaakt door een rotavirus infectie. Deze gegevens tonen aan dat NSP4 dus voor een 
belangrijk deel verantwoordelijk is voor de diarree die ontstaat tijdens een rotavirus infectie. 
In hoofdstuk 6 is onderzocht met welke cellulaire eiwitten NSP4 een interactie aangaat. Die 
eiwitten spelen mogelijk een rol bij het ontstaan van diarree. Met behulp van de zogenaamde 
two-hybrid techniek in gist cellen, waarmee eiwit interacties kunnen worden aangetoond, 
vonden we twee extracellulaire matrix (ECM) eiwitten, laminine-β3 en fibronectine. De 
interactie van deze twee eiwitten met NSP4 werd vervolgens ook aangetoond door middel 
van co-immuunprecipitatie. Bovendien kon NSP4 samen met laminine-β3 in de basale 
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membraan van geïnfecteerde muizen worden aangetoond. Dit duidt er op dat er een 
fysiologische interactie plaatsvindt. De binding van NSP4 aan extracellulaire matrix eiwitten 
in de basale membraan duidt er op dat NSP4 vrijkomt vanuit de basale kant van 
geïnfecteerde cellen. De beschreven bevindingen wijzen mogelijk op een nieuw mechanisme 
waarop rotavirus diarree en ziekte ontstaat. 
 
Hoofdstuk 7 tenslotte, geeft een opsomming en bediscussieerd de resultaten van de 
voorgaande hoofdstukken. De figuur in dit hoofdstuk geeft een overzicht van gevestigde en 
speculatieve gebeurtenissen die betrokken (kunnen) zijn bij het ontstaan van rotavirus 
pathogenese. 
 References 
 
 
 
 
 
 
 
 
 
 
 
 
  
References   137 
 
1. Adams, W. R., and L. M. Kraft. 1963. Epizootic diarrhea of infant mice: indentification of the etiologic 
agent. Science 141:359-60. 
2. Afrikanova, I., E. Fabbretti, M. C. Miozzo, and O. R. Burrone. 1998. Rotavirus NSP5 phosphorylation is 
up-regulated by interaction with NSP2. J Gen Virol 79 ( Pt 11):2679-86. 
3. Afrikanova, I., M. C. Miozzo, S. Giambiagi, and O. Burrone. 1996. Phosphorylation generates different 
forms of rotavirus NSP5. J Gen Virol 77 ( Pt 9):2059-65. 
4. Anderson, E. J., and S. G. Weber. 2004. Rotavirus infection in adults. Lancet Infect Dis 4:91-9. 
5. Angel, J., B. Tang, N. Feng, H. B. Greenberg, and D. Bass. 1998. Studies of the role for NSP4 in the 
pathogenesis of homologous murine rotavirus diarrhea. J Infect Dis 177:455-8. 
6. Ansari, S. A., S. A. Sattar, V. S. Springthorpe, G. A. Wells, and W. Tostowaryk. 1988. Rotavirus 
survival on human hands and transfer of infectious virus to animate and nonporous inanimate surfaces. J 
Clin Microbiol 26:1513-8. 
7. Aponte, C., N. M. Mattion, M. K. Estes, A. Charpilienne, and J. Cohen. 1993. Expression of two bovine 
rotavirus non-structural proteins (NSP2, NSP3) in the baculovirus system and production of monoclonal 
antibodies directed against the expressed proteins. Arch Virol 133:85-95. 
8. Arias, C. F., M. A. Dector, L. Segovia, T. Lopez, M. Camacho, P. Isa, R. Espinosa, and S. Lopez. 2004. 
RNA silencing of rotavirus gene expression. Virus Res 102:43-51. 
9. Arias, C. F., S. Lopez, and R. T. Espejo. 1982. Gene protein products of SA11 simian rotavirus genome. 
J Virol 41:42-50. 
10. Arias, C. F., P. Romero, V. Alvarez, and S. Lopez. 1996. Trypsin activation pathway of rotavirus 
infectivity. J Virol 70:5832-9. 
11. Au, K. S., W. K. Chan, J. W. Burns, and M. K. Estes. 1989. Receptor activity of rotavirus nonstructural 
glycoprotein NS28. J Virol 63:4553-62. 
12. Au, K. S., N. M. Mattion, and M. K. Estes. 1993. A subviral particle binding domain on the rotavirus 
nonstructural glycoprotein NS28. Virology 194:665-73. 
13. Audie, J. P., A. Janin, N. Porchet, M. C. Copin, B. Gosselin, and J. P. Aubert. 1993. Expression of 
human mucin genes in respiratory, digestive, and reproductive tracts ascertained by in situ hybridization. 
J Histochem Cytochem 41:1479-85. 
14. Awad, A. B., A. Kamei, P. J. Horvath, and C. S. Fink. 1995. Prostaglandin synthesis in human cancer 
cells: influence of fatty acids and butyrate. Prostaglandins Leukot Essent Fatty Acids 53:87-93. 
15. Azim, T., S. M. Ahmad, E. K. Sefat, M. S. Sarker, L. E. Unicomb, S. De, J. D. Hamadani, M. A. Salam, 
M. A. Wahed, and M. J. Albert. 1999. Immune response of children who develop persistent diarrhea 
following rotavirus infection. Clin Diagn Lab Immunol 6:690-5. 
16. Ball, J. M., P. Tian, C. Q. Zeng, A. P. Morris, and M. K. Estes. 1996. Age-dependent diarrhea induced by 
a rotaviral nonstructural glycoprotein. Science 272:101-4. 
17. Barkalow, F. J., and J. E. Schwarzbauer. 1991. Localization of the major heparin-binding site in 
fibronectin. J Biol Chem 266:7812-8. 
18. Barnes, G. L., J. S. Lund, S. V. Mitchell, L. De Bruyn, L. Piggford, A. L. Smith, J. Furmedge, P. J. 
Masendycz, H. C. Bugg, N. Bogdanovic-Sakran, J. B. Carlin, and R. F. Bishop. 2002. Early phase II trial 
of human rotavirus vaccine candidate RV3. Vaccine 20:2950-6. 
19. Bass, D., E. Cordoba, C. Dekker, A. Schuind, and C. Cassady. 2004. Intestinal imaging of children with 
acute rotavirus gastroenteritis. J Pediatr Gastroenterol Nutr 39(3):270-274. 
20. Beaulieu, J. F. 1992. Differential expression of the VLA family of integrins along the crypt-villus axis in 
the human small intestine. J Cell Sci 102 ( Pt 3):427-36. 
21. Beaulieu, J. F. 1999. Integrins and human intestinal cell functions. Front Biosci 4:D310-21. 
22. Beaulieu, J. F., P. H. Vachon, and S. Chartrand. 1991. Immunolocalization of extracellular matrix 
components during organogenesis in the human small intestine. Anat Embryol (Berl) 183:363-9. 
23. Beisner, B., D. Kool, A. Marich, and I. H. Holmes. 1998. Characterisation of G serotype dependent non-
antibody inhibitors of rotavirus in normal mouse serum. Arch Virol 143:1277-94. 
24. Bell, L. M., H. F. Clark, E. A. O'Brien, M. J. Kornstein, S. A. Plotkin, and P. A. Offit. 1987. 
Gastroenteritis caused by human rotaviruses (serotype three) in a suckling mouse model. Proc Soc Exp 
Biol Med 184:127-32. 
25. Belley, A., and K. Chadee. 1999. Prostaglandin E(2) stimulates rat and human colonic mucin exocytosis 
via the EP(4) receptor. Gastroenterology 117:1352-62. 
26. Berghem, L. E., and K. J. Johanson. 1983. Effect of 137Cs gamma radiation on the fibronectin content in 
basement membrane of mouse small intestine. Acta Radiol Oncol 22:389-93. 
138   
 
27. Bern, C., and R. I. Glass. 1994. Impact of diarrheal diseases worldwide. In A. Z. Kapikian (ed.), Viral 
Infections of the Gastrointestinal Tract. Marcel Dekker, New York. 
28. Bern, C., J. Martines, I. de Zoysa, and R. I. Glass. 1992. The magnitude of the global problem of 
diarrhoeal disease: a ten-year update. Bull World Health Organ 70:705-14. 
29. Bernstein, D. I., M. M. McNeal, G. M. Schiff, and R. L. Ward. 1989. Induction and persistence of local 
rotavirus antibodies in relation to serum antibodies. J Med Virol 28:90-5. 
30. Bican, P., J. Cohen, A. Charpilienne, and R. Scherrer. 1982. Purification and characterization of bovine 
rotavirus cores. J Virol 43:1113-7. 
31. Bishop, R. F., G. L. Barnes, E. Cipriani, and J. S. Lund. 1983. Clinical immunity after neonatal rotavirus 
infection. A prospective longitudinal study in young children. N Engl J Med 309:72-6. 
32. Bishop, R. F., G. P. Davidson, I. H. Holmes, and B. J. Ruck. 1974. Detection of a new virus by electron 
microscopy of faecal extracts from children with acute gastroenteritis. Lancet 1:149-51. 
33. Bishop, R. F., G. P. Davidson, I. H. Holmes, and B. J. Ruck. 1973. Virus particles in epithelial cells of 
duodenal mucosa from children with acute non-bacterial gastroenteritis. Lancet 2:1281-3. 
34. Black, R. E., M. H. Merson, A. S. Rahman, M. Yunus, A. R. Alim, I. Huq, R. H. Yolken, and G. T. 
Curlin. 1980. A two-year study of bacterial, viral, and parasitic agents associated with diarrhea in rural 
Bangladesh. J Infect Dis 142:660-4. 
35. Black, T. L., G. N. Barber, and M. G. Katze. 1993. Degradation of the interferon-induced 68,000-M(r) 
protein kinase by poliovirus requires RNA. J Virol 67:791-800. 
36. Blackhall, J., A. Fuentes, K. Hansen, and G. Magnusson. 1997. Serine protein kinase activity associated 
with rotavirus phosphoprotein NSP5. J Virol 71:138-44. 
37. Blomback, B., B. Hessel, D. Hogg, and L. Therkildsen. 1978. A two-step fibrinogen--fibrin transition in 
blood coagulation. Nature 275:501-5. 
38. Bloom, L., K. C. Ingham, and R. O. Hynes. 1999. Fibronectin regulates assembly of actin filaments and 
focal contacts in cultured cells via the heparin-binding site in repeat III13. Mol Biol Cell 10:1521-36. 
39. Blutt, S. E., S. E. Crawford, K. L. Warfield, D. E. Lewis, M. K. Estes, and M. E. Conner. 2004. The VP7 
outer capsid protein of rotavirus induces polyclonal B-cell activation. J Virol 78:6974-81. 
40. Blutt, S. E., C. D. Kirkwood, V. Parreno, K. L. Warfield, M. Ciarlet, M. K. Estes, K. Bok, R. F. Bishop, 
and M. E. Conner. 2003. Rotavirus antigenaemia and viraemia: a common event? Lancet 362:1445-9. 
41. Bolivar, R., R. H. Conklin, J. J. Vollet, L. K. Pickering, H. L. DuPont, D. L. Walters, and S. Kohl. 1978. 
Rotavirus in travelers' diarrhea: study of an adult student population in Mexico. J Infect Dis 137:324-7. 
42. Borchers, M. T., M. P. Carty, and G. D. Leikauf. 1999. Regulation of human airway mucins by acrolein 
and inflammatory mediators. Am J Physiol 276:L549-55. 
43. Boshuizen, J. A., J. H. Reimerink, A. M. Korteland-Van Male, V. J. Van Ham, M. P. Koopmans, H. A. 
Buller, J. Dekker, and A. W. Einerhand. 2003. Changes in Small Intestinal Homeostasis, Morphology, 
and Gene Expression during Rotavirus Infection of Infant Mice. J Virol 77:13005-16. 
44. Boshuizen, J. A., J. W. Rossen, C. K. Sitaram, F. F. Kimenai, Y. Simons-Oosterhuis, C. Laffeber, H. A. 
Buller, and A. W. Einerhand. 2004. Rotavirus enterotoxin NSP4 binds to the extracellular matrix proteins 
laminin-beta3 and fibronectin. J Virol 78:10045-53. 
45. Both, G. W., J. S. Mattick, and A. R. Bellamy. 1983. Serotype-specific glycoprotein of simian 11 
rotavirus: coding assignment and gene sequence. Proc Natl Acad Sci U S A 80:3091-5. 
46. Both, G. W., L. J. Siegman, A. R. Bellamy, and P. H. Atkinson. 1983. Coding assignment and nucleotide 
sequence of simian rotavirus SA11 gene segment 10: location of glycosylation sites suggests that the 
signal peptide is not cleaved. J Virol 48:335-9. 
47. Bowman, G. D., I. M. Nodelman, O. Levy, S. L. Lin, P. Tian, T. J. Zamb, S. A. Udem, B. 
Venkataraghavan, and C. E. Schutt. 2000. Crystal structure of the oligomerization domain of NSP4 from 
rotavirus reveals a core metal-binding site. J Mol Biol 304:861-71. 
48. Boyle, J. F., and K. V. Holmes. 1986. RNA-binding proteins of bovine rotavirus. J Virol 58:561-8. 
49. Brandt, C. D., H. W. Kim, W. J. Rodriguez, J. O. Arrobio, B. C. Jeffries, E. P. Stallings, C. Lewis, A. J. 
Miles, R. M. Chanock, A. Z. Kapikian, and R. H. Parrott. 1983. Pediatric viral gastroenteritis during 
eight years of study. J Clin Microbiol 18:71-8. 
50. Bresee, J. S., R. I. Glass, B. Ivanoff, and J. R. Gentsch. 1999. Current status and future priorities for 
rotavirus vaccine development, evaluation and implementation in developing countries. Vaccine 
17:2207-22. 
51. Bridger, J. C., W. Dhaliwal, M. J. Adamson, and C. R. Howard. 1998. Determinants of rotavirus host 
range restriction--a heterologous bovine NSP1 gene does not affect replication kinetics in the pig. 
Virology 245:47-52. 
References   139 
 
52. Bridger, J. C., G. A. Hall, and K. R. Parsons. 1992. A study of the basis of virulence variation of bovine 
rotaviruses. Vet Microbiol 33:169-74. 
53. Broome, R. L., P. T. Vo, R. L. Ward, H. F. Clark, and H. B. Greenberg. 1993. Murine rotavirus genes 
encoding outer capsid proteins VP4 and VP7 are not major determinants of host range restriction and 
virulence. J Virol 67:2448-55. 
54. Brown, K. A., and P. A. Offit. 1998. Rotavirus-specific proteins are detected in murine macrophages in 
both intestinal and extraintestinal lymphoid tissues. Microb Pathog 24:327-31. 
55. Buisine, M. P., P. Desreumaux, E. Leteurtre, M. C. Copin, J. F. Colombel, N. Porchet, and J. P. Aubert. 
2001. Mucin gene expression in intestinal epithelial cells in Crohn's disease. Gut 49:544-51. 
56. Buisine, M. P., J. L. Desseyn, N. Porchet, P. Degand, A. Laine, and J. P. Aubert. 1998. Genomic 
organization of the 3'-region of the human MUC5AC mucin gene: additional evidence for a common 
ancestral gene for the 11p15.5 mucin gene family. Biochem J 332 ( Pt 3):729-38. 
57. Buller, H. A., M. J. Kothe, D. A. Goldman, S. A. Grubman, W. V. Sasak, P. T. Matsudaira, R. K. 
Montgomery, and R. J. Grand. 1990. Coordinate expression of lactase-phlorizin hydrolase mRNA and 
enzyme levels in rat intestine during development. J Biol Chem 265:6978-83. 
58. Burke, B., and U. Desselberger. 1996. Rotavirus pathogenicity. Virology 218:299-305. 
59. Burns, J. W., A. A. Krishnaney, P. T. Vo, R. V. Rouse, L. J. Anderson, and H. B. Greenberg. 1995. 
Analyses of homologous rotavirus infection in the mouse model. Virology 207:143-53. 
60. Busby, T. F., W. S. Argraves, S. A. Brew, I. Pechik, G. L. Gilliland, and K. C. Ingham. 1995. Heparin 
binding by fibronectin module III-13 involves six discontinuous basic residues brought together to form a 
cationic cradle. J Biol Chem 270:18558-62. 
61. Bushell, M., and P. Sarnow. 2002. Hijacking the translation apparatus by RNA viruses. J Cell Biol 
158:395-9. 
62. Campbell, I. D., and C. Spitzfaden. 1994. Building proteins with fibronectin type III modules. Structure 
2:333-7. 
63. Carpio, M. M., L. A. Babiuk, V. Misra, and R. M. Blumenthal. 1981. Bovine rotavirus-cell interactions: 
effect of virus infection on cellular integrity and macromolecular synthesis. Virology 114:86-97. 
64. Carter, W. G., M. C. Ryan, and P. J. Gahr. 1991. Epiligrin, a new cell adhesion ligand for integrin alpha 
3 beta 1 in epithelial basement membranes. Cell 65:599-610. 
65. Casola, A., M. K. Estes, S. E. Crawford, P. L. Ogra, P. B. Ernst, R. P. Garofalo, and S. E. Crowe. 1998. 
Rotavirus infection of cultured intestinal epithelial cells induces secretion of CXC and CC chemokines. 
Gastroenterology 114:947-55. 
66. Chan, B. M., M. J. Elices, E. Murphy, and M. E. Hemler. 1992. Adhesion to vascular cell adhesion 
molecule 1 and fibronectin. Comparison of alpha 4 beta 1 (VLA-4) and alpha 4 beta 7 on the human B 
cell line JY. J Biol Chem 267:8366-70. 
67. Chan, W. K., K. S. Au, and M. K. Estes. 1988. Topography of the simian rotavirus nonstructural 
glycoprotein (NS28) in the endoplasmic reticulum membrane. Virology 164:435-42. 
68. Chang, K. O., Y. J. Kim, and L. J. Saif. 1999. Comparisons of nucleotide and deduced amino acid 
sequences of NSP4 genes of virulent and attenuated pairs of group A and C rotaviruses. Virus Genes 
18:229-33. 
69. Chang, S. K., A. F. Dohrman, C. B. Basbaum, S. B. Ho, T. Tsuda, N. W. Toribara, J. R. Gum, and Y. S. 
Kim. 1994. Localization of mucin (MUC2 and MUC3) messenger RNA and peptide expression in human 
normal intestine and colon cancer. Gastroenterology 107:28-36. 
70. Charpilienne, A., M. J. Abad, F. Michelangeli, F. Alvarado, M. Vasseur, J. Cohen, and M. C. Ruiz. 1997. 
Solubilized and cleaved VP7, the outer glycoprotein of rotavirus, induces permeabilization of cell 
membrane vesicles. J Gen Virol 78 ( Pt 6):1367-71. 
71. Chemello, M. E., O. C. Aristimuno, F. Michelangeli, and M. C. Ruiz. 2002. Requirement for vacuolar 
H+ -ATPase activity and Ca2+ gradient during entry of rotavirus into MA104 cells. J Virol 76:13083-7. 
72. Chen, C. C., M. Baylor, and D. M. Bass. 1993. Murine intestinal mucins inhibit rotavirus infection. 
Gastroenterology 105:84-92. 
73. Chen, D., C. L. Luongo, M. L. Nibert, and J. T. Patton. 1999. Rotavirus open cores catalyze 5'-capping 
and methylation of exogenous RNA: evidence that VP3 is a methyltransferase. Virology 265:120-30. 
74. Chen, N., and C. S. Reis. 2002. Distinct roles of eicosanoids in the immune response to viral 
encephalitis: or why you should take NSAIDS. Viral Immunol 15:133-46. 
75. Cheng, Y. S., M. F. Champliaud, R. E. Burgeson, M. P. Marinkovich, and P. D. Yurchenco. 1997. Self-
assembly of laminin isoforms. J Biol Chem 272:31525-32. 
140   
 
76. Chien, C. T., P. L. Bartel, R. Sternglanz, and S. Fields. 1991. The two-hybrid system: a method to 
identify and clone genes for proteins that interact with a protein of interest. Proc Natl Acad Sci U S A 
88:9578-82. 
77. Ciarlet, M., M. E. Conner, M. J. Finegold, and M. K. Estes. 2002. Group A Rotavirus Infection and Age-
Dependent Diarrheal Disease in Rats: a New Animal Model To Study the Pathophysiology of Rotavirus 
Infection. J Virol 76:41-57. 
78. Ciarlet, M., S. E. Crawford, and M. K. Estes. 2001. Differential infection of polarized epithelial cell lines 
by sialic acid-dependent and sialic acid-independent rotavirus strains. J Virol 75:11834-50. 
79. Ciarlet, M., and M. K. Estes. 1999. Human and most animal rotavirus strains do not require the presence 
of sialic acid on the cell surface for efficient infectivity. J Gen Virol 80:943-8. 
80. Ciarlet, M., F. Liprandi, M. E. Conner, and M. K. Estes. 2000. Species specificity and interspecies 
relatedness of NSP4 genetic groups by comparative NSP4 sequence analyses of animal rotaviruses. Arch 
Virol 145:371-83. 
81. Clark, S. M., J. R. Roth, M. L. Clark, B. B. Barnett, and R. S. Spendlove. 1981. Trypsin enhancement of 
rotavirus infectivity: mechanism of enhancement. J Virol 39:816-22. 
82. Coelho, K. I., A. S. Bryden, C. H. Hall, and T. H. Flewett. 1981. Pathology of rotavirus infection in 
suckling mice: a study by conventional histology, immunofluorescence, ultrathin sections, and scanning 
electron microscopy. Ultrastruct Pathol 2:59-80. 
83. Cohen, J., A. Charpilienne, S. Chilmonczyk, and M. K. Estes. 1989. Nucleotide sequence of bovine 
rotavirus gene 1 and expression of the gene product in baculovirus. Virology 171:131-40. 
84. Collins, J., W. G. Starkey, T. S. Wallis, G. J. Clarke, K. J. Worton, A. J. Spencer, S. J. Haddon, M. P. 
Osborne, D. C. Candy, and J. Stephen. 1988. Intestinal enzyme profiles in normal and rotavirus-infected 
mice. J Pediatr Gastroenterol Nutr 7:264-72. 
85. Collins, J. E., D. A. Benfield, and J. R. Duimstra. 1989. Comparative virulence of two porcine group-A 
rotavirus isolates in gnotobiotic pigs. Am J Vet Res 50:827-35. 
86. Colognato, H., and P. D. Yurchenco. 2000. Form and function: the laminin family of heterotrimers. Dev 
Dyn 218:213-34. 
87. Control, C. f. D. 1999. Rotavirus vaccine for prevention of rotavirus gastroenteritis among children. 
Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb Mortal Wkly 
Rep 48:1-20. 
88. Corpe, C. P., and C. F. Burant. 1996. Hexose transporter expression in rat small intestine: effect of diet 
on diurnal variations. Am J Physiol 271:G211-6. 
89. Coulson, B. S., S. L. Londrigan, and D. J. Lee. 1997. Rotavirus contains integrin ligand sequences and a 
disintegrin-like domain that are implicated in virus entry into cells. Proc Natl Acad Sci U S A 94:5389-
94. 
90. Coulson, B. S., P. D. Witterick, Y. Tan, M. J. Hewish, J. N. Mountford, L. C. Harrison, and M. C. 
Honeyman. 2002. Growth of rotaviruses in primary pancreatic cells. J Virol 76:9537-44. 
91. Cox, K. H., D. V. DeLeon, L. M. Angerer, and R. C. Angerer. 1984. Detection of mrnas in sea urchin 
embryos by in situ hybridization using asymmetric RNA probes. Dev Biol 101:485-502. 
92. Cox, M. J., and G. F. Medley. 2003. Serological survey of anti-group A rotavirus IgM in UK adults. 
Epidemiol Infect 131:719-26. 
93. Crawford, S. E., M. Labbe, J. Cohen, M. H. Burroughs, Y. J. Zhou, and M. K. Estes. 1994. 
Characterization of virus-like particles produced by the expression of rotavirus capsid proteins in insect 
cells. J Virol 68:5945-52. 
94. Crawford, S. E., S. K. Mukherjee, M. K. Estes, J. A. Lawton, A. L. Shaw, R. F. Ramig, and B. V. Prasad. 
2001. Trypsin cleavage stabilizes the rotavirus VP4 spike. J Virol 75:6052-61. 
95. Crawley, J. M., R. F. Bishop, and G. L. Barnes. 1993. Rotavirus gastroenteritis in infants aged 0-6 
months in Melbourne, Australia: implications for vaccination. J Paediatr Child Health 29:219-21. 
96. Cuadras, M. A., D. A. Feigelstock, S. An, and H. B. Greenberg. 2002. Gene expression pattern in Caco-2 
cells following rotavirus infection. J Virol 76:4467-82. 
97. Davidson, G. P., and G. L. Barnes. 1979. Structural and functional abnormalities of the small intestine in 
infants and young children with rotavirus enteritis. Acta Paediatr Scand 68:181-6. 
98. Davidson, G. P., R. F. Bishop, R. R. Townley, and I. H. Holmes. 1975. Importance of a new virus in 
acute sporadic enteritis in children. Lancet 1:242-6. 
99. Davidson, G. P., D. G. Gall, M. Petric, D. G. Butler, and J. R. Hamilton. 1977. Human rotavirus enteritis 
induced in conventional piglets. Intestinal structure and transport. J Clin Invest 60:1402-9. 
References   141 
 
100. Davril, M., S. Degroote, P. Humbert, C. Galabert, V. Dumur, J. J. Lafitte, G. Lamblin, and P. Roussel. 
1999. The sialylation of bronchial mucins secreted by patients suffering from cystic fibrosis or from 
chronic bronchitis is related to the severity of airway infection. Glycobiology 9:311-21. 
101. de Wit, M. A., M. P. Koopmans, L. M. Kortbeek, N. J. van Leeuwen, J. Vinje, and Y. T. van Duynhoven. 
2001. Etiology of gastroenteritis in sentinel general practices in the netherlands. Clin Infect Dis 33:280-8. 
102. de Wit, M. A., M. P. Koopmans, J. F. van der Blij, and Y. T. van Duynhoven. 2000. Hospital admissions 
for rotavirus infection in the Netherlands. Clin Infect Dis 31:698-704. 
103. Dector, M. A., P. Romero, S. Lopez, and C. F. Arias. 2002. Rotavirus gene silencing by small interfering 
RNAs. EMBO Rep 3:1175-80. 
104. Dekker J, E., AWC, Büller HA. 2002. Carbohydrate malabsorption, p. 339-374. In L. CH (ed.), Pediatric 
gastroenterology and nutrition in clinical practice. Marcel Dekker Inc, New York. 
105. Dekker, J., J. W. Rossen, H. A. Buller, and A. W. Einerhand. 2002. The MUC family: an obituary. 
Trends Biochem Sci 27:126-31. 
106. Delmotte, P., S. Degroote, M. D. Merten, I. Van Seuningen, A. Bernigaud, C. Figarella, P. Roussel, and 
J. M. Perini. 2001. Influence of TNFalpha on the sialylation of mucins produced by a transformed cell 
line MM-39 derived from human tracheal gland cells. Glycoconj J 18:487-97. 
107. Delorme, C., H. Brussow, J. Sidoti, N. Roche, K. A. Karlsson, J. R. Neeser, and S. Teneberg. 2001. 
Glycosphingolipid binding specificities of rotavirus: identification of a sialic acid-binding epitope. J 
Virol 75:2276-87. 
108. Denisova, E., W. Dowling, R. LaMonica, R. Shaw, S. Scarlata, F. Ruggeri, and E. R. Mackow. 1999. 
Rotavirus capsid protein VP5* permeabilizes membranes. J Virol 73:3147-53. 
109. Deo, R. C., C. M. Groft, K. R. Rajashankar, and S. K. Burley. 2002. Recognition of the rotavirus mRNA 
3' consensus by an asymmetric NSP3 homodimer. Cell 108:71-81. 
110. Deplancke, B., and H. R. Gaskins. 2001. Microbial modulation of innate defense: goblet cells and the 
intestinal mucus layer. Am J Clin Nutr 73:1131S-1141S. 
111. Desselberger, U. 1999. Rotavirus infections: guidelines for treatment and prevention. Drugs 58:447-52. 
112. Dickman, K. G., S. J. Hempson, J. Anderson, S. Lippe, L. Zhao, R. Burakoff, and R. D. Shaw. 2000. 
Rotavirus alters paracellular permeability and energy metabolism in Caco-2 cells. Am J Physiol 
Gastrointest Liver Physiol 279:G757-66. 
113. Dohrman, A., S. Miyata, M. Gallup, J. D. Li, C. Chapelin, A. Coste, E. Escudier, J. Nadel, and C. 
Basbaum. 1998. Mucin gene (MUC 2 and MUC 5AC) upregulation by Gram-positive and Gram-
negative bacteria. Biochim Biophys Acta 1406:251-9. 
114. Dong, Y., C. Q. Zeng, J. M. Ball, M. K. Estes, and A. P. Morris. 1997. The rotavirus enterotoxin NSP4 
mobilizes intracellular calcium in human intestinal cells by stimulating phospholipase C-mediated 
inositol 1,4,5- trisphosphate production. Proc Natl Acad Sci U S A 94:3960-5. 
115. Dormitzer, P. R., and H. B. Greenberg. 1992. Calcium chelation induces a conformational change in 
recombinant herpes simplex virus-1-expressed rotavirus VP7. Virology 189:828-32. 
116. Einerhand, A. W., I. B. Renes, M. K. Makkink, M. van der Sluis, H. A. Buller, and J. Dekker. 2002. Role 
of mucins in inflammatory bowel disease: important lessons from experimental models. Eur J 
Gastroenterol Hepatol 14:757-65. 
117. Enss, M. L., H. K. Heim, S. Wagner, W. Beil, R. Eisenblatter, K. F. Sewing, and H. J. Hedrich. 1998. 
Effects of PGE2 and of different synthetic PGE derivatives on the glycosylation of pig gastric mucins. 
Prostaglandins Leukot Essent Fatty Acids 59:49-54. 
118. Ericson, B. L., D. Y. Graham, B. B. Mason, and M. K. Estes. 1982. Identification, synthesis, and 
modifications of simian rotavirus SA11 polypeptides in infected cells. J Virol 42:825-39. 
119. Ericson, B. L., D. Y. Graham, B. B. Mason, H. H. Hanssen, and M. K. Estes. 1983. Two types of 
glycoprotein precursors are produced by the simian rotavirus SA11. Virology 127:320-32. 
120. Escande, F., N. Porchet, A. Bernigaud, D. Petitprez, J. P. Aubert, and M. P. Buisine. 2004. The mouse 
secreted gel-forming mucin gene cluster. Biochim Biophys Acta 1676:240-50. 
121. Espejo, R. T., S. Lopez, and C. Arias. 1981. Structural polypeptides of simian rotavirus SA11 and the 
effect of trypsin. J Virol 37:156-60. 
122. Estes, M. K. 2001. Rotaviruses and their replication, p. 1747-1785. In D. M. Knipe and P. M. Howley 
(ed.), Fields virology. Lippencott-Raven Publishers, Philadelphia. 
123. Estes, M. K., and J. Cohen. 1989. Rotavirus structure and function. Microbiological reviews 53:410-449. 
124. Estes, M. K., S. E. Crawford, M. E. Penaranda, B. L. Petrie, J. W. Burns, W. K. Chan, B. Ericson, G. E. 
Smith, and M. D. Summers. 1987. Synthesis and immunogenicity of the rotavirus major capsid antigen 
using a baculovirus expression system. J Virol 61:1488-94. 
142   
 
125. Estes, M. K., D. Y. Graham, and B. B. Mason. 1981. Proteolytic enhancement of rotavirus infectivity: 
molecular mechanisms. J Virol 39:879-88. 
126. Estes, M. K., and A. P. Morris. 1999. A viral enterotoxin. A new mechanism of virus-induced 
pathogenesis. Adv Exp Med Biol 473:73-82. 
127. Fabbretti, E., I. Afrikanova, F. Vascotto, and O. R. Burrone. 1999. Two non-structural rotavirus proteins, 
NSP2 and NSP5, form viroplasm-like structures in vivo. J Gen Virol 80 ( Pt 2):333-9. 
128. Farthing, M. J. 1993. Pathophysiology of infective diarrhoea. Eur J Gastroenterol Hepatol 5:796-807. 
129. Feng, N., J. W. Burns, L. Bracy, and H. B. Greenberg. 1994. Comparison of mucosal and systemic 
humoral immune responses and subsequent protection in mice orally inoculated with a homologous or a 
heterologous rotavirus. J Virol 68:7766-73. 
130. Feng, N., M. A. Franco, and H. B. Greenberg. 1997. Murine model of rotavirus infection. Adv Exp Med 
Biol 412:233-40. 
131. ffrench-Constant, C. 1995. Alternative splicing of fibronectin--many different proteins but few different 
functions. Exp Cell Res 221:261-71. 
132. Fields, S., and O. Song. 1989. A novel genetic system to detect protein-protein interactions. Nature 
340:245-6. 
133. Fiore, L., H. B. Greenberg, and E. R. Mackow. 1991. The VP8 fragment of VP4 is the rhesus rotavirus 
hemagglutinin. Virology 181:553-63. 
134. Fireman, P. 2003. Understanding asthma pathophysiology. Allergy Asthma Proc 24:79-83. 
135. Flewett, T. H., A. S. Bryden, and H. Davies. 1973. Letter: Virus particles in gastroenteritis. Lancet 
2:1497. 
136. Flewett, T. H., A. S. Bryden, H. Davies, G. N. Woode, J. C. Bridger, and J. M. Derrick. 1974. Relation 
between viruses from acute gastroenteritis of children and newborn calves. Lancet 2:61-3. 
137. Forstner, J. F., and G. G. Forstner. 1994. Gastrointestinal mucus, p. 1255-1284. In J. L.R. (ed.), 
Physiology of the Gastrointestinal Tract, 3rd ed. Raven, New York. 
138. Franco, M. A., and H. B. Greenberg. 2000. Immunity to homologous rotavirus infection in adult mice. 
Trends Microbiol 8:50-2. 
139. Franco, M. A., I. Prieto, M. Labbe, D. Poncet, F. Borras-Cuesta, and J. Cohen. 1993. An 
immunodominant cytotoxic T cell epitope on the VP7 rotavirus protein overlaps the H2 signal peptide. J 
Gen Virol 74 ( Pt 12):2579-86. 
140. Fromantin, C., L. Piroth, I. Petitpas, P. Pothier, and E. Kohli. 1998. Oral delivery of homologous and 
heterologous strains of rotavirus to BALB/c mice induces the same profile of cytokine production by 
spleen cells. Virology 244:252-60. 
141. Fukuhara, N., O. Yoshie, S. Kitaoka, and T. Konno. 1988. Role of VP3 in human rotavirus 
internalization after target cell attachment via VP7. J Virol 62:2209-18. 
142. Furness, J. B. 1987. The enteric nervous system. Churchill Livingstone, New York. 
143. Gache, Y., M. Allegra, C. Bodemer, A. Pisani-Spadafora, Y. de Prost, J. P. Ortonne, and G. Meneguzzi. 
2001. Genetic bases of severe junctional epidermolysis bullosa presenting spontaneous amelioration with 
aging. Hum Mol Genet 10:2453-61. 
144. Gietz, D., A. St Jean, R. A. Woods, and R. H. Schiestl. 1992. Improved method for high efficiency 
transformation of intact yeast cells. Nucleic Acids Res 20:1425. 
145. Gilger, M. A., D. O. Matson, M. E. Conner, H. M. Rosenblatt, M. J. Finegold, and M. K. Estes. 1992. 
Extraintestinal rotavirus infections in children with immunodeficiency. J Pediatr 120:912-7. 
146. Golantsova, N. E., E. E. Gorbunova, and E. R. Mackow. 2004. Discrete domains within the rotavirus 
VP5* direct peripheral membrane association and membrane permeability. J Virol 78:2037-44. 
147. Gonzalez, R. A., M. A. Torres-Vega, S. Lopez, and C. F. Arias. 1998. In vivo interactions among 
rotavirus nonstructural proteins. Arch Virol 143:981-96. 
148. Gonzalez, S. A., and O. R. Burrone. 1991. Rotavirus NS26 is modified by addition of single O-linked 
residues of N-acetylglucosamine. Virology 182:8-16. 
149. Gouvea, V. S., A. A. Alencar, O. M. Barth, L. de Castro, A. M. Fialho, H. P. Araujo, S. Majerowicz, and 
H. G. Pereira. 1986. Diarrhoea in mice infected with a human rotavirus. J Gen Virol 67:577-81. 
150. Graham, K. L., P. Halasz, Y. Tan, M. J. Hewish, Y. Takada, E. R. Mackow, M. K. Robinson, and B. S. 
Coulson. 2003. Integrin-using rotaviruses bind alpha2beta1 integrin alpha2 I domain via VP4 DGE 
sequence and recognize alphaXbeta2 and alphaVbeta3 by using VP7 during cell entry. J Virol 77:9969-
78. 
151. Greenberg, H. B., H. F. Clark, and P. A. Offit. 1994. Rotavirus pathology and pathophysiology. Curr Top 
Microbiol Immunol 185:255-83. 
References   143 
 
152. Grimwood, K., J. C. Lund, B. S. Coulson, I. L. Hudson, R. F. Bishop, and G. L. Barnes. 1988. 
Comparison of serum and mucosal antibody responses following severe acute rotavirus gastroenteritis in 
young children. J Clin Microbiol 26:732-8. 
153. Grohmann, G. S., R. I. Glass, H. G. Pereira, S. S. Monroe, A. W. Hightower, R. Weber, and R. T. Bryan. 
1993. Enteric viruses and diarrhea in HIV-infected patients. Enteric Opportunistic Infections Working 
Group. N Engl J Med 329:14-20. 
154. Guarino, A., R. B. Canani, S. Russo, F. Albano, M. B. Canani, F. M. Ruggeri, G. Donelli, and A. 
Rubino. 1994. Oral immunoglobulins for treatment of acute rotaviral gastroenteritis. Pediatrics 93:12-6. 
155. Guarino, A., R. B. Canani, M. I. Spagnuolo, F. Albano, and L. Di Benedetto. 1997. Oral bacterial therapy 
reduces the duration of symptoms and of viral excretion in children with mild diarrhea. J Pediatr 
Gastroenterol Nutr 25:516-9. 
156. Guerin-Danan, C., J. C. Meslin, A. Chambard, A. Charpilienne, P. Relano, C. Bouley, J. Cohen, and C. 
Andrieux. 2001. Food supplementation with milk fermented by Lactobacillus casei DN-114 001 protects 
suckling rats from rotavirus-associated diarrhea. J Nutr 131:111-7. 
157. Guerin-Danan, C., J. C. Meslin, F. Lambre, A. Charpilienne, M. Serezat, C. Bouley, J. Cohen, and C. 
Andrieux. 1998. Development of a heterologous model in germfree suckling rats for studies of rotavirus 
diarrhea. J Virol 72:9298-302. 
158. Guerrero, C. A., D. Bouyssounade, S. Zarate, P. Isa, T. Lopez, R. Espinosa, P. Romero, E. Mendez, S. 
Lopez, and C. F. Arias. 2002. Heat shock cognate protein 70 is involved in rotavirus cell entry. J Virol 
76:4096-102. 
159. Gum, J. R., J. W. Hicks, D. M. Swallow, R. L. Lagace, J. C. Byrd, D. T. Lamport, B. Siddiki, and Y. S. 
Kim. 1990. 
160. Gum, J. R., Jr., J. W. Hicks, N. W. Toribara, B. Siddiki, and Y. S. Kim. 1994. Molecular cloning of 
human intestinal mucin (MUC2) cDNA. Identification of the amino terminus and overall sequence 
similarity to prepro-von Willebrand factor. J Biol Chem 269:2440-6. 
161. Guo, C. T., O. Nakagomi, M. Mochizuki, H. Ishida, M. Kiso, Y. Ohta, T. Suzuki, D. Miyamoto, K. I. 
Hidari, and Y. Suzuki. 1999. Ganglioside GM(1a) on the cell surface is involved in the infection by 
human rotavirus KUN and MO strains. J Biochem (Tokyo) 126:683-8. 
162. Halaihel, N., V. Lievin, F. Alvarado, and M. Vasseur. 2000. Rotavirus infection impairs intestinal brush-
border membrane Na(+)-solute cotransport activities in young rabbits. Am J Physiol Gastrointest Liver 
Physiol 279:G587-96. 
163. Halaihel, N., V. Lievin, J. M. Ball, M. K. Estes, F. Alvarado, and M. Vasseur. 2000. Direct inhibitory 
effect of rotavirus NSP4(114-135) peptide on the Na(+)-D-glucose symporter of rabbit intestinal brush 
border membrane. J Virol 74:9464-70. 
164. Hamilton, J. R. 1988. Viral enteritis. Pediatr Clin North Am 35:89-101. 
165. Heimer, G. V., and C. E. Taylor. 1974. Improved mountant for immunofluorescence preparations. J Clin 
Pathol 27:254-6. 
166. Hershey, J. W. B., and W. C. Merrick. 2000. The pathway and mechanism of initiation of protein 
synthesis, p. 33-88. In N. Sonenberg, J. W. B. Hershey, and M. B. Mathews (ed.), Translational control 
of gene expression. Cold Spring Harbor Press, New York. 
167. Hewish, M. J., Y. Takada, and B. S. Coulson. 2000. Integrins alpha2beta1 and alpha4beta1 can mediate 
SA11 rotavirus attachment and entry into cells. J Virol 74:228-36. 
168. Heyman, M., G. Corthier, A. Petit, J. C. Meslin, C. Moreau, and J. F. Desjeux. 1987. Intestinal 
absorption of macromolecules during viral enteritis: an experimental study on rotavirus-infected 
conventional and germ-free mice. Pediatr Res 22:72-8. 
169. Hirayama, B. A., M. P. Lostao, M. Panayotova-Heiermann, D. D. Loo, E. Turk, and E. M. Wright. 1996. 
Kinetic and specificity differences between rat, human, and rabbit Na+- glucose cotransporters (SGLT-
1). Am J Physiol 270:G919-26. 
170. Holmen, J. M., F. J. Olson, H. Karlsson, and G. C. Hansson. 2002. Two glycosylation alterations of 
mouse intestinal mucins due to infection caused by the parasite Nippostrongylus brasiliensis. Glycoconj J 
19:67-75. 
171. Holmes, I. H., B. J. Ruck, R. F. Bishop, and G. P. Davidson. 1975. Infantile enteritis; morphogenesis and 
morphology. J Virol 16:937-943. 
172. Homaidan, F. R., A. Torres, M. Donowitz, and G. W. Sharp. 1991. Electrolyte transport in piglets 
infected with transmissible gastroenteritis virus. Stimulation by verapamil and clonidine. 
Gastroenterology 101:895-901. 
144   
 
173. Horie, Y., O. Nakagomi, Y. Koshimura, T. Nakagomi, Y. Suzuki, T. Oka, S. Sasaki, Y. Matsuda, and S. 
Watanabe. 1999. Diarrhea induction by rotavirus NSP4 in the homologous mouse model system. 
Virology 262:398-407. 
174. Hoshino, Y., L. J. Saif, S. Y. Kang, M. M. Sereno, W. K. Chen, and A. Z. Kapikian. 1995. Identification 
of group A rotavirus genes associated with virulence of a porcine rotavirus and host range restriction of a 
human rotavirus in the gnotobiotic piglet model. Virology 209:274-80. 
175. Hoshino, Y., L. J. Saif, M. M. Sereno, R. M. Chanock, and A. Z. Kapikian. 1988. Infection immunity of 
piglets to either VP3 or VP7 outer capsid protein confers resistance to challenge with a virulent rotavirus 
bearing the corresponding antigen. J Virol 62:744-8. 
176. Hoshino, Y., M. M. Sereno, K. Midthun, J. Flores, A. Z. Kapikian, and R. M. Chanock. 1985. 
Independent segregation of two antigenic specificities (VP3 and VP7) involved in neutralization of 
rotavirus infectivity. Proc Natl Acad Sci U S A 82:8701-4. 
177. Hoshino, Y., R. G. Wyatt, H. B. Greenberg, J. Flores, and A. Z. Kapikian. 1984. Serotypic similarity and 
diversity of rotaviruses of mammalian and avian origin as studied by plaque-reduction neutralization. J 
Infect Dis 149:694-702. 
178. Hrdy, D. B. 1987. Epidemiology of rotaviral infection in adults. Rev Infect Dis 9:461-9. 
179. Hsu, K. T., and J. Storch. 1996. Fatty acid transfer from liver and intestinal fatty acid-binding proteins to 
membranes occurs by different mechanisms. J Biol Chem 271:13317-23. 
180. Hua, J., and J. T. Patton. 1994. The carboxyl-half of the rotavirus nonstructural protein NS53 (NSP1) is 
not required for virus replication. Virology 198:567-76. 
181. Huang, W., R. Chiquet-Ehrismann, J. V. Moyano, A. Garcia-Pardo, and G. Orend. 2001. Interference of 
tenascin-C with syndecan-4 binding to fibronectin blocks cell adhesion and stimulates tumor cell 
proliferation. Cancer Res 61:8586-94. 
182. Hunter, I., T. Schulthess, M. Bruch, K. Beck, and J. Engel. 1990. Evidence for a specific mechanism of 
laminin assembly. Eur J Biochem 188:205-11. 
183. Ikeshima-Kataoka, H., J. B. Skeath, Y. Nabeshima, C. Q. Doe, and F. Matsuzaki. 1997. Miranda directs 
Prospero to a daughter cell during Drosophila asymmetric divisions. Nature 390:625-9. 
184. Inaba, T., H. Sano, Y. Kawahito, T. Hla, K. Akita, M. Toda, I. Yamashina, M. Inoue, and H. Nakada. 
2003. Induction of cyclooxygenase-2 in monocyte/macrophage by mucins secreted from colon cancer 
cells. Proc Natl Acad Sci U S A 100:2736-41. 
185. Ingham, K. C., S. A. Brew, and D. H. Atha. 1990. Interaction of heparin with fibronectin and isolated 
fibronectin domains. Biochem J 272:605-11. 
186. Iosef, C., T. Van Nguyen, K. Jeong, K. Bengtsson, B. Morein, Y. Kim, K. O. Chang, M. S. Azevedo, L. 
Yuan, P. Nielsen, and L. J. Saif. 2002. Systemic and intestinal antibody secreting cell responses and 
protection in gnotobiotic pigs immunized orally with attenuated Wa human rotavirus and Wa 2/6-
rotavirus-like-particles associated with immunostimulating complexes. Vaccine 20:1741-53. 
187. Ishida, S. I., N. Feng, J. M. Gilbert, B. Tang, and H. B. Greenberg. 1997. Immune responses to individual 
rotavirus proteins following heterologous and homologous rotavirus infection in mice. J Infect Dis 
175:1317-23. 
188. Iturriza-Gomara, M., I. A. Auchterlonie, W. Zaw, P. Molyneaux, U. Desselberger, and J. Gray. 2002. 
Rotavirus gastroenteritis and central nervous system (CNS) infection: characterization of the VP7 and 
VP4 genes of rotavirus strains isolated from paired fecal and cerebrospinal fluid samples from a child 
with CNS disease. J Clin Microbiol 40:4797-9. 
189. Iturriza-Gomara, M., J. Green, D. W. Brown, M. Ramsay, U. Desselberger, and J. J. Gray. 2000. 
Molecular epidemiology of human group A rotavirus infections in the United Kingdom between 1995 
and 1998. J Clin Microbiol 38:4394-401. 
190. Jarvis, W. R., P. J. Middleton, and E. W. Gelfand. 1983. Significance of viral infections in severe 
combined immunodeficiency disease. Pediatr Infect Dis 2:187-92. 
191. Jass, J. R., and A. M. Roberton. 1994. Colorectal mucin histochemistry in health and disease: a critical 
review. Pathol Int 44:487-504. 
192. Jiang, B., J. R. Gentsch, and R. I. Glass. 2002. The role of serum antibodies in the protection against 
rotavirus disease: an overview. Clin Infect Dis 34:1351-61. 
193. Jiang, B., L. Snipes-Magaldi, P. Dennehy, H. Keyserling, R. C. Holman, J. Bresee, J. Gentsch, and R. I. 
Glass. 2003. Cytokines as mediators for or effectors against rotavirus disease in children. Clin Diagn Lab 
Immunol 10:995-1001. 
References   145 
 
194. Joensuu, J., E. Koskenniemi, X. L. Pang, and T. Vesikari. 1997. Randomised placebo-controlled trial of 
rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis. Lancet 
350:1205-9. 
195. Johnson, C. A., T. G. Snider, 3rd, W. G. Henk, and R. W. Fulton. 1986. A scanning and transmission 
electron microscopic study of rotavirus- induced intestinal lesions in neonatal gnotobiotic dogs. Vet 
Pathol 23:443-53. 
196. Jolly, C. L., B. M. Beisner, and I. H. Holmes. 2000. Rotavirus infection of MA104 cells is inhibited by 
Ricinus lectin and separately expressed single binding domains. Virology 275:89-97. 
197. Jonckheere, N., M. Van Der Sluis, A. Velghe, M. P. Buisine, M. Sutmuller, M. P. Ducourouble, P. Pigny, 
H. A. Buller, J. P. Aubert, A. W. Einerhand, and I. Van Seuningen. 2004. Transcriptional activation of 
the murine Muc5ac mucin gene in epithelial cancer cells by TGF-beta/Smad4 signalling pathway is 
potentiated by Sp1. Biochem J 377:797-808. 
198. Jourdan, N., M. Maurice, D. Delautier, A. M. Quero, A. L. Servin, and G. Trugnan. 1997. Rotavirus is 
released from the apical surface of cultured human intestinal cells through nonconventional vesicular 
transport that bypasses the Golgi apparatus. J Virol 71:8268-78. 
199. Kabcenell, A. K., and P. H. Atkinson. 1985. Processing of the rough endoplasmic reticulum membrane 
glycoproteins of rotavirus SA11. J Cell Biol 101:1270-80. 
200. Kalica, A. R., J. Flores, and H. B. Greenberg. 1983. Identification of the rotaviral gene that codes for 
hemagglutination and protease-enhanced plaque formation. Virology 125:194-205. 
201. Kaljot, K. T., R. D. Shaw, D. H. Rubin, and H. B. Greenberg. 1988. Infectious rotavirus enters cells by 
direct cell membrane penetration, not by endocytosis. J Virol 62:1136-44. 
202. Kapikian, A. Z. 1993. Viral gastroenteritis. 
203. Kapikian, A. Z., and R. M. Chanock. 1990. Rotaviruses, p. 1353-1404. In B. N. Fields, D. M. Knipe, R. 
M. Chanock, M. S. Hirsch, J. L. Melnick, and B. Roizman (ed.), Virology, 2nd ed. Raven press, New 
York. 
204. Kapikian, A. Z., Y. Hoshino, and R. M. Chanock. 2001. Rotaviruses, p. 1787-1833. In D. M. Knipe and 
P. M. Howley (ed.), Fields' virology, 4th ed. Lippincott Williams and Wilkins, Philadelphia. 
205. Kapikian, A. Z., Y. Hoshino, R. M. Chanock, and I. Perez-Schael. 1996. Jennerian and modified 
Jennerian approach to vaccination against rotavirus diarrhea using a quadrivalent rhesus rotavirus (RRV) 
and human-RRV reassortant vaccine. Arch Virol Suppl 12:163-75. 
206. Kapikian, A. Z., H. W. Kim, R. G. Wyatt, W. L. Cline, J. O. Arrobio, C. D. Brandt, W. J. Rodriguez, D. 
A. Sack, R. M. Chanock, and R. H. Parrott. 1976. Human reovirus-like agent as the major pathogen 
associated with "winter" gastroenteritis in hospitalized infants and young children. N Engl J Med 
294:965-72. 
207. Kapikian, A. Z., H. W. Kim, R. G. Wyatt, W. J. Rodriguez, S. Ross, W. L. Cline, R. H. Parrott, and R. 
M. Chanock. 1974. Reoviruslike agent in stools: association with infantile diarrhea and development of 
serologic tests. Science 185:1049-53. 
208. Karaki, S. I., and A. Kuwahara. 2004. Regulation of intestinal secretion involved in the interaction 
between neurotransmitters and prostaglandin E2. Neurogastroenterol Motil 16 Suppl 1:96-9. 
209. Katyal, R., S. V. Rana, K. Vaiphei, S. Ohja, K. Singh, and V. Singh. 1999. Effect of rotavirus infection 
on small gut pathophysiology in a mouse model. J Gastroenterol Hepatol 14:779-84. 
210. Keenan, K. P., H. R. Jervis, R. H. Marchwicki, and L. N. Binn. 1976. Intestinal infection of neonatal 
dogs with canine coronavirus 1-71: studies by virologic, histologic, histochemical, and 
immunofluorescent techniques. Am J Vet Res 37:247-56. 
211. Keljo, D. J., D. G. Butler, and J. R. Hamilton. 1985. Altered jejunal permeability to macromolecules 
during viral enteritis in the piglet. Gastroenterology 88:998-1004. 
212. Keljo, D. J., R. J. MacLeod, M. H. Perdue, D. G. Butler, and J. R. Hamilton. 1985. D-Glucose transport 
in piglet jejunal brush-border membranes: insights from a disease model. Am J Physiol 249:G751-60. 
213. Kerzner, B., M. H. Kelly, D. G. Gall, D. G. Butler, and J. R. Hamilton. 1977. Transmissible 
gastroenteritis: sodium transport and the intestinal epithelium during the course of viral enteritis. 
Gastroenterology 72:457-61. 
214. Kim, T. G., N. Befus, and W. H. Langridge. 2004. Co-immunization with an HIV-1 Tat transduction 
peptide-rotavirus enterotoxin fusion protein stimulates a Th1 mucosal immune response in mice. Vaccine 
22:431-8. 
215. Kim, Y. D., E. J. Kwon, D. W. Park, S. Y. Song, S. K. Yoon, and S. H. Baek. 2002. Interleukin-1beta 
induces MUC2 and MUC5AC synthesis through cyclooxygenase-2 in NCI-H292 cells. Mol Pharmacol 
62:1112-8. 
146   
 
216. Kirkwood, C. D., B. S. Coulson, and R. F. Bishop. 1996. G3P2 rotaviruses causing diarrhoeal disease in 
neonates differ in VP4, VP7 and NSP4 sequence from G3P2 strains causing asymptomatic neonatal 
infection. Arch Virol 141:1661-76. 
217. Konno, T., H. Suzuki, N. Katsushima, A. Imai, F. Tazawa, T. Kutsuzawa, S. Kitaoka, M. Sakamoto, N. 
Yazaki, and N. Ishida. 1983. Influence of temperature and relative humidity on human rotavirus infection 
in Japan. J Infect Dis 147:125-8. 
218. Kordasti, S., H. Sjovall, O. Lundgren, and L. Svensson. 2004. Serotonin and vasoactive intestinal peptide 
antagonists attenuate rotavirus diarrhoea. Gut 53:952-7. 
219. Korhonen, M., M. Ormio, R. E. Burgeson, I. Virtanen, and E. Savilahti. 2000. Unaltered distribution of 
laminins, fibronectin, and tenascin in celiac intestinal mucosa. J Histochem Cytochem 48:1011-20. 
220. Kosmehl, H., A. Berndt, and D. Katenkamp. 1996. Molecular variants of fibronectin and laminin: 
structure, physiological occurrence and histopathological aspects. Virchows Arch 429:311-22. 
221. Krasinski, S. D., G. Estrada, K. Y. Yeh, M. Yeh, P. G. Traber, E. H. Rings, H. A. Buller, M. Verhave, R. 
K. Montgomery, and R. J. Grand. 1994. Transcriptional regulation of intestinal hydrolase biosynthesis 
during postnatal development in rats. Am J Physiol 267:G584-94. 
222. Kujubu, D. A., B. S. Fletcher, B. C. Varnum, R. W. Lim, and H. R. Herschman. 1991. TIS10, a phorbol 
ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin 
synthase/cyclooxygenase homologue. J Biol Chem 266:12866-72. 
223. Kwong, A. D., and N. Frenkel. 1987. Herpes simplex virus-infected cells contain a function(s) that 
destabilizes both host and viral mRNAs. Proc Natl Acad Sci U S A 84:1926-30. 
224. Laan, M. P., M. R. Baert, A. M. Bijl, A. E. Vredendaal, F. B. De Waard-van der Spek, A. P. Oranje, H. 
F. Savelkoul, and H. J. Neijens. 2000. Markers for early sensitization and inflammation in relation to 
clinical manifestations of atopic disease up to 2 years of age in 133 high-risk children. Clin Exp Allergy 
30:944-53. 
225. Labbe, M., P. Baudoux, A. Charpilienne, D. Poncet, and J. Cohen. 1994. Identification of the nucleic 
acid binding domain of the rotavirus VP2 protein. J Gen Virol 75 ( Pt 12):3423-30. 
226. LaMonica, R., S. S. Kocer, J. Nazarova, W. Dowling, E. Geimonen, R. D. Shaw, and E. R. Mackow. 
2001. VP4 differentially regulates TRAF2 signaling, disengaging JNK activation while directing NF-
kappa B to effect rotavirus-specific cellular responses. J Biol Chem 276:19889-96. 
227. Larralde, G., and M. Gorziglia. 1992. Distribution of conserved and specific epitopes on the VP8 subunit 
of rotavirus VP4. J Virol 66:7438-43. 
228. Laurie, G. W., C. P. Leblond, and G. R. Martin. 1982. Localization of type IV collagen, laminin, heparan 
sulfate proteoglycan, and fibronectin to the basal lamina of basement membranes. J Cell Biol 95:340-4. 
229. Le, P. U., and I. R. Nabi. 2003. Distinct caveolae-mediated endocytic pathways target the Golgi 
apparatus and the endoplasmic reticulum. J Cell Sci 116:1059-71. 
230. Leivo, I., T. Tani, L. Laitinen, R. Bruns, E. Kivilaakso, V. P. Lehto, R. E. Burgeson, and I. Virtanen. 
1996. Anchoring complex components laminin-5 and type VII collagen in intestine: association with 
migrating and differentiating enterocytes. J Histochem Cytochem 44:1267-77. 
231. Lewis, H. M., J. V. Parry, H. A. Davies, R. P. Parry, A. Mott, R. R. Dourmashkin, P. J. Sanderson, D. A. 
Tyrrell, and H. B. Valman. 1979. A year's experience of the rotavirus syndrome and its association with 
respiratory illness. Arch Dis Child 54:339-46. 
232. Li, J. D., W. Feng, M. Gallup, J. H. Kim, J. Gum, Y. Kim, and C. Basbaum. 1998. Activation of NF-
kappaB via a Src-dependent Ras-MAPK-pp90rsk pathway is required for Pseudomonas aeruginosa-
induced mucin overproduction in epithelial cells. Proc Natl Acad Sci U S A 95:5718-23. 
233. Lindenbergh-Kortleve, D. J., R. R. Rosato, J. W. van Neck, J. Nauta, M. van Kleffens, C. Groffen, E. C. 
Zwarthoff, and S. L. Drop. 1997. Gene expression of the insulin-like growth factor system during mouse 
kidney development. Mol Cell Endocrinol 132:81-91. 
234. Lishko, V. K., V. P. Yakubenko, and T. P. Ugarova. 2003. The interplay between integrins alphaMbeta2 
and alpha5beta1 during cell migration to fibronectin. Exp Cell Res 283:116-26. 
235. Little, E., P. Bork, and R. F. Doolittle. 1994. Tracing the spread of fibronectin type III domains in 
bacterial glycohydrolases. J Mol Evol 39:631-43. 
236. Little, L. M., and J. A. Shadduck. 1982. Pathogenesis of rotavirus infection in mice. Infect Immun 
38:755-63. 
237. Liu, M., N. M. Mattion, and M. K. Estes. 1992. Rotavirus VP3 expressed in insect cells possesses 
guanylyltransferase activity. Virology 188:77-84. 
238. Londhe, V., N. McNamara, H. Lemjabbar, and C. Basbaum. 2003. Viral dsRNA activates mucin 
transcription in airway epithelial cells. FEBS Lett 553:33-8. 
References   147 
 
239. Longman, R. J., J. Douthwaite, P. A. Sylvester, D. O'Leary, B. F. Warren, A. P. Corfield, and M. G. 
Thomas. 2000. Lack of mucin MUC5AC field change expression associated with tubulovillous and 
villous colorectal adenomas. J Clin Pathol 53:100-4. 
240. Lopez, S., and C. F. Arias. 2004. Multistep entry of rotavirus into cells: a Versaillesque dance. Trends 
Microbiol 12:271-8. 
241. Lopez, S., C. F. Arias, J. R. Bell, J. H. Strauss, and R. T. Espejo. 1985. Primary structure of the cleavage 
site associated with trypsin enhancement of rotavirus SA11 infectivity. Virology 144:11-9. 
242. Losonsky, G. A., J. P. Johnson, J. A. Winkelstein, and R. H. Yolken. 1985. Oral administration of human 
serum immunoglobulin in immunodeficient patients with viral gastroenteritis. A pharmacokinetic and 
functional analysis. J Clin Invest 76:2362-7. 
243. Lu, W., K. Miyazaki, H. Mizushima, and N. Nemoto. 2001. Immunohistochemical distribution of 
laminin-5 gamma2 chain and its developmental change in human embryonic and foetal tissues. 
Histochem J 33:629-37. 
244. Lu, Y., M. Wambach, M. G. Katze, and R. M. Krug. 1995. Binding of the influenza virus NS1 protein to 
double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the elF-2 
translation initiation factor. Virology 214:222-8. 
245. Ludert, J. E., A. A. Krishnaney, J. W. Burns, P. T. Vo, and H. B. Greenberg. 1996. Cleavage of rotavirus 
VP4 in vivo. J Gen Virol 77 ( Pt 3):391-5. 
246. Lundgren, O., A. T. Peregrin, K. Persson, S. Kordasti, I. Uhnoo, and L. Svensson. 2000. Role of the 
enteric nervous system in the fluid and electrolyte secretion of rotavirus diarrhea. Science 287:491-5. 
247. Lundgren, O., and L. Svensson. 2001. Pathogenesis of rotavirus diarrhea. Microbes Infect 3:1145-56. 
248. Lynch, M., B. Lee, P. Azimi, J. Gentsch, C. Glaser, S. Gilliam, H. G. Chang, R. Ward, and R. I. Glass. 
2001. Rotavirus and central nervous system symptoms: cause or contaminant? Case reports and review. 
Clin Infect Dis 33:932-8. 
249. Maass, D. R., and P. H. Atkinson. 1990. Rotavirus proteins VP7, NS28, and VP4 form oligomeric 
structures. J Virol 64:2632-41. 
250. Mack, D. R., and P. M. Sherman. 1991. Mucin isolated from rabbit colon inhibits in vitro binding of 
Escherichia coli RDEC-1. Infect Immun 59:1015-23. 
251. Majerowicz, S., C. F. Kubelka, P. Stephens, and O. M. Barth. 1994. Ultrastructural study on 
experimental infection of rotavirus in a murine heterologous model. Mem Inst Oswaldo Cruz 89:395-
402. 
252. Makkink, M. K., N. M. Schwerbrock, M. Mahler, J. A. Boshuizen, I. B. Renes, M. Cornberg, H. J. 
Hedrich, A. W. Einerhand, H. A. Buller, S. Wagner, M. L. Enss, and J. Dekker. 2002. Fate of goblet cells 
in experimental colitis. Dig Dis Sci 47:2286-97. 
253. Marchisio, P. C., O. Cremona, P. Savoia, G. Pellegrini, J. P. Ortonne, P. Verrando, R. E. Burgeson, R. 
Cancedda, and M. De Luca. 1993. The basement membrane protein BM-600/nicein codistributes with 
kalinin and the integrin alpha 6 beta 4 in human cultured keratinocytes. Exp Cell Res 205:205-12. 
254. Marquet, F., D. Pansu, and M. Descroix-Vagne. 1999. Distant intestinal stimulation by cholera toxin in 
rat in vivo. Eur J Pharmacol 374:103-11. 
255. Mashimo, H., D. C. Wu, D. K. Podolsky, and M. C. Fishman. 1996. Impaired defense of intestinal 
mucosa in mice lacking intestinal trefoil factor. Science 274:262-5. 
256. Mason, B. B., D. Y. Graham, and M. K. Estes. 1980. In vitro transcription and translation of simian 
rotavirus SA11 gene products. J Virol 33:1111-21. 
257. Mathan, M. M., G. Chandy, and V. I. Mathan. 1995. Ultrastructural changes in the upper small intestinal 
mucosa in patients with cholera. Gastroenterology 109:422-30. 
258. Mathews, M. B., and T. Shenk. 1991. Adenovirus virus-associated RNA and translation control. J Virol 
65:5657-62. 
259. Matricardi, P. M., F. Rosmini, V. Panetta, L. Ferrigno, and S. Bonini. 2002. Hay fever and asthma in 
relation to markers of infection in the United States. J Allergy Clin Immunol 110:381-7. 
260. Matricardi, P. M., F. Rosmini, S. Riondino, M. Fortini, L. Ferrigno, M. Rapicetta, and S. Bonini. 2000. 
Exposure to foodborne and orofecal microbes versus airborne viruses in relation to atopy and allergic 
asthma: epidemiological study. Bmj 320:412-7. 
261. Mattion, N. M., J. Cohen, C. Aponte, and M. K. Estes. 1992. Characterization of an oligomerization 
domain and RNA-binding properties on rotavirus nonstructural protein NS34. Virology 190:68-83. 
262. Mattion, N. M., J. Cohen, and M. K. Estes. 1994. The rotavirus proteins, p. 169-249. In A. Z. Kapikian 
(ed.), Viral Infections of the Gastrointestinal Tract. Marcel Dekker, New York. 
148   
 
263. Mattion, N. M., J. Cohen, and M. K. Estes. 1994. Viral infections of the gastrointestinal tract, p. 169-249. 
In A. Z. Kapikian (ed.). Marcel Dekker, New York. 
264. Mattion, N. M., D. B. Mitchell, G. W. Both, and M. K. Estes. 1991. Expression of rotavirus proteins 
encoded by alternative open reading frames of genome segment 11. Virology 181:295-304. 
265. McClung, H. J., D. G. Butler, B. Kerzner, D. G. Gall, and J. R. Hamilton. 1976. Transmissible 
gastroenteritis. Mucosal ion transport in acute viral enteritis. Gastroenterology 70:1091-5. 
266. McNeal, M. M., K. S. Barone, M. N. Rae, and R. L. Ward. 1995. Effector functions of antibody and 
CD8+ cells in resolution of rotavirus infection and protection against reinfection in mice. Virology 
214:387-97. 
267. McNeal, M. M., R. L. Broome, and R. L. Ward. 1994. Active immunity against rotavirus infection in 
mice is correlated with viral replication and titers of serum rotavirus IgA following vaccination. Virology 
204:642-50. 
268. Mebus, C. A., M. Kono, N. R. Underdahl, and M. J. Twiehaus. 1971. Cell culture propagation of 
neonatal calf diarrhea (scours) virus. Can Vet J 12:69-72. 
269. Medicine, I. o. 1986. New vaccine development:establishing priorities. In Diseases of importance in 
developing countries. Natl. Acad. Press, Washington DC. 
270. Merchant, A. A., W. S. Groene, E. H. Cheng, and R. D. Shaw. 1991. Murine intestinal antibody response 
to heterologous rotavirus infection. J Clin Microbiol 29:1693-701. 
271. Meyer, J. C., C. C. Bergmann, and A. R. Bellamy. 1989. Interaction of rotavirus cores with the 
nonstructural glycoprotein NS28. Virology 171:98-107. 
272. Michel, Y. M., D. Poncet, M. Piron, K. M. Kean, and A. M. Borman. 2000. Cap-Poly(A) synergy in 
mammalian cell-free extracts. Investigation of the requirements for poly(A)-mediated stimulation of 
translation initiation. J Biol Chem 275:32268-76. 
273. Mirazimi, A., M. Nilsson, and L. Svensson. 1998. The molecular chaperone calnexin interacts with the 
NSP4 enterotoxin of rotavirus in vivo and in vitro. J Virol 72:8705-9. 
274. Mohri, H., J. Tanabe, K. Katoh, and T. Okubo. 1996. Identification of a novel binding site to the integrin 
alphaIIbbeta3 located in the C-terminal heparin-binding domain of human plasma fibronectin. J Biol 
Chem 271:15724-8. 
275. Moon, A., and R. E. Kleinman. 1995. Allergic gastroenteropathy in children. Ann Allergy Asthma 
Immunol 74:5-12. 
276. Mori, Y., M. A. Borgan, N. Ito, M. Sugiyama, and N. Minamoto. 2002. Diarrhea-inducing activity of 
avian rotavirus NSP4 glycoproteins, which differ greatly from mammalian rotavirus NSP4 glycoproteins 
in deduced amino acid sequence in suckling mice. J Virol 76:5829-34. 
277. Mori, Y., M. A. Borgan, M. Takayama, N. Ito, M. Sugiyama, and N. Minamoto. 2003. Roles of outer 
capsid proteins as determinants of pathogenicity and host range restriction of avian rotaviruses in a 
suckling mouse model. Virology 316:126-34. 
278. Morris, A. P. 1999. The regulation of the epithelial cell cAMP-and calcium-dependent chloride channels. 
Adv Pharmacol 46:209-251. 
279. Morris, A. P., and M. K. Estes. 2001. Microbes and microbial toxins: paradigms for microbial-mucosal 
interactions. VIII. Pathological consequences of rotavirus infection and its enterotoxin. Am J Physiol 
Gastrointest Liver Physiol 281:G303-10. 
280. Morris, A. P., J. K. Scott, J. M. Ball, C. Q. Zeng, W. K. O'Neal, and M. K. Estes. 1999. NSP4 elicits age-
dependent diarrhea and Ca(2+)mediated I(-) influx into intestinal crypts of CF mice. Am J Physiol 
277:G431-44. 
281. Mosesson, M. W., K. R. Siebenlist, and D. A. Meh. 2001. The structure and biological features of 
fibrinogen and fibrin. Ann N Y Acad Sci 936:11-30. 
282. Mossel, E. C., and R. F. Ramig. 2003. A lymphatic mechanism of rotavirus extraintestinal spread in the 
neonatal mouse. J Virol 77:12352-6. 
283. Mota-Hernandez, F., J. J. Calva, C. Gutierrez-Camacho, S. Villa-Contreras, C. F. Arias, L. Padilla-
Noriega, H. Guiscafre-Gallardo, M. de Lourdes Guerrero, S. Lopez, O. Munoz, J. F. Contreras, R. 
Cedillo, I. Herrera, and F. I. Puerto. 2003. Rotavirus diarrhea severity is related to the VP4 type in 
Mexican children. J Clin Microbiol 41:3158-62. 
284. Mould, A. P., A. Komoriya, K. M. Yamada, and M. J. Humphries. 1991. The CS5 peptide is a second 
site in the IIICS region of fibronectin recognized by the integrin alpha 4 beta 1. Inhibition of alpha 4 beta 
1 function by RGD peptide homologues. J Biol Chem 266:3579-85. 
285. Munro, S., and H. R. Pelham. 1987. A C-terminal signal prevents secretion of luminal ER proteins. Cell 
48:899-907. 
References   149 
 
286. Murakami, M., K. Nakashima, D. Kamei, S. Masuda, Y. Ishikawa, T. Ishii, Y. Ohmiya, K. Watanabe, 
and I. Kudo. 2003. Cellular prostaglandin E2 production by membrane-bound prostaglandin E synthase-2 
via both cyclooxygenases-1 and -2. J Biol Chem 278:37937-47. 
287. Murphy, T. V., P. M. Gargiullo, M. S. Massoudi, D. B. Nelson, A. O. Jumaan, C. A. Okoro, L. R. 
Zanardi, S. Setia, E. Fair, C. W. LeBaron, M. Wharton, J. R. Livengood, and J. R. Livingood. 2001. 
Intussusception among infants given an oral rotavirus vaccine. N Engl J Med 344:564-72. 
288. Nakajima, H., T. Nakagomi, T. Kamisawa, N. Sakaki, K. Muramoto, T. Mikami, H. Nara, and O. 
Nakagomi. 2001. Winter seasonality and rotavirus diarrhoea in adults. Lancet 357:1950. 
289. Newburg, D. S., J. A. Peterson, G. M. Ruiz-Palacios, D. O. Matson, A. L. Morrow, J. Shults, M. L. 
Guerrero, P. Chaturvedi, S. O. Newburg, C. D. Scallan, M. R. Taylor, R. L. Ceriani, and L. K. Pickering. 
1998. Role of human-milk lactadherin in protection against symptomatic rotavirus infection. Lancet 
351:1160-4. 
290. Newton, K., J. C. Meyer, A. R. Bellamy, and J. A. Taylor. 1997. Rotavirus nonstructural glycoprotein 
NSP4 alters plasma membrane permeability in mammalian cells. J Virol 71:9458-65. 
291. Nibert, M. L., D. B. Furlong, and B. N. Fields. 1991. Mechanisms of viral pathogenesis. Distinct forms 
of reoviruses and their roles during replication in cells and host. J Clin Invest 88:727-34. 
292. Niessen, C. M., F. Hogervorst, L. H. Jaspars, A. A. de Melker, G. O. Delwel, E. H. Hulsman, I. 
Kuikman, and A. Sonnenberg. 1994. The alpha 6 beta 4 integrin is a receptor for both laminin and 
kalinin. Exp Cell Res 211:360-7. 
293. Nieuw Amerongen, A. V., J. G. Bolscher, E. Bloemena, and E. C. Veerman. 1998. Sulfomucins in the 
human body. Biol Chem 379:1-18. 
294. Nishimura, S., H. Ushijima, H. Shiraishi, C. Kanazawa, T. Abe, K. Kaneko, and Y. Fukuyama. 1993. 
Detection of rotavirus in cerebrospinal fluid and blood of patients with convulsions and gastroenteritis by 
means of the reverse transcription polymerase chain reaction. Brain Dev 15:457-9. 
295. Niv, Y., J. C. Byrd, S. B. Ho, R. Dahiya, and Y. S. Kim. 1992. Mucin synthesis and secretion in relation 
to spontaneous differentiation of colon cancer cells in vitro. Int J Cancer 50:147-52. 
296. Obert, G., I. Peiffer, and A. L. Servin. 2000. Rotavirus-induced structural and functional alterations in 
tight junctions of polarized intestinal Caco-2 cell monolayers. J Virol 74:4645-51. 
297. O'Brien, J. A., J. A. Taylor, and A. R. Bellamy. 2000. Probing the structure of rotavirus NSP4: a short 
sequence at the extreme C terminus mediates binding to the inner capsid particle. J Virol 74:5388-94. 
298. Offit, P. A. 1996. Host factors associated with protection against rotavirus disease: the skies are clearing. 
J Infect Dis 174 Suppl 1:S59-64. 
299. Offit, P. A. 1994. Immunologic determinants of protection against rotavirus disease. Curr Top Microbiol 
Immunol 185:229-54. 
300. Offit, P. A., G. Blavat, H. B. Greenberg, and H. F. Clark. 1986. Molecular basis of rotavirus virulence: 
role of gene segment 4. J Virol 57:46-9. 
301. Offit, P. A., D. B. Boyle, G. W. Both, N. L. Hill, Y. M. Svoboda, S. L. Cunningham, R. J. Jenkins, and 
M. A. McCrae. 1991. Outer capsid glycoprotein vp7 is recognized by cross-reactive, rotavirus-specific, 
cytotoxic T lymphocytes. Virology 184:563-8. 
302. Offit, P. A., H. F. Clark, M. J. Kornstein, and S. A. Plotkin. 1984. A murine model for oral infection with 
a primate rotavirus (simian SA11). J Virol 51:233-6. 
303. Oishi, I., T. Kimura, T. Murakami, K. Haruki, K. Yamazaki, Y. Seto, Y. Minekawa, and H. Funamoto. 
1991. Serial observations of chronic rotavirus infection in an immunodeficient child. Microbiol Immunol 
35:953-61. 
304. Okada, J., N. Kobayashi, K. Taniguchi, and S. Urasawa. 1999. Analysis on reassortment of rotavirus 
NSP1 genes lacking coding region for cysteine-rich zinc finger motif. Arch Virol 144:345-53. 
305. O'Neal, C. M., G. R. Harriman, and M. E. Conner. 2000. Protection of the villus epithelial cells of the 
small intestine from rotavirus infection does not require immunoglobulin A. J Virol 74:4102-9. 
306. Osborne, M. P., S. J. Haddon, A. J. Spencer, J. Collins, W. G. Starkey, T. S. Wallis, G. J. Clarke, K. J. 
Worton, D. C. Candy, and J. Stephen. 1988. An electron microscopic investigation of time-related 
changes in the intestine of neonatal mice infected with murine rotavirus. J Pediatr Gastroenterol Nutr 
7:236-48. 
307. Osborne, M. P., S. J. Haddon, K. J. Worton, A. J. Spencer, W. G. Starkey, D. Thornber, and J. Stephen. 
1991. Rotavirus-induced changes in the microcirculation of intestinal villi of neonatal mice in relation to 
the induction and persistence of diarrhea. J Pediatr Gastroenterol Nutr 12:111-20. 
150   
 
308. Owens, J. R., R. Broadhead, R. G. Hendrickse, O. P. Jaswal, and R. N. Gangal. 1981. Loperamide in the 
treatment of acute gastroenteritis in early childhood. Report of a two centre, double-blind, controlled 
clinical trial. Ann Trop Paediatr 1:135-41. 
309. Padilla-Noriega, L., S. J. Dunn, S. Lopez, H. B. Greenberg, and C. F. Arias. 1995. Identification of two 
independent neutralization domains on the VP4 trypsin cleavage products VP5* and VP8* of human 
rotavirus ST3. Virology 206:148-54. 
310. Pang, X. L., J. Joensuu, and T. Vesikari. 1996. Detection of rotavirus RNA in cerebrospinal fluid in a 
case of rotavirus gastroenteritis with febrile seizures. Pediatr Infect Dis J 15:543-5. 
311. Pankov, R., and K. M. Yamada. 2002. Fibronectin at a glance. J Cell Sci 115:3861-3. 
312. Parashar, U. D., J. S. Bresee, J. R. Gentsch, and R. I. Glass. 1998. Rotavirus. Emerg Infect Dis 4:561-70. 
313. Parashar, U. D., E. G. Hummelman, J. S. Bresee, M. A. Miller, and R. I. Glass. 2003. Global illness and 
deaths caused by rotavirus disease in children. Emerg Infect Dis 9:565-72. 
314. Patel, R. S., E. Odermatt, J. E. Schwarzbauer, and R. O. Hynes. 1987. Organization of the fibronectin 
gene provides evidence for exon shuffling during evolution. Embo J 6:2565-72. 
315. Patton, J. T. 1996. Rotavirus VP1 alone specifically binds to the 3' end of viral mRNA, but the 
interaction is not sufficient to initiate minus-strand synthesis. J Virol 70:7940-7. 
316. Patton, J. T., M. T. Jones, A. N. Kalbach, Y. W. He, and J. Xiaobo. 1997. Rotavirus RNA polymerase 
requires the core shell protein to synthesize the double-stranded RNA genome. J Virol 71:9618-26. 
317. Patton, J. T., and E. Spencer. 2000. Genome replication and packaging of segmented double-stranded 
RNA viruses. Virology 277:217-25. 
318. Pediatrics, A. A. o. 2003. Rotavirus infections, p. 536. In L. K. Pickering (ed.), Red book 2003 report of 
Committee on Infectious Diseases, vol. 26. American Academy of Pediatrics, Elk Grove Village. 
319. Peigue-Lafeuille, H., C. Henquell, M. Chambon, N. Gazuy, C. De Champs, and R. Cluzel. 1991. 
Nosocomial rotavirus infections in adult renal transplant recipients. J Hosp Infect 18:67-70. 
320. Peregrin, A. T., H. Ahlman, M. Jodal, and O. Lundgren. 1999. Involvement of serotonin and calcium 
channels in the intestinal fluid secretion evoked by bile salt and cholera toxin. Br J Pharmacol 127:887-
94. 
321. Perez-Schael, I., M. J. Guntinas, M. Perez, V. Pagone, A. M. Rojas, R. Gonzalez, W. Cunto, Y. Hoshino, 
and A. Z. Kapikian. 1997. Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and 
young children in Venezuela. N Engl J Med 337:1181-7. 
322. Perreault, N., P. H. Vachon, and J. F. Beaulieu. 1995. Appearance and distribution of laminin A chain 
isoforms and integrin alpha 2, alpha 3, alpha 6, beta 1, and beta 4 subunits in the developing human small 
intestinal mucosa. Anat Rec 242:242-50. 
323. Peterson, J. A., C. D. Scallan, R. L. Ceriani, and M. Hamosh. 2001. Structural and functional aspects of 
three major glycoproteins of the human milk fat globule membrane. Adv Exp Med Biol 501:179-87. 
324. Petrie, B. L., M. K. Estes, and D. Y. Graham. 1983. Effects of tunicamycin on rotavirus morphogenesis 
and infectivity. J Virol 46:270-4. 
325. Piron, M., T. Delaunay, J. Grosclaude, and D. Poncet. 1999. Identification of the RNA-binding, 
dimerization, and eIF4GI-binding domains of rotavirus nonstructural protein NSP3. J Virol 73:5411-21. 
326. Piron, M., P. Vende, J. Cohen, and D. Poncet. 1998. Rotavirus RNA-binding protein NSP3 interacts with 
eIF4GI and evicts the poly(A) binding protein from eIF4F. Embo J 17:5811-21. 
327. Pizarro, J. L., A. M. Sandino, J. M. Pizarro, J. Fernandez, and E. Spencer. 1991. Characterization of 
rotavirus guanylyltransferase activity associated with polypeptide VP3. J Gen Virol 72 ( Pt 2):325-32. 
328. Pizarro, J. M., J. L. Pizarro, J. Fernandez, A. M. Sandino, and E. Spencer. 1991. Effect of nucleotide 
analogues on rotavirus transcription and replication. Virology 184:768-72. 
329. Plow, E. F., T. A. Haas, L. Zhang, J. Loftus, and J. W. Smith. 2000. Ligand binding to integrins. J Biol 
Chem 275:21785-8. 
330. Poncet, D., C. Aponte, and J. Cohen. 1993. Rotavirus protein NSP3 (NS34) is bound to the 3' end 
consensus sequence of viral mRNAs in infected cells. J Virol 67:3159-65. 
331. Poncet, D., S. Laurent, and J. Cohen. 1994. Four nucleotides are the minimal requirement for RNA 
recognition by rotavirus non-structural protein NSP3. Embo J 13:4165-73. 
332. Poncet, D., P. Lindenbaum, R. L'Haridon, and J. Cohen. 1997. In vivo and in vitro phosphorylation of 
rotavirus NSP5 correlates with its localization in viroplasms. J Virol 71:34-41. 
333. Poruchynsky, M. S., and P. H. Atkinson. 1988. Primary sequence domains required for the retention of 
rotavirus VP7 in the endoplasmic reticulum. J Cell Biol 107:1697-706. 
334. Poruchynsky, M. S., and P. H. Atkinson. 1991. Rotavirus protein rearrangements in purified membrane-
enveloped intermediate particles. J Virol 65:4720-7. 
References   151 
 
335. Poruchynsky, M. S., D. R. Maass, and P. H. Atkinson. 1991. Calcium depletion blocks the maturation of 
rotavirus by altering the oligomerization of virus-encoded proteins in the ER. J Cell Biol 114:651-6. 
336. Poruchynsky, M. S., C. Tyndall, G. W. Both, F. Sato, A. R. Bellamy, and P. H. Atkinson. 1985. 
Deletions into an NH2-terminal hydrophobic domain result in secretion of rotavirus VP7, a resident 
endoplasmic reticulum membrane glycoprotein. J Cell Biol 101:2199-209. 
337. Prasad, B. V., J. W. Burns, E. Marietta, M. K. Estes, and W. Chiu. 1990. Localization of VP4 
neutralization sites in rotavirus by three-dimensional cryo-electron microscopy. Nature 343:476-9. 
338. Prasad, B. V., R. Rothnagel, C. Q. Zeng, J. Jakana, J. A. Lawton, W. Chiu, and M. K. Estes. 1996. 
Visualization of ordered genomic RNA and localization of transcriptional complexes in rotavirus. Nature 
382:471-3. 
339. Quaroni, A., and K. J. Isselbacher. 1985. Study of intestinal cell differentiation with monoclonal 
antibodies to intestinal cell surface components. Dev Biol 111:267-79. 
340. Quaroni, A., K. J. Isselbacher, and E. Ruoslahti. 1978. Fibronectin synthesis by epithelial crypt cells of 
rat small intestine. Proc Natl Acad Sci U S A 75:5548-52. 
341. Ramig, R. F. 1988. The effects of host age, virus dose, and virus strain on heterologous rotavirus 
infection of suckling mice. Microb Pathog 4:189-202. 
342. Ramig, R. F. 2004. Pathogenesis of intestinal and systemic rotavirus infection. Journal of Virology In 
Press. 
343. Ramirez, C. V., C. Vilela, K. Berthelot, and J. E. McCarthy. 2002. Modulation of eukaryotic mRNA 
stability via the cap-binding translation complex eIF4F. J Mol Biol 318:951-62. 
344. Rao, G. G. 1995. Control of outbreaks of viral diarrhoea in hospitals--a practical approach. J Hosp Infect 
30:1-6. 
345. Renes, I. B., J. A. Boshuizen, D. J. Van Nispen, N. P. Bulsing, H. A. Buller, J. Dekker, and A. W. 
Einerhand. 2002. Alterations in Muc2 biosynthesis and secretion during dextran sulfate sodium-induced 
colitis. Am J Physiol Gastrointest Liver Physiol 282:G382-9. 
346. Renes, I. B., M. Verburg, N. P. Bulsing, S. Ferdinandusse, H. A. Buller, J. Dekker, and A. W. Einerhand. 
2002. Protection of the Peyer's patch-associated crypt and villus epithelium against methotrexate-induced 
damage is based on its distinct regulation of proliferation. J Pathol 198:60-8. 
347. Reynolds, D. J., G. A. Hall, T. G. Debney, and K. R. Parsons. 1985. Pathology of natural rotavirus 
infection in clinically normal calves. Res Vet Sci 38:264-9. 
348. Rhoads, J. M., E. O. Keku, J. Quinn, J. Woosely, and J. G. Lecce. 1991. L-glutamine stimulates jejunal 
sodium and chloride absorption in pig rotavirus enteritis. Gastroenterology 100:683-91. 
349. Rhoads, J. M., R. J. MacLeod, and J. R. Hamilton. 1986. Alanine enhances jejunal sodium absorption in 
the presence of glucose: studies in piglet viral diarrhea. Pediatr Res 20:879-83. 
350. Rhoads, J. M., R. J. MacLeod, and J. R. Hamilton. 1989. Diminished brush border membrane Na-
dependent L-alanine transport in acute viral enteritis in piglets. J Pediatr Gastroenterol Nutr 9:225-31. 
351. Rijke, R. P., W. R. Hanson, H. M. Plaisier, and J. W. Osborne. 1976. The effect of ischemic villus cell 
damage on crypt cell proliferation in the small intestine: evidence for a feedback control mechanism. 
Gastroenterology 71:786-92. 
352. Robertson, A. M., and D. P. Wright. 1997. Bacterial glycosulphatases and sulphomucin degradation. Can 
J Gastroenterol 11:361-6. 
353. Robinson, J. W., V. Mirkovitch, B. Winistorfer, and F. Saegesser. 1981. Response of the intestinal 
mucosa to ischaemia. Gut 22:512-27. 
354. Rodriguez, W. J., H. W. Kim, J. O. Arrobio, C. D. Brandt, R. M. Chanock, A. Z. Kapikian, R. G. Wyatt, 
and R. H. Parrott. 1977. Clinical features of acute gastroenteritis associated with human reovirus-like 
agent in infants and young children. J Pediatr 91:188-93. 
355. Rollo, E. E., K. P. Kumar, N. C. Reich, J. Cohen, J. Angel, H. B. Greenberg, R. Sheth, J. Anderson, B. 
Oh, S. J. Hempson, E. R. Mackow, and R. D. Shaw. 1999. The epithelial cell response to rotavirus 
infection. J Immunol 163:4442-52. 
356. Rolsma, M. D., T. B. Kuhlenschmidt, H. B. Gelberg, and M. S. Kuhlenschmidt. 1998. Structure and 
function of a ganglioside receptor for porcine rotavirus. J Virol 72:9079-91. 
357. Rose, J., M. A. Franco, and H. B. Greenberg. 1998. The immunology of rotavirus infection in the mouse. 
Adv Virus Res 51:203-235. 
358. Rossen, J. W., J. Bouma, R. H. Raatgeep, H. A. Buller, and A. W. Einerhand. 2004. Inhibition of 
cyclooxygenase activity reduces rotavirus infection at a postbinding step. J Virol 78:9721-30. 
152   
 
359. Roth, K. A., J. M. Hertz, and J. I. Gordon. 1990. Mapping enteroendocrine cell populations in transgenic 
mice reveals an unexpected degree of complexity in cellular differentiation within the gastrointestinal 
tract. J Cell Biol 110:1791-801. 
360. Rothenberg, M. E., A. Mishra, M. H. Collins, and P. E. Putnam. 2001. Pathogenesis and clinical features 
of eosinophilic esophagitis. J Allergy Clin Immunol 108:891-4. 
361. Ruegg, C., A. A. Postigo, E. E. Sikorski, E. C. Butcher, R. Pytela, and D. J. Erle. 1992. Role of integrin 
alpha 4 beta 7/alpha 4 beta P in lymphocyte adherence to fibronectin and VCAM-1 and in homotypic cell 
clustering. J Cell Biol 117:179-89. 
362. Ruggeri, F. M., and H. B. Greenberg. 1991. Antibodies to the trypsin cleavage peptide VP8 neutralize 
rotavirus by inhibiting binding of virions to target cells in culture. J Virol 65:2211-9. 
363. Ruiz, M. C., M. J. Abad, A. Charpilienne, J. Cohen, and F. Michelangeli. 1997. Cell lines susceptible to 
infection are permeabilized by cleaved and solubilized outer layer proteins of rotavirus. J Gen Virol 78 ( 
Pt 11):2883-93. 
364. Ruiz, M. C., S. R. Alonso-Torre, A. Charpilienne, M. Vasseur, F. Michelangeli, J. Cohen, and F. 
Alvarado. 1994. Rotavirus interaction with isolated membrane vesicles. J Virol 68:4009-16. 
365. Sachs, A. B. 2000. Physical and functional interactions between th mRNA cap structure and the poly(A) 
tail, p. 447-465. In N. Sonenberg, J. W. B. Hershey, and M. B. Mathews (ed.), Translational control of 
gene expression. Cold Spring Harbor Press, New York. 
366. Sachs, A. B., and G. Varani. 2000. Eukaryotic translation initiation: there are (at least) two sides to every 
story. Nat Struct Biol 7:356-61. 
367. Saif, L. J., B. I. Rosen, and A. V. Parwani. 1994. Animal Rotaviruses, p. 279-367. In A. Z. Kapikian 
(ed.), Viral Infections of the Gastrointestinal tract. Marcel Dekker, New York. 
368. Salazar-Lindo, E., J. Santisteban-Ponce, E. Chea-Woo, and M. Gutierrez. 2000. Racecadotril in the 
treatment of acute watery diarrhea in children. N Engl J Med 343:463-7. 
369. Salim, A. F., A. D. Phillips, and M. J. Farthing. 1990. Pathogenesis of gut virus infection. Baillieres Clin 
Gastroenterol 4:593-607. 
370. Salim, A. F., A. D. Phillips, J. A. Walker-Smith, and M. J. Farthing. 1995. Sequential changes in small 
intestinal structure and function during rotavirus infection in neonatal rats. Gut 36:231-8. 
371. Sanchez-San Martin, C., T. Lopez, C. F. Arias, and S. Lopez. 2004. Characterization of rotavirus cell 
entry. J Virol 78:2310-8. 
372. Sandino, A. M., M. Jashes, G. Faundez, and E. Spencer. 1986. Role of the inner protein capsid on in vitro 
human rotavirus transcription. J Virol 60:797-802. 
373. Sapin, C., O. Colard, O. Delmas, C. Tessier, M. Breton, V. Enouf, S. Chwetzoff, J. Ouanich, J. Cohen, C. 
Wolf, and G. Trugnan. 2002. Rafts promote assembly and atypical targeting of a nonenveloped virus, 
rotavirus, in Caco-2 cells. J Virol 76:4591-602. 
374. Sasaki, S., Y. Horie, T. Nakagomi, M. Oseto, and O. Nakagomi. 2001. Group C rotavirus NSP4 induces 
diarrhea in neonatal mice. Arch Virol 146:801-6. 
375. Sato, E., T. Uezato, M. Fujita, and K. Nishimura. 1982. Developmental profiles of glycolipids in mouse 
small intestine. J Biochem (Tokyo) 91:2013-9. 
376. Sattar, S. A., N. Lloyd-Evans, V. S. Springthorpe, and R. C. Nair. 1986. Institutional outbreaks of 
rotavirus diarrhoea: potential role of fomites and environmental surfaces as vehicles for virus 
transmission. J Hyg (Lond) 96:277-89. 
377. Saulsbury, F. T., J. A. Winkelstein, and R. H. Yolken. 1980. Chronic rotavirus infection in 
immunodeficiency. J Pediatr 97:61-5. 
378. Saxena, S. K., J. S. Thompson, D. A. Crouse, and J. G. Sharp. 1991. Epithelial cell proliferation and 
uptake of radiolabeled urogastrone in the intestinal tissues following abdominal irradiation in the mouse. 
Radiat Res 128:37-42. 
379. Schiestl, R. H., and R. D. Gietz. 1989. High efficiency transformation of intact yeast cells using single 
stranded nucleic acids as a carrier. Curr Genet 16:339-46. 
380. Schwartz, M. A. 2001. Integrin signaling revisited. Trends Cell Biol 11:466-70. 
381. Shahrabadi, M. S., and P. W. Lee. 1986. Bovine rotavirus maturation is a calcium-dependent process. 
Virology 152:298-307. 
382. Shaoul, R., Y. Okada, E. Cutz, and M. A. Marcon. 2004. Colonic expression of MUC2, MUC5AC, and 
TFF1 in inflammatory bowel disease in children. J Pediatr Gastroenterol Nutr 38:488-93. 
383. Sharma, A., J. A. Askari, M. J. Humphries, E. Y. Jones, and D. I. Stuart. 1999. Crystal structure of a 
heparin- and integrin-binding segment of human fibronectin. Embo J 18:1468-79. 
References   153 
 
384. Sharma, R., M. L. Hudak, B. R. Premachandra, G. Stevens, C. B. Monteiro, J. A. Bradshaw, A. M. 
Kaunitz, and R. A. Hollister. 2002. Clinical manifestations of rotavirus infection in the neonatal intensive 
care unit. Pediatr Infect Dis J 21:1099-105. 
385. Shaw, R. D., and S. J. Hempson. 1996. Replication as a determinant of the intestinal response to 
rotavirus. J Infect Dis 174:1328-31. 
386. Sheahan, D. G., and H. R. Jervis. 1976. Comparative histochemistry of gastrointestinal mucosubstances. 
Am J Anat 146:103-31. 
387. Shekels, L. L., D. A. Hunninghake, A. S. Tisdale, I. K. Gipson, M. Kieliszewski, C. A. Kozak, and S. B. 
Ho. 1998. Cloning and characterization of mouse intestinal MUC3 mucin: 3' sequence contains 
epidermal-growth-factor-like domains. Biochem J 330 ( Pt 3):1301-8. 
388. Shekels, L. L., C. Lyftogt, M. Kieliszewski, J. D. Filie, C. A. Kozak, and S. B. Ho. 1995. Mouse gastric 
mucin: cloning and chromosomal localization. Biochem J 311 ( Pt 3):775-85. 
389. Shepherd, R. W., D. G. Butler, E. Cutz, D. G. Gall, and J. R. Hamilton. 1979. The mucosal lesion in viral 
enteritis. Extent and dynamics of the epithelial response to virus invasion in transmissible gastroenteritis 
of piglets. Gastroenterology 76:770-7. 
390. Shepherd, R. W., D. G. Gall, D. G. Butler, and J. R. Hamilton. 1979. Determinants of diarrhea in viral 
enteritis. The role of ion transport and epithelial changes in the ileum in transmissible gastroenteritis in 
piglets. Gastroenterology 76:20-4. 
391. Sherman, M. P., and K. L. Cox. 1982. Neonatal eosinophilic colitis. J Pediatr 100:587-9. 
392. Shornikova, A. V., I. A. Casas, H. Mykkanen, E. Salo, and T. Vesikari. 1997. Bacteriotherapy with 
Lactobacillus reuteri in rotavirus gastroenteritis. Pediatr Infect Dis J 16:1103-7. 
393. Shukry, S., A. M. Zaki, H. L. DuPont, I. Shoukry, M. el Tagi, and Z. Hamed. 1986. Detection of 
enteropathogens in fatal and potentially fatal diarrhea in Cairo, Egypt. J Clin Microbiol 24:959-62. 
394. Simon, T. C., K. A. Roth, and J. I. Gordon. 1993. Use of transgenic mice to map cis-acting elements in 
the liver fatty acid-binding protein gene (Fabpl) that regulate its cell lineage- specific, differentiation-
dependent, and spatial patterns of expression in the gut epithelium and in the liver acinus. J Biol Chem 
268:18345-58. 
395. Simon-Assmann, P., O. Lefebvre, A. Bellissent-Waydelich, J. Olsen, V. Orian-Rousseau, and A. De 
Arcangelis. 1998. The laminins: role in intestinal morphogenesis and differentiation. Ann N Y Acad Sci 
859:46-64. 
396. Singer, II, D. W. Kawka, S. Schloemann, T. Tessner, T. Riehl, and W. F. Stenson. 1998. Cyclooxygenase 
2 is induced in colonic epithelial cells in inflammatory bowel disease. Gastroenterology 115:297-306. 
397. Smirnova, M. G., J. P. Birchall, and J. P. Pearson. 2000. TNF-alpha in the regulation of MUC5AC 
secretion: some aspects of cytokine-induced mucin hypersecretion on the in vitro model. Cytokine 
12:1732-6. 
398. Snodgrass, D. R., K. W. Angus, and E. W. Gray. 1977. Rotavirus infection in lambs: pathogenesis and 
pathology. Arch Virol 55:263-74. 
399. Snodgrass, D. R., A. Ferguson, F. Allan, K. W. Angus, and B. Mitchell. 1979. Small intestinal 
morphology and epithelial cell kinetics in lamb rotavirus infections. Gastroenterology 76:477-81. 
400. Soriano-Brucher, H., P. Avendano, M. O'Ryan, S. D. Braun, M. D. Manhart, T. K. Balm, and H. A. 
Soriano. 1991. Bismuth subsalicylate in the treatment of acute diarrhea in children: a clinical study. 
Pediatrics 87:18-27. 
401. Starkey, W. G., J. Collins, D. C. Candy, A. J. Spencer, M. P. Osborne, and J. Stephen. 1990. Transport of 
water and electrolytes by rotavirus-infected mouse intestine: a time course study. J Pediatr Gastroenterol 
Nutr 11:254-60. 
402. Starkey, W. G., J. Collins, T. S. Wallis, G. J. Clarke, A. J. Spencer, S. J. Haddon, M. P. Osborne, D. C. 
Candy, and J. Stephen. 1986. Kinetics, tissue specificity and pathological changes in murine rotavirus 
infection of mice. J Gen Virol 67:2625-34. 
403. Steer, S. A., and J. A. Corbett. 2003. The role and regulation of COX-2 during viral infection. Viral 
Immunol 16:447-60. 
404. Steer, S. A., J. M. Moran, L. B. Maggi, Jr., R. M. Buller, H. Perlman, and J. A. Corbett. 2003. Regulation 
of cyclooxygenase-2 expression by macrophages in response to double-stranded RNA and viral 
infection. J Immunol 170:1070-6. 
405. Stintzing, G., K. Johansen, K. E. Magnusson, L. Svensson, and T. Sundqvist. 1986. Intestinal 
permeability in small children during and after rotavirus diarrhoea assessed with different-size 
polyethyleneglycols (PEG 400 and PEG 1000). Acta Paediatr Scand 75:1005-9. 
406. Strachan, D. P. 1989. Hay fever, hygiene, and household size. Bmj 299:1259-60. 
154   
 
407. Strous, G. J., and J. Dekker. 1992. Mucin-type glycoproteins. Crit Rev Biochem Mol Biol 27:57-92. 
408. Suemori, S., K. Lynch-Devaney, and D. K. Podolsky. 1991. Identification and characterization of rat 
intestinal trefoil factor: tissue- and cell-specific member of the trefoil protein family. Proc Natl Acad Sci 
U S A 88:11017-21. 
409. Superti, F., M. G. Ammendolia, A. Tinari, B. Bucci, A. M. Giammarioli, G. Rainaldi, R. Rivabene, and 
G. Donelli. 1996. Induction of apoptosis in HT-29 cells infected with SA-11 rotavirus. J Med Virol 
50:325-34. 
410. Superti, F., and G. Donelli. 1991. Gangliosides as binding sites in SA-11 rotavirus infection of LLC-
MK2 cells. J Gen Virol 72 ( Pt 10):2467-74. 
411. Tafazoli, F., C. Q. Zeng, M. K. Estes, K. E. Magnusson, and L. Svensson. 2001. NSP4 enterotoxin of 
rotavirus induces paracellular leakage in polarized epithelial cells. J Virol 75:1540-6. 
412. Taraporewala, Z., D. Chen, and J. T. Patton. 1999. Multimers formed by the rotavirus nonstructural 
protein NSP2 bind to RNA and have nucleoside triphosphatase activity. J Virol 73:9934-43. 
413. Targan, S. R., and L. K. Murphy. 1995. Clarifying the causes of Crohn's. Nat Med 1:1241-3. 
414. Taylor, J. A., J. C. Meyer, M. A. Legge, J. A. O'Brien, J. E. Street, V. J. Lord, C. C. Bergmann, and A. R. 
Bellamy. 1992. Transient expression and mutational analysis of the rotavirus intracellular receptor: the 
C-terminal methionine residue is essential for ligand binding. J Virol 66:3566-72. 
415. Taylor, J. A., J. A. O'Brien, V. J. Lord, J. C. Meyer, and A. R. Bellamy. 1993. The RER-localized 
rotavirus intracellular receptor: a truncated purified soluble form is multivalent and binds virus particles. 
Virology 194:807-14. 
416. Taylor, J. A., J. A. O'Brien, and M. Yeager. 1996. The cytoplasmic tail of NSP4, the endoplasmic 
reticulum-localized non-structural glycoprotein of rotavirus, contains distinct virus binding and coiled 
coil domains. Embo J 15:4469-76. 
417. Telch, J., R. W. Shepherd, D. G. Butler, M. Perdue, J. R. Hamilton, and D. G. Gall. 1981. Intestinal 
glucose transport in acute viral enteritis in piglets. Clin Sci (Lond) 61:29-34. 
418. Teller, I. C., and J. F. Beaulieu. 2001. Interactions between laminin and epithelial cells in intestinal 
health and disease. Expert Rev Mol Med 2001:1-18. 
419. Thim, L. 1997. Trefoil peptides: from structure to function. Cell Mol Life Sci 53:888-903. 
420. Tian, P., J. M. Ball, C. Q. Zeng, and M. K. Estes. 1996. The rotavirus nonstructural glycoprotein NSP4 
possesses membrane destabilization activity. J Virol 70:6973-81. 
421. Tian, P., M. K. Estes, Y. Hu, J. M. Ball, C. Q. Zeng, and W. P. Schilling. 1995. The rotavirus 
nonstructural glycoprotein NSP4 mobilizes Ca2+ from the endoplasmic reticulum. J Virol 69:5763-72. 
422. Timpl, R., and J. C. Brown. 1996. Supramolecular assembly of basement membranes. Bioessays 18:123-
32. 
423. Torpier, G., J. F. Colombel, C. Mathieu-Chandelier, M. Capron, J. P. Dessaint, A. Cortot, J. C. Paris, and 
A. Capron. 1988. Eosinophilic gastroenteritis: ultrastructural evidence for a selective release of 
eosinophil major basic protein. Clin Exp Immunol 74:404-8. 
424. Torres-Vega, M. A., R. A. Gonzalez, M. Duarte, D. Poncet, S. Lopez, and C. F. Arias. 2000. The C-
terminal domain of rotavirus NSP5 is essential for its multimerization, hyperphosphorylation and 
interaction with NSP6. J Gen Virol 81:821-30. 
425. Tosser, G., T. Delaunay, E. Kohli, J. Grosclaude, P. Pothier, and J. Cohen. 1994. Topology of bovine 
rotavirus (RF strain) VP6 epitopes by real-time biospecific interaction analysis. Virology 204:8-16. 
426. Tytgat, K. M., H. A. Buller, F. J. Opdam, Y. S. Kim, A. W. Einerhand, and J. Dekker. 1994. Biosynthesis 
of human colonic mucin: Muc2 is the prominent secretory mucin. Gastroenterology 107:1352-63. 
427. Tytgat, K. M., J. W. van der Wal, A. W. Einerhand, H. A. Buller, and J. Dekker. 1995. Muc2 in 
ulcerative colitis: a quantitative study. Biochem Soc Trans 23:531S. 
428. Ugarova, T. P., and V. P. Yakubenko. 2001. Recognition of fibrinogen by leukocyte integrins. Ann N Y 
Acad Sci 936:368-85. 
429. Uhnoo, I., T. Dharakul, M. Riepenhoff-Talty, and P. L. Ogra. 1988. Immunological aspects of interaction 
between rotavirus and the intestine in infancy. Immunol Cell Biol 66:135-45. 
430. Uhnoo, I., M. Riepenhoff-Talty, T. Dharakul, P. Chegas, J. E. Fisher, H. B. Greenberg, and P. L. Ogra. 
1990. Extramucosal spread and development of hepatitis in immunodeficient and normal mice infected 
with rhesus rotavirus. J Virol 64:361-8. 
431. Ushijima, H., K. Q. Xin, S. Nishimura, S. Morikawa, and T. Abe. 1994. Detection and sequencing of 
rotavirus VP7 gene from human materials (stools, sera, cerebrospinal fluids, and throat swabs) by reverse 
transcription and PCR. J Clin Microbiol 32:2893-7. 
References   155 
 
432. Utani, A., M. Nomizu, R. Timpl, P. P. Roller, and Y. Yamada. 1994. Laminin chain assembly. Specific 
sequences at the C terminus of the long arm are required for the formation of specific double- and triple-
stranded coiled-coil structures. J Biol Chem 269:19167-75. 
433. Valenzuela, S., J. Pizarro, A. M. Sandino, M. Vasquez, J. Fernandez, O. Hernandez, J. Patton, and E. 
Spencer. 1991. Photoaffinity labeling of rotavirus VP1 with 8-azido-ATP: identification of the viral RNA 
polymerase. J Virol 65:3964-7. 
434. Van Beers, E. H., H. A. Buller, R. J. Grand, A. W. Einerhand, and J. Dekker. 1995. Intestinal brush 
border glycohydrolases: structure, function, and development. Crit Rev Biochem Mol Biol 30:197-262. 
435. Van De Bovenkamp, J. H., A. M. Korteland-Van Male, H. A. Buller, A. W. Einerhand, and J. Dekker. 
2003. Metaplasia of the duodenum shows a Helicobacter pylori-correlated differentiation into gastric-
type protein expression. Hum Pathol 34:156-65. 
436. Van De Bovenkamp, J. H., A. M. Korteland-Van Male, C. Warson, H. A. Buller, A. W. Einerhand, N. L. 
Ectors, and J. Dekker. 2003. Gastric-type mucin and TFF-peptide expression in Barrett's oesophagus is 
disturbed during increased expression of MUC2. Histopathology 42:555-65. 
437. Van den Brink, G. R., K. M. Tytgat, R. W. Van der Hulst, C. M. Van der Loos, A. W. Einerhand, H. A. 
Buller, and J. Dekker. 2000. H pylori colocalises with MUC5AC in the human stomach. Gut 46:601-7. 
438. Van Klinken, B. J., J. Dekker, H. A. Buller, and A. W. Einerhand. 1995. Mucin gene structure and 
expression: protection vs. adhesion. Am J Physiol 269:G613-27. 
439. van Klinken, B. J., J. Dekker, S. A. van Gool, J. van Marle, H. A. Buller, and A. W. Einerhand. 1998. 
MUC5B is the prominent mucin in human gallbladder and is also expressed in a subset of colonic goblet 
cells. Am J Physiol 274:G871-8. 
440. van Klinken, B. J., A. W. Einerhand, L. A. Duits, M. K. Makkink, K. M. Tytgat, I. B. Renes, M. 
Verburg, H. A. Buller, and J. Dekker. 1999. Gastrointestinal expression and partial cDNA cloning of 
murine Muc2. Am J Physiol 276:G115-24. 
441. van Klinken, B. J., E. Oussoren, J. J. Weenink, G. J. Strous, H. A. Buller, J. Dekker, and A. W. 
Einerhand. 1996. The human intestinal cell lines Caco-2 and LS174T as models to study cell-type 
specific mucin expression. Glycoconj J 13:757-68. 
442. Van Klinken, B. J., J. W. Van der Wal, A. W. Einerhand, H. A. Buller, and J. Dekker. 1999. Sulphation 
and secretion of the predominant secretory human colonic mucin MUC2 in ulcerative colitis. Gut 
44:387-93. 
443. Van Seuningen, I., P. Pigny, M. Perrais, N. Porchet, and J. P. Aubert. 2001. Transcriptional regulation of 
the 11p15 mucin genes. Towards new biological tools in human therapy, in inflammatory diseases and 
cancer? Front Biosci 6:D1216-34. 
444. Velazquez, F. R., D. O. Matson, J. J. Calva, L. Guerrero, A. L. Morrow, S. Carter-Campbell, R. I. Glass, 
M. K. Estes, L. K. Pickering, and G. M. Ruiz-Palacios. 1996. Rotavirus infections in infants as protection 
against subsequent infections. N Engl J Med 335:1022-8. 
445. Vende, P., M. Piron, N. Castagne, and D. Poncet. 2000. Efficient translation of rotavirus mRNA requires 
simultaneous interaction of NSP3 with the eukaryotic translation initiation factor eIF4G and the mRNA 
3' end. J Virol 74:7064-71. 
446. Verburg, M., I. B. Renes, H. P. Meijer, J. A. Taminiau, H. A. Buller, A. W. Einerhand, and J. Dekker. 
2000. Selective sparing of goblet cells and paneth cells in the intestine of methotrexate-treated rats. Am J 
Physiol Gastrointest Liver Physiol 279:G1037-47. 
447. Verburg, M., I. B. Renes, D. J. Van Nispen, S. Ferdinandusse, M. Jorritsma, H. A. Buller, A. W. 
Einerhand, and J. Dekker. 2002. Specific responses in rat small intestinal epithelial mRNA expression 
and protein levels during chemotherapeutic damage and regeneration. J Histochem Cytochem 50:1525-
36. 
448. Vesikari, T., T. Rautanen, T. Varis, G. M. Beards, and A. Z. Kapikian. 1990. Rhesus Rotavirus candidate 
vaccine. Clinical trial in children vaccinated between 2 and 5 months of age. Am J Dis Child 144:285-9. 
449. Vollet, J. J., C. D. Ericsson, G. Gibson, L. K. Pickering, H. L. DuPont, S. Kohl, and R. H. Conklin. 1979. 
Human rotavirus in an adult population with travelers' diarrhea and its relationship to the location of food 
consumption. J Med Virol 4:81-7. 
450. Walsh, R. E., and T. S. Gaginella. 1991. The eosinophil in inflammatory bowel disease. Scand J 
Gastroenterol 26:1217-24. 
451. Ward, L. A., B. I. Rosen, L. Yuan, and L. J. Saif. 1996. Pathogenesis of an attenuated and a virulent 
strain of group A human rotavirus in neonatal gnotobiotic pigs. J Gen Virol 77 ( Pt 7):1431-41. 
452. Ward, R. L. 2003. Possible mechanisms of protection elicited by candidate rotavirus vaccines as 
determined with the adult mouse model. Viral Immunol 16:17-24. 
156   
 
453. Ward, R. L., M. M. McNeal, and J. F. Sheridan. 1990. Development of an adult mouse model for studies 
on protection against rotavirus. J Virol 64:5070-5. 
454. Welch, S. K., S. E. Crawford, and M. K. Estes. 1989. Rotavirus SA11 genome segment 11 protein is a 
nonstructural phosphoprotein. J Virol 63:3974-82. 
455. Westerwoudt, R. J., A. M. Naipal, and C. M. Harrisson. 1984. Improved fusion technique. II. Stability 
and purity of hybrid clones. J Immunol Methods 68:89-101. 
456. Whitfeld, P. L., C. Tyndall, S. C. Stirzaker, A. R. Bellamy, and G. W. Both. 1987. Location of sequences 
within rotavirus SA11 glycoprotein VP7 which direct it to the endoplasmic reticulum. Mol Cell Biol 
7:2491-7. 
457. Wilde, J., R. Yolken, R. Willoughby, and J. Eiden. 1991. Improved detection of rotavirus shedding by 
polymerase chain reaction. Lancet 337:323-6. 
458. Willemsen, L. E., M. A. Koetsier, S. J. van Deventer, and E. A. van Tol. 2003. Short chain fatty acids 
stimulate epithelial mucin 2 expression through differential effects on prostaglandin E(1) and E(2) 
production by intestinal myofibroblasts. Gut 52:1442-7. 
459. Willoughby, R. E., and R. H. Yolken. 1990. SA11 rotavirus is specifically inhibited by an acetylated 
sialic acid. J Infect Dis 161:116-9. 
460. Wong, W. M., R. Poulsom, and N. A. Wright. 1999. Trefoil peptides. Gut 44:890-5. 
461. Wood, D. J., T. J. David, I. L. Chrystie, and B. Totterdell. 1988. Chronic enteric virus infection in two T-
cell immunodeficient children. J Med Virol 24:435-44. 
462. Woods, A., R. L. Longley, S. Tumova, and J. R. Couchman. 2000. Syndecan-4 binding to the high 
affinity heparin-binding domain of fibronectin drives focal adhesion formation in fibroblasts. Arch 
Biochem Biophys 374:66-72. 
463. Xiao, H., C. Neuveut, M. Benkirane, and K. T. Jeang. 1998. Interaction of the second coding exon of Tat 
with human EF-1 delta delineates a mechanism for HIV-1-mediated shut-off of host mRNA translation. 
Biochem Biophys Res Commun 244:384-9. 
464. Xu, A., A. R. Bellamy, and J. A. Taylor. 1998. BiP (GRP78) and endoplasmin (GRP94) are induced 
following rotavirus infection and bind transiently to an endoplasmic reticulum-localized virion 
component. J Virol 72:9865-72. 
465. Xu, A., A. R. Bellamy, and J. A. Taylor. 2000. Immobilization of the early secretory pathway by a virus 
glycoprotein that binds to microtubules. Embo J 19:6465-74. 
466. Yamashiro, Y., T. Shimizu, S. Oguchi, and M. Sato. 1989. Prostaglandins in the plasma and stool of 
children with rotavirus gastroenteritis. J Pediatr Gastroenterol Nutr 9:322-7. 
467. Yeager, M., J. A. Berriman, T. S. Baker, and A. R. Bellamy. 1994. Three-dimensional structure of the 
rotavirus haemagglutinin VP4 by cryo-electron microscopy and difference map analysis. Embo J 
13:1011-8. 
468. Yolken, R., S. Arango-Jaramillo, J. Eiden, and S. Vonderfecht. 1988. Lack of genomic reassortment 
following infection of infant rats with group A and group B rotaviruses. J Infect Dis 158:1120-3. 
469. Yolken, R., and J. Wilde. 1994. Assays for detecting human rotavirus, p. 251-278. In A. Z. Kapikian 
(ed.), Viral infections of the gastrointestinal tract, 2 ed. Marcel Dekker, New York. 
470. Yolken, R. H., C. A. Bishop, T. R. Townsend, E. A. Bolyard, J. Bartlett, G. W. Santos, and R. Saral. 
1982. Infectious gastroenteritis in bone-marrow-transplant recipients. N Engl J Med 306:1010-2. 
471. Yolken, R. H., C. Ojeh, I. A. Khatri, U. Sajjan, and J. F. Forstner. 1994. Intestinal mucins inhibit 
rotavirus replication in an oligosaccharide-dependent manner. J Infect Dis 169:1002-6. 
472. Yolken, R. H., R. Willoughby, S. B. Wee, R. Miskuff, and S. Vonderfecht. 1987. Sialic acid 
glycoproteins inhibit in vitro and in vivo replication of rotaviruses. J Clin Invest 79:148-54. 
473. Yolken, R. H., R. G. Wyatt, G. Zissis, C. D. Brandt, W. J. Rodriguez, H. W. Kim, R. H. Parrott, J. J. 
Urrutia, L. Mata, H. B. Greenberg, A. Z. Kapikian, and R. M. Chanock. 1978. Epidemiology of human 
rotavirus Types 1 and 2 as studied by enzyme-linked immunosorbent assay. N Engl J Med 299:1156-61. 
474. Yoshida, A., T. Kawamitu, R. Tanaka, M. Okumura, S. Yamakura, Y. Takasaki, H. Hiramatsu, T. 
Momoi, M. Iizuka, and O. Nakagomi. 1995. Rotavirus encephalitis: detection of the virus genomic RNA 
in the cerebrospinal fluid of a child. Pediatr Infect Dis J 14:914-6. 
475. Yurchenco, P. D., and J. J. O'Rear. 1994. Basement membrane assembly. Methods Enzymol 245:489-
518. 
476. Zarate, S., M. A. Cuadras, R. Espinosa, P. Romero, K. O. Juarez, M. Camacho-Nuez, C. F. Arias, and S. 
Lopez. 2003. Interaction of rotaviruses with Hsc70 during cell entry is mediated by VP5. J Virol 
77:7254-60. 
References   157 
 
477. Zarate, S., P. Romero, R. Espinosa, C. F. Arias, and S. Lopez. 2004. VP7 Mediates the Interaction of 
Rotaviruses with Integrin {alpha}v{beta}3 through a Novel Integrin-Binding Site. J Virol 78:10839-
10847. 
478. Zeng, C. Q., M. K. Estes, A. Charpilienne, and J. Cohen. 1998. The N terminus of rotavirus VP2 is 
necessary for encapsidation of VP1 and VP3. J Virol 72:201-8. 
479. Zhang, M., C. Q. Zeng, Y. Dong, J. M. Ball, L. J. Saif, A. P. Morris, and M. K. Estes. 1998. Mutations in 
rotavirus nonstructural glycoprotein NSP4 are associated with altered virus virulence. J Virol 72:3666-
72. 
480. Zhang, M., C. Q. Zeng, A. P. Morris, and M. K. Estes. 2000. A functional NSP4 enterotoxin peptide 
secreted from rotavirus-infected cells. J Virol 74:11663-70. 
481. Zijlstra, R. T., B. A. McCracken, J. Odle, S. M. Donovan, H. B. Gelberg, B. W. Petschow, F. A. 
Zuckermann, and H. R. Gaskins. 1999. Malnutrition modifies pig small intestinal inflammatory 
responses to rotavirus. J Nutr 129:838-43. 
  
 
 Dankwoord 
  
& 
 
Curriculum 
  vitae 
 
160                                                                                      
 
Dankwoord 
 
Een proefschrift produceer je niet alleen en dat geld zeker ook voor dit proefschrift. Om het 
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Chapter 3, Figure 7. (page 166, top) The number of goblet cells containing sulfated mucins and acidic mucins 
during rotavirus infection. Using a combined AB-PAS staining, goblet cells in control tissue (A; at 4 dpi) stained 
pink, whereas goblet cells stained blue in the crypt region or dark purple on the villi in infected tissue (B; at 4 dpi). 
This phenomenon was observed from 1 to 4 dpi in all analyzed sections from infected animals. Using a combined 
HID-AB staining (C-E), goblet cells in control mice stained black/brown indicating that they contained sulfated 
mucins (C; at 7 dpi). In infected mice, goblet cells stained blue indicating that they predominantly contained 
sialomucin (D; at 7 dpi). During infection, the percentage of HID-stained goblet cells was significantly decreased at 
1 and 7 dpi (E). a P<.005, ‡ P<0.001 vs. control using Student’s t-test. 
 
Chapter 6, Figure 2. (page 166, bottom) NSP4 associates with the epithelial basement membrane in mouse 
jejunum during rotavirus infection in neonatal mice. Using the anti-NSP4 (114-135) rabbit polyclonal serum, NSP4 
protein was detected in epithelial cells at the tips of intestinal villi at 4 days post infection and at the epithelial BM 
of infected- and non-infected cells (A and C, arrowheads). Localization of NSP4 at the BM was not observed with 
pre-immune serum (B). NSP4 protein expression was not detected in control mice (D). An antibody that recognizes 
rotavirus structural proteins stained infected epithelial cells, but failed to stain the epithelial basement membranes 
(E). NSP4 could occasionally be detected in the BM of lower villus- and crypt cells (F, arrowhead). Panels A and B 
are cross-sectional slides, original magnification, X 400. Panels C to F are longitudinal slides, original 
magnification, X 200 (C to E) and X 600 (F). 
 
Chapter 3, Figure 3. (page 167) Goblet cell migration kinetics in the ileum during rotavirus infection. Just before 
inoculation, mice were injected with BrdU. Goblet cells in control (A-D) and infected mice (E-H) at 1 (A and E), 2 
(B and F), 4 (C and G), and 7 dpi (D and H) were detected by AB staining. From 1 to 7 dpi, BrdU-labeled 
enterocytes (arrows) in infected mice migrated faster up the villus than in control animals. In infected mice, goblet 
cells (solid arrowheads or open arrowheads when BrdU-labeled) tended to accumulate at the tips of the villi (E-H), 
whereas in control mice goblet cells appeared evenly distributed in the villus epithelium. 
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